<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<!-- Created by: EDGAR Online, Inc. EDGAR Filing HTML Converter, Version: 4.65, http://www.edgar-online.com -->
<TITLE> PALATIN TECHNOLOGIES INC (Form: 10-K, Received: 09/19/2016 16:23:49) </TITLE>
<META NAME="TABLES" CONTENT="FIS_FORM **FIS_PART_I **FIS_BUSINESS **FIS_RISK_FACTORS **FIS_PART_II **FIS_MARKET **FIS_MARKET_RISK **FIS_FINANCIAL_STATEMENTS **FIS_AUDITORS_OPINION **FIS_BALANCE_SHEET **FIS_INCOME_STATEMENT **FIS_STOCKHOLDERS_EQUITY **FIS_CASH_FLOW **FIS_NOTES_TO_FINANCIAL_STATEMENT **FIS_ACCOUNTING_CHANGES **FIS_CONTROL_AND_PROCEDURES **FIS_PART_III **FIS_DIRECTORS_AND_OFFICERS **FIS_NAME_AND_TITLE **FIS_NAME_AND_TITLE_2 **FIS_COMPENSATION_TABLE **FIS_OPTIONS_AGGREGATE **FIS_BENEFICIAL_OWNERS **FIS_BENEFICIAL_OWNERS_2 **FIS_PART_IV **FIS_EXHIBITS **FIS_SIGNATURES FIS_EXHIBIT_10 FIS_EXHIBIT_10_2 FIS_EXHIBIT_21 FIS_EXHIBIT_23 **FIS_EXPERTS_CONSENT FIS_EXHIBIT_31 FIS_EXHIBIT_31_2 FIS_EXHIBIT_32 **FIS_CERTIFICATION FIS_EXHIBIT_32_2 **FIS_CERTIFICATION_2 ">
<META NAME="DETECTED PAGES" CONTENT="136">
<STYLE TYPE="text/css">
<!--
	body          { background-color: white; color: black }
	.eolNewPage   { page-break-after: always; line-height: 0; height: 0; margin: 0; padding: 0 }
	.eolLeftAlign { text-align: left; margin-left: auto; margin-right: auto }
	.eolCenter    { text-align: center }
	a:link        { color: blue }
	a:active      { color: red }
	a:visited     { color: purple }
	
	@media print
	{
		@page           { margin: 0.25in }
		body            { font-size: 10pt }
		a               { text-decoration: none }
		thead           { display: table-header-group }
		tfoot           { display: table-footer-group }
		hr.eolPageBreak { display: none }
		.eolPrint50pt   { font-size: 5pt }
		.eolPrint55pt   { font-size: 5.5pt }
		.eolPrint60pt   { font-size: 6pt }
		.eolPrint65pt   { font-size: 6.5pt }
		.eolPrint70pt   { font-size: 7pt }
		.eolPrint75pt   { font-size: 7.5pt }
		.eolPrint80pt   { font-size: 8pt }
		.eolPrint85pt   { font-size: 8.5pt }
		.eolPrint90pt   { font-size: 9pt }
		.eolPrint95pt   { font-size: 9.5pt }
	}
-->
</STYLE>
</HEAD>
<BODY>
<A NAME="eolPage1"></A>
<A NAME="FIS_TOP_OF_DOCUMENT"></A>

<A NAME="PTN_10K_HTM"></A>
<EFX_FORM>
<A NAME="FIS_FORM"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 8PX; BORDER-TOP: 4PX SOLID #000000; BORDER-BOTTOM: 1PX SOLID #000000">
<!--STYLE HEADER-->
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-VARIANT: SMALL-CAPS; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	UNITED STATES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-VARIANT: SMALL-CAPS; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	SECURITIES AND EXCHANGE COMMISSION
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Washington,
	D.C. 20549
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	FORM
	10 - K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2611;
	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
	EXCHANGE ACT OF 1934
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For the
	fiscal year ended June 30, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	or
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2610;
	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
	EXCHANGE ACT OF 1934
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For the
	transition period from ___________ to __________
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Commission file
	number: 001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(Exact
	name of registrant as specified in its charter)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; MARGIN: 0PX AUTO 0PX 0PX;">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Delaware
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 1%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	95-4078884
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(State
	or other jurisdiction of&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	incorporation or
	organization)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 1%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(I.R.S.
	Employer Identification No.)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: CENTER; WIDTH: 50%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; MARGIN: 0PX AUTO;">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 30%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4B Cedar Brook Drive
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Cranbury, New Jersey
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 1%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	08512
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 30%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(Address
	of principal executive offices)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 1%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(Zip
	Code)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(609)
	495-2200
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(Registrant&#x2019;s
	telephone number, including area code)
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_2"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Securities
	registered pursuant to Section 12(b) of the Act:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: CENTER; WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; MARGIN: 0PX AUTO;">
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Title of Each Class
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 1%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Name of Each Exchange&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	on
	Which Registered
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
	Stock, par value $.01 per share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 1%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	NYSE
	MKT
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Securities
	registered pursuant to Section 12(g) of the Act: None
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Indicate by check
	mark if the registrant is a well-known seasoned issuer, as defined
	in Rule 405 of the Securities Act. Yes &#x2610; No
	&#x2611;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Indicate by check
	mark if the registrant is not required to file reports pursuant to
	Section 13 or Section 15(d) of the Act. Yes &#x2610; No
	&#x2611;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Indicate by check
	mark whether the registrant (1) has filed all reports required to
	be filed by Section 13 or 15(d) of the Securities Exchange Act of
	1934 during the preceding 12 months (or for such shorter period
	that the registrant was required to file such reports), and (2) has
	been subject to such filing requirements for the past 90
	days.
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Yes &#x2611; No
	&#x2610;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Indicate by check
	mark whether the registrant has submitted electronically and posted
	on its corporate Web site, if any, every Interactive Data File
	required to be submitted and posted pursuant to Rule 405 of
	Regulation S-T during the preceding 12 months (or for such shorter
	period that the registrant was required to submit and post such
	files).
<FONT STYLE="FONT-SIZE: 13PX">
	&#xA0;
</FONT>
	Yes&#xA0;
	&#x2611;&#xA0;&#xA0; No&#xA0; &#x2610;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Indicate by check
	mark if disclosure of delinquent filers pursuant to Item 405 of
	Regulation S-K is not contained herein, and will not be contained,
	to the best of the registrant&#x2019;s knowledge, in definitive
	proxy or information statements incorporated by reference in Part
	III of this Form 10-K or any amendment to this Form 10-K.
	&#x2610;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Indicate by check
	mark whether the registrant is a large accelerated filer, an
	accelerated filer, a non-accelerated filer, or a smaller reporting
	company. See the definitions of &#x201C;large accelerated
	filer,&#x201D; &#x201C;accelerated filer&#x201D; and &#x201C;smaller
	reporting company&#x201D; in Rule 12b-2 of the Exchange Act. (Check
	one):
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; MARGIN: 0 AUTO;WIDTH: 100%;">
<TR>
<TD STYLE="WIDTH: 25%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Large accelerated
	filer
</FONT>
</TD>
<TD STYLE="WIDTH: 25%">
	&#x2610;
</TD>
<TD STYLE="WIDTH: 25%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accelerated
	filer
</FONT>
</TD>
<TD STYLE="WIDTH: 25%">
	&#x2610;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 25%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Non-accelerated
	filer
</FONT>
</TD>
<TD STYLE="WIDTH: 25%">
	&#x2610;
</TD>
<TD STYLE="WIDTH: 25%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Smaller reporting
	company
</FONT>
</TD>
<TD STYLE="WIDTH: 25%">
	&#x2611;
</TD>
</TR>
<TR>
<TD STYLE="WIDTH: 25%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(Do not check if a smaller
	reporting company)
</FONT>
</FONT>
</TD>
<TD STYLE="WIDTH: 25%">
<DIV>
<FONT>
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 25%">
<DIV>
<FONT>
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 25%">
<DIV>
<FONT>
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<BR>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Indicate by check
	mark whether the registrant is a shell company (as defined in Rule
	12b-2 of the Exchange Act). Yes &#x2610; No &#x2611;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	State
	the aggregate market value of the voting and non-voting common
	equity held by non-affiliates, computed by reference to the price
	at which the common equity was last sold, or the average bid and
	asked price of such common equity, as of the last business day of
	the registrant&#x2019;s most recently completed second fiscal
	quarter (December 31, 2015): $44,069,665.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Indicate the number
	of shares outstanding of each of the registrant&#x2019;s classes of
	common stock, as of the latest practicable date (September 16,
	2016): 85,934,037.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 8PX; BORDER-TOP: 1PX SOLID #000000; BORDER-BOTTOM: 4PX SOLID #000000">
<!--STYLE FOOTER-->
<BR>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: RGB(255, 255, 255);">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage2"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	PALATIN TECHNOLOGIES, INC
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Table
	of Contents
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; MARGIN: 0PX AUTO 0PX 0PX;">
<TR>
<TD COLSPAN="2" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 92%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD COLSPAN="3" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PART
	I
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	1.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Business
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	1A.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Risk
	Factors
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	1B.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Unresolved Staff
	Comments
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	38
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	2.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Properties
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	38
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	3.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Legal
	Proceedings
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	38
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	4.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Mine
	Safety Disclosures
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	38
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD COLSPAN="3" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PART
	II
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	5.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Market
	for Registrant&#x2019;s Common Equity, Related Stockholder Matters
	and Issuer Purchases of Equity Securities
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	39
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	6.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Selected Financial
	Data
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	39
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	7.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Management&#x2019;s
	Discussion and Analysis of Financial Condition and Results of
	Operations
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	39
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	7A.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Quantitative and
	Qualitative Disclosures About Market Risk
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	43
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	8.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Financial
	Statements and Supplementary Data
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	44
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	9.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Changes
	in and Disagreements with Accountants on Accounting and Financial
	Disclosure
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	67
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	9A.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Controls and
	Procedures
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	67
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	9B.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	Information
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	67
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD COLSPAN="3" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD COLSPAN="3" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PART
	III
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD COLSPAN="3" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	10.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Directors,
	Executive Officers and Corporate Governance
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	68
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	11.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Executive
	Compensation
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	72
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	12.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 60PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -60PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Security Ownership
	of Certain Beneficial Owners and Management and Related Stockholder
	Matters
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	78
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	13.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certain
	Relationships and Related Transactions, and Director
	Independence
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	81
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	14.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Principal
	Accountant Fees and Services
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	81
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD COLSPAN="3" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD COLSPAN="3" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PART
	IV
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD COLSPAN="3" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	15.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 82%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Exhibits, Financial
	Statement Schedules
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 8%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	82
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<A NAME="PTN_10K_HTM_A001">
	&#xA0;
</A>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Forward-Looking
	Statements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Statements in this
	Annual Report on Form 10-K (this Annual Report), as well as oral
	statements that may be made by us or by our officers, directors, or
	employees acting on our behalf, that are not historical facts
	constitute &#x201C;forward-looking statements,&#x201D; which are made
	pursuant to the safe harbor provisions of Section 21E of the
	Securities Exchange Act of 1934, or the Exchange Act. The
	forward-looking statements in this Annual Report do not constitute
	guarantees of future performance. Investors are cautioned that
	statements that are not strictly historical facts contained in this
	Annual Report, including, without limitation, those relating to our
	current or future financial performance, management&#x2019;s plans
	and objectives for future operations, ability to raise capital or
	repay debt, if required, clinical trials and results, uncertainties
	associated with product research and development, product plans and
	performance, management&#x2019;s assessment of market factors, as
	well as statements regarding our strategy and plans and those of
	our strategic partners, constitute forward-looking statements. In
	some cases, you can identify forward-looking statements by
	terminology such as &#x201C;believe,&#x201D; will,&#x201D;
	&#x201C;may,&#x201D; &#x201C;estimate,&#x201D; &#x201C;continue,&#x201D;
	&#x201C;anticipated,&#x201D; &#x201C;intend,&#x201D;
	&#x201C;should,&#x201D; &#x201C;plan,&#x201D; &#x201C;expect,&#x201D;
	&#x201C;predict,&#x201D; &#x201C;could,&#x201D;
	&#x201C;potentially,&#x201D; or the negative of these terms or other
	similar expressions. Such forward-looking statements involve
	substantial risks, uncertainties and other factors that could cause
	our actual results to be materially different from our historical
	results or from any results expressed or implied by such
	forward-looking statements. Our future operating results are
	subject to risks and uncertainties and are dependent upon many
	factors, including, without limitation, the risks identified under
	the caption &#x201C;Risk Factors&#x201D; and elsewhere in this Annual
	Report, and any of those made in our other reports filed with the
	Securities and Exchange Commission, or the SEC. Except as required
	by law, we do not intend, and undertake no obligation, to publicly
	update forward-looking statements to reflect events or
	circumstances after the date of this document or to reflect the
	occurrence of unanticipated events.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In this
	Annual Report, references to &#x201C;we,&#x201D; &#x201C;our,&#x201D;
	&#x201C;us,&#x201D; the &#x201C;Company&#x201D; or
	&#x201C;Palatin&#x201D; means Palatin Technologies, Inc. and its
	subsidiary.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage3"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_PART_I>
<A NAME="FIS_PART_I"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PART
	I
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_BUSINESS>
<A NAME="FIS_BUSINESS"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	1. Business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Overview
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	a biopharmaceutical company developing targeted, receptor-specific
	peptide therapeutics for the treatment of diseases with significant
	unmet medical need and commercial potential. Our programs are based
	on molecules that modulate the activity of the melanocortin and
	natriuretic peptide receptor systems. Our primary product in
	clinical development is bremelanotide for the treatment of
	premenopausal women with hypoactive sexual desire disorder, or
	HSDD, which is a type of female sexual dysfunction, or FSD, defined
	as low desire with associated distress. In addition, we have drug
	candidates or development programs for obesity, erectile
	dysfunction, cardiovascular diseases, pulmonary diseases,
	inflammatory diseases and dermatologic diseases.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following drug development programs are actively under
	development:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Bremelanotide, an
	as needed subcutaneous injectable peptide melanocortin receptor
	agonist, for treatment of HSDD in premenopausal women.
	Bremelanotide, which is a melanocortin agonist, is a synthetic
	peptide analog of the naturally occurring hormone alpha-MSH
	(melanocyte-stimulating hormone). The novel mechanism of action
	involves activating endogenous melanocortin hormone pathways
	involved in sexual response. Bremelanotide has completed the
	efficacy portion of patient studies in the primary Phase 3 clinical
	studies;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Melanocortin
	receptor-4, or MC4r, compounds for treatment of obesity and
	diabetes. Results of our studies involving MC4r peptides suggest
	that certain of these peptides may have significant commercial
	potential for treatment of conditions responsive to MC4r
	activation, including FSD, HSDD, erectile dysfunction or ED,
	obesity and diabetes;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PL-3994, a
	natriuretic peptide receptor-A, or NPR-A, agonist, for treatment of
	cardiovascular and pulmonary indications. PL-3994 is our lead
	natriuretic peptide receptor product candidate, and is a synthetic
	mimetic of the neuropeptide hormone atrial natriuretic peptide, or
	ANP. PL-3994 is in development for treatment of heart failure,
	acute exacerbations of asthma and refractory hypertension;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Melanocortin
	receptor-1, or MC1r, agonist peptides for treatment of inflammatory
	and dermatologic disease indications. Our MC1r peptide drug
	candidates are highly specific, with substantially greater binding
	and efficacy at MC1r than at other melanocortin receptors. We have
	selected one of our MC1r peptide drug candidates, designated
	PL-8177, as a clinical trial candidate.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following chart illustrates the status of our drug development
	programs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<IMG SRC="http://content.edgar-online.com/edgar_conv_img/2016/09/19/0001654954-16-002272_PTN_10K000.JPG">
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage4"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	Strategy
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Key
	elements of our business strategy include:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Using our
	technology and expertise to develop and commercialize products in
	our active drug development programs;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Entering into
	strategic alliances and partnerships with pharmaceutical companies
	to facilitate the development, manufacture, marketing, sale and
	distribution of product candidates that we are
	developing;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Partially funding
	our product development programs with the cash flow generated from
	research collaboration and license agreements and any potential
	future agreements with third parties; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Completing
	development and seeking regulatory approval of bremelanotide for
	HSDD and our other product candidates.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	Melanocortin Receptor-Specific Programs
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	melanocortin system is involved in a large and diverse number of
	physiologic functions. Therapeutic agents modulating this system
	may have the potential to treat a variety of conditions and
	diseases, including sexual dysfunction, obesity and related
	disorders, pigmentation disorders and inflammation-related
	diseases.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Bremelanotide for HSDD.
</FONT>
	We are
	developing subcutaneously administered bremelanotide for the
	treatment of HSDD in premenopausal women. HSDD is characterized by
	a decrease in sexual desire with significant personal distress or
	interpersonal difficulty as a result of the lack of desire.
	Bremelanotide is a melanocortin agonist with a mechanism of action
	involving activation of endogenous neuronal pathways regulating
	sexual arousal and desire responses.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	initiated patient screening in our Phase 3 clinical study program
	of bremelanotide for the treatment of HSDD in premenopausal women,
	called the RECONNECT STUDY, in the fourth quarter of calendar 2014,
	completed patient enrollment in the fourth quarter of calendar
	2015, and completed the last patient visits in the double blind, or
	efficacy, portion of the studies in the third quarter of calendar
	2016. Topline results are projected early fourth quarter of
	calendar 2016. The open-label safety extension portion of the
	RECONNECT STUDY is continuing. We cannot assure you that the Phase
	3 efficacy data will support approval of bremelanotide for HSDD or
	that the U.S. Food and Drug Administration, or FDA, will approve a
	new drug application, or NDA, for bremelanotide.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Phase 3 Clinical Program.
</FONT>
	Prior to
	initiating our Phase 3 RECONNECT STUDY
<FONT STYLE="FONT-STYLE: ITALIC">
	&#xA0;
</FONT>
	clinical program, we reached
	preliminary agreement with the FDA on key aspects of the
	bremelanotide efficacy Phase 3 pivotal registration studies,
	including HSDD patient population, primary and key secondary
	efficacy endpoints, general study design, dose selection and safety
	monitoring. In addition, the FDA agreed that the Phase 2 data
	adequately characterized blood pressure and heart rate signals of
	bremelanotide. The FDA also agreed that the intranasal Definitive
	QTc study (an electrocardiographic evaluation), the carcinogenicity
	studies and the reproductive toxicity studies we conducted were
	acceptable for NDA submission.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	RECONNECT STUDY is being conducted in premenopausal women diagnosed
	with HSDD, either with or without arousal difficulties. HSDD is the
	single largest specific diagnosis in FSD. We enrolled a combined
	total of approximately 1,250 randomized subjects in the two pivotal
	efficacy studies, which are double blind placebo-controlled,
	randomized parallel group studies. Each study had two arms, one a
	1.75 mg bremelanotide dose and one a placebo. The double blind or
	efficacy portion of each study consisted of a 24-week treatment
	evaluation period, with primary and key secondary endpoints of
	satisfying sexual events, or SSEs, the Female Sexual Function
	Index, or FSFI, desire subdomain (a 28 day recall), and question 13
	of the Female Sexual Distress Scale-Desire/Arousal/Orgasm, or
	FSDS-DAO, questionnaire.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	last patient visits for efficacy portion of the RECONNECT STUDY
	were completed in the third quarter of calendar 2016. Patients in
	the efficacy portion of the RECONNECT STUDY had the option, after
	completion of the randomized portion of the study, to continue in
	an open-label safety extension study, in which all patients receive
	the 1.75 mg bremelanotide dose. The open-label safety extension
	study has enrolled approximately 680 patients. The open-label
	safety extension study will continue through the third quarter of
	calendar 2017, and the purpose of the extension study is to gather
	additional data on the safety of long-term and repeated use of
	bremelanotide.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	analysis of Phase 3 efficacy data is anticipated to be completed in
	the fourth quarter of calendar 2016. Assuming we believe that the
	Phase 3 data will support approval of bremelanotide for HSDD by
	FDA, we will conduct drug interaction and other ancillary studies,
	and certain chemistry, manufacturing and controls activities,
	required for FDA approval in the fourth quarter of calendar 2016
	and first half of calendar 2017. We anticipate submitting an NDA to
	FDA for approval of bremelanotide for HSDD in mid-calendar 2017. We
	cannot assure you that the Phase 3 data will support approval of
	bremelanotide for HSDD or that the FDA will approve an NDA for
	bremelanotide.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the
	RECONNECT STUDY patients self-administer bremelanotide with a
	single-use autoinjector pen. The bremelanotide single-use
	autoinjector pen, intended to be the commercial drug product, does
	not have a visible needle, is stored at room temperature and is
	easy to use. Women administer bremelanotide by pressing the
	autoinjector pen collar against either their thigh or abdomen, and
	the autoinjector pen automatically introduces the needle,
	administers the dose of bremelanotide under the skin and audibly
	signals when the drug has been delivered and the needle is
	retracted.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage5"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Phase 2B Clinical Study Results.
</FONT>
	The
	bremelanotide RECONNECT STUDY was predicated on the results of a
	Phase 2B clinical study of bremelanotide. The Phase 2B clinical
	study was a multicenter, placebo-controlled, randomized, parallel
	group, dose-finding trial testing three dose levels, 0.75 mg, 1.25
	mg and 1.75 mg, of subcutaneously administered bremelanotide
	against placebo in premenopausal women diagnosed with hypoactive
	sexual desire disorder, female sexual arousal disorder or both. The
	1.75 mg dose demonstrated clinically meaningful and statistically
	significant results for all predefined endpoints and was
	well-tolerated. Full data on the Phase 2B clinical study was
	presented at the March 2013 annual meeting of the International
	Society for the Study of Women&#x2019;s Sexual Health, and was
	published in
<FONT STYLE="FONT-STYLE: ITALIC">
	Women&#x2019;s
	Health
</FONT>
	, 12:3425-337 (2016).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Phase 2B clinical study enrolled 395 premenopausal women across 66
	sites within the United States and Canada, with patients randomized
	to one of three bremelanotide treatment arms and a placebo arm for
	16 weeks of treatment. The objective of the Phase 2B study was to
	measure safety and efficacy in premenopausal women with hypoactive
	sexual desire disorder, female sexual arousal disorder or both of
	bremelanotide compared to placebo. In the Phase 2B study,
	subcutaneous doses of bremelanotide and placebo were
	self-administered by the patient prior to a sexual encounter. The
	primary efficacy endpoint was change from baseline to end of study
	in the number of SSEs, with pre-specified analysis of pooled 1.25
	and 1.75 mg doses compared to placebo.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the
	Phase 2B clinical study, the primary endpoint data analysis of 327
	premenopausal women with hypoactive sexual desire disorder, female
	sexual arousal disorder or both showed statistically significant
	and clinically meaningful increases in the number of SSEs, and
	statistically significant and clinically meaningful improvement in
	secondary endpoint measures of overall sexual functioning and
	distress related to sexual dysfunction, for women taking
	bremelanotide compared to placebo. Satisfying sexual events were
	measured with an event log and overall sexual functioning and
	distress related to sexual dysfunction were measured using
	validated patient reported outcome measurement tools. Bremelanotide
	showed a statistically significant increase from baseline in the
	number of SSEs compared against placebo at both the 1.75 mg dose
	and pooled results of the 1.75 and 1.25 mg doses. The mean increase
	in SSEs at 1.75 mg dose levels was 0.8 SSEs per month, from 1.8 to
	2.6, with a p value of 0.021 against placebo. For the pooled doses,
	the mean increase in SSEs was 0.7 SSEs per month, from 1.6 to 2.4
	(a 50% increase), with a p value of 0.018 against placebo. By
	contrast, with placebo, the mean change from baseline was from 1.7
	to 1.9 (a 12% increase) in SSEs. The 0.75 mg dose demonstrated a
	response that was not significant different from
	placebo.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	mean change from baseline in a validated measurement tool of
	overall sexual functioning, the FSFI total score, was 4.4 at the
	1.75 mg dose level, compared to 1.88 for placebo, with a p value of
	0.0021 against placebo. For the pooled doses, the FSFI total score
	mean change from baseline was 3.55, compared to 1.88 for placebo,
	with a p value of 0.0017 against placebo. The FSFI is a 19-item
	questionnaire measuring improvement in arousal, desire and overall
	sexual function.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	mean change from baseline in a validated measurement tool of
	distress related to sexual dysfunction, the FSDS-DAO total score,
	was -13.1 at the 1.75 mg dose level, compared to -6.8 for placebo,
	with a p value of 0.0005 against placebo. For the pooled doses, the
	FSDS-DAO total score mean change from baseline was -11.1, compared
	to -6.8 for placebo, with a p value of 0.036 against placebo. The
	FSDS-DAO is a 15-item questionnaire that measures personal distress
	associated with HSDD.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A
	significantly higher percentage of women receiving the 1.75 mg
	bremelanotide dose &#x2013; 55% &#x2013; achieved a clinically
	meaningful change from baseline of at least one satisfying sexual
	event, compared to 37% of women receiving placebo. In addition,
	compared against placebo a significantly higher percentage of women
	also achieved a clinically meaningful improvement in sexual
	function, as measured by the FSFI (53% vs. 29%), and a clinically
	meaningful decrease in distress associated with sexual dysfunction
	as measured by the FSDS-DAO (69% vs. 45%).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Using a
	validated self-assessment questionnaire of treatment benefit, 79.5%
	of blinded patients receiving the 1.75 mg dose of bremelanotide
	reported they benefited from taking the drug, compared to 48.4% of
	blinded patients receiving placebo.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Bremelanotide was
	well-tolerated during the Phase 2B clinical study. The most common
	types of treatment-emergent adverse events reported more frequently
	in the bremelanotide arms were facial flushing, nausea, emesis and
	headache, which were mainly mild-to-moderate in severity. Adverse
	events that most commonly led to discontinuation were nausea and
	emesis, with less than 3% discontinuation due to an adverse event.
	Twenty-six patients, evenly distributed among placebo and active
	arms of the Phase 2B clinical study, met the predefined blood
	pressure withdrawal criteria. Drug treated patients had
	approximately a 2 mm Hg change in blood pressure, predominately
	during the first four hours following dosing. No serious adverse
	events were attributable to bremelanotide during the
	trial.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage6"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Medical Need &#x2014; HSDD.
</FONT>
	Hypoactive
	sexual desire disorder, either with or without arousal
	difficulties, is the largest single category of FSD. Female sexual
	dysfunction is a multifactorial condition that has anatomical,
	physiological, medical, psychological and social components, and is
	defined as persistent or recurring problems during one or more of
	the stages of sexual response with associated distress. HSDD has a
	significant impact on a patient&#x2019;s self-image, relationships
	and general well-being. The 2006 PRESIDE (Prevalence of Female
	Sexual Problems Associated with Distress and Determinants of
	Treatment Seeking) study, a cross-sectional, population-based
	survey of 31,581 female adult respondents in the United States
	published in 2008 in the journal
<FONT STYLE="FONT-STYLE: ITALIC">
	Obstetrics &amp; Gynecology
</FONT>
	, found that
	approximately 22% of women reported a sexual problem and 11% were
	women with HSDD. Based on the number of premenopausal women in the
	United States according to the U.S. Census, the presenting market
	size of premenopausal women with primary HSDD is at least 5.1
	million women.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Subcutaneous Bremelanotide.
</FONT>
	Bremelanotide, which is believed to act through activation of
	melanocortin receptors in the central nervous system, is a
	first-in-class pharmaceutical agent in development as a treatment
	of HSDD. Bremelanotide is intended for as needed use and is
	self-administered by the patient thirty minutes to one hour prior
	to anticipated sexual activity. We selected a simple and
	patient-friendly single-use autoinjector pen used in the RECONNECT
	STUDY and intended for commercialization of the bremelanotide drug
	product.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Partnering.
</FONT>
	In August 2014, we entered
	into a license agreement with Gedeon Richter to co-develop and
	commercialize bremelanotide for FSD in the European Union, other
	European countries and additional selected countries. We received
	&#x20AC;7.5 million ($9.8 million) in total upfront payments from
	Gedeon Richter, and a milestone payment of &#x20AC;2.5 million ($3.1
	million) upon the initiation of our Phase 3 clinical trial program
	in the United States. On September 16, 2015, we entered into a
	termination agreement pursuant to which we and Gedeon Richter
	agreed to mutually and amicably terminate the license agreement. In
	connection with this termination, all rights and licenses to
	co-develop and commercialize bremelanotide for FSD indications held
	by Gedeon Richter terminated and reverted back to us. Neither we
	nor Gedeon Richter have any future material obligations under the
	license agreement.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	worldwide rights for bremelanotide for FSD, HSDD and all other
	indications. We are in active discussions with potential partners
	for U.S. marketing and commercialization rights for bremelanotide
	for HSDD. We may not be able to enter into suitable agreements with
	potential partners on acceptable terms, if at all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Prior Clinical Trials.
</FONT>
	We have
	completed several Phase 1 clinical studies in which various safety
	parameters, including blood pressure effects of subcutaneously
	administered bremelanotide, were studied. Based in part on these
	studies, our Phase 2B clinical trial assessed the magnitude and
	duration of blood pressure effect, and determined that subcutaneous
	administration of selected doses of bremelanotide for treatment of
	HSDD in premenopausal women provides acceptable control of blood
	pressure effects. We have also completed clinical studies involving
	an alternative route of administration. Bremelanotide has been
	administered in 34 clinical studies involving about 3,000 subjects,
	including studies of premenopausal and postmenopausal women with
	HSDD and other forms of FSD and men with ED.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	MC1r Peptide Agonists.
</FONT>
	We have conducted
	preclinical animal studies with MC1r peptide drug candidates for
	inflammatory disease and autoimmune indications. The MC1r is
	upregulated in a number of diseases, including inflammatory bowel
	disease, nephritis, which is inflammation of the kidneys, and
	rheumatoid arthritis, and ocular indications such as uveitis and
	dry eye. We believe that MC1r peptides have broad anti-inflammatory
	effects and appear to utilize mechanisms engaged by the endogenous
	melanocortin system in regulation of the immune system and
	resolution of pro-inflammatory responses. MC1r peptides also have
	potential application in a number of dermatologic indications,
	including vitiligo and erythropoietic protoporphyria.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	MC1r peptide drug candidates are highly specific, with
	substantially greater binding and efficacy at MC1r than at other
	melanocortin receptors. In vitro safety studies have shown that our
	MC1r peptide drug candidates have no activity in a wide range of
	various receptors, ion channels and kinases. We have selected one
	of our MC1r peptide drug candidates, designated PL-8177, as a
	clinical trial candidate.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Animal
	studies that we have conducted with our MC1r peptide drug
	candidates have shown positive results in experimental models of
	inflammatory bowel disease, uveitis and nephritis. We are
	continuing to conduct studies on a number of different indications.
	We have completed preclinical toxicology testing on PL-8177 and
	chemistry, controls and manufacturing activities to support Phase 1
	studies, and anticipate filing an IND application on
	PL-8177.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Next Generation MC4r Peptide and Small Molecule
	Agonists.
</FONT>
	We have developed a series of highly selective
	MC4r peptides and are developing orally active small molecules. In
	developing these compounds, we examined effectiveness in animal
	models of sexual response, obesity and related metabolic signals,
	and also determined cardiovascular effects, primarily looking at
	changes in blood pressure. Results of these studies suggest that
	certain of these compounds may have significant commercial
	potential for treatment of conditions responsive to MC4r
	activation, including HSDD, FSD, ED, obesity and diabetes. We are
	engaged in preclinical activities with these compounds, and are
	evaluating potential pharmaceutical applications.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage7"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	selected an internal lead compound for obesity, designated PL-8905,
	which has over 100-fold functional selectivity for MC4r over MC1r
	with minimal effect on blood pressure and limited central nervous
	system penetration. PL-8905 exhibits significant chemical and
	metabolic stability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Obesity.
</FONT>
	Obesity is a multifactorial
	condition with numerous biochemical components relating to satiety
	(feeling full), energy utilization and homeostasis. A number of
	different metabolic and hormonal pathways are being evaluated by
	companies around the world in efforts to develop better treatments
	for obesity. Scientific research has established that melanocortin
	receptors have a role in eating behavior and energy homeostasis,
	and that melanocortin receptor agonists can decrease food intake
	and induce weight loss. With a previous partner, we completed
	clinical proof-of-concept studies for the MC4r mechanism in
	obesity, which met the primary objectives of significant decrease
	in food intake and weight loss.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Other Melanocortin Receptor-Specific
	Programs.
</FONT>
	We are continuing drug discovery efforts in the
	melanocortin receptor field, primarily developing peptide
	compounds, including highly selective MC1r agonists and peptides
	specific for MC4r, including both agonists and
	antagonists.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	Natriuretic Peptide Receptor-Specific Programs
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	natriuretic peptide receptor system has numerous cardiovascular
	functions, and therapeutic agents modulating this system may be
	useful in treatment of heart failure, acute asthma, other pulmonary
	diseases and hypertension. While the therapeutic potential of
	modulating this system is well appreciated, development of
	therapeutic agents has been difficult due, in part, to the short
	biological half-life of native peptide agonists.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	designed and are developing candidate drugs that are selective for
	different natriuretic peptide receptors, including NPR-A,
	natriuretic peptide receptor B, or NPR-B, natriuretic peptide
	receptor C, or NPRC, and both NPR-A and NPR-B.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	in active discussions with potential partners for marketing and
	commercialization rights in the United States and the rest of the
	world for PL-3994 and our related candidate drugs. We may not be
	able to enter into suitable agreements on acceptable terms with
	potential partners, if at all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	PL-3994.
</FONT>
	PL-3994 is our lead natriuretic
	peptide receptor product candidate, and is a synthetic mimetic of
	the neuropeptide hormone ANP and an NPR-A agonist. PL-3994 is in
	development for treatment of heart failure, acute exacerbations of
	asthma and refractory hypertension. PL-3994 activates NPR-A, a
	receptor known to play a role in cardiovascular homeostasis.
	Consistent with being an NPR-A agonist, PL-3994 increases plasma
	cyclic guanosine monophosphate, or cGMP, levels, a pharmacological
	response consistent with the effects of endogenous (naturally
	produced) natriuretic peptides on cardiovascular function and
	smooth muscle relaxation. PL-3994 also decreases activity of the
	renin-angiotensin-aldosterone system, or RAAS, a hormone system
	that regulates blood pressure and fluid balance. The RAAS system is
	frequently over-activated in heart failure patients, leading to
	worsening of cardiovascular function.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PL-3994, our lead
	product development candidate which is ready for Phase 2 safety and
	efficacy studies, is one of a number of natriuretic peptide
	receptor agonist compounds we have developed. PL-3994 is a
	synthetic molecule incorporating a novel and proprietary amino acid
	mimetic structure, and has an extended circulation half-life and
	metabolic stability compared to endogenous ANP. Based on the
	half-life and pharmacokinetics, we believe that PL-3994 is amenable
	to once daily chronic use subcutaneous administration.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	PL-3994 for Heart Failure.
</FONT>
	Heart
	failure is an illness in which the heart is unable to pump blood
	efficiently, and includes acutely decompensated heart failure with
	dyspnea (shortness of breath) at rest or with minimal activity.
	Endogenous natriuretic peptides have a number of beneficial
	effects, including vasodilation (relaxation of blood vessels),
	natriuresis (excretion of sodium) and diuresis (excretion of
	fluids).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Patients who have
	been admitted to the hospital with an episode of worsening heart
	failure have an increased risk of either death or hospital
	readmission in the three months following discharge. Up to 15% of
	patients die in this period and as many as 30% need to be
	readmitted to the hospital. We believe that decreasing mortality
	and hospital readmission in patients discharged following
	hospitalization for worsening heart failure is a large unmet
	medical need for which PL-3994 may be effective. PL-3994 could
	potentially be utilized as an adjunct to existing heart failure
	medications, and may, if successfully developed, be
	self-administered by patients as a subcutaneous injection following
	hospital discharge. We believe that PL-3994, through activation of
	NPR-A, may, if successful, reduce cardiac hypertrophy (increase in
	heart size due to disease), which is an independent risk factor for
	cardiovascular morbidity and mortality.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage8"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	According to a
	report from the American Heart Association published in 2014 in the
	journal
<FONT STYLE="FONT-STYLE: ITALIC">
	Circulation
</FONT>
	, an
	estimated 5.7 million Americans suffer from heart failure, with
	870,000 new cases of heart failure diagnosed each year, with
	disease incidence expected to increase with the aging of the
	American population. Heart failure has tremendous human and
	financial costs. The same report estimated that the 2012 total
	costs in the United States for heart failure were $30.7 billion,
	with heart failure constituting the leading cause of
	hospitalization in people over 65 years of age and with over 1
	million hospital discharges for heart failure in 2010. Heart
	failure is a high mortality disease, with approximately one-half of
	heart failure patients dying within five years of initial
	diagnosis.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Patient
	populations have been identified which have reduced levels of
	endogenous active natriuretic peptides, including endogenous active
	ANP. The reduced levels have a variety of causes, including
	mutations in endogenous natriuretic peptides and in enzymes
	necessary to convert natriuretic peptide sequences to their active
	form. Patients with reduced levels of endogenous active natriuretic
	peptides are reported to have a poor response to current drug
	therapies and to have increased rates of cardiac remodeling and
	cardiac events.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	believe that PL-3994 has the potential to treat heart failure with
	preserved ejection fraction, or HFpEF, which is a high unmet
	medical need with no approved treatment options, heart failure with
	reduced ejection fraction, or HFrEF, and patients with reduced
	levels of endogenous active natriuretic peptides, such as corin
	deficiencies, which is a high unmet medical need in patients with a
	poor response to current therapies, with the objective to restore
	normal natriuretic peptide function.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	planned a repeat dose Phase 2 clinical trial in patients with
	HFpEF, HFrEF and corin deficiency to evaluate safety profiles and
	symptom relief as well as pharmacokinetic (period to metabolize or
	excrete the drug) and pharmacodynamic (period of action or effect
	of the drug) endpoints. Analysis will include cardiac imaging and
	measurement of left ventricular ejection fraction. Contingent on
	adequate available funds, we intend to initiate this trial in the
	first half of calendar 2017. Assuming favorable results from this
	trial, we have planned a repeat dose Phase 2 proof-of-principle
	clinical trial in patients with heart failure, which would involve
	treatment for a three- to six-month period, and would evaluate
	safety, cardiac function, effects on remodeling, symptom
	improvement and hospitalization admission rates. Contingent on
	adequate available funds, the proof-of-principle Phase 2 trial will
	be initiated following completion of the first repeat dose Phase 2
	clinical trial.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	PL-3994 for Acute Exacerbations of
	Asthma.
</FONT>
	Research over the past two decades has demonstrated
	potent bronchodilator effects with both systemic and inhalation
	administration of natriuretic peptides. NPR-A agonism is known to
	relax smooth muscles in airways and works through a pathway
	independent of the beta-2 adrenergic receptor. Preclinical testing
	demonstrated potent airway smooth muscle relaxation in guinea pig
	and human tissues using PL-3994, and animal studies in sensitized
	guinea pigs have demonstrated a bronchodilator effect with PL-3994
	using both subcutaneous and inhalation administration.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Acute
	exacerbations of asthma, also called acute severe asthma, is an
	ongoing, unremitting asthma episode in which asthma symptoms do not
	adequately respond to initial bronchodilator therapy. Inhaled
	beta-2 adrenergic receptor agonists, such as albuterol, inhaled
	anticholinergic drugs, such as ipratropium, and systemic
	corticosteroids are primary treatments for episodes of acute
	exacerbations of asthma. Some patients with acute exacerbations of
	asthma become unresponsive to beta-2 adrenergic receptor agonists,
	significantly limiting treatment options and increasing risk.
	Patients who do not respond to initial therapy are at risk of
	severe complications. We intend to initially target PL-3994 as a
	treatment for those at-risk unresponsive patients.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	According to a 2014
	report from the National Center for Environmental Health, Asthma
	Prevalence in the United States, in 2010 there were 1.8 million
	emergency room visits and 439,000 hospitalizations attributed to
	asthma. Approximately 25.7 million Americans have
	asthma.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Endogenous
	natriuretic peptides have a very short half-life, due primarily to
	degradation by neutral endopeptidase and clearance through the
	natriuretic peptide clearance receptor. PL-3994 is resistant to
	neutral endopeptidase and clears from the body much more slowly
	than endogenous natriuretic peptides. PL-3994 has a blood-plasma
	half-life of at least three hours in humans when administered by
	subcutaneous injection, with biological effects seen for over eight
	hours post-administration.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Clinical Studies with PL-3994.
</FONT>
	Human
	clinical studies of PL-3994 commenced with a Phase 1 trial, which
	concluded in 2008. This was a randomized, double-blind,
	placebo-controlled study in 26 healthy volunteers who received
	either PL-3994 or a placebo subcutaneously. The evaluations
	included safety, tolerability, pharmacokinetics and several
	pharmacodynamic endpoints, including levels of cGMP. Dosing
	concluded with the successful achievement of the primary endpoint
	of the study, a pre-specified reduction in systemic blood pressure.
	No volunteer experienced a serious or severe adverse event.
	Elevations in plasma cGMP levels, increased diuresis and increased
	natriuresis were all observed for several hours after single
	subcutaneous doses.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage9"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Later
	in 2008, we conducted a Phase 2A trial in volunteers with
	controlled hypertension who were receiving one or more conventional
	antihypertensive medications. In this trial, which was a
	randomized, double-blind, placebo-controlled, single ascending dose
	study in 21 volunteers, the objective was to demonstrate that
	PL-3994 can be given safely to patients taking antihypertensive
	medications commonly used in heart failure and hypertension
	patients. Dosing concluded with the successful achievement of the
	primary endpoint of the study, a pre-specified reduction in
	systemic blood pressure. No volunteer experienced a serious or
	severe adverse event. Elevations in plasma cGMP levels were
	observed for several hours after single subcutaneous doses. Based
	on the studies to date, PL-3994 is ready for Phase 2 safety and
	efficacy studies.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Administration of PL-3994.
</FONT>
	For heart
	failure and refractory hypertension indications we believe that
	subcutaneous administration of PL-3994 may be preferable. PL-3994
	is well absorbed through the subcutaneous route of administration.
	In human studies, the pharmacokinetic and pharmacodynamic
	half-lives were on the order of hours, significantly longer than
	the comparable half-lives of endogenous natriuretic peptides. We
	believe that subcutaneous PL-3994, if successful, will be
	appropriate for self-administration by patients, similar to insulin
	and other self-administered drugs. For asthma indications we
	believe that inhalation administration of PL-3994 may be preferable
	to subcutaneous or other systemic administration.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Technologies
	We Use
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We used
	a rational drug design approach to discover and develop proprietary
	peptide, peptide mimetic and small molecule agonist compounds,
	focusing on melanocortin and natriuretic peptide receptor systems.
	Computer-aided drug design models of receptors are optimized based
	on experimental results obtained with peptides and small molecules
	that we develop. With our approach, we believe we are developing an
	advanced understanding of the factors which drive
	agonism.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	developed a series of proprietary technologies used in our drug
	development programs. One technology employs novel amino acid
	mimetics in place of selected amino acids. These mimetics provide
	the receptor-binding functions of conventional amino acids while
	providing structural, functional and physiochemical advantages. The
	amino acid mimetic technology is employed in PL-3994, our compound
	in development for treatment of heart failure, acute exacerbations
	of asthma and refractory hypertension.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Some
	compound series have been derived using our proprietary and
	patented platform technology, called MIDAS&#x2122;, or
<FONT STYLE="FONT-STYLE: ITALIC">
	M
</FONT>
	etal
<FONT STYLE="FONT-STYLE: ITALIC">
	I
</FONT>
	on-induced
<FONT STYLE="FONT-STYLE: ITALIC">
	D
</FONT>
	istinctive
<FONT STYLE="FONT-STYLE: ITALIC">
	A
</FONT>
	rray of
<FONT STYLE="FONT-STYLE: ITALIC">
	S
</FONT>
	tructures. This technology employs
	metal ions to fix the three-dimensional configuration of peptides,
	forming conformationally rigid molecules that remain folded
	specifically in their active state. These MIDAS molecules are
	generally simple to synthesize, are chemically and proteolytically
	stable, and have the potential to be orally bioavailable. In
	addition, MIDAS molecules are information-rich and provide data on
	structure-activity relationships that may be used to design small
	molecule, non-peptide drugs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Amount
	Spent on Research and Development Activities
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Research and
	development expenses were approximately $43.1 million for the
	fiscal year ended June 30, 2016, or fiscal 2016, $24.6 million for
	the fiscal year ended June 30, 2015, or fiscal 2015, and $10.8
	million for the fiscal year ended June 30, 2014, or fiscal
	2014.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Competition
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	General.
</FONT>
	Our products under development
	will compete on the basis of quality, performance, cost
	effectiveness and application suitability with numerous established
	products and technologies. We have many competitors, including
	pharmaceutical, biopharmaceutical and biotechnology companies.
	Furthermore, there are several well-established products in our
	target markets that we will have to compete against. Products using
	new technologies which may be competitive with our proposed
	products may also be introduced by others. Most of the companies
	selling or developing competitive products have financial,
	technological, manufacturing and distribution resources
	significantly greater than ours and may represent significant
	competition for us. In addition, if any of our product candidates
	are approved by FDA, they will eventually face competition from
	generic versions that will sell at significantly reduced prices, be
	preferred by managed care and health insurance payers, and be
	eligible for automatic pharmacy substitution even when a prescriber
	writes a prescription for our product. The timing and extent of
	future generic competition is dependent upon both our intellectual
	property rights and the FDA regulatory process, but cannot be
	accurately predicted.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	pharmaceutical and biotechnology industries are characterized by
	extensive research efforts and rapid technological change. Many
	biopharmaceutical companies have developed or are working to
	develop products similar to ours or that address the same markets.
	Such companies may succeed in developing technologies and products
	that are more effective or less costly than any of those that we
	may develop. Such companies may be more successful than us in
	developing, manufacturing and marketing products.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage10"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	cannot guarantee that we will be able to compete successfully in
	the future or that developments by others will not render our
	proposed products under development or any future product
	candidates obsolete or noncompetitive or that our collaborators or
	customers will not choose to use competing technologies or
	products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Bremelanotide for Treatment of HSDD.
</FONT>
	There is competition and financial incentive to develop, market and
	sell drugs for the treatment of HSDD and other forms of FSD.
	Flibanserin, sold under the trade name Addyi&#xAE;, is the only
	drug currently approved in the United States for treatment of HSDD.
	Flibanserin, a non-hormonal oral serotonin 5-HT1A agonist, 5-HT2A
	antagonist, which requires chronic dosing, was approved by the FDA
	on August 18, 2015 for treatment of premenopausal women with HSDD.
	The FDA approval included a risk evaluation and mitigation
	strategy, or REMS, because of the increased risk of severe
	hypotension and syncope due to the interaction between flibanserin
	and alcohol, and a Boxed Warning to highlight the risks of severe
	hypotension and syncope in patients who drink alcohol during
	treatment with flibanserin, in those who also use moderate or
	strong CYP3A4 inhibitors, and in those who have liver impairment.
	Approval by the FDA followed a positive FDA advisory committee
	recommendation in June 2015. We are aware of several other drugs at
	various stages of development, most of which are taken on a
	chronic, typically once-daily, basis. An oral fixed-dose
	combination of two antidepressants, bupropion and trazodone, is
	reported to be entering Phase 2 studies in premenopausal women with
	HSDD. Another company is developing two different oral fixed-dose
	combination drugs, one a combination of sildenafil and testosterone
	and the other a combination of testosterone and buspirone
	hydrochloride, and has conducted Phase 2 studies. Libigel&#xAE;, a
	testosterone gel, completed two Phase 3 efficacy trials for
	treatment of FSD in surgically post-menopausal women, but did not
	show statistical separation from placebo in those trials. Intrinsa,
	a transdermal testosterone patch, successfully completed a Phase 3
	clinical program, but was not approved in the United States based
	on potential long-term use safety risks of cancer and
	cardiovascular adverse events. There are other companies reported
	to be developing new drugs for FSD indications, some of which may
	be in clinical trials in the United States or elsewhere. We are not
	aware of any company actively developing a melanocortin receptor
	agonist drug for HSDD.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	PL-3994 for Heart Failure Indications.
</FONT>
	Nesiritide (sold under the trade name Natrecor&#xAE;), a
	recombinant human B-type natriuretic peptide drug, is marketed in
	the United States by Scios Inc., a Johnson &amp; Johnson company.
	Nesiritide is approved for treatment of acutely decompensated
	congestive heart failure patients who have dyspnea at rest or with
	minimal activity. Other peptide drugs, including carperitide, a
	recombinant human atrial natriuretic peptide drug, and ularitide, a
	synthetic form of urodilatin, a naturally occurring human
	natriuretic peptide related to atrial natriuretic peptide, have
	been investigated for treatment of congestive heart failure, but we
	are not aware of any active development in the United States. We
	are aware of other companies developing intravenously administered
	natriuretic peptide drugs, with at least one reported to have
	completed Phase 2 clinical trials for acute heart failure. A
	combination drug comprised of sacubitril and valsartan developed by
	Novartis AG, sold under the trade name Entresto&#xAE;, inhibits
	both the angiotensin II receptor and neprilysin (an enzyme which
	inactivates endogenous active natriuretic peptides). This
	combination drug, which was approved by the FDA in July 2015,
	results in increases of endogenous active ANP levels, and thus has
	a mechanism of action with similarities to PL-3994. In a Phase 3
	trial, the combination drug was compared to an
	angiotensin-converting-enzyme inhibitor, enalapril, in heart
	failure patients with reduced ejection fraction. It significantly
	improved the rate of death from cardiovascular causes,
	significantly reduced hospitalization for heart failure and
	significantly improved heart failure symptoms. This combination
	drug demonstrated that upregulation of the natriuretic peptide
	system in combination with angiotensin-converting-enzyme inhibition
	is superior to angiotensin-converting-enzyme inhibition alone, and
	thus provides validation of the natriuretic peptide system as a
	target for improving outcomes in treating heart failure patients.
	In addition, there are a number of approved drugs and drugs in
	development for treatment of heart failure through mechanisms or
	pathways other than agonism of NPR-A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	PL-3994 for Acute Exacerbations of Asthma
	Indications.
</FONT>
	The asthma market is intensively competitive,
	with substantial competition and financial incentive to develop,
	market and sell drugs for treatment of asthma, with projected costs
	of prescription drugs of $5.9 billion in the United States in 2010.
	We are aware of companies developing drugs for the specific
	indications of either acute exacerbations of asthma or acute severe
	asthma, including at least one company with a drug reported to be
	currently in clinical trials. Certain of these drugs under
	development work by mechanisms of action different from the
	mechanisms of action of currently approved products. In addition, a
	number of clinical trials are conducted by hospitals, research
	institutes and others exploring various methods and combinations of
	drugs to treat acute exacerbations of asthma. There are a number of
	drugs and therapies currently used to treat acute exacerbations of
	asthma, including administration of oral or intravenous systemic
	steroids, use of oxygen or heliox, a mixture of helium and oxygen,
	nebulized short-acting beta-2 adrenergic receptor agonists,
	intravenous or nebulized anticholinergic agents and, for patients
	in or approaching respiratory arrest, intubation and mechanical
	ventilation. However, each of these drugs or therapies has
	recognized limitations or liabilities, and we believe that there
	remains an unmet medical need for a safe and effective treatment
	for acute exacerbations of asthma. We are not aware of any other
	company actively developing a drug to treat asthma using a
	natriuretic peptide receptor pathway.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage11"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	MC4r Peptides for Erectile Dysfunction.
</FONT>
	Leading drugs approved for erectile dysfunction, or ED, indications
	are PDE-5 inhibitors which target the vascular system, such as
	sildenafil (sold under the trade name Viagra&#xAE;), vardenafil
	(sold under the trade name Levitra&#xAE;) and tadalafil (sold under
	the trade name Cialis&#xAE;). Other drugs approved for ED
	indications include alprostadil for injection (sold under the trade
	name Caverject Impulse&#xAE; among others), which is injected
	directly into the penis, and alprostadil in urethral suppository
	format (sold under the trade name MUSE&#xAE;). In addition, a
	variety of devices, including vacuum devices and surgical penile
	implants, have been approved for ED indications. We are aware of a
	number of companies developing new drugs for ED indications, some
	of which are in clinical trials in the United States and elsewhere.
	We are not aware of any company actively developing a melanocortin
	receptor agonist drug for ED.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Obesity.
</FONT>
	There are a number of
	FDA-approved drugs and medical devices for the treatment of
	obesity, and a large number of products in clinical development by
	other companies, including products which target melanocortin
	receptors. At least one Phase 2 study has been reported on use of
	an MC4r agonist for obesity indications.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	MC1r Peptides for Dermatologic and
	Inflammatory Disease-Related Indications.
</FONT>
	Many dermatologic
	and inflammatory disease-related indications are treated using
	systemic steroids or immunosuppressant drugs, both of which have
	side effects which can be dose limiting. There are a large number
	of approved biological drugs and biological drugs under development
	for treatment of dermatologic and inflammatory disease-related
	indications.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Patents
	and Proprietary Information
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Patent Protection.
</FONT>
	Our success will
	depend in substantial part on our ability to obtain, defend and
	enforce patents, maintain trade secrets and operate without
	infringing upon the proprietary rights of others, both in the
	United States and abroad. We own a number of issued United States
	patents and have pending United States patent applications, many
	with issued or pending counterpart patents in selected foreign
	countries. We seek patent protection for our technologies and
	products in the United States and those foreign countries where we
	believe patent protection is commercially important.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We own
	two issued United States patents claiming the bremelanotide
	substance and an issued patent claiming the bremelanotide substance
	in each of Australia, Austria, Belgium, Brazil, Canada, Cyprus,
	Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland,
	Italy, Japan, Korea, Luxembourg, Mexico, Monaco, Netherlands, New
	Zealand, Portugal, Spain, Sweden, Switzerland, and the United
	Kingdom. The issued United States patents have a term until 2020,
	which term may be subject to extension for a maximum period of up
	to five years as compensation for patent term lost during drug
	development and the FDA regulatory review process, pursuant to the
	Drug Price Competition and Patent Term Restoration Act of 1984, or
	the Hatch-Waxman Amendments. Whether we will be able to obtain
	patent term extensions under the Hatch-Waxman Amendments and the
	length of any such extension cannot be determined until the FDA
	approves for marketing, if ever, a product in which bremelanotide
	is the active ingredient. In addition, the claims of issued patents
	covering bremelanotide may not provide meaningful protection.
	Further, third parties may challenge the validity or scope of any
	issued patent, and under the Hatch-Waxman Amendments, potentially
	receive approval of a competing generic version of our product or
	products even before a court rules on the validity or infringement
	of our patents.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We own
	an issued United States patent and pending patent applications in
	the United States for methods of treating FSD with bremelanotide,
	and related patent applications are pending in Australia, Brazil,
	Canada, China, Colombia, Georgia, Hong Kong, India, Indonesia,
	Israel, Japan, Korea, Malaysia, Mexico, New Zealand, Philippines,
	Singapore, South Africa, Ukraine, Vietnam and before the European
	and Eurasian patent offices. The issued United States patent has a
	term until 2033. Whether we will be able to obtain a patent term
	extension in the United States under the Hatch-Waxman Amendments,
	assuming that a relevant patent issues in the United States, and
	the length of any such extension, cannot be determined until the
	FDA approves for marketing, if ever, a product utilizing
	bremelanotide by methods claimed in the patent. Pending
	applications in the United States and elsewhere in the world have a
	presumptive term, if a patent is issued, until 2033.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	patents and patent applications on an alternative class of
	melanocortin receptor-specific peptides for treatment of sexual
	dysfunction and other indications, including obesity, consisting of
	two issued patents in the United States, an issued patent in each
	of Australia, Canada, China, Israel, Mexico, New Zealand, Japan and
	Russia, and pending patent applications on the same class in
	Brazil, India, Korea, and South Africa and before the European
	patent office. The presumptive term of the issued patents and
	pending patent applications is until 2029. We also have patents and
	pending patent applications for a second class of alternative
	melanocortin receptor-specific peptides for treatment of sexual
	dysfunction and other indications, including obesity, consisting of
	issued patents in the United States, Australia, China, Japan,
	Mexico, New Zealand, Russia, and South Africa and pending patent
	applications on the same class in Brazil, Canada, China, India,
	Israel, Korea, and before the European patent office. The
	presumptive term of the issued patents and pending patent
	applications is until 2030. Until one or more product candidates
	covered by a claim of one of these patents and patent applications
	are developed for commercialization, which may never occur, we
	cannot evaluate the duration of any potential patent term extension
	under the Hatch-Waxman Amendments.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage12"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We own
	issued patents in the United States, Mexico, New Zealand, South
	Africa and Russia claiming highly selective MC1r agonist peptides
	for treatment of inflammation-related diseases and disorders and
	related indications, and pending patent applications on two broad
	classes of highly selective MC1r agonist peptides in the United
	States, Australia, Brazil, Canada, China, India, Israel, Japan,
	Korea, and Mexico and before the European patent office. The
	presumptive term of the issued patents and pending patent
	applications is until 2030. Until one or more product candidates
	covered by a claim of one of these patent applications are
	developed for commercialization, which may never occur, we cannot
	evaluate the duration of any potential patent term extension under
	the Hatch-Waxman Amendments.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We own
	two issued United States patents claiming the PL-3994 substance and
	other natriuretic peptide receptor agonist compounds that we have
	developed and an issued United States patent claiming a precursor
	molecule to the PL-3994 substance, both of which expire in 2027.
	Corresponding patents on the PL-3994 substance and other
	natriuretic peptide receptor agonist compounds were issued in
	Australia, Austria, Belgium, China, Colombia, Denmark, Finland,
	France, Germany, Hong Kong, Hungary, India, Ireland, Israel, Italy,
	Japan, Korea, Mexico, Netherlands, Philippines, Russia, South
	Africa, Spain, Sweden, Switzerland, and the United Kingdom, with
	terms until 2027. Patent applications on the PL-3994 substance and
	other natriuretic peptide receptor agonist compounds are pending in
	Brazil and Canada, with presumptive terms until 2027. Applications
	claiming precursor molecules for the PL-3994 substance and other
	compounds have issued in the United States, Australia, China,
	France, Germany, Hong Kong, India, Ireland, Israel, Japan, Mexico,
	Netherlands, Philippines, Korea, South Africa, Sweden, Switzerland
	and the United Kingdom, and expire in 2027. Patent applications on
	the precursor molecules are pending in Brazil, Canada, and before
	the Eurasian Patent Office, with presumptive terms until 2027. We
	also own an issued United States patent claiming use of the PL-3994
	substance for treatment of acute asthma and chronic obstructive
	pulmonary disease, which expires in 2031. We do not know the full
	scope of patent coverage we will obtain, or whether any patents
	will issue other than the patents already issued. Until one or more
	product candidates covered by a claim of the issued patents or one
	of these patent applications are developed for commercialization,
	which may never occur, we cannot evaluate the duration of any
	potential patent term extension under the Hatch-Waxman
	Amendments.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	additionally have 31 issued United States patents on melanocortin
	receptor specific peptides and small molecules, and three issued
	United States patents on natriuretic peptide receptor agonist
	compounds, but we are not actively developing any product candidate
	covered by a claim of any of these patents.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the
	event that a third party has also filed a patent application
	relating to an invention we claimed in a patent application, we may
	be required to participate in an interference proceeding
	adjudicated by the United States Patent and Trademark Office to
	determine priority of invention. The possibility of an interference
	proceeding could result in substantial uncertainties and cost, even
	if the eventual outcome is favorable to us. An adverse outcome
	could result in the loss of patent protection for the subject of
	the interference, subjecting us to significant liabilities to third
	parties, the need to obtain licenses from third parties at
	undetermined cost, or requiring us to cease using the
	technology.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Future Patent Infringement.
</FONT>
	We do not
	know for certain that our commercial activities will not infringe
	upon patents or patent applications of third parties, some of which
	may not even have been issued. Although we are not aware of any
	valid United States patents which are infringed by bremelanotide or
	PL-3994, we cannot exclude the possibility that such patents might
	exist or arise in the future. We may be unable to avoid
	infringement of any such patents and may have to seek a license,
	defend an infringement action, or challenge the validity of such
	patents in court. Patent litigation is costly and time consuming.
	If such patents are valid and we do not obtain a license under any
	such patents, or we are found liable for infringement, we may be
	liable for significant monetary damages, may encounter significant
	delays in bringing products to market, or may be precluded from
	participating in the manufacture, use or sale of products or
	methods of treatment covered by such patents.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Proprietary Information.
</FONT>
	We rely on
	proprietary information, such as trade secrets and know-how, which
	is not patented. We have taken steps to protect our unpatented
	trade secrets and know-how, in part through the use of
	confidentiality and intellectual property agreements with our
	employees, consultants and certain contractors. If our employees,
	scientific consultants, collaborators or licensees develop
	inventions or processes independently that may be applicable to our
	product candidates, disputes may arise about the ownership of
	proprietary rights to those inventions and processes. Such
	inventions and processes will not necessarily become our property,
	but may remain the property of those persons or their employers.
	Protracted and costly litigation could be necessary to enforce and
	determine the scope of our proprietary rights.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage13"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If
	trade secrets are breached, our recourse will be solely against the
	person who caused the secrecy breach. This might not be an adequate
	remedy to us because third parties other than the person who causes
	the breach will be free to use the information without
	accountability to us. This is an inherent limitation of the law of
	trade secret protection.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	U.S.
	Governmental Regulation of Pharmaceutical Products
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	General
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Regulation by
	governmental authorities in the United States and other countries
	will continue to significantly impact our research, product
	development, manufacturing and marketing of any pharmaceutical
	products. The nature and the extent to which regulations apply to
	us will vary depending on the nature of any such products. Our
	potential pharmaceutical products will require regulatory approval
	by governmental agencies prior to commercialization. The products
	we are developing are subject to federal regulation in the United
	States, principally by the FDA under the Federal Food, Drug, and
	Cosmetic Act, or FFDCA, and by state and local governments, as well
	as regulatory and other authorities in foreign governments that
	include rigorous preclinical and clinical testing and other
	approval procedures. Such regulations govern or influence, among
	other things, the research, development, testing, manufacture,
	safety and efficacy requirements, labeling, storage, recordkeeping,
	licensing, advertising, promotion, distribution and export of
	products, manufacturing and the manufacturing process. In many
	foreign countries, such regulations also govern the prices charged
	for products under their respective national social security
	systems and availability to consumers.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All
	drugs intended for human use are subject to rigorous regulation by
	the FDA in the United States and similar regulatory bodies in other
	countries. The steps ordinarily required by the FDA before an
	innovative new drug product may be marketed in the United States
	are similar to steps required in most other countries and include,
	but are not limited to:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	completion of
	preclinical laboratory tests, preclinical animal testing and
	formulation studies;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	submission to the
	FDA of an IND, which must be in effect before clinical trials may
	commence;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	submission to the
	FDA of an NDA that includes preclinical data, clinical trial data
	and manufacturing information;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	payment of
	substantial user fees for filing the NDA and other recurring user
	fees;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	FDA review of the
	NDA;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	satisfactory
	completion of an FDA pre-approval inspection of the manufacturing
	facilities; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	FDA approval of the
	NDA, including approval of all product labeling.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For
	combination products deemed to have a
	&#x2018;&#x2018;drug&#x2019;&#x2019; primary mode of action, primary
	review of the product will be conducted by the appropriate division
	within the Center for Drug Evaluation and Research, or CDER, but
	CDER will consult with the Center for Devices and Radiological
	Health, or CDRH, to ensure that the device components of the
	product meet all applicable device requirements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	research, development and approval process requires substantial
	time, effort and financial resources, and approvals may not be
	granted on a timely or commercially viable basis, if at
	all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Preclinical testing
	includes laboratory evaluations to characterize the product&#x2019;s
	composition, impurities, stability, and mechanism of its
	pharmacologic effect, as well as animal studies to assess the
	potential safety and efficacy of each product. Preclinical safety
	tests must be conducted by laboratories that comply with FDA
	regulations regarding Good Laboratory Practices, or GLP, and the
	U.S. Department of Agriculture&#x2019;s Animal Welfare Act.
	Violations of these laws and regulations can, in some cases, lead
	to invalidation of the tests, requiring such tests to be repeated
	and delaying approval of the NDA. The results of the preclinical
	tests, together with manufacturing information and analytical data,
	are submitted to the FDA as part of an IND and are reviewed by the
	FDA before the commencement of human clinical trials. Unless the
	FDA objects to an IND by placing the study on clinical hold, the
	IND will go into effect 30 days following its receipt by the FDA.
	The FDA may authorize trials only on specified terms and may
	suspend ongoing clinical trials at any time on various grounds,
	including a finding that patients are being exposed to unacceptable
	health risks. If the FDA places a study on clinical hold, the
	sponsor must resolve all of the FDA&#x2019;s concerns before the
	study may begin or continue. The IND application process may become
	extremely costly and substantially delay development of products.
	Similar restrictive requirements also apply in other countries.
	Additionally, positive results of preclinical tests will not
	necessarily indicate positive results in clinical
	trials.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Clinical trials
	involve the administration of the investigational product to humans
	under the supervision of qualified principal investigators. Our
	clinical trials must be conducted in accordance with Good Clinical
	Practice, or GCP, regulations under protocols submitted to the FDA
	as part of an IND. In addition, each clinical trial is approved and
	conducted under the auspices of an institutional review board, or
	IRB, and requires the patients&#x2019; informed consent. An IRB
	considers, among other things, ethical factors, the safety of human
	subjects, and the possibility of liability of the institutions
	conducting the trial. The IRB at each institution at which a
	clinical trial is being performed may suspend a clinical trial at
	any time for a variety of reasons, including a belief that the test
	subjects are being exposed to an unacceptable health risk. As the
	sponsor, we can also suspend or terminate a clinical trial at any
	time.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage14"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Clinical trials are
	typically conducted in three sequential phases, Phases 1, 2, and 3,
	involving an increasing number of human subjects. These phases may
	sometimes overlap or be combined. Phase 1 trials are performed in a
	small number of healthy human subjects or subjects with the
	targeted condition, and involve testing for safety, dosage
	tolerance, absorption, distribution, metabolism and excretion.
	Phase 2 studies, which may involve up to hundreds of subjects, seek
	to identify possible adverse effects and safety risks, preliminary
	information related to the efficacy of the product for specific
	targeted diseases, dosage tolerance, and optimal dosage. Finally,
	Phase 3 trials may involve up to thousands of individuals often at
	geographically dispersed clinical trial sites, and are intended to
	provide the documentation of effectiveness and important additional
	safety data required for approval. Prior to commencing Phase 3
	clinical trials many sponsors elect to meet with FDA officials to
	discuss the conduct and design of the proposed trial or
	trials.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	addition, federal law requires the listing, on a publicly-available
	website, of detailed information on clinical trials for
	investigational drugs. Some states have similar or supplemental
	clinical trial reporting laws.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Success
	in early-stage animal studies and clinical trials does not
	necessarily assure success in later-stage clinical trials. Data
	obtained from animal studies and clinical activities are not always
	conclusive and may be subject to alternative interpretations that
	could delay, limit or even prevent regulatory
	approval.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All
	data obtained from the preclinical studies and clinical trials, in
	addition to detailed information on the manufacture and composition
	of the product, would be submitted in an NDA to the FDA for review
	and approval for the manufacture, marketing and commercial
	shipments of any of our products. FDA approval of the NDA is
	required before commercial marketing or non-investigational
	interstate shipment may begin in the United States. The FDA may
	also conduct an audit of the clinical trial data used to support
	the NDA.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The FDA
	may deny or delay approval of an NDA that does not meet applicable
	regulatory criteria. For example the FDA may determine that the
	preclinical or clinical data or the manufacturing information does
	not adequately establish the safety and efficacy of the drug. The
	FDA has substantial discretion in the approval process and may
	disagree with an applicant&#x2019;s interpretation of the data
	submitted in its NDA. The FDA can request additional information,
	seek clarification regarding information already provided in the
	submission or ask that new additional clinical trials be conducted,
	all of which can delay approval. Similar types of regulatory
	processes will be encountered as efforts are made to market any
	drug internationally. We will be required to assure product
	performance and manufacturing processes from one country to
	another.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Even if
	the FDA approves a product, it may limit the approved uses for the
	product as described in the product labeling, require that
	contraindications, warning statements or precautions be included in
	the product labeling, require that additional studies be conducted
	following approval as a condition of the approval, impose
	restrictions and conditions on product distribution, prescribing or
	dispensing in the form of a REMS, or otherwise limit the scope of
	any approval or limit labeling. Once it approves an NDA, the FDA
	may revoke or suspend the product approval if compliance with
	post-market regulatory standards is not maintained or if problems
	occur after the product reaches the marketplace. In addition, the
	FDA may require post-marketing studies to monitor the effect of
	approved products, and may limit further marketing of the product
	based on the results of these post-market studies. The FDA and
	other government agencies have broad post-market regulatory and
	enforcement powers, including the ability to levy civil and
	criminal penalties, suspend or delay issuance of approvals, seize
	or recall products and revoke approvals.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Pharmaceutical
	manufacturers, distributors and their subcontractors are required
	to register their facilities with the FDA and state agencies.
	Manufacturers are required to list their marketed drugs with the
	FDA, are subject to periodic inspection by the FDA and other
	authorities, where applicable, and must comply with the FDA&#x2019;s
	current Good Manufacturing Practices, or GMP, regulations, and the
	product specifications set forth in the approved NDA. The GMP
	requirements for pharmaceutical products are extensive and
	compliance with them requires considerable time, resources and
	ongoing investment. The regulations require manufacturers and
	suppliers of raw materials and components to establish validated
	systems and to employ and train qualified employees to ensure that
	products meet high standards of safety, efficacy, stability,
	sterility (where applicable), purity, and potency. The requirements
	apply to all stages of the manufacturing process, including the
	synthesis, processing, sterilization, packaging, labeling, storage
	and shipment of the drug product. For all drug products, the
	regulations require investigation and correction of any deviations
	from GMP requirements and impose documentation requirements upon us
	and any third-party manufacturers that we may decide to use.
	Manufacturing establishments are subject to mandatory user fees,
	and to periodic unannounced inspections by the FDA and state
	agencies for compliance with all GMP requirements. The FDA is
	authorized to inspect manufacturing facilities without a warrant at
	reasonable times and in a reasonable manner.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage15"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We or
	our present or future suppliers may not be able to comply with GMP
	and other FDA regulatory requirements. Failure to comply with the
	statutory and regulatory requirements subjects the manufacturer
	and/or the NDA sponsor or distributor to possible legal or
	regulatory action, such as a delay or refusal to approve an NDA,
	suspension of manufacturing, seizure or recall of a product, or
	civil or criminal prosecution of the company or individual officers
	or employees.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Post-Marketing Regulation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Any
	drug products manufactured or distributed by us pursuant to FDA
	approvals, as well as the materials and components used in our
	products, are subject to pervasive and continuing regulation by the
	FDA, including:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	recordkeeping
	requirements;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	periodic reporting
	requirements;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	GMP requirements
	related to all stages of manufacturing, testing, storage,
	packaging, labeling and distribution of finished dosage forms of
	the product;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	monitoring and
	reporting of adverse experiences with the product; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	advertising and
	promotional reporting requirements and restrictions.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Adverse
	experiences with the product must be reported to the FDA and could
	result in the imposition of market restriction through labeling
	changes or product removal. Product approvals may be revoked if
	compliance with regulatory requirements is not maintained or if
	problems concerning safety or effectiveness of the product occur
	following approval. The FDA is developing a national electronic
	drug safety tracking system known as SENTINEL that may impose
	additional safety monitoring burdens, and enhanced FDA enforcement
	authority, beyond the extensive requirements already in effect. As
	a condition of NDA approval, the FDA may require post-approval
	testing and surveillance to monitor a product&#x2019;s safety or
	efficacy. The FDA also may impose other conditions, including
	labeling restrictions which can materially impact the potential
	market and profitability of a product.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	With
	respect to post-market product advertising and promotion, the FDA
	and other government agencies including the Department of Health
	and Human Services and the Department of Justice, and individual
	States, impose a number of complex regulations on entities that
	advertise and promote pharmaceuticals, including, among others,
	standards and restrictions on direct-to-consumer advertising,
	off-label promotion, industry-sponsored scientific and educational
	activities and promotional activities involving the Internet. The
	FDA has very broad enforcement authority under the FFDCA, and
	failure to abide by these regulations can result in administrative
	and judicial enforcement actions, including the issuance of a
	Warning Letter directing correction of deviations from FDA
	standards, a requirement that future advertising and promotional
	materials be pre-cleared by the FDA, False Claims Act prosecution
	based on alleged off-label marketing seeking monetary and other
	penalties, including potential exclusion of the drug and/or the
	company from participation in government health care programs, and
	state and federal civil and criminal investigations and
	prosecutions. Foreign regulatory bodies also strictly enforce these
	and other regulatory requirements and drug marketing may be
	prohibited in whole or in part in other countries.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We, our
	collaborators or our third-party contract manufacturers may not be
	able to comply with the applicable regulations. After regulatory
	approvals are obtained, the subsequent discovery of previously
	unknown problems, or the failure to maintain compliance with
	existing or new regulatory requirements, may result
	in:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	restrictions on the
	marketing or manufacturing of a product;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Warning Letters or
	Untitled Letters from the FDA asking us, our collaborators or
	third-party contractors to take or refrain from taking certain
	actions;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	withdrawal of the
	product from the market;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the FDA&#x2019;s
	refusal to approve pending applications or supplements to approved
	applications;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	voluntary or
	mandatory product recall;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	fines or
	disgorgement of profits or revenue;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	suspension or
	withdrawal of regulatory approvals;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	refusals to permit
	the import or export of products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	product seizure;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	13
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage16"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	injunctions or the
	imposition of civil or criminal penalties.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may
	also be subject to healthcare laws, regulations and enforcement and
	our failure to comply with any such laws, regulations or
	enforcement could adversely affect our business, operations and
	financial condition. Certain federal and state healthcare laws and
	regulations pertaining to fraud and abuse and patients&#x2019;
	rights are and will be applicable to our business. We are subject
	to regulation by both the federal government and the states in
	which we or our partners conduct our business. The laws and
	regulations that may affect our ability to operate
	include:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the federal
	Anti-Kickback Statute, which prohibits, among other things, any
	person or entity from knowingly and willfully offering, soliciting,
	receiving or providing any remuneration (including any kickback,
	bribe or rebate), directly or indirectly, overtly or covertly, in
	cash or in kind, to induce either the referral of an individual or
	in return for the purchase, lease, or order of any good, facility
	item or service, for which payment may be made, in whole or in
	part, under federal healthcare programs such as the Medicare and
	Medicaid programs;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	federal civil and
	criminal false claims laws and civil monetary penalty laws,
	including, for example, the federal civil False Claims Act, which
	impose criminal and civil penalties, including civil whistleblower
	or qui tam actions, against individuals or entities for, among
	other things, knowingly presenting, or causing to be presented, to
	the federal government, including the Medicare and Medicaid
	programs, claims for payment that are false or fraudulent or making
	a false statement to avoid, decrease or conceal an obligation to
	pay money to the federal government;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the federal Health
	Insurance Portability and Accountability Act of 1996, or HIPAA,
	which created new federal criminal statutes that prohibit knowingly
	and willfully executing, or attempting to execute, a scheme to
	defraud any healthcare benefit program or obtain, by means of false
	or fraudulent pretenses, representations or promises, any of the
	money or property owned by, or under the custody or control of, any
	healthcare benefit program, regardless of the payer (e.g., public
	or private), knowingly and willfully embezzling or stealing from a
	health care benefit program, willfully obstructing a criminal
	investigation of a health care offense and knowingly and willfully
	falsifying, concealing or covering up by any trick or device a
	material fact or making any materially false statements in
	connection with the delivery of, or payment for, healthcare
	benefits, items or services relating to healthcare
	matters;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	HIPAA, as amended
	by the Health Information Technology for Economic and Clinical
	Health Act, and their implementing regulations, which impose
	obligations on covered entities, including healthcare providers,
	health plans, and healthcare clearinghouses, as well as their
	respective business associates that create, receive, maintain or
	transmit individually identifiable health information for or on
	behalf of a covered entity, with respect to safeguarding the
	privacy, security and transmission of individually identifiable
	health information;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the federal
	physician sunshine requirements under the Patient Protection and
	Affordable Care Act, or Affordable Care Act, which require
	manufacturers of drugs, devices, biologics and medical supplies to
	report annually to the Centers for Medicare &amp; Medicaid Services
	information related to payments and other transfers of value
	provided to physicians and teaching hospitals, and ownership and
	investment interests held by physicians and their immediate family
	members; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	state law
	equivalents of each of the above federal laws, such as
	anti-kickback and false claims laws, which may apply to items or
	services reimbursed by any third-party payer, including commercial
	insurers; state laws that require pharmaceutical companies to
	comply with the pharmaceutical industry&#x2019;s voluntary
	compliance guidelines and the applicable compliance guidance
	promulgated by the federal government, or otherwise restrict
	payments that may be provided to healthcare providers and other
	potential referral sources; state laws that require drug
	manufacturers to report information related to payments and other
	transfers of value to healthcare providers or marketing
	expenditures; and state laws governing the privacy and security of
	health information in certain circumstances, many of which differ
	from each other in significant ways and may not have the same
	effect, thus complicating compliance efforts.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Because
	of the breadth of these laws and the narrowness of the statutory
	exceptions and safe harbors available, it is possible that some of
	our business activities could be subject to challenge under one or
	more of such laws. In addition, recent health care reform
	legislation has strengthened these laws. For example, the
	Affordable Care Act, among other things, amended the intent
	requirement of the federal Anti-Kickback Statute and certain
	criminal healthcare fraud statutes. A person or entity no longer
	needs to have actual knowledge of the statute or specific intent to
	violate it. In addition, the Affordable Care Act provided that the
	government may assert that a claim including items or services
	resulting from a violation of the federal Anti-Kickback Statute
	constitutes a false or fraudulent claim for purposes of the federal
	civil False Claims Act.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	14
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage17"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Achieving and
	sustaining compliance with these laws may prove costly. In
	addition, any action against us for violation of these laws, even
	if we successfully defend against it, could cause us to incur
	significant legal expenses and divert our management&#x2019;s
	attention from the operation of our business. If our operations are
	found to be in violation of any of the laws described above or any
	other governmental laws or regulations that apply to us, we may be
	subject to penalties, including administrative, civil and criminal
	penalties, damages, fines, disgorgement, the exclusion from
	participation in federal and state healthcare programs, individual
	imprisonment or the curtailment or restructuring of our operations,
	any of which could adversely affect our ability to operate our
	business and our financial results.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Generic Competition
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Orange Book Listing.
</FONT>
	In seeking
	approval for a drug through an NDA, applicants are required to list
	with the FDA each patent whose claims cover the applicant&#x2019;s
	product. Upon approval of a drug, the applicant identifies all
	patents that claim the approved product&#x2019;s active
	ingredient(s), the drug product&#x2019;s approved formulation, or an
	approved method of use of the drug. Each of the identified patents
	are then published in the FDA&#x2019;s Approved Drug Products with
	Therapeutic Equivalence Evaluations, commonly known as the Orange
	Book. Drugs listed in the Orange Book can, in turn, be cited by
	potential generic competitors in support of approval of an
	abbreviated new drug application, or ANDA. An ANDA provides for
	marketing of a drug product that has the same active ingredients in
	the same strengths and dosage form as the listed drug and has been
	shown through bioequivalence testing, unless such testing is waived
	by the FDA, as is the case with some injectable drug products, to
	be therapeutically equivalent to the listed drug. Other than
	bioequivalence testing, ANDA applicants are not required to
	conduct, or submit results of, preclinical or clinical tests to
	prove the safety or effectiveness of their drug product. Drugs
	approved in this way are commonly referred to as
	&#x2018;&#x2018;generic equivalents&#x2019;&#x2019; to the listed drug,
	and can usually be substituted by pharmacists under prescriptions
	written for the original listed drug.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	ANDA applicant is required to certify to the FDA concerning any
	patents listed for the approved product in the FDA&#x2019;s Orange
	Book. Specifically, the applicant must certify either that: (1) the
	required patent information has not been filed (a Paragraph I
	Certification); (2) the listed patent has expired (a Paragraph II
	Certification); (3) the listed patent has not expired, but will
	expire on a particular date and the generic approval is being
	sought only after patent expiration (a Paragraph III
	Certification); or (4) the listed patent is invalid, unenforceable,
	or will not be infringed by the proposed generic product (a
	Paragraph IV Certification). In certain circumstances, the ANDA
	applicant may also elect to submit a &#x2018;&#x2018;section
	(viii)&#x2019;&#x2019; statement instead of a Paragraph IV
	Certification, certifying that its proposed ANDA label does not
	contain (or carves out) any language regarding the patented
	method-of-use rather than certify to a listed method-of-use patent.
	If the application contains only Paragraph I or Paragraph II
	Certifications, the ANDA may be approved as soon as FDA completes
	its review and concludes that all approval requirements have been
	met. If the ANDA contains one or more Paragraph III Certifications,
	the ANDA cannot not be approved until each listed patent for which
	a Paragraph III Certification was filed have expired.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If the
	ANDA applicant has provided a Paragraph IV certification to the
	FDA, the applicant must also send notice of the Paragraph IV
	certification to the NDA holder and patent owner once the ANDA has
	been accepted for filing by the FDA. The patent owner or NDA holder
	may then commence a patent infringement lawsuit in response to the
	notice of the Paragraph IV certification. The filing of a patent
	infringement lawsuit within 45 days of the receipt of a Paragraph
	IV certification automatically prevents the FDA from approving the
	ANDA until the earlier of 30 months (the &#x2018;&#x2018;30-month
	stay&#x2019;&#x2019;), expiration of the patent, settlement of the
	lawsuit in which the patent owner admits that the patent is invalid
	or not infringed by the ANDA product, or a decision in the
	infringement case that holds the patent to be invalid or not
	infringed, or an order by the court shortening the 30-month stay
	due to actions by the patent holder to delay the litigation. In
	most circumstances, NDA holder is only eligible for one 30-month
	stay against an ANDA.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If a
	patent infringement action is filed against an ANDA applicant, any
	settlement of the litigation must be submitted to the Federal Trade
	Commission, or the FTC. If the FTC believes the terms or effects of
	the settlement are anticompetitive, FTC may bring an antitrust
	enforcement action against the parties. Private parties may also
	bring antitrust lawsuits against drug companies based on such
	patent litigation settlements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	ANDA also will not be approved until any applicable non-patent
	regulatory exclusivity listed in the Orange Book for the referenced
	product has expired.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Regulatory Exclusivity.
</FONT>
	Upon NDA
	approval of a new chemical entity or NCE, which is a drug that
	contains no active moiety that has been approved by the FDA in any
	other NDA, that drug receives five years of marketing exclusivity
	during which the FDA cannot receive for review any ANDA seeking
	approval of a generic version of that drug. An ANDA containing a
	Paragraph IV Certification may be received by FDA 4 years after the
	NCE drug&#x2019;s approval, but any 30-month stay that ensues would
	be extended so that it expires seven and one half years after the
	NCE approval date, subject to early termination by reason of a
	court decision or settlement as described above.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	15
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage18"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certain
	changes to an NDA drug, such as the addition of a new indication to
	the package insert, for which new clinical trials, conducted or
	sponsored by the applicant are deemed by FDA to be essential to the
	approval of the change, can be eligible for a three-year period of
	exclusivity during which the FDA cannot approve an ANDA for a
	generic drug that includes the change. An ANDA that contains a
	section (viii) statement to a method of use patent may be approved
	with labeling that omits the patented use before the use patent
	expires. Generic drugs approved with such a labeling carve out may
	be substituted by pharmacists for the original branded drug before
	the method of use patent expires.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Section 505(b)(2) New Drug
	Applications.
</FONT>
	Most drug products obtain FDA marketing
	approval pursuant to an NDA or an ANDA. A third alternative is a
	special type of NDA, commonly referred to as a 505(b)(2) NDA, which
	enables the applicant to rely, in part, on the FDA&#x2019;s previous
	approval of a similar product, or published literature, in support
	of its application.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	505(b)(2) NDAs
	often provide an alternate path to FDA approval for new or improved
	formulations or new uses of previously approved products. A
	505(b)(2) NDA may be used where at least some of the information
	required for approval comes from studies not conducted by, or for,
	the applicant and for which the applicant has not obtained a right
	of reference. If the 505(b)(2) applicant can establish that
	reliance on the FDA&#x2019;s previous approval is scientifically
	appropriate, it may eliminate the need to conduct certain
	preclinical or clinical studies of the new product. The FDA may
	also require companies to perform additional studies or
	measurements to support the change from the approved product. The
	FDA may then approve the new product candidate for all, or some, of
	the label indications for which the referenced product has been
	approved, as well as for any new indication or conditions of use
	sought by the Section 505(b)(2) applicant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	To the
	extent that the Section 505(b)(2) applicant is relying on studies
	conducted for an already approved product, the applicant is
	required to certify to the FDA concerning any patents listed for
	the approved product in the Orange Book to the same extent that an
	ANDA applicant would. As a result, approval of a 505(b)(2) NDA can
	be stalled until all the listed patents claiming the referenced
	product have expired, until any non-patent exclusivity, such as
	exclusivity for obtaining approval of a new chemical entity, listed
	in the Orange Book for the referenced product has expired, and, in
	the case of a Paragraph IV certification and subsequent patent
	infringement suit, until the expiration of any 30-month stay,
	subject to early termination of the stay as described
	above.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Changing Legal and Regulatory Landscape
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Periodically,
	legislation is introduced in the U.S. Congress that could change
	the statutory and regulatory provisions governing the approval,
	manufacturing and marketing of our drugs. In addition, the FDCA,
	FDA regulations and guidance are often revised or reinterpreted by
	the FDA or the courts in ways that may significantly affect our
	business and products. We cannot predict whether or when
	legislation or court decisions impacting our business will be
	enacted or issued, what FDA regulations, guidance or
	interpretations may change, or what the impact of such changes, if
	any, may be in the future.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Third-Party
	Reimbursements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Successful sales of
	our proposed products in the United States and other countries
	depend, in large part, on the availability of adequate
	reimbursement from third-party payers such as governmental
	entities, managed care organizations, health maintenance
	organizations, or HMOs, and private insurance plans. Reimbursement
	by a third-party payer depends on a number of factors, including
	the payer&#x2019;s determination that the product has been approved
	by the FDA for the indication for which the claim is being made,
	that it is neither experimental nor investigational, and that the
	use of the product is safe and efficacious, medically necessary,
	appropriate for the specific patient and cost
	effective.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Since
	reimbursement by one payer does not guarantee reimbursement by
	another, we or our licensees may be required to seek approval from
	each payer individually. Seeking such approvals is a time-consuming
	and costly process. Third-party payers routinely limit the products
	that they will cover and the amount of money that they will pay
	and, in many instances, are exerting significant pressure on
	medical suppliers to lower their prices.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Payers
	frequently employ a tiered system in reimbursing end users for
	pharmaceutical products, with tier designation affecting copay or
	deductible amounts. The only approved product for treating HSDD is
	flibanserin, sold under the trade name Addyi&#xAE;. There is
	significant uncertainty concerning the extent and scope of
	third-party reimbursement for products treating HSDD. Based on
	third-party reimbursement for approved products treating ED, we
	believe bremelanotide will be classified as a Tier 3 drug, so that
	reimbursement will be limited for bremelanotide for treatment of
	premenopausal women with HSDD, assuming the product is approved by
	the FDA. Less than full reimbursement by governmental and other
	third-party payers may adversely affect the market acceptance of
	bremelanotide. Further, healthcare reimbursement systems vary from
	country to country, and third-party reimbursement might not be made
	available for bremelanotide for HSDD under any other reimbursement
	system.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	16
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage19"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Manufacturing
	and Marketing
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	To be
	successful, our proposed products will need to be manufactured in
	commercial quantities under GMP prescribed by the FDA and at
	acceptable costs. We do not have the facilities to manufacture any
	of our proposed products under GMP. We intend to rely on
	collaborators, licensees or contract manufacturers for the
	commercial manufacture of our proposed products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	bremelanotide product candidate is a synthetic peptide. While the
	production process involves well-established technology, there are
	few manufacturers capable of scaling up to commercial quantities
	under GMP at acceptable costs. We have identified one third-party
	manufacturer for the production of bremelanotide, Lonza Ltd., and
	have validated manufacturing of the bremelanotide drug substance
	under GMP with that manufacturer. We are in the process of
	negotiating a long-term supply agreement with Lonza, and may not be
	able to enter into a supply agreement on acceptable terms, if at
	all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	bremelanotide product candidate will be a combination product,
	incorporating both the bremelanotide drug substance and a delivery
	device. We will rely on a third-party manufacturer, Ypsomed AG, to
	make the delivery device and to ensure its and the device&#x2019;s
	continued compliance with all FDA medical device regulations. We
	have selected an autoinjector pen delivery device, and are
	negotiating a long-term supply and manufacturing agreement, but may
	not be able to enter into such an agreement on acceptable terms, if
	at all. A third-party contract manufacturer, Catalent Belgium S.A.,
	performs fill, finish and packaging of our bremelanotide product
	candidate. We have negotiated a long-term commercial supply
	agreement with Catalent Belgium S.A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	PL-3994 product candidate is a peptide mimetic molecule,
	incorporating a proprietary amino acid mimetic structure and amino
	acids. We identified a manufacturer that made the product in
	quantities sufficient for Phase 1, and are evaluating
	commercial-scale manufacturers. Scaling up to commercial quantities
	may involve production, purification, formulation and other
	problems not present in the scale of manufacturing done to
	date.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	MC1r and MC4r agonist product candidates are synthetic peptides,
	which we have manufactured only at laboratory scale. We have not
	contracted with a third-party manufacturer to produce these
	synthetic peptides for either clinical trials or commercial
	purposes. While the production process involves well-established
	technology, there are few manufacturers capable of scaling up to
	commercial quantities under GMP at acceptable costs. Additionally,
	scaling up to commercial quantities may involve production,
	purification, formulation and other problems not present in the
	scale of manufacturing done to date.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	failure of any manufacturer or supplier to comply with FDA
	regulations, including GMP or medical device quality systems
	regulations, or QSR, or to supply the device component or drug
	substance and services as agreed, would force us to seek
	alternative sources of supply and could interfere with our ability
	to deliver product on a timely and cost effective basis or at all.
	Establishing relationships with new manufacturers or suppliers, any
	of whom must be FDA-approved, is a time-consuming and costly
	process.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Product
	Liability and Insurance
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	business may be affected by potential product liability risks that
	are inherent in the testing, manufacturing, marketing and use of
	our proposed products. We have liability insurance providing $10
	million coverage in the aggregate as to certain clinical trial
	risks.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Employees
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As of
	September 16, 2016, we employed 22 people full time, of whom 16 are
	engaged in research and development activities and 6 are engaged in
	administration and management, and had no part-time employees.
	While we have been successful in attracting skilled and experienced
	scientific personnel, competition for personnel in our industry is
	intense. None of our employees are covered by a collective
	bargaining agreement. All of our employees have executed
	confidentiality and intellectual property agreements. We consider
	relations with our employees to be good.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We rely
	on contractors and scientific consultants to work on specific
	research and development programs. We also rely on independent
	organizations, advisors and consultants to provide services,
	including aspects of manufacturing, testing, preclinical
	evaluation, clinical management, regulatory strategy and market
	research. Our independent advisors, contractors and consultants
	sign agreements that provide for confidentiality of our proprietary
	information and that we have the rights to any intellectual
	property developed while working for us.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Corporate
	Information
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We were
	incorporated under the laws of the State of Delaware on November
	21, 1986 and commenced operations in the biopharmaceutical area in
	1996. Our corporate offices are located at 4B Cedar Brook Drive,
	Cranbury, New Jersey 08512 and our telephone number is (609)
	495-2200. We maintain an Internet site at
<FONT STYLE="FONT-STYLE: ITALIC">
	www.palatin.com
</FONT>
	, where among other
	things, we make available free of charge on and through this
	website our Forms 3, 4 and 5, annual reports on Form 10-K,
	quarterly reports on Form 10-Q, current reports on Form 8-K, and
	amendments to those reports filed or furnished pursuant to Section
	13(a) or 15(d) and Section 16 of the Exchange Act as soon as
	reasonably practicable after we electronically file such material
	with, or furnish it to, the SEC. Our website and the information
	contained in it or connected to it are not incorporated into this
	prospectus. The reference to our website is an inactive textual
	reference only.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	17
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage20"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_BUSINESS>
</EFX_PART_I>
<EFX_RISK_FACTORS>
<A NAME="FIS_RISK_FACTORS"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	1A. Risk Factors.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Risks
	Related to Our Financial Results and Need for
	Financing
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our auditors have expressed substantial doubt about our ability to
	continue as a going concern. If we do not have sufficient funding,
	we may have to suspend or cease operations within twelve
	months.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	audited financial statements for the year ended June 30, 2016 were
	prepared using the assumption that we will continue our operations
	as a going concern. As of June 30, 2016, we had an accumulated
	deficit of $343,412,252 and stockholders&#x2019; deficiency of
	$17,585,967. As a result, our independent registered public
	accounting firm, in their audit report, has expressed substantial
	doubt about our ability to continue as a going concern. Continued
	operations are dependent on our ability to complete equity or debt
	financing activities or collaboration arrangements or to generate
	positive cash flow from operations, neither of which is certain. We
	believe that if we do not have sufficient funding, we may have to
	curtail or cease certain programs or operations within twelve
	months. Therefore, we may be unable to continue operations in the
	future as a going concern. If we cannot continue as a viable
	entity, our stockholders may lose some or all of their investment
	in the Company. Investors in our securities should review carefully
	the report of our independent registered public accounting firm
	included in this Annual Report.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have a history of substantial net losses and expect to continue
	to incur substantial net losses over the next few years; we may
	never achieve or maintain profitability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	never been profitable and we may never become profitable. As of
	June 30, 2016, we had an accumulated deficit of $343,412,252. We
	expect to incur additional losses as we continue our development of
	bremelanotide, PL-3994 and other product candidates. These losses,
	among other things, have had and will continue to have an adverse
	effect on our stockholders&#x2019; equity, total assets and working
	capital.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Since
	2005 we have not had any products available for commercial sale and
	have received no revenues from the sale of our product candidates.
	For the foreseeable future, we will have to fund all of our
	operations and capital expenditures from license and contract
	revenue under collaborative development agreements, existing cash
	balances and outside sources of financing, which may not be
	available on acceptable terms, if at all. Unless and until we
	receive approval from the FDA or other equivalent regulatory
	authorities outside the United States, we cannot sell our products
	and will not have product revenues from them. We have devoted
	substantially all of our efforts to research and development,
	including preclinical and clinical trials. Because of the numerous
	risks associated with developing drugs, we are unable to predict
	the extent of future losses, whether or when any of our product
	candidates will become commercially available, or when we will
	become profitable, if at all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We will need additional financing, including financing to submit
	required regulatory applications to the FDA for bremelanotide for
	HSDD and to complete clinical trials for our other product
	candidates, which may be difficult to obtain.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As of
	June 30, 2016, we had cash, cash equivalents and investments of
	$9,383,224, with current liabilities of $13,994,439. On August 4,
	2016, we closed on an equity private placement, with net proceeds
	of approximately $8,500,000. We believe we currently have
	sufficient existing capital resources to fund our planned
	operations through the anticipated release date of topline data
	from the double blind efficacy portion of our Phase 3 trial and
	through the quarter ending December 31, 2016. We will need
	additional funding to complete development of our bremelanotide for
	HSDD program, including completing ancillary studies and clinical
	trials, completing certain chemistry, manufacturing and controls
	activities, preparing and submitting regulatory filings for product
	approval, and launch readiness commercialization efforts. We will
	also need additional funding to conduct and complete required
	clinical trials for our other product candidates and, assuming
	those clinical trials are successful, as to which there can be no
	assurance, to complete submission of required regulatory
	applications to the FDA.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	completed the last patient visits in the double blind portion of
	our Phase 3 clinical trial of bremelanotide for HSDD, and have
	adequate funds to analyze the efficacy data and disclose results.
	However, we do not have adequate funds to complete the open-label
	safety extension study, all ancillary studies and clinical trials
	required for submission of an NDA to FDA for approval of
	bremelanotide for HSDD, or to prepare and submit the NDA to FDA. We
	may be required to curtail or delay our bremelanotide for HSDD
	program unless we have adequate funds to complete the program. We
	estimate that the bremelanotide for HSDD program, including
	regulatory filings for product approval, will cost at least
	$87,000,000, of which approximately $57,000,000 has been expensed
	to date. We will seek funds to support the program through
	collaborative arrangements on bremelanotide, including marketing
	and distribution partnering agreements, public or private equity or
	debt financings, and other sources, but such additional funding may
	not be available on acceptable terms, or at all.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage21"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We do
	not have any source of significant recurring revenue and must
	depend on financing or partnering to sustain our operations. We may
	raise additional funds through public or private equity or debt
	financings, collaborative arrangements on our product candidates,
	or other sources. However, additional funding may not be available
	on acceptable terms, or at all. To obtain additional funding, we
	may need to enter into arrangements that require us to develop only
	certain of our product candidates or relinquish rights to certain
	technologies, product candidates and/or potential
	markets.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we
	are unable to raise sufficient additional funds when needed, we may
	be required to curtail operations significantly, cease clinical
	trials and decrease staffing levels. We may seek to license, sell
	or otherwise dispose of our product candidates, technologies and
	contractual rights on the best possible terms available. Even if we
	are able to license, sell or otherwise dispose of our product
	candidates, technologies and contractual rights, it is likely to be
	on unfavorable terms and for less value than if we had the
	financial resources to develop or otherwise advance our product
	candidates, technologies and contractual rights
	ourselves.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	future capital requirements depend on many factors,
	including:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the results of our
	Phase 3 clinical trials for bremelanotide for HSDD;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the timing of, and
	the costs involved in, obtaining regulatory approvals for
	bremelanotide for HSDD and our other product
	candidates;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the number and
	characteristics of any additional product candidates we develop or
	acquire;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the scope,
	progress, results and costs of researching and developing
	bremelanotide for HSDD, PL-3994 or any future product candidates,
	and conducting preclinical and clinical trials;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the cost of
	commercialization activities if bremelanotide for HSDD, PL-3994 or
	any future product candidates are approved for sale, including
	marketing, sales and distribution costs;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the cost of
	manufacturing bremelanotide for HSDD, PL-3994 or any future product
	candidates and any products we successfully commercialize and
	maintaining our related facilities;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	establish and maintain strategic collaborations, licensing or other
	arrangements and the terms and timing of such
	arrangements;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the degree and rate
	of market acceptance of any future approved products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the emergence,
	approval, availability, perceived advantages, relative cost,
	relative safety and relative efficacy of alternative and competing
	products or treatments;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	any product
	liability or other lawsuits related to our products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the expenses needed
	to attract and retain skilled personnel;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the costs involved
	in preparing, filing, prosecuting, maintaining, defending and
	enforcing patent claims, including litigation costs and the outcome
	of such litigation; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the timing, receipt
	and amount of sales of, or royalties on, future approved products,
	if any.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have a limited operating history upon which to base an
	investment decision.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	operations are primarily focused on acquiring, developing and
	securing our proprietary technology, conducting preclinical and
	clinical studies and formulating and manufacturing on a small-scale
	basis our principal product candidates. These operations provide a
	limited basis for stockholders to assess our ability to
	commercialize our product candidates.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	not yet demonstrated our ability to perform the functions necessary
	for the successful commercialization of any of our current product
	candidates. The successful commercialization of our product
	candidates will require us to perform a variety of functions,
	including:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	continuing to
	conduct preclinical development and clinical trials;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	participating in
	regulatory approval processes;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	formulating and
	manufacturing products, or having third parties formulate and
	manufacture products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	post-approval
	monitoring and surveillance of our products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	conducting sales
	and marketing activities, either alone or with a partner;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	obtaining
	additional capital.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we
	are unable to obtain regulatory approval of any of our product
	candidates, to successfully commercialize any products for which we
	receive regulatory approval or to obtain additional capital, we may
	not be able to recover our investment in our development
	efforts.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	19
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage22"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	clinical and commercial success of our product candidates will
	depend on a number of factors, including the
	following:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the ability to
	raise additional capital on acceptable terms, or at
	all;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	timely completion
	of our clinical trials, which may be significantly slower or cost
	more than we currently anticipate and will depend substantially
	upon the performance of third-party contractors;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	whether we are
	required by the FDA or similar foreign regulatory agencies to
	conduct additional clinical trials beyond those planned to support
	the approval and commercialization of our product candidates or any
	future product candidates;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	acceptance of our
	proposed indications and primary endpoint assessments relating to
	the proposed indications of our product candidates by the FDA and
	similar foreign regulatory authorities;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	demonstrate to the satisfaction of the FDA and similar foreign
	regulatory authorities, the safety and efficacy of our product
	candidates or any future product candidates;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the prevalence,
	duration and severity of potential side effects experienced with
	our product candidates or future approved products, if
	any;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the timely receipt
	of necessary marketing approvals from the FDA and similar foreign
	regulatory authorities;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	achieving and
	maintaining, and, where applicable, ensuring that our third-party
	contractors achieve and maintain, compliance with our contractual
	obligations and with all regulatory requirements applicable to our
	product candidates or any future product candidates or approved
	products, if any;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the ability of
	third parties with whom we contract to manufacture clinical trial
	and commercial supplies of our product candidates or any future
	product candidates, remain in good standing with regulatory
	agencies and develop, validate and maintain commercially viable
	manufacturing processes that are compliant with GMP;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	a continued
	acceptable safety profile and efficacy during clinical development
	and following approval of our product candidates or any future
	product candidates;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	successfully commercialize our product candidates or any future
	product candidates in the United States and internationally, if
	approved for marketing, sale and distribution in such countries and
	territories, whether alone or in collaboration with
	others;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	acceptance by
	physicians and patients of the benefits, safety and efficacy of our
	product candidates or any future product candidates, if approved,
	including relative to alternative and competing
	treatments;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our and our
	partners&#x2019; ability to establish and enforce intellectual
	property rights in and to our product candidates or any future
	product candidates;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our and our
	partners&#x2019; ability to avoid third-party patent interference or
	intellectual property infringement claims; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	in-license or acquire additional product candidates or
	commercial-stage products that we believe can be successfully
	developed and commercialized.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we
	do not achieve one or more of these factors, many of which are
	beyond our control, in a timely manner or at all, we could
	experience significant delays or an inability to obtain regulatory
	approvals or commercialize our product candidates. Even if
	regulatory approvals are obtained, we may never be able to
	successfully commercialize any of our product candidates.
	Accordingly, we cannot assure you that we will be able to generate
	sufficient revenue through the sale of our product candidates or
	any future product candidates to continue our
	business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Raising additional capital may cause dilution to existing
	shareholders, restrict our operations or require us to relinquish
	rights.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may
	seek the additional capital necessary to fund our operations
	through public or private equity offerings, collaboration
	agreements, debt financings or licensing arrangements. To the
	extent that we raise additional capital through the sale of equity
	or convertible debt securities, existing shareholders&#x2019;
	ownership interests will be diluted and the terms may include
	liquidation or other preferences that adversely affect their rights
	as a shareholder. Debt financing, if available, may involve
	agreements that include covenants limiting or restricting our
	ability to take specific actions such as incurring additional debt,
	making capital expenditures or declaring dividends. If we raise
	additional funds through collaborations and licensing arrangements
	with third parties, we may have to relinquish valuable rights to
	our technologies or product candidates, or grant licenses on terms
	that are not favorable to us.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	20
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage23"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Risks
	Related to Our Business, Strategy and Industry
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are substantially dependent on the clinical and commercial
	success of our product candidates, primarily our lead product
	candidate, bremelanotide for HSDD, which is in Phase 3 clinical
	development. We cannot be certain that we will be able to obtain
	regulatory approval for or successfully commercialize any of our
	product candidates.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	To
	date, we have invested most of our efforts and financial resources
	in the research and development of bremelanotide for HSDD, which is
	currently our lead product candidate. We have completed the last
	patient visit in the double blind efficacy portion of our Phase 3
	RECONNECT STUDY for bremelanotide for HSDD. Our near-term
	prospects, including our ability to finance our company and
	generate revenue, will depend heavily on the successful
	development, regulatory approval and commercialization of
	bremelanotide for HSDD, as well as any future product candidates.
	The clinical and commercial success of our product candidates will
	depend on a number of factors, including the
	following:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	timely completion
	of, or need to conduct additional, clinical trials, including for
	bremelanotide for HSDD, which may be significantly slower or cost
	more than we currently anticipate and will depend substantially
	upon the accurate and satisfactory performance of third-party
	contractors;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	demonstrate to the satisfaction of the FDA the safety and efficacy
	of bremelanotide for HSDD or any future product candidates through
	clinical trials;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	whether we are
	required by the FDA or other similar foreign regulatory agencies to
	conduct additional clinical trials to support the approval of
	bremelanotide for HSDD or any future product
	candidates;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the acceptance of
	parameters for regulatory approval, including our proposed
	indication, primary endpoint assessment and primary endpoint
	measurement, relating to our lead indications of bremelanotide for
	HSDD;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our success in
	educating physicians and patients about the benefits,
	administration and use of bremelanotide for HSDD or any future
	product candidates, if approved;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the prevalence and
	severity of adverse events experienced with bremelanotide for HSDD
	or any future product candidates or approved products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the adequacy and
	regulatory compliance of the autoinjector device, supplied by an
	unaffiliated third party, to be used as part of our bremelanotide
	combination product;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the timely receipt
	of necessary marketing approvals from the FDA and similar foreign
	regulatory authorities;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	raise additional capital on acceptable terms to achieve our
	goals;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	achieving and
	maintaining compliance with all regulatory requirements applicable
	to bremelanotide for HSDD or any future product candidates or
	approved products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the availability,
	perceived advantages, relative cost, relative safety and relative
	efficacy of alternative and competing treatments;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the effectiveness
	of our own or our future potential strategic collaborators&#x2019;
	marketing, sales and distribution strategy and
	operations;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	manufacture clinical trial supplies of bremelanotide for HSDD or
	any future product candidates and to develop, validate and maintain
	a commercially viable manufacturing process that is compliant with
	current GMP;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	successfully commercialize bremelanotide for HSDD or any future
	product candidates, if approved for marketing and sale, whether
	alone or in collaboration with others;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	enforce our intellectual property rights in and to bremelanotide
	for HSDD or any future product candidates;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our ability to
	avoid third-party patent interference or intellectual property
	infringement claims;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	acceptance of
	bremelanotide for HSDD or any future product candidates, if
	approved, as safe and effective by patients and the medical
	community; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	a continued
	acceptable safety profile and efficacy of bremelanotide for HSDD or
	any future product candidates following approval.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we
	do not achieve one or more of these factors, many of which are
	beyond our control, in a timely manner or at all, we could
	experience significant delays or an inability to successfully
	commercialize our product candidates. Accordingly, we cannot assure
	you that we will be able to generate sufficient revenue through the
	sale of bremelanotide for HSDD or any future product candidate to
	continue our business. In addition to preventing us from executing
	our current business plan, any delays in our clinical trials, or
	inability to successfully commercialize our products could impair
	our reputation in the industry and the investment community, and
	could hinder our ability to fulfill our existing contractual
	commitments. As a result, our share price would likely decline
	significantly, and we would have difficulty raising necessary
	capital for future projects.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	21
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage24"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Most of our product candidates are still in the early stages of
	development, and all of our product candidates remain subject to
	clinical testing and regulatory approval. If we are unable to
	successfully develop and test our product candidates, we will not
	be successful.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	product candidates are at various stages of research and
	development, will require regulatory approval, and may never be
	successfully developed or commercialized. Our product candidates
	will require significant further research, development and testing
	before we can seek regulatory approval to market and sell them. We
	must demonstrate that our product candidates are safe and effective
	for use in patients in order to receive regulatory approval for
	commercial sale. Preclinical studies in animals, using various
	doses and formulations, must be performed before we can begin human
	clinical trials. Even if we obtain favorable results in the
	preclinical studies, the results in humans may be different.
	Numerous small-scale human clinical trials may be necessary to
	obtain initial data on a product candidate&#x2019;s safety and
	efficacy in humans before advancing to large scale human clinical
	trials. We face the risk that the results of our trials in later
	phases of clinical trials may be inconsistent with those obtained
	in earlier phases. Adverse or inconclusive results could delay the
	progress of our development programs and may prevent us from filing
	for regulatory approval of our product candidates. Additional
	factors that could inhibit the successful development of our
	product candidates include:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	lack of
	effectiveness of any product candidate during clinical trials or
	the failure of our product candidates to meet specified
	endpoints;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	failure to design
	appropriate clinical trial protocols;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	uncertainty
	regarding proper dosing;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	inability to
	develop or obtain a supplier for an autoinjector device that meets
	the FDA&#x2019;s medical device requirements;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	insufficient data
	to support regulatory approval;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	inability or
	unwillingness of medical investigators to follow our clinical
	protocols;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	inability to add a
	sufficient number of clinical trial sites; or
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the availability of
	sufficient capital to sustain operations and clinical
	trials.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	You
	should evaluate us in light of these uncertainties, difficulties
	and expenses commonly experienced by early stage biopharmaceutical
	companies, as well as unanticipated problems and additional costs
	relating to:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	product approval or
	clearance;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	regulatory
	compliance;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	good manufacturing
	practices;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	intellectual
	property rights;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	product
	introduction; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	marketing and
	competition.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If clinical trials for our product candidates are prolonged or
	delayed, we may be unable to commercialize our product candidates
	on a timely basis, which would require us to incur additional costs
	and delay our receipt of any revenue from potential product
	sales.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may
	be unable to commercialize our product candidates on a timely basis
	due to unexpected delays in our human clinical trials. Potential
	delaying events include:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	discovery of
	serious or unexpected toxicities or side effects experienced by
	study participants or other safety issues;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	slower than
	expected rates of subject recruitment and enrollment rates in
	clinical trials resulting from numerous factors, including the
	prevalence of other companies&#x2019; clinical trials for their
	product candidates for the same indication, or clinical trials for
	indications for which patients do not as commonly seek
	treatment;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	difficulty in
	retaining subjects who have initiated a clinical trial but may
	withdraw at any time due to adverse side effects from the therapy,
	insufficient efficacy, fatigue with the clinical trial process or
	for any other reason;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	difficulty in
	obtaining institutional review board, or IRB, approval for studies
	to be conducted at each site;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	delays in
	manufacturing or obtaining, or inability to manufacture or obtain,
	sufficient quantities of materials for use in clinical
	trials;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	inadequacy of or
	changes in our manufacturing process or the product formulation or
	method of delivery;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	changes in
	applicable laws, regulations and regulatory policies;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	22
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage25"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	delays or failure
	in reaching agreement on acceptable terms in clinical trial
	contracts or protocols with prospective contract research
	organizations, or CROs, clinical trial sites and other third-party
	contractors;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	failure of our CROs
	or other third-party contractors to comply with contractual and
	regulatory requirements or to perform their services in a timely or
	acceptable manner;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	failure by us, our
	employees, our CROs or their employees or any partner with which we
	may collaborate or their employees to comply with applicable FDA or
	other regulatory requirements relating to the conduct of clinical
	trials or the handling, storage, security and recordkeeping for
	drug, medical device and biologic products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	delays in the
	scheduling and performance by the FDA of required inspections of
	us, our CROs, our suppliers, or our clinical trial sites, and
	violations of law or regulations by discovered in the course of FDA
	inspections;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	scheduling
	conflicts with participating clinicians and clinical institutions;
	or
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	difficulty in
	maintaining contact with subjects during or after treatment, which
	may result in incomplete data.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Any of
	these events or other delaying events, individually or in the
	aggregate, could delay the commercialization of our product
	candidates and have a material adverse effect on our business,
	results of operations and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may not be able to secure and maintain research institutions to
	conduct our clinical trials.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We rely
	on research institutions to conduct our clinical trials, and we
	therefore have limited control over the timing and cost of clinical
	trials and our ability to recruit subjects. If we are unable to
	reach agreements with suitable research institutions on acceptable
	terms, or if any such agreement is terminated, we may be unable to
	quickly replace the research institution with another qualified
	institution on acceptable terms. We may not be able to secure and
	maintain suitable research institutions to conduct our clinical
	trials.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Even if our product candidates receive regulatory approval, they
	may never achieve market acceptance, in which case our business,
	financial condition and results of operation will be materially
	adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Regulatory approval
	for the marketing and sale of any of our product candidates does
	not assure the product&#x2019;s commercial success. Any approved
	product will compete with other products manufactured and marketed
	by major pharmaceutical and other biotechnology companies. If any
	of our product candidates are approved by the FDA and do not
	achieve adequate market acceptance, our business, financial
	condition and results of operations will be materially adversely
	affected. The degree of market acceptance of any such product will
	depend on a number of factors, including:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	perceptions by
	members of the healthcare community, including physicians, about
	the safety and effectiveness of any such product;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	cost-effectiveness
	relative to competing products and technologies;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	availability of
	reimbursement for our products from third-party payers such as
	health insurers, health maintenance organizations and government
	programs such as Medicare and Medicaid; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	advantages over
	alternative treatment methods.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	is one FDA approved product for treatment of HSDD, flibanserin,
	which is sold under the trade name Addyi&#xAE;, and started
	marketing in October 2015. The actual market size and market
	dynamics for HSDD are unknown, and there is significant uncertainty
	concerning the extent and scope of third-party reimbursement for
	products treating HSDD. While we believe that an on-demand drug for
	HSDD has competitive advantages compared to chronic or daily use
	hormones and other drugs, we may not be able to realize this
	perceived advantage in the market. Bremelanotide is administered by
	subcutaneous injection. While the single-use, disposable
	autoinjector pen format is designed to maximize market
	acceptability, bremelanotide as a subcutaneous injectable drug for
	HSDD may never achieve significant market acceptance. In addition,
	we believe reimbursement of bremelanotide from third-party payers
	such as health insurers, HMOs or other third-party payers of
	healthcare costs will be similar to reimbursement for ED drugs, and
	that the ultimate user may pay a substantial part of the cost of
	bremelanotide for HSDD. If the market opportunity for bremelanotide
	is smaller than we anticipate, it may also be difficult for us to
	find marketing partners and, as a result, we may be unable to
	generate revenue and business from bremelanotide. If bremelanotide
	for HSDD does not achieve adequate market acceptance at an
	acceptable price point, our business, financial condition and
	results of operations will be materially adversely
	affected.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	23
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage26"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Even if our product candidates receive regulatory approval in the
	United States, we may never receive approval or commercialize our
	products outside of the United States.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	order to market any products outside of the United States, we must
	establish and comply with numerous and varying regulatory
	requirements of other countries regarding safety and efficacy.
	Approval procedures vary among countries and can involve additional
	product testing and additional administrative review periods. The
	time required to obtain approval in other countries might differ
	from that required to obtain FDA approval. The regulatory approval
	process in other countries may include all of the risks detailed
	above regarding FDA approval in the United States as well as other
	risks. Regulatory approval in one country does not ensure
	regulatory approval in another, but a failure or delay in obtaining
	regulatory approval in one country may have a negative effect on
	the regulatory process in others. Failure to obtain regulatory
	approval in other countries or any delay or setbacks in obtaining
	such approval would impair our ability to develop foreign markets
	for our product candidates and may have a material adverse effect
	on our results of operations and financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If side effects emerge that can be linked to our product candidates
	(either while they are in development or after they are approved
	and on the market), we may be required to perform lengthy
	additional clinical trials, change the labeling of any such
	products, or withdraw such products from the market, any of which
	would hinder or preclude our ability to generate
	revenues.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we
	identify side effects or other problems occur in future clinical
	trials, we may be required to terminate or delay clinical
	development of the product candidate. Furthermore, even if any of
	our product candidates receive marketing approval, as greater
	numbers of patients use a drug following its approval, if the
	incidence of side effects increases or if other problems are
	observed after approval that were not seen or anticipated during
	pre-approval clinical trials, a number of potentially significant
	negative consequences could result, including:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	regulatory
	authorities may withdraw their approval of the
	product;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	we may be required
	to reformulate such products or change the way the product is
	manufactured;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	we may become the
	target of lawsuits, including class action suits; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	our reputation in
	the market place may suffer resulting in a significant drop in the
	sales of such products.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Any of
	these events could substantially increase the costs and expenses of
	developing, commercializing and marketing any such product
	candidates or could harm or prevent sales of any approved
	products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The number of subjects in our study pools in our clinical trials
	may be deemed by regulators to be too small, which could cause
	unanticipated delays or higher than anticipated costs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	clinical trials have been conducted on a pool of subjects that is
	structured for such research. Nevertheless, there is the
	possibility that for statistical reasons, the pool of subjects may
	be determined by the FDA or another regulatory body to be too small
	to verify statistical significance. In such a case, the conclusions
	from the previous trials will need to be established with at least
	another set of clinical trials testing the relevant issue. Due to
	the need to find new subjects for any additional clinical trials
	and the limited pool from which such subjects can be selected, any
	such determination by the FDA could result in a delay in obtaining
	FDA approval or require additional financial
	expenditures.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may not be able to keep up with the rapid technological change
	in the biotechnology and pharmaceutical industries, which could
	make any future approved products obsolete and reduce our
	revenue.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Biotechnology and
	related pharmaceutical technologies have undergone and continue to
	be subject to rapid and significant change. Our future will depend
	in large part on our ability to maintain a competitive position
	with respect to these technologies. Our competitors may render our
	technologies obsolete by advances in existing technological
	approaches or the development of new or different approaches,
	potentially eliminating the advantages in our drug discovery
	process that we believe we derive from our research approach and
	proprietary technologies. In addition, any future products that we
	develop, including our clinical product candidates, may become
	obsolete before we recover expenses incurred in developing those
	products, which may require that we raise additional funds to
	continue our operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Competing products and technologies may make our proposed products
	noncompetitive.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Flibanserin, a
	daily-use oral drug sold under the trade name Addyi&#xAE;, has been
	approved by the FDA for HSDD in premenopausal women. There are
	other products being developed for HSDD and other FSD indications,
	including a number of oral combination drugs, some of which
	incorporate testosterone, antidepressants or PDE-5 inhibitors.
	There is competition to develop drugs for treatment of HSDD and FSD
	in both premenopausal and postmenopausal patients. Our
	bremelanotide drug product is intended to be administered by
	subcutaneous injection, and an as needed drug product for the same
	indication which utilizes another route of administration, such as
	a conventional oral drug product, may make subcutaneous
	bremelanotide noncompetitive.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	24
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage27"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	are three oral FDA-approved PDE-5 inhibitor drugs for the treatment
	of ED, other approved products and devices for ED, and other
	products in development for treatment of ED, including products in
	clinical trials. There is competition to develop drugs for ED in
	patients non-responsive to PDE-5 inhibitor drugs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	are several products approved for use in treatment of obesity and
	related indications, and a number of other products being developed
	for treatment of obesity, including products in clinical trials.
	There is intense competition to develop drugs for treatment of
	obesity and related indications.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	are a number of products approved for use in treating inflammatory
	diseases and dermatologic indication, and other products being
	developed, including products in clinical trials.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	aware of one recombinant natriuretic peptide product for acutely
	decompensated congestive heart failure approved and marketed in the
	United States, and another recombinant natriuretic peptide product
	approved and marketed in Japan. Clinical trials on other
	natriuretic peptide products are being conducted in the United
	States. In addition, other products for treatment of heart failure
	are either currently being marketed or in development, including a
	combination drug which increases active levels of ANP.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	are numerous products approved for use in treatment of asthma, and
	a number of other products being developed for treatment of acute
	exacerbations of asthma, including products in clinical trials.
	There is intense competition to develop drugs for treatment of
	acute exacerbations of asthma.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As
	discussed above, the biopharmaceutical industry is highly
	competitive. We are likely to encounter significant competition
	with respect to bremelanotide, other melanocortin receptor agonist
	compounds and PL-3994. Most of our competitors have substantially
	greater financial and technological resources than we do. Many of
	them also have significantly greater experience in research and
	development, marketing, distribution and sales than we do.
	Accordingly, our competitors may succeed in developing, marketing,
	distributing and selling products and underlying technologies more
	rapidly than we can. These competitive products or technologies may
	be more effective and useful or less costly than bremelanotide,
	other melanocortin receptor agonist compounds or PL-3994. In
	addition, academic institutions, hospitals, governmental agencies
	and other public and private research organizations are also
	conducting research and may develop competing products or
	technologies on their own or through strategic alliances or
	collaborative arrangements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We rely on third parties over whom we have no control to conduct
	preclinical studies, clinical trials and other research for our
	product candidates and their failure to timely perform their
	obligations could significantly harm our product
	development.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	limited research and development staff and do not have dedicated
	research or development facilities. We rely on third parties and
	independent contractors, such as researchers at CROs and
	universities, in certain areas that are particularly relevant to
	our research and product development plans. We engage such
	researchers to conduct our preclinical studies, clinical trials and
	associated tests. These outside contractors are not our employees
	and may terminate their engagements with us at any time. In
	addition, we have limited control over the resources that these
	contractors devote to our programs and they may not assign as great
	a priority to our programs or pursue them as diligently as we would
	if we were undertaking such programs ourselves. There is also
	competition for these relationships, and we may not be able to
	maintain our relationships with our contractors on acceptable
	terms. If our third-party contractors do not carry out their duties
	under their agreements with us, fail to meet expected deadlines or
	fail to comply with appropriate standards for preclinical or
	clinical research, our ability to develop our product candidates
	and obtain regulatory approval on a timely basis, if at all, may be
	materially adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Production and supply of our product candidates depend on contract
	manufacturers over whom we have no control, with the risk that we
	may not have adequate supplies of our product candidates or
	products.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We do
	not have the facilities to manufacture the bremelanotide active
	drug ingredient, the autoinjector pen component of our
	bremelanotide combination product, or to fill, assemble and package
	our bremelanotide combination product, or to manufacture any of our
	other potential products such as PL-3994, PL-8177 and other
	melanocortin receptor agonist compounds. Our contract manufacturers
	must perform these manufacturing activities in a manner that
	complies with FDA regulations. Our ability to control third-party
	compliance with FDA requirements is limited to contractual remedies
	and rights of inspection. The manufacturers of approved products
	and their manufacturing facilities will be subject to continual
	review and periodic inspections by the FDA and other authorities
	where applicable, and must comply with ongoing regulatory
	requirements, including FDA regulations concerning GMP. Failure of
	third-party manufacturers to comply with GMP, medical device QSR,
	or other FDA requirements may result in enforcement action by the
	FDA. Failure to conduct their activities in compliance with FDA
	regulations could delay our development programs or negatively
	impact our ability to receive FDA approval of our potential
	products or continue marketing if they are approved. Establishing
	relationships with new suppliers, who must be FDA-approved, is a
	time-consuming and costly process.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	25
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage28"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Reliance on
	third-party manufacturers entails risk, to which we would not be
	subject if we manufactured product candidates or products
	ourselves, including:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	reliance on the
	third party for regulatory compliance and quality
	assurance;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the possible breach
	of the manufacturing agreement by the third party because of
	factors beyond our control;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the possible
	termination or non-renewal of the agreement by the third party,
	based on its own business priorities, at a time that is costly or
	inconvenient for us; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	drug product
	supplies not meeting the requisite requirements for clinical trial
	use.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we
	are not able to obtain adequate supplies of our product candidates,
	it will be more difficult for us to develop our product candidates
	and compete effectively. Our product candidates and any products
	that we and/or our potential future collaborators may develop may
	compete with other product candidates and products for access to
	manufacturing facilities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we are unable to establish sales and marketing capabilities
	within our organization or enter into and maintain agreements with
	third parties to market and sell our product candidates, we may be
	unable to generate product revenue.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We do
	not currently have any experience in sales, marketing and
	distribution of pharmaceutical products. We will need to establish
	sales and marketing capabilities within our organization or
	establish and maintain agreements with third parties to market and
	sell our product candidates. We do not have marketing partners for
	any of our products, including bremelanotide and PL-3994. If any of
	these products are approved by the FDA or other regulatory
	authorities, we must either develop marketing, distribution and
	selling capacity and expertise, which will be costly and time
	consuming, or enter into agreements with other companies to provide
	these capabilities. We may not be able to enter into suitable
	agreements on acceptable terms, if at all. Engaging a third party
	to perform these services could delay the commercialization of any
	of our product candidates, if approved for commercial sale. If we
	are unable to establish adequate sales, marketing and distribution
	capabilities, whether independently or with third parties, we may
	not be able to generate product revenue and our business would
	suffer. In addition, if we enter into arrangements with third
	parties to perform sales, marketing and distribution services, our
	product revenues are likely to be lower than if we could market and
	sell any products that we develop ourselves.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We will need to hire additional employees in order to commercialize
	our product candidates in the future. Any inability to manage
	future growth could harm our ability to commercialize our product
	candidates, increase our costs and adversely impact our ability to
	compete effectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	order to commercialize our product candidates, we will need to hire
	experienced sales and marketing personnel to sell and market those
	product candidates we decide to commercialize, and we will need to
	expand the number of our managerial, operational, financial and
	other employees to support commercialization. Competition exists
	for qualified personnel in the biopharmaceutical
	field.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Future
	growth will impose significant added responsibilities on members of
	management, including the need to identify, recruit, maintain and
	integrate additional employees. Our future financial performance
	and our ability to commercialize our product candidates and to
	compete effectively will depend, in part, on our ability to manage
	any future growth effectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our ability to achieve revenues from the sale of our products in
	development will depend, in part, on our ability to obtain adequate
	reimbursement from Medicare, Medicaid, private insurers and other
	healthcare payers.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	ability to successfully commercialize our products in development
	will depend, in significant part, on the extent to which we or our
	marketing partners can obtain reimbursement for our products and
	also reimbursement at appropriate levels for the cost of our
	products. Obtaining reimbursement from governmental payers,
	insurance companies, HMOs and other third-party payers of
	healthcare costs is a time-consuming and expensive process. There
	is no guarantee that our products will ultimately be reimbursed.
	There is significant uncertainty concerning third-party
	reimbursement for the use of any pharmaceutical product
	incorporating new technology and third-party reimbursement might
	not be available for our proposed products once approved, or if
	obtained, might not be adequate.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	is significant uncertainty concerning the extent and scope of
	third-party reimbursement for products treating HSDD and other
	forms of FSD. Based on third-party reimbursement for approved
	products treating ED, we believe bremelanotide for HSDD will be
	classified as a Tier 3 drug, so that reimbursement will be limited
	for bremelanotide for treatment of premenopausal women with HSDD,
	assuming the product is approved by the FDA. If we are able to
	obtain reimbursement, continuing efforts by governmental and
	third-party payers to contain or reduce costs of healthcare may
	adversely affect our future revenues and ability to achieve
	profitability. Third-party payers are increasingly challenging the
	prices charged for diagnostic and therapeutic products and related
	services. Reimbursement from governmental payers is subject to
	statutory and regulatory changes, retroactive rate adjustments,
	administrative rulings and other policy changes, all of which could
	materially decrease the range of products for which we are
	reimbursed or the rates of reimbursement by government payers. In
	addition, recent legislation reforming the healthcare system may
	result in lower prices or the actual inability of prospective
	customers to purchase our products in development. The cost
	containment measures that healthcare payers and providers are
	instituting and the effect of any healthcare reform could
	materially and adversely affect our ability to operate profitably.
	Furthermore, even if reimbursement is available, it may not be
	available at price levels sufficient for us to realize a positive
	return on our investment, which would have a material adverse
	effect on our business, financial condition and results of
	operations.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	26
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage29"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Even if we receive regulatory approval for our products in Europe,
	we may not be able to secure adequate pricing and reimbursement in
	Europe for us or any strategic partner to achieve
	profitability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Even if
	one or more of our products are approved in Europe, we may be
	unable to obtain appropriate pricing and reimbursement for such
	products. In most European markets, demand levels for healthcare in
	general and for pharmaceuticals in particular are principally
	regulated by national governments. Therefore, pricing and
	reimbursement for our products will have to be negotiated on a
	&#x201C;Member State by Member State&#x201D; basis according to
	national rules, as there does not exist a centralized European
	process. As each Member State has its own national rules governing
	pricing control and reimbursement policy for pharmaceuticals, there
	are likely to be uncertainties attaching to the review process, and
	the level of reimbursement that national governments are prepared
	to accept. In the current economic environment, governments and
	private payers or insurers are increasingly looking to contain
	healthcare costs, including costs on drug therapies. If we are
	unable to obtain adequate pricing and reimbursement for our
	products in Europe, we or a potential strategic partner or
	collaborator may not be able to cover the costs necessary to
	manufacture, market and sell the product, limiting or preventing
	our ability to achieve profitability.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may incur substantial liabilities and may be required to limit
	commercialization of our products in response to product liability
	lawsuits.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	testing and marketing of medical products entails an inherent risk
	of product liability. If we cannot successfully defend ourselves
	against product liability claims, we may incur substantial
	liabilities or be required to limit commercialization of our
	products or cease clinical trials. Our inability to obtain
	sufficient product liability insurance at an acceptable cost to
	protect against potential product liability claims could prevent or
	inhibit the commercialization of pharmaceutical products we
	develop, alone or with corporate collaborators. We currently carry
	$10 million liability insurance in the aggregate as to certain
	clinical trial risks, but we do not have and have not obtained
	quotations for commercial product liability insurance. We, or any
	corporate collaborators, may not in the future be able to obtain
	insurance at a reasonable cost or in sufficient amounts, if at all.
	Even if our agreements with any future corporate collaborators
	entitle us to indemnification against losses, such indemnification
	may not be available or adequate should any claim
	arise.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our internal computer systems, or those of our third-party
	contractors or consultants, may fail or suffer security breaches,
	which could result in a material disruption of our product
	development programs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Despite
	the implementation of security measures, our internal computer
	systems and those of our third-party contractors and consultants
	are vulnerable to damage from computer viruses, unauthorized
	access, natural disasters, terrorism, war and telecommunication and
	electrical failures. We rely on industry accepted measures and
	technology to secure confidential and proprietary information
	maintained on our computer systems. However, these measures and
	technology may not adequately prevent security breaches. While we
	do not believe that we have experienced any such system failure,
	accident, or security breach to date, if such an event were to
	occur and cause interruptions in our operations, it could result in
	a loss of clinical trial data for our product candidates which
	could result in delays in our regulatory approval efforts and
	significantly increase our costs to recover or reproduce the data.
	To the extent that any disruption or security breach results in a
	loss of or damage to our data or applications or other data or
	applications relating to our technology, intellectual property,
	research and development or product candidates, or inappropriate
	disclosure of confidential or proprietary information, we could
	incur liabilities and the further development of our product
	candidates could be delayed.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may be subject, directly or indirectly, to federal and state
	healthcare fraud and abuse laws, false claims laws, and health
	information privacy and security laws. If we are unable to comply,
	or have not fully complied, with such laws, we could face
	substantial penalties.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we
	begin commercializing any of our products in the United States, our
	operations may be directly, or indirectly through our customers,
	subject to various federal and state fraud and abuse laws,
	including, without limitation, the federal Anti-Kickback Statute,
	the federal False Claims Act, and physician sunshine laws and
	regulations. These laws may impact, among other things, our
	proposed sales, marketing, and education programs. In addition, we
	may be subject to patient privacy regulation by both the federal
	government and the states in which we conduct our business. The
	laws that may affect our ability to operate include:
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	27
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage30"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the federal
	Anti-Kickback Statute, which prohibits, among other things, persons
	or entities from soliciting, receiving, offering or providing
	remuneration, directly or indirectly, in return for or to induce
	either the referral of an individual for, or the purchase order or
	recommendation of, any item or services for which payment may be
	made under a federal health care program such as the Medicare and
	Medicaid programs;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	federal civil and
	criminal false claims laws and civil monetary penalty laws, which
	prohibit, among other things, individuals or entities from
	knowingly presenting, or causing to be presented, claims for
	payment from Medicare, Medicaid, or other third-party payors that
	are false or fraudulent;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the federal Health
	Insurance Portability and Accountability Act of 1996, or HIPAA,
	which created new federal criminal statutes that prohibit executing
	a scheme to defraud any healthcare benefit program and making false
	statements relating to healthcare matters;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	HIPPA, as amended
	by the Health Information Technology and Clinical Health Act, or
	HITECH, and its implementing regulations, which imposes certain
	requirements relating to the privacy, security, and transmission of
	individually identifiable health information;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The federal
	physician sunshine requirements under the Affordable Care Act,
	which require manufacturers of drugs, devices, biologics, and
	medical supplies to report annually to the U.S. Department of
	Health and Human Services information related to payments and other
	transfers of value to physicians, other healthcare providers, and
	teaching hospitals, and ownership and investment interests held by
	physicians and other healthcare providers and their immediate
	family members and applicable group purchasing organizations;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	state law
	equivalents of each of the above federal laws, such as
	anti-kickback and false claims laws that may apply to items or
	services reimbursed by any third-party payor, including commercial
	insurers, state laws that require pharmaceutical companies to
	comply with the pharmaceutical industry's voluntary compliance
	guidelines and the relevant compliance guidance promulgated by the
	federal government, or otherwise restrict payments that may be made
	to healthcare providers and other potential referral sources; state
	laws that require drug manufacturers to report information related
	to payments and other transfers of value to physicians and other
	healthcare providers or marketing expenditures; and state laws
	governing the privacy and security of health information in certain
	circumstances, many of which differ from each other in significant
	ways and may not have the same effect, thus complicating compliance
	efforts.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Because
	of the breadth of these laws and the narrowness of the statutory
	exceptions and safe harbors available, it is possible that some of
	our business activities could be subject to challenge under one or
	more of such laws. In addition, recent health care reform
	legislation has strengthened these laws. For example, the
	Affordable Care Act, among other things, amends the intent
	requirement of the federal anti-kickback and criminal healthcare
	fraud statutes. A person or entity no longer needs to have actual
	knowledge of this statute or specific intent to violate it.
	Moreover, the Affordable Care Act provides that the government may
	assert that a claim including items or services resulting from a
	violation of the federal anti-kickback statute constitutes a false
	or fraudulent claim for purposes of the False Claims
	Act.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If our
	operations are found to be in violation of any of the laws
	described above or any other governmental regulations that apply to
	us, we may be subject to penalties, including civil and criminal
	penalties, damages, fines, exclusion from participation in
	government health care programs, such as Medicare and Medicaid,
	imprisonment, and the curtailment or restructuring of our
	operations, any of which could adversely affect our ability to
	operate our business and our results of operations
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are highly dependent on our management team, senior staff
	professionals and third-party contractors and consultants, and the
	loss of their services could materially adversely affect our
	business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We rely
	on our relatively small management team and staff as well as
	various contractors and consultants to provide critical services.
	Our ability to execute our clinical programs for bremelanotide and
	PL-3994 and our preclinical programs for MC1r and MC4r peptide drug
	candidates depends on our continued retention and motivation of our
	management and senior staff professionals, including executive
	officers and senior members of product development and management,
	including commercialization, who possess significant technical
	expertise and experience and oversee our development and
	commercialization programs. If we lose the services of existing key
	personnel, our development programs could be adversely affected if
	suitable replacement personnel are not recruited quickly. Our
	success also depends on our ability to develop and maintain
	relationships with contractors, consultants and scientific
	advisors.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	is competition for qualified personnel, contractors and consultants
	in the pharmaceutical industry, which makes it difficult to attract
	and retain the qualified personnel, contractors and consultants
	necessary for the development and growth of our business. Our
	failure to attract and retain such personnel, contractors and
	consultants could have a material adverse effect on our business,
	results of operations and financial condition.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	28
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage31"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Because we expect bremelanotide for the treatment of HSDD to be
	classified as a Tier 3 drug with reimbursement by third-party
	payers similar to approved products for treating ED, demand for
	this product will be tied to discretionary spending levels of our
	targeted patient population and particularly affected by
	unfavorable economic conditions.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	market for HSDD may be particularly vulnerable to unfavorable
	economic conditions. We expect bremelanotide for the treatment of
	HSDD to have significant copay or deductible requirements and to be
	only partially reimbursed by third-party payers and, as a result,
	demand for this product may be tied to discretionary spending
	levels of our targeted patient population. The recent global
	financial crisis caused extreme volatility and disruptions in the
	capital and credit markets. A severe or prolonged economic downturn
	could result in a variety of risks to our business, including
	weakened demand for bremelanotide for HSDD or any future product
	candidates, if approved, and our ability to raise additional
	capital when needed on acceptable terms, if at all. This is
	particularly true in Europe, which is undergoing a continued severe
	economic crisis. A weak or declining economy could also strain our
	suppliers, possibly resulting in supply disruption, or cause our
	customers to delay making payments for our services. Any of the
	foregoing could harm our business and we cannot anticipate all of
	the ways in which future economic climates and financial market
	conditions could adversely impact our business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Risks
	Related to Government Regulation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Both before and after marketing approval, our product candidates
	are subject to ongoing regulatory requirements and, if we fail to
	comply with these continuing requirements, we could be subject to a
	variety of sanctions and the sale of any approved commercial
	products could be suspended.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Both
	before and after regulatory approval to market a particular product
	candidate, the manufacturing, labeling, packaging, adverse event
	reporting, storage, advertising and promotion and record keeping
	related to the product candidates are subject to extensive
	regulatory requirements. If we fail to comply with the regulatory
	requirements of the FDA and other applicable U.S. and foreign
	regulatory authorities, we could be subject to administrative or
	judicially imposed sanctions, including:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	restrictions on the
	products or manufacturing process;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	warning
	letters;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	civil or criminal
	penalties;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	fines;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	injunctions;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	imposition of a
	Corporate Integrity Agreement requiring heightened monitoring of
	our compliance functions, overseen by outside monitors, and
	enhanced reporting requirements to, and oversight by, the FDA and
	other government agencies;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	product seizures or
	detentions and related publicity requirements;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	suspension or
	withdrawal of regulatory approvals;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	regulators or IRBs
	may not authorize us or any potential future collaborators to
	commence a clinical trial or conduct a clinical trial at a
	prospective trial site;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	total or partial
	suspension of production; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	refusal to approve
	pending applications for marketing approval of new product
	candidates.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Changes
	in the regulatory approval policy during the development period,
	changes in or the enactment of additional regulations or statutes,
	or changes in the regulatory review for each submitted product
	application may cause delays in the approval or rejection of an
	application. Even if the FDA approves a product candidate, the
	approval may impose significant restrictions on the indicated uses,
	conditions for use, labeling, advertising, promotion, marketing
	and/or production of such product, and may impose ongoing
	requirements for post-approval studies, including additional
	research and development and clinical trials. The approval may also
	impose risk evaluation mitigation strategies, or REMS, on a product
	if the FDA believes there is a reason to monitor the safety of the
	drug in the marketplace. REMS may include requirements for
	additional training for health care professionals, safety
	communication efforts and limits on channels of distribution, among
	other things. The sponsor would be required to evaluate and monitor
	the various REMS activities and adjust them if need be. The FDA
	also may impose various civil or criminal sanctions for failure to
	comply with regulatory requirements, including withdrawal of
	product approval.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Furthermore, the
	approval procedure and the time required to obtain approval varies
	among countries and can involve additional testing beyond that
	required by the FDA. Approval by one regulatory authority does not
	ensure approval by regulatory authorities in other jurisdictions.
	The FDA has substantial discretion in the approval process and may
	refuse to accept any application or may decide that our data are
	insufficient for approval and require additional preclinical,
	clinical or other studies.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	29
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage32"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	addition, varying interpretations of the data obtained for
	preclinical and clinical testing could delay, limit or prevent
	regulatory approval of a product candidate. Even if we submit an
	application to the FDA for marketing approval of a product
	candidate, it may not result in marketing approval from the
	FDA.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We do
	not expect to receive regulatory approval for the commercial sale
	of any of our product candidates that are in development in the
	near future, if at all. The inability to obtain FDA approval or
	approval from comparable authorities in other countries for our
	product candidates would prevent us or any potential future
	collaborators from commercializing these product candidates in the
	United States or other countries.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may not be able to obtain regulatory approval of bremelanotide
	for HSDD even if the product is effective in treating
	HSDD.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Clinical drug
	development programs for our product candidates are very expensive,
	time-consuming, difficult to design and implement and their outcome
	is inherently uncertain. Approval of bremelanotide for treatment of
	HSDD in premenopausal women requires a determination by the FDA
	that the product is both safe and effective. Our Phase 2B clinical
	trials for HSDD demonstrated an acceptable safety profile and, at
	selected doses, statistically significant efficacy. However, the
	FDA may ultimately disagree with our definition of efficacy in
	HSDD, our clinical trial designs, or our interpretation of our
	clinical trial results. Moreover, results obtained in Phase 3
	clinical trials may be inconsistent with results obtained in our
	Phase 2B trials, and may demonstrate either an unacceptable safety
	profile or insufficient efficacy. It is also possible that safety
	or efficacy results obtained in Phase 3 clinical trials will be
	inconclusive. It is not possible to predict, with any assurance,
	whether the FDA will approve bremelanotide for any indications. The
	FDA may deny or delay approval of any application for bremelanotide
	if the FDA determines that the clinical data do not adequately
	establish the safety of the drug even if efficacy is established.
	If FDA approves bremelanotide, the approved labeling of the product
	may be limited or restricted in such ways as to inhibit or prevent
	the successful market acceptance and profitability of the product.
	Bremelanotide could take a significantly longer time to obtain
	approval than we expect and it may never gain approval. If
	regulatory approval of bremelanotide is delayed, limited or never
	obtained, our business, financial condition and results of
	operations would be materially adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The regulatory approval process is lengthy, expensive and
	uncertain, and may prevent us from obtaining the approvals that we
	require.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Government
	authorities in the United States and other countries extensively
	regulate the advertising, labeling, storage, record-keeping,
	safety, efficacy, research, development, testing, manufacture,
	promotion, marketing and distribution of drug products. Drugs are
	subject to rigorous regulation in the United States by the FDA and
	similar regulatory bodies in other countries. The steps ordinarily
	required by the FDA before a new drug may be marketed in the United
	States include:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	completion of
	non-clinical tests including preclinical laboratory and formulation
	studies and animal testing and toxicology;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	submission to the
	FDA of an investigational new drug, or IND, application, which must
	become effective before clinical trials may begin, and which may be
	placed on &#x201C;clinical hold&#x201D; by the FDA, meaning the trial
	may not commence, or must be suspended or terminated prior to
	completion;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	performance of
	adequate and well-controlled Phase 1, 2 and 3 human clinical trials
	to establish the safety and efficacy of the drug for each proposed
	indication, and potentially post-approval or Phase 4 studies to
	further define the drug&#x2019;s efficacy and safety, generally or
	in specific patient populations;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	submission to the
	FDA of a new drug application, or NDA, that must be accompanied by
	a substantial &#x201C;user fee&#x201D; payment;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	FDA review and
	approval of the NDA before any commercial marketing or sale;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 9.6PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	compliance with
	post-approval commitments and requirements.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Satisfaction of FDA
	pre-market approval requirements for new drugs typically takes a
	number of years and the actual time required for approval may vary
	substantially based upon the type, complexity and novelty of the
	product or disease to be treated by the drug. The results of
	product development, preclinical studies and clinical trials are
	submitted to the FDA as part of an NDA. The NDA also must contain
	extensive manufacturing information, demonstrating compliance with
	applicable GMP requirements. Once the submission has been accepted
	for filing, the FDA generally has twelve months to review the
	application and respond to the applicant. Such response may be an
	approval, or may be a &#x201C;complete response letter&#x201D;
	outlining additional data or steps that must be completed prior to
	further FDA review of the NDA. The review process is often
	significantly extended by FDA requests for additional information
	or clarification. Success in early stage clinical trials does not
	assure success in later stage clinical trials. Data obtained from
	clinical trials is not always conclusive and may be susceptible to
	varying interpretations that could delay, limit or prevent
	regulatory approval. The FDA may refer the NDA to an advisory
	committee for review, evaluation and recommendation as to whether
	the application should be approved, but the FDA is not bound by the
	recommendation of the advisory committee. The FDA may deny or delay
	approval of applications that do not meet applicable regulatory
	criteria or if the FDA determines that the clinical data do not
	adequately establish the safety and efficacy of the drug.
	Therefore, our proposed products could take a significantly longer
	time than we expect or may never gain approval. If regulatory
	approval is delayed or never obtained, our business, financial
	condition and results of operations would be materially adversely
	affected.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	30
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage33"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Some of
	our products or product candidates, including bremelanotide, may be
	used in combination with a drug delivery device, such as an
	injector or other delivery system. Medical products containing a
	combination of new drugs, biological products or medical devices
	are regulated as &#x201C;combination products&#x201D; in the United
	States. A combination product generally is defined as a product
	comprised of components from two or more regulatory categories
	(e.g., drug/device, device/biologic, drug/biologic). Each component
	of a combination product is subject to the requirements established
	by the FDA for that type of component, whether a new drug, biologic
	or device. In order to facilitate pre-market review of combination
	products, the FDA designates one of its centers to have primary
	jurisdiction for the pre-market review and regulation of the
	overall product based upon a determination by the FDA of the
	primary mode of action of the combination product. The
	determination whether a product is a combination product or two
	separate products is made by the FDA on a case-by-case basis. Our
	product candidates intended for use with such devices, or expanded
	indications that we may seek for our products used with such
	devices, may not be approved or may be substantially delayed in
	receiving approval if the devices do not gain and/or maintain their
	own regulatory approvals or clearances. Where approval of the drug
	product and device is sought under a single application, the
	increased complexity of the review process may delay approval. In
	addition, because these drug delivery devices are provided by
	single source unaffiliated third-party companies, we are dependent
	on the sustained cooperation and effort of those third-party
	companies both to supply the devices, maintain their own regulatory
	compliance, and, in some cases, to conduct the studies required for
	approval or other regulatory clearance of the devices. We are also
	dependent on those third-party companies continuing to maintain
	such approvals or clearances once they have been received. Failure
	of third-party companies to supply the devices, to successfully
	complete studies on the devices in a timely manner, or to obtain or
	maintain required approvals or clearances of the devices, and
	maintain compliance with all regulatory requirements, could result
	in increased development costs, delays in or failure to obtain
	regulatory approval and delays in product candidates reaching the
	market or in gaining approval or clearance for expanded labels for
	new indications.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Upon
	approval, a product candidate may be marketed only in those dosage
	forms and for those indications approved by the FDA. Once approved,
	the FDA may withdraw the product approval if compliance with
	regulatory requirements is not maintained or if problems occur
	after the product reaches the marketplace. In addition, the FDA may
	require post-marketing studies, referred to as Phase 4 studies, to
	monitor the approved products in a specific subset of patients or a
	larger number of patients than were required for product approval
	and may limit further marketing of the product based on the results
	of these post-market studies. The FDA has broad post-market
	regulatory and enforcement powers, including the ability to seek
	injunctions, levy fines and civil penalties, criminal prosecution,
	withdraw approvals and seize products or request
	recalls.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If
	regulatory approval of any of our product candidates is granted, it
	will be limited to certain disease states or conditions, patient
	populations, duration or frequency of use, and will be subject to
	other conditions as set forth in the FDA-approved labeling. Adverse
	experiences with the product must be reported to the FDA and could
	result in the imposition of market restriction through labeling
	changes or in product removal. Product approvals may be withdrawn
	if compliance with regulatory requirements is not maintained or if
	problems concerning safety or efficacy of the product occur
	following approval.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Outside
	the United States, our ability to market our product candidates
	will also depend on receiving marketing authorizations from the
	appropriate regulatory authorities. The foreign regulatory approval
	process generally includes all of the risks associated with FDA
	approval described above. The requirements governing the conduct of
	clinical trials and marketing authorization vary widely from
	country to country. At present, foreign marketing authorizations
	are applied for at a national level, although within the European
	Community, or EC, registration procedures are available to
	companies wishing to market a product to more than one EC member
	state. If the regulatory authority is satisfied that adequate
	evidence of safety, quality and efficiency has been presented, a
	marketing authorization will be granted. If we do not obtain, or
	experience difficulties in obtaining, such marketing
	authorizations, our business, financial condition and results of
	operations may be materially adversely affected.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	31
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage34"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Legislative or regulatory healthcare reforms in the United States
	may make it more difficult and costly for us to obtain regulatory
	clearance or approval of bremelanotide for HSDD or any future
	product candidates and to produce, market and distribute our
	products after clearance or approval is obtained.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	From
	time to time, legislation is drafted and introduced in Congress,
	and court decisions are issued, that could significantly change the
	statutory provisions governing the regulatory clearance or
	approval, manufacture and marketing of regulated products or the
	reimbursement thereof. In addition, FDA regulations and guidance
	are often revised or reinterpreted by the FDA in ways that may
	significantly affect our business and our products. Any new
	regulations or revisions or reinterpretations of existing
	regulations may impose additional costs or lengthen review times of
	bremelanotide for HSDD or any future product candidates. We cannot
	determine what effect changes in regulations, statutes, court
	decisions, legal interpretation or policies, when and if
	promulgated, enacted, issued or adopted may have on our business in
	the future. Such changes could, among other things:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	require changes to
	manufacturing methods;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	require recall,
	replacement or discontinuance of one or more of our
	products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	require additional
	recordkeeping;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	limit or restrict
	our ability to engage in certain types of marketing or promotional
	activities;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	alter or eliminate
	the scope or terms of any currently available regulatory
	exclusivities; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	restrict or
	eliminate our ability to settle any patent litigation we may bring
	against potential generic competitors.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Each of
	these would likely entail substantial time and cost and could
	materially harm our business and our financial results. In
	addition, delays in receipt of or failure to receive regulatory
	clearances or approvals for any future products would harm our
	business, financial condition and results of
	operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Changes in healthcare policy could adversely affect our
	business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	U.S.
	and foreign governments continue to propose and pass legislation
	designed to reduce the cost of healthcare. For example, the
	Medicare Prescription Drug Improvement and Modernization Act of
	2003, or MMA, expanded Medicare coverage for drugs purchased by
	Medicare beneficiaries and introduced new reimbursement
	methodologies. In addition, this law provided authority for
	limiting the number of drugs that will be covered in any
	therapeutic class. We do not know what impact the MMA and similar
	laws will have on the availability of coverage for and the price
	that we receive for any approved products. Moreover, while the MMA
	applies only to drug benefits for Medicare beneficiaries, private
	payers often follow Medicare policies in setting their own
	reimbursement policies, and any reduction in reimbursement that
	results from the MMA may result in similar reductions by private
	payers.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	March 2010, the President signed the Patient Protection and
	Affordable Care Act, as amended by the Health Care and Education
	Affordability Reconciliation Act, together the ACA. This law has
	resulted in an increase in the number of people who are covered by
	both public and private insurance and has changed the way health
	care is financed by both government health program and private
	insurers, with significant impacts on the pharmaceutical industry.
	The ACA contains a number of provisions that may impact our
	business and operations in ways that may negatively affect our
	potential revenues in the future. For example, the ACA imposes a
	non-deductible excise tax on pharmaceutical manufacturers or
	importers that sell branded prescription drugs to U.S. government
	programs which we believe will increase the cost of any products
	that we develop. Moreover, the ACA established a 2.3% medical
	device excise tax on certain transactions, including many United
	States sales of medical devices, which currently includes, and we
	expect will continue to include, United States sales of drug/device
	combination products. While the 2.3% medical device excise tax has
	been suspended for two years, until September 2017, unless
	legislative action is taken it will go back into effect after the
	suspension period. In addition, as part of the ACA&#x2019;s
	provisions closing a funding gap that currently exists in the
	Medicare Part D prescription drug program (commonly known as the
	&#x201C;donut hole&#x201D;), we will be required to provide a 50%
	discount on any branded prescription drugs that we develop sold to
	beneficiaries who fall within the donut hole. While it is too early
	to predict all of the specific effects the ACA or any future
	healthcare reform legislation will have on our business, they could
	have a material adverse effect on our business and financial
	condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	availability of government reimbursement for prescription drugs
	will be impacted by the Budget Control Act of 2011, which was
	signed into law on August 2, 2011. This law is expected to result
	in federal spending cuts totaling between $1.2 trillion and $1.5
	trillion over the next decade, over half of which will include cuts
	in Medicare and other health-related spending.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Risks
	Related to Our Intellectual Property
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we fail to adequately protect or enforce our intellectual
	property rights or secure rights to patents of others, the value of
	our intellectual property rights would diminish.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	success, competitive position and future revenues will depend in
	part on our ability and the abilities of our licensors to obtain
	and maintain patent protection for our products, methods, processes
	and other technologies, to preserve our trade secrets, to prevent
	third parties from infringing on our proprietary rights and to
	operate without infringing the proprietary rights of third parties.
	We cannot predict:
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	32
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage35"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the degree and
	range of protection any patents will afford us against competitors,
	including whether third parties will find ways to invalidate or
	otherwise circumvent our patents;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	if and when patents
	will be issued;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	whether or not
	others will obtain patents claiming aspects similar to those
	covered by our patents and patent applications; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	whether we will
	need to initiate litigation or administrative proceedings, which
	may be costly whether we win or lose.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If our
	products, methods, processes and other technologies infringe the
	proprietary rights of other parties we could incur substantial
	costs and we may have to:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	obtain licenses,
	which may not be available on commercially reasonable terms, if at
	all;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	redesign our
	products or processes to avoid infringement;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	stop using the
	subject matter claimed in the patents held by others;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	pay damages;
	or
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	defend litigation
	or administrative proceedings, which may be costly whether we win
	or lose, and which could result in a substantial diversion of our
	management resources.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may become involved in lawsuits to protect or enforce our
	patents or other intellectual property or the patents of our
	licensors, which could be expensive and time
	consuming.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Competitors may
	infringe our intellectual property, including our patents or the
	patents of our licensors. As a result, we may be required to file
	infringement claims to stop third-party infringement or
	unauthorized use. This can be expensive, particularly for a company
	of our size, and time-consuming. In addition, in an infringement
	proceeding, a court may decide that a patent of ours is not valid
	or is unenforceable, or may refuse to stop the other party from
	using the technology at issue on the grounds that our patent claims
	do not cover its technology or that the factors necessary to grant
	an injunction against an infringer are not satisfied.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	An
	adverse determination of any litigation or other proceedings could
	put one or more of our patents at risk of being invalidated or
	interpreted narrowly and could put our patent applications at risk
	of not issuing.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Interference,
	derivation or other proceedings brought at the United States Patent
	and Trademark Office, or USPTO, may be necessary to determine the
	priority or patentability of inventions with respect to our patent
	applications or those of our licensors or collaborators. Litigation
	or USPTO proceedings brought by us may fail or may be invoked
	against us by third parties. Even if we are successful, domestic or
	foreign litigation or USPTO or foreign patent office proceedings
	may result in substantial costs and distraction to our management.
	We may not be able, alone or with our licensors or collaborators,
	to prevent misappropriation of our proprietary rights, particularly
	in countries where the laws may not protect such rights as fully as
	in the United States.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Furthermore,
	because of the substantial amount of discovery required in
	connection with intellectual property litigation or other
	proceedings, there is a risk that some of our confidential
	information could be compromised by disclosure during this type of
	litigation or proceedings. In addition, during the course of this
	kind of litigation or proceedings, there could be public
	announcements of the results of hearings, motions or other interim
	proceedings or developments or public access to related documents.
	If investors perceive these results to be negative, the market
	price for our common stock could be significantly
	harmed.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we infringe or are alleged to infringe intellectual property
	rights of third parties, our business could be harmed.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	research, development and commercialization activities may infringe
	or otherwise violate or be claimed to infringe or otherwise violate
	patents owned or controlled by other parties. There may also be
	patent applications that have been filed but not published that,
	when issued as patents, could be asserted against us. These third
	parties could bring claims against us that would cause us to incur
	substantial expenses and, if successful against us, could cause us
	to pay substantial damages. Further, if a patent infringement suit
	were brought against us, we could be forced to stop or delay
	research, development, manufacturing or sales of the product or
	product candidate that is the subject of the suit.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As a
	result of patent infringement claims, or to avoid potential claims,
	we may choose or be required to seek licenses from third parties.
	These licenses may not be available on acceptable terms, or at all.
	Even if we are able to obtain a license, the license would likely
	obligate us to pay license fees or royalties or both, and the
	rights granted to us might be nonexclusive, which could result in
	our competitors gaining access to the same intellectual property.
	Ultimately, we could be prevented from commercializing a product,
	or be forced to cease some aspect of our business operations, if,
	as a result of actual or threatened patent infringement claims, we
	are unable to enter into licenses on acceptable terms, if at
	all.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	33
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage36"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	has been substantial litigation and other proceedings regarding
	patent and other intellectual property rights in the pharmaceutical
	industry. In addition to infringement claims against us, we may
	become a party to other patent litigation and other proceedings,
	including interference, derivation or post-grant proceedings
	declared or granted by the USPTO and similar proceedings in foreign
	countries, regarding intellectual property rights with respect to
	our current or future products. The cost to us of any patent
	litigation or other proceeding, even if resolved in our favor,
	could be substantial. Some of our competitors may be able to
	sustain the costs of such litigation or proceedings more
	effectively than we can because of their substantially greater
	financial resources. Patent litigation and other proceedings may
	also absorb significant management time. Uncertainties resulting
	from the initiation and continuation of patent litigation or other
	proceedings could impair our ability to compete in the marketplace.
	The occurrence of any of the foregoing could have a material
	adverse effect on our business, financial condition or results of
	operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We may not be able to protect our intellectual property rights
	throughout the world.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Filing,
	prosecuting and defending patents on product candidates in all
	countries throughout the world would be prohibitively expensive,
	and our intellectual property rights in some countries outside the
	United States can be less extensive than those in the United
	States. In addition, the laws of some foreign countries do not
	protect intellectual property rights to the same extent as federal
	and state laws in the United States and in some cases may even
	force us to grant a compulsory license to competitors or other
	third parties. Consequently, we may not be able to prevent third
	parties from practicing our inventions in all countries outside the
	United States, or from selling or importing products made using our
	inventions in and into the United States or other jurisdictions.
	Competitors may use our technologies in jurisdictions where we have
	not obtained patent protection to develop their own products and
	further, may export otherwise infringing products to territories
	where we have patent protection, but enforcement is not as strong
	as that in the United States. These products may compete with our
	products and our patents or other intellectual property rights may
	not be effective or sufficient to prevent them from
	competing.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Many
	companies have encountered significant problems in protecting and
	defending intellectual property rights in foreign jurisdictions.
	The legal systems of certain countries, particularly certain
	developing countries, do not favor the enforcement of patents and
	other intellectual property protection, particularly those relating
	to biopharmaceuticals, which could make it difficult for us to stop
	the infringement of our patents or marketing of competing products
	in violation of our proprietary rights generally. Proceedings to
	enforce our patent rights in foreign jurisdictions could result in
	substantial costs and divert our efforts and attention from other
	aspects of our business, could put our patents at risk of being
	invalidated or interpreted narrowly and our patent applications at
	risk of not issuing and could provoke third parties to assert
	claims against us. We may not prevail in any lawsuits that we
	initiate and the damages or other remedies awarded, if any, may not
	be commercially meaningful. Accordingly, our efforts to enforce our
	intellectual property rights around the world may be inadequate to
	obtain a significant commercial advantage from the intellectual
	property that we develop or license.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	addition, our ability to protect and enforce our intellectual
	property rights may be adversely affected by unforeseen changes in
	domestic and foreign intellectual property laws.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If we are unable to keep our trade secrets confidential, our
	technologies and other proprietary information may be used by
	others to compete against us.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	addition to our reliance on patents, we attempt to protect our
	proprietary technologies and processes by relying on trade secret
	laws and agreements with our employees and other persons who have
	access to our proprietary information. These agreements and
	arrangements may not provide meaningful protection for our
	proprietary technologies and processes in the event of unauthorized
	use or disclosure of such information, and may not provide an
	adequate remedy in the event of unauthorized disclosure of
	confidential information. In addition, our competitors may
	independently develop substantially equivalent technologies and
	processes or gain access to our trade secrets or technology, either
	of which could materially and adversely affect our competitive
	position.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Risks
	Related to Obligations in Our 2012, 2014 and 2015 Private
	Placements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Under agreements relating to our 2012, 2014 and 2015 private
	placements, we are required to allow purchasers in the 2012, 2014
	and 2015 private placements to participate in certain future equity
	and debt financings, which may restrict our ability to raise funds
	on acceptable terms, or at all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For six
	years after our 2012 private placement, unless the purchasers own
	less than 20% of our outstanding common stock calculated as if the
	warrants were exercised, and for four years after our 2014 and 2015
	private placements, unless the FDA earlier approves bremelanotide
	for HSDD, the purchasers have the right of first negotiation on any
	subsequent equity or debt financing. Under our 2012 private
	placement, if we do not agree to terms of a financing with the
	purchasers, and negotiate with a third party on a financing, we
	must offer to sell to the purchasers at least 55% of the financing,
	and the purchasers may elect to purchase all or a portion of the
	financing. Under our 2014 and 2015 private placements, if we do not
	agree to terms of a financing with the purchasers, depending on
	pricing of the financing, the purchasers have the right to purchase
	between 83.5% and all of the financing. We will require significant
	additional resources and capital for our bremelanotide development
	program, including completing safety and ancillary studies,
	preparing and submitting an NDA, and implementing commercial scale
	manufacturing, as well as for our other clinical trial programs.
	The right of first negotiation and right of participation granted
	to the purchasers in our 2012, 2014 and 2015 private placements may
	make it more difficult to raise additional funding through public
	or private equity or debt financings or other sources. If we are
	able to obtain additional funding, such funding may not be
	available on acceptable terms
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	34
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage37"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Under agreements relating to our 2012, 2014 and 2015 private
	placements, so long as any Series A 2012, Series B 2012, Series C
	2014 and Series E 2015 warrants are outstanding, we are required to
	redeem such warrants at the option of the holders in the event of
	any takeover, change of control or other fundamental transaction
	which we permit.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Under
	the purchase agreements and forms of our Series A, Series B, Series
	C and Series E warrants for our 2012, 2014 and 2015 private
	placements, if we permit, make or allow a takeover, change of
	control or other fundamental transaction, including any transfer of
	all or substantially all of our properties or assets, then so long
	as any warrants remain outstanding we are required, as elected by
	such warrant holders, to pay such holders a warrant early
	termination price tied to the greater of the then market price of
	our common stock or the amount per share paid to any other person.
	The application of these provisions could adversely affect our
	financial position and have the effect of delaying or preventing a
	change of control or other fundamental transaction, which could
	adversely affect the market price of our common stock, and could
	make any potential acquisition or change of control more
	costly.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Under agreements relating to our 2012, 2014 and 2015 private
	placements, so long as any Series A 2012, Series B 2012, Series C
	2014 and Series E 2015 warrants are outstanding, we are required to
	oppose any takeover or change of control that does not provide
	specified rights to holders of such warrants.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Under
	the purchase agreements and forms of our Series A, Series B, Series
	C and Series E warrants for our 2012, 2014 and 2015 private
	placements, so long as any such warrants remain outstanding we are
	required to (i) not permit, (ii) take necessary action to prevent
	both the occurrence or consummation of, and (iii) not be a party to
	any fundamental transaction, change of control or similar event
	unless contractually-specified rights are provided with respect to
	payment of any such warrant early termination price tied to the
	greater of the then market price of our common stock or the amount
	per share paid to any other person.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	also required, subject to the exercise by our board of its
	fiduciary duties, to take all reasonable efforts to adopt a poison
	pill or any other anti-takeover provision or method necessary to
	prevent the fundamental transaction, change of control or similar
	event. The application of these provisions could have the effect of
	delaying or preventing a change of control or other fundamental
	transaction, which could adversely affect the market price of our
	common stock, and could make any potential acquisition or change of
	control more costly.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Risks
	Related to the Ownership of Our Common Stock
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our stock price is volatile and may fluctuate in a way that is
	disproportionate to our operating performance and we expect it to
	remain volatile, which could limit investors&#x2019; ability to sell
	stock at a profit.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	volatile price of our stock makes it difficult for investors to
	predict the value of their investment, to sell shares at a profit
	at any given time or to plan purchases and sales in advance. A
	variety of factors may affect the market price of our common stock.
	These include, but are not limited to:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	publicity regarding
	actual or potential clinical results relating to products under
	development by our competitors or us;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	delay or failure in
	initiating, completing or analyzing preclinical or clinical trials
	or unsatisfactory designs or results of these trials;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	interim decisions
	by regulatory agencies, including the FDA, as to clinical trial
	designs, acceptable safety profiles and the benefit/risk ratio of
	products under development;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	achievement or
	rejection of regulatory approvals by our competitors or by
	us;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	announcements of
	technological innovations or new commercial products by our
	competitors or by us;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	developments
	concerning proprietary rights, including patents;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	developments
	concerning our collaborations;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	regulatory
	developments in the United States and foreign
	countries;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	economic or other
	crises and other external factors;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	35
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage38"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	period-to-period
	fluctuations in our revenue and other results of
	operations;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	changes in the
	structure of healthcare payment systems or other actions that
	affect the effective reimbursement rates for treatment regimens
	containing our products;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	changes in
	financial estimates and recommendations by securities analysts
	following our business or our industry;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	sales of our common
	stock (or the perception that such sales could occur);
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 4PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the other factors
	described in this &#x201C;Risk Factors&#x201D; section.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We will
	not be able to control many of these factors, and we believe that
	period-to-period comparisons of our financial results will not
	necessarily be indicative of our future performance. If our
	revenues, if any, in any particular period do not meet
	expectations, we may not be able to adjust our expenditures in that
	period, which could cause our operating results to suffer further.
	If our operating results in any future period fall below the
	expectations of securities analysts or investors, our stock price
	may fall by a significant amount.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For the
	12-month period ended June 30, 2016, the price of our stock has
	been volatile, ranging from a high of $1.18 per share to a low of
	$0.36 per share. In addition, the stock market in general, and the
	market for biotechnology companies in particular, has experienced
	extreme price and volume fluctuations that may have been unrelated
	or disproportionate to the operating performance of individual
	companies. These broad market and industry factors may seriously
	harm the market price of our common stock, regardless of our
	operating performance.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As a public company in the United States, we are subject to the
	Sarbanes-Oxley Act of 2002, or Sarbanes-Oxley. We can provide no
	assurance that we will, at all times, in the future be able to
	report that our internal controls over financial reporting are
	effective.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Companies that file
	reports with the SEC, including us, are subject to the requirements
	of Section 404 of Sarbanes-Oxley. Section 404 requires management
	to establish and maintain a system of internal control over
	financial reporting, and annual reports on Form 10-K filed under
	the Exchange Act, must contain a report from management assessing
	the effectiveness of a company&#x2019;s internal control over
	financial reporting. Ensuring that we have adequate internal
	financial and accounting controls and procedures in place to
	produce accurate financial statements on a timely basis will be a
	costly and time-consuming effort that needs to be re-evaluated
	frequently. Failure on our part to have effective internal
	financial and accounting controls would cause our financial
	reporting to be unreliable, could have a material adverse effect on
	our business, operating results, and financial condition, and could
	cause the trading price of our common stock to fall
	dramatically.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If securities or industry analysts do not publish research or
	publish unfavorable research about our business, our stock price
	and trading volume could decline.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As a
	smaller company, it may be difficult for us to attract or retain
	the interest of equity research analysts. A lack of research
	coverage may adversely affect the liquidity of and market price of
	our common stock. We do not have any control of the equity research
	analysts or the content and opinions included in their reports. The
	price of our stock could decline if one or more equity research
	analysts downgrade our stock or issue other unfavorable commentary
	or research. If one or more equity research analysts ceases
	coverage of our company, or fails to publish reports on us
	regularly, demand for our stock could decrease, which in turn could
	cause our stock price or trading volume to decline.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Holders of our preferred stock may have interests different from
	our common stockholders.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	permitted under our certificate of incorporation to issue up to
	10,000,000 shares of preferred stock. We can issue shares of our
	preferred stock in one or more series and can set the terms of the
	preferred stock without seeking any further approval from our
	common stockholders. 4,030 shares of our Series A Preferred Stock
	remain outstanding as of September 16, 2016. Each share of Series A
	Preferred Stock is convertible at any time, at the option of the
	holder, and such conversion could dilute the value of our common
	stock to current stockholders and could adversely affect the market
	price of our common stock. The conversion price decreases if we
	sell common stock (or equivalents) for a price per share less than
	the conversion price or less than the market price of the common
	stock and is also subject to adjustment upon the occurrence of a
	merger, reorganization, consolidation, reclassification, stock
	dividend or stock split which results in an increase or decrease in
	the number of shares of common stock outstanding. Upon (i)
	liquidation, dissolution or winding up of the Company, whether
	voluntary or involuntary, (ii) sale or other disposition of all or
	substantially all of the assets of the Company, or (iii) any
	consolidation, merger, combination, reorganization or other
	transaction in which the Company is not the surviving entity or in
	which the shares of common stock constituting in excess of 50% of
	the voting power of the Company are exchanged for or changed into
	other stock or securities, cash and/or any other property, after
	payment or provision for payment of the debts and other liabilities
	of the Company, the holders of Series A Preferred Stock will be
	entitled to receive, pro rata and in preference to the holders of
	any other capital stock, an amount per share equal to $100 plus
	accrued but unpaid dividends, if any. Any preferred stock that we
	issue may rank ahead of our common stock in terms of dividend
	priority or liquidation premiums and may have greater voting rights
	than our common stock.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	36
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage39"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Because we do not anticipate paying any cash dividends on our
	common stock in the foreseeable future, capital appreciation, if
	any, will be your sole source of gains.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We do
	not anticipate paying any cash dividends in the foreseeable future
	and intend to retain future earnings, if any, for the development
	and expansion of our business. Our outstanding Series A Preferred
	Stock, consisting of 4,030 shares on September 16, 2016, provides
	that we may not pay a dividend or make any distribution to holders
	of any class of stock unless we first pay a special dividend or
	distribution of $100 per share to the holders of the Series A
	Preferred Stock. In addition, the terms of existing or future
	agreements may limit our ability to pay dividends. As a result,
	capital appreciation, if any, of our common stock will be your sole
	source of gain for the foreseeable future.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Anti-takeover provisions of Delaware law and our charter documents
	may make potential acquisitions more difficult and could result in
	the entrenchment of management.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	incorporated in Delaware. Anti-takeover provisions of Delaware law
	and our charter documents may make a change in control or efforts
	to remove management more difficult. Also, under Delaware law, our
	board of directors may adopt additional anti-takeover measures.
	Under Section 203 of the Delaware General Corporation Law, a
	corporation may not engage in a business combination with an
	&#x201C;interested stockholder&#x201D; for a period of three years
	after the date of the transaction in which the person first becomes
	an &#x201C;interested stockholder,&#x201D; unless the business
	combination is approved in a prescribed manner.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	authorized to issue up to 300,000,000 shares of common stock. To
	the extent that we sell or otherwise issue authorized but currently
	unissued shares, this could have the effect of making it more
	difficult for a third party to acquire a majority of our
	outstanding voting stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	charter authorizes us to issue up to 10,000,000 shares of preferred
	stock and to determine the terms of those shares of stock without
	any further action by our stockholders. If we exercise this right,
	it could be more difficult for a third party to acquire a majority
	of our outstanding voting stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	addition, our equity incentive plans generally permit us to
	accelerate the vesting of options and other stock rights granted
	under these plans in the event of a change of control. If we
	accelerate the vesting of options or other stock rights, this
	action could make an acquisition more costly.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	application of these provisions could have the effect of delaying
	or preventing a change of control, which could adversely affect the
	market price of our common stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are a smaller reporting company and the reduced disclosure
	requirements applicable to smaller reporting companies may make our
	Common Stock less attractive to investors.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	currently a &#x201C;smaller reporting company&#x201D; as defined in
	the Exchange Act. Smaller reporting companies are able to provide
	simplified executive compensation disclosures in their filings, are
	exempt from the provisions of Section 404(b) of the Sarbanes-Oxley
	Act requiring that an independent registered public accounting firm
	provide an attestation report on the effectiveness of internal
	control over financial reporting, and have certain other decreased
	disclosure obligations in their SEC filings. We cannot predict
	whether investors will find our common stock less attractive
	because of our reliance on any of these exemptions. If some
	investors find our common stock less attractive as a result, there
	may be a less active trading market for our common stock and our
	stock price may be more volatile.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As of September 16, 2016 there were 129,030,427 shares of common
	stock underlying outstanding convertible preferred stock, options,
	restricted stock units and warrants. Stockholders may experience
	dilution from the conversion of preferred stock, exercise of
	outstanding options and warrants and vesting of restricted stock
	units.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As of
	September 16, 2016, holders of our outstanding dilutive securities
	had the right to acquire the following amounts of underlying common
	stock:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 36PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	60,592 shares
	issuable on the conversion of immediately convertible Series A
	Convertible preferred stock, subject to adjustment, for no further
	consideration;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 36PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6,409,020 shares
	issuable on the exercise of stock options, at exercise prices
	ranging from $0.49 to $24.90 per share;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 36PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3,559,768 shares
	issuable under restricted stock units which vest on dates between
	December 8, 2016 and January 11, 2020, subject to the fulfillment
	of service conditions; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 36PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	119,001,047 shares
	issuable on the exercise of warrants at exercise prices ranging
	from $0.01 to $1.00 per share, of which 84,546,764 are prefunded
	warrants with an exercise price of $0.01.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If the
	holders convert, exercise or receive these securities, or similar
	dilutive securities we may issue in the future, stockholders may
	experience dilution in the net book value of their common stock. In
	addition, the sale or availability for sale of the underlying
	shares in the marketplace could depress our stock price. We have
	registered or agreed to register for resale substantially all of
	the underlying shares listed above. Holders of registered
	underlying shares could resell the shares immediately upon
	issuance, which could result in significant downward pressure on
	our stock price.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	37
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage40"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our failure to meet the continued listing requirements of the NYSE
	MKT could result in a de-listing of our common stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	common shares are listed on the NYSE MKT, a national securities
	exchange, under the symbol &#x201C;PTN&#x201D;. Although we currently
	meet the NYSE MKT&#x2019;s listing standards, which generally
	mandate that we meet certain requirements relating to
	stockholders&#x2019; equity, market capitalization, aggregate market
	value of publicly held shares and distribution requirements, we
	cannot assure you that we will be able to continue to meet the NYSE
	MKT&#x2019;s listing requirements. If we fail to satisfy the
	continued listing requirements of the NYSE MKT, such as the
	corporate governance requirements or the minimum closing bid price
	requirement, the NYSE MKT may take steps to de-list our common
	stock. If the NYSE MKT delists our securities for trading on its
	exchange, we could face significant material adverse consequences,
	including:
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	a limited
	availability of market quotations for our securities;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	reduced liquidity
	with respect to our securities;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	a determination
	that our shares of common stock are &#x201C;penny stock&#x201D; which
	will require brokers trading in our shares of common stock to
	adhere to more stringent rules, possibly resulting in a reduced
	level of trading activity in the secondary trading market for our
	shares of common stock;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	a limited amount of
	news and analyst coverage for our company; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	a decreased ability
	to issue additional securities or obtain additional financing in
	the future.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Such a
	de-listing would likely have a negative effect on the price of our
	common stock and would impair your ability to sell or purchase our
	common stock when you wish to do so. In the event of a de-listing,
	we may take actions to restore our compliance with the NYSE
	MKT&#x2019;s listing requirements, but we can provide no assurance
	that any such action taken by us would allow our common stock to
	become listed again, stabilize the market price or improve the
	liquidity of our common stock, prevent our common stock from
	dropping below the NYSE MKT minimum bid price requirement or
	prevent future non-compliance with the NYSE MKT&#x2019;s listing
	requirements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	National Securities Markets Improvement Act of 1996, which is a
	federal statute, prevents or preempts the states from regulating
	the sale of certain securities, which are referred to as
	&#x201C;covered securities.&#x201D; Our common shares are considered
	to be covered securities because they are listed on the NYSE MKT.
	Although the states are preempted from regulating the sale of our
	securities, the federal statute does allow the states to
	investigate companies if there is a suspicion of fraud, and, if
	there is a finding of fraudulent activity, then the states can
	regulate or bar the sale of covered securities in a particular
	case. Further, if we were no longer listed on the NYSE MKT, our
	common stock would not be covered securities and we would be
	subject to regulation in each state in which we offer our
	securities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	1B. Unresolved Staff Comments
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	None.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	2. Properties
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	corporate offices are located at 4B Cedar Brook Drive, Cedar Brook
	Corporate Center, Cranbury, NJ 08512, where we lease approximately
	10,000 square feet of office space under a lease that expires in
	June 2020. We also lease approximately 1,000 square feet of
	laboratory space in the Township of South Brunswick, NJ, under a
	lease that expires in July 2017. We believe our present facilities
	are adequate for our current needs. We do not own any real
	property.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	3. Legal Proceedings
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We are
	involved, from time to time, in various claims and legal
	proceedings arising in the ordinary course of our business. We are
	not currently a party to any claim or legal
	proceeding.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	4. Mine Safety Disclosures
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Not
	applicable.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	38
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage41"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_RISK_FACTORS>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_PART_II>
<A NAME="FIS_PART_II"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PART
	II
</FONT>
</DIV>
<EFX_MARKET>
<A NAME="FIS_MARKET"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	5. Market for Registrant&#x2019;s Common Equity, Related Stockholder
	Matters and Issuer Purchases of Equity Securities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	table below provides, for the fiscal quarters indicated, the
	reported high and low sales prices for our common stock on the NYSE
	MKT since July 1, 2014.
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_3"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	FISCAL YEAR ENDED
	JUNE 30, 2016
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	HIGH
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	LOW
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Fourth
	Quarter
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.74
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.40
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Third
	Quarter
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.69
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.36
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Second
	Quarter
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.90
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.62
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	First
	Quarter
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.18
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_4"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	FISCAL YEAR ENDED
	JUNE 30, 2015
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	HIGH
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	LOW
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Fourth
	Quarter
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.58
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.85
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Third
	Quarter
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.34
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.65
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Second
	Quarter
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.93
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.59
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	First
	Quarter
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.28
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.82
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	common stock has been listed on NYSE MKT under the symbol
	&#x201C;PTN&#x201D; since December 21, 1999. It previously traded on
	The Nasdaq SmallCap Market under the symbol
	&#x201C;PLTN.&#x201D;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	On
	September 16, 2016, we had approximately 105 record holders of
	common stock and the closing sales price of our common stock as
	reported on the NYSE MKT was $0.50 per share.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Issuer purchases of equity securities.
</FONT>
	We have not and do not currently intend to retire or repurchase any
	of our capital securities other than providing our employees with
	the option to withhold shares to satisfy tax withholding amounts
	due from employees upon the vesting of restricted stock units in
	connection with our 2011 Stock Incentive Plan. The following
	123,127 shares were withheld during the quarter ended June 30, 2016
	at the direction of the employees as permitted under the 2011 Stock
	Incentive Plan in order to pay the minimum amount of tax liability
	owed by the employee from the vesting of those units:
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_5"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Period
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Total Number of Shares Purchased (1)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Weighted Average Price Paid per Share
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Total Number of Shares Purchased as Part of Publicly Announced
	Plans or Programs
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Maximum
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Number of Shares that May Yet be Purchased Under Announced Plans or
	Programs
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	April
	1-30, 2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May
	1-31, 2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June
	1-30, 2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	123,127
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	0.47
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	123,127
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	0.47
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)
	Consists solely of 123,127 shares that were withheld to satisfy tax
	withholding amounts due from employees upon the vesting of
	previously issued restricted stock units.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Dividends and dividend policy
</FONT>
	. We have
	never declared or paid any dividends. We currently intend to retain
	earnings, if any, for use in our business. We do not anticipate
	paying dividends in the foreseeable future.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Dividend restrictions
</FONT>
	. Our outstanding
	Series A Preferred Stock, consisting of 4,030 shares on September
	16, 2016, provides that we may not pay a dividend or make any
	distribution to holders of any class of stock unless we first pay a
	special dividend or distribution of $100 per share to the holders
	of the Series A Preferred Stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Equity Compensation Plan
	Information.
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-STYLE: ITALIC">
	&#xA0;
</FONT>
	Reference is
	made to the information contained in the Equity Compensation Plan
	table contained in Item 12 of this Annual Report.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	6. Selected Financial Data.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Not
	Applicable.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	7.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;Management&#x2019;s
	Discussion and Analysis of Financial Condition and Results of
	Operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following discussion and analysis should be read in conjunction
	with the consolidated financial statements and notes to the
	consolidated financial statements filed as part of this Annual
	Report.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	39
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage42"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Forward-Looking Statements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following discussion and analysis contains forward-looking
	statements within the meaning of the federal securities laws. You
	are urged to carefully review our description and examples of
	forward-looking statements included earlier in this Annual Report
	on Form 10-K immediately prior to Part I, under the heading
	&#x201C;Forward-Looking Statements.&#x201D; Forward-looking
	statements are subject to risks and uncertainties that could cause
	actual results to differ materially from those expressed in the
	forward-looking statements. You are urged to carefully review the
	disclosures we make concerning risks and other factors that may
	affect our business and operating results, including those made in
	Part I, Item 1A of this Annual Report on Form 10-K, and any of
	those made in our other reports filed with the SEC. You are
	cautioned not to place undue reliance on the forward-looking
	statements included herein, which speak only as of the date of this
	document. We do not intend, and undertake no obligation, to publish
	revised forward-looking statements to reflect events or
	circumstances after the date of this document or to reflect the
	occurrence of unanticipated events.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Critical
	Accounting Policies and Estimates
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	significant accounting policies are described in Note 2 to the
	consolidated financial statements included in this Annual Report.
	We believe that our accounting policies and estimates relating to
	revenue recognition, accrued expenses and stock-based compensation
	charges are the most critical.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Revenue Recognition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Revenue
	resulting from license fees is recognized upon delivery of the
	license for the portion of the license fee payment that is
	non-contingent and non-refundable, if the license has standalone
	value. Revenue resulting from the achievement of development
	milestones is recorded in accordance with the accounting guidance
	for the milestone method of revenue recognition. Revenue resulting
	from the achievement of sales milestone events is recognized when
	the milestone is achieved. Revenue from royalties is recorded when
	earned.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accrued Expenses.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Third
	parties perform a significant portion of our development
	activities. We review the activities performed under significant
	contracts each quarter and accrue expenses and the amount of any
	reimbursement to be received from our collaborators based upon the
	estimated amount of work completed. Estimating the value or stage
	of completion of certain services requires judgment based on
	available information. If we do not identify services performed for
	us but not billed by the service-provider, or if we underestimate
	or overestimate the value of services performed as of a given date,
	reported expenses will be understated or overstated.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stock-based Compensation.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	fair value of stock options granted has been calculated using the
	Black-Scholes option pricing model, which requires us to make
	estimates of expected volatility and expected option lives. We
	estimate these factors at the time of grant based on our own prior
	experience, public sources of information and information for
	comparable companies. The amount of recorded compensation related
	to an option grant is not adjusted for subsequent changes in these
	estimates or for actual experience. The amount of our recorded
	compensation is also dependent on our estimates of future option
	forfeitures. If we initially over-estimate future forfeitures, our
	reported expenses will be understated until such time as we adjust
	our estimate. Changes in estimated forfeitures will affect our
	reported expenses in the period of change and future periods. In
	addition, awards containing a market condition are valued using a
	multifactor Monte Carlo simulation.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	amount and timing of compensation expense to be recorded in future
	periods related to grants of restricted stock units may be affected
	by employment terminations. As a result, stock-based compensation
	charges may vary significantly from period to period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Results
	of Operations
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Year Ended June 30, 2016 Compared to the Year Ended June 30,
	2015:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Revenue &#x2013;
</FONT>
	For the fiscal year
	ended June 30, 2016 (fiscal 2016), we did not recognize any
	revenue. For the fiscal year ended June 30, 2015 (fiscal 2015), we
	recognized $12,951,730 in revenue pursuant to our license,
	co-development and commercialization agreement with Gedeon
	Richter.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	August 2014, we entered into a license, co-development and
	commercialization agreement with Gedeon Richter, which provided for
	$9,763,347 in upfront payments. The non-refundable portion of the
	upfront payment, $4,932,315, was recorded as revenue in the three
	months ended September 30, 2014 and the remaining balance was
	recorded as revenue in the three months ended December 31, 2014,
	which became non-refundable upon initiation of our Phase 3 clinical
	trial program in the United States. We also recognized $3,188,383
	in the three months ended December 31, 2014 relating to the
	milestone payment due upon initiation of our Phase 3 clinical trial
	program in the United States, which was initiated in December 2014.
	On September 16, 2015, we entered into a termination agreement
	pursuant to which we and Gedeon Richter agreed to mutually and
	amicably terminate the license agreement.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	40
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage43"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.4PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Research and Development
</FONT>
	&#x2013;
	Research and development expenses were $43,071,051 for fiscal 2016
	compared to $24,560,233 for fiscal 2015. These costs primarily
	relate to our bremelanotide Phase 3 clinical trial
	program.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.4PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Research and
	development expenses related to our bremelanotide, PL-3994, MC1r,
	MC4r and other preclinical programs were $39,371,908 and
	$21,879,136 in fiscal years 2016 and 2015, respectively. Spending
	to date has been primarily related to our bremelanotide for the
	treatment of HSDD program. The increase in research and development
	expenses is mainly attributable to the continued progress of Phase
	3 clinical trial and development of bremelanotide for HSDD. The
	amount of such spending and the nature of future development
	activities are dependent on a number of factors, including
	primarily the availability of funds to support future development
	activities, success of our clinical trials and preclinical and
	discovery programs, and our ability to progress compounds in
	addition to bremelanotide and PL-3994 into human clinical
	trials.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.4PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	amounts of project spending above exclude general research and
	development spending, which were $3,699,143 and $2,681,097 in
	fiscal years 2016 and 2015, respectively. The increase in general
	research and development spending is primarily attributable to
	additional staffing and secondarily to the recognition of
	stock-based compensation primarily related to the restricted stock
	units granted in December 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Cumulative spending
	from inception to June 30, 2016 is approximately $234,800,000 on
	our bremelanotide program and approximately $123,900,000 on all our
	other programs (which include PL-3994, PL-8177, other melanocortin
	receptor agonists, obesity, other discovery programs and terminated
	programs). Due to various risk factors described herein under
	&#x201C;Risk Factors,&#x201D; including the difficulty in currently
	estimating the costs and timing of future Phase 1 clinical trials
	and larger-scale Phase 2 and Phase 3 clinical trials for any
	product under development, we cannot predict with reasonable
	certainty when, if ever, a program will advance to the next stage
	of development or be successfully completed, or when, if ever,
	related net cash inflows will be generated.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.4PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	General and Administrative
</FONT>
	&#x2013;
	General and administrative expenses, which consist mainly of
	compensation and related costs, were $6,179,084 for fiscal 2016
	compared to $5,677,654 for fiscal 2015. The increase in general and
	administrative expenses is primarily attributable to the
	recognition of stock-based compensation primarily related to the
	restricted stock units granted in December 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Other Income (Expense)
</FONT>
	&#x2013; Other
	income (expense) was $(2,462,801) and $(910,914) for fiscal 2016
	and fiscal 2015, respectively. For fiscal 2016, we recognized
	$50,226 of investment income offset by $(2,513,027) of interest
	expense primarily related to our venture debt. For fiscal 2015, we
	recognized $35,439 of investment income offset by a $(284,656)
	foreign exchange transaction loss and $(661,697) of interest
	expense primarily related to our venture debt.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Income Tax Benefit &#x2013;
</FONT>
	We did not
	record any income tax benefits in fiscal 2016. For fiscal 2015,
	income tax benefits recorded of $531,508 related to the sale of New
	Jersey state net operating loss carryforwards and tax credits. The
	amount of such losses and tax credits that we were able to sell
	depended on annual pools and allocations established by the state
	of New Jersey. This program enables approved, unprofitable
	biotechnology businesses to sell their unused Net Operating Loss
	Carryovers, or NOLs, and unused Research and Development, or
	R&amp;D, Tax Credits to unaffiliated, profitable corporate
	taxpayers in the state of New Jersey.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Year Ended June 30, 2015 Compared to the Year Ended June 30,
	2014:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Revenue &#x2013;
</FONT>
	For the fiscal year
	ended June 30, 2015 (fiscal 2015), we recognized $12,951,730 in
	revenue pursuant to our license, co-development and
	commercialization agreement with Gedeon Richter. We did not
	recognize any revenue for the fiscal year ended June 30, 2014
	(fiscal 2014).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.4PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Research and Development
</FONT>
	&#x2013;
	Research and development expenses were $24,560,233 for fiscal 2015
	compared to $10,826,921 for fiscal 2014. These costs primarily
	relate to our bremelanotide Phase 3 clinical trial
	program.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.4PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Research and
	development expenses related to our bremelanotide, PL-3994, MC1r,
	MC4r and other preclinical programs were $21,879,136 and $7,918,537
	in fiscal years 2015 and 2014, respectively. Spending to date has
	been primarily related our bremelanotide for the treatment of HSDD
	program. The increase in research and development expenses is
	mainly attributable to the initiation of Phase 3 clinical studies
	of bremelanotide for HSDD. The amounts of project spending above
	exclude general research and development spending, which were
	$2,681,097 and $2,908,384 in fiscal years 2015 and 2014,
	respectively.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	41
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage44"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.4PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	General and Administrative
</FONT>
	&#x2013;
	General and administrative expenses, which consist mainly of
	compensation and related costs, were $5,677,654 for fiscal 2015
	compared to $4,960,731 for fiscal 2014. The increase was
	attributable to the fair value of stock-based compensation related
	to restricted stock units granted in June 2014 and amortized to
	expense through fiscal 2015 and increases in accounting and other
	professional services.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Other Income (Expense)
</FONT>
	&#x2013; Other
	income (expense) was $(910,914) and $12,712 for fiscal 2015 and
	fiscal 2014, respectively. For fiscal 2015, we recognized $35,439
	of investment income offset by a $(284,656) foreign exchange
	transaction loss and $(661,697) of interest expense primarily
	related to our venture debt. For fiscal 2014, we recognized $18,923
	of investment income offset by $(6,211) of interest
	expense.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 5.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Income Tax Benefit &#x2013;
</FONT>
	Income tax
	benefits of $531,508 in fiscal 2015 and $1,846,646 in fiscal 2014
	relate to the sale of New Jersey state net operating loss
	carryforwards and tax credits.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Effects of Inflation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We do
	not believe that inflation has had a material impact on our
	business, revenues or operating results during the periods
	presented.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Liquidity
	and Capital Resources
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Since
	inception, we have incurred net operating losses, primarily related
	to spending on our research and development programs. We have
	financed our net operating losses primarily through debt and equity
	financings and amounts received under collaborative
	agreements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	product candidates are at various stages of development and will
	require significant further research, development and testing and
	some may never be successfully developed or commercialized. We may
	experience uncertainties, delays, difficulties and expenses
	commonly experienced by early stage biopharmaceutical companies,
	which may include unanticipated problems and additional costs
	relating to:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the development and
	testing of products in animals and humans;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	product approval or
	clearance;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	regulatory
	compliance;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	GMP
	compliance;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	intellectual
	property rights;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	product
	introduction;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 5.3PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	marketing, sales
	and competition; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-TOP: 5.3PX; ; PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	obtaining
	sufficient capital.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 5.3PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Failure
	to enter into or successfully perform under collaboration
	agreements and obtain timely regulatory approval for our product
	candidates and indications would impact our ability to increase
	revenues and could make it more difficult to attract investment
	capital for funding our operations. Any of these possibilities
	could materially and adversely affect our operations and require us
	to curtail or cease certain programs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	fiscal 2016, net cash used in operating activities was $47,363,814,
	compared to $13,358,042 in fiscal 2015 and $12,207,656 in fiscal
	2014. Higher net cash outflows from operations in fiscal 2016
	compared to fiscal 2015 were primarily the result of spending on
	our bremelanotide for the treatment of HSDD program. Higher net
	cash outflows from operation in fiscal 2015 compared to fiscal 2014
	were primarily the result of spending on our bremelanotide for the
	treatment of HSDD program offset by the receipt of the upfront and
	milestone payments, relating to the license, co-development and
	commercialization agreement with Gedeon Richter on bremelanotide
	for the treatment of HSDD in Europe and selected other countries.
	Our periodic prepaid expenses, accounts payable and accrued
	expenses balances will continue to be highly dependent on the
	timing of our operating costs.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	fiscal 2016, net cash used in investing activities was $1,404,717
	consisting primarily of the purchase of investments. We did not
	engage in any investing activities in fiscal 2015. During fiscal
	2014, net cash provided by investing activities was $5,243,415,
	which consisted of $5,249,654 of proceeds from the maturity of
	short-term investments offset by $6,239 used for capital
	expenditures.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	fiscal 2016, net cash provided by financing activities was
	$29,471,931, which consisted of a private placement with net
	proceeds of $19,834,278, a loan of $9,853,885, net of related debt
	issuance costs offset by $216,232 for the payment of withholding
	taxes related to restricted stock units and capital lease payments.
	During fiscal 2015, net cash provided by financing activities was
	$28,472,705, which consisted of a private placement with net
	proceeds of $18,556,111, a loan of $9,790,634, net of related
	issuance costs and $254,148 of proceeds from the exercise of common
	stock warrants offset by $128,188 for the payment of withholding
	taxes related restricted stock units and capital lease payments.
	During fiscal 2014, cash used in financing activities of $18,786
	consisted of the payment of withholding taxes related to restricted
	stock units of $36,377 and payments on capital lease obligation of
	$19,909 offset by $37,500 of proceeds from the exercise of common
	stock warrants.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	incurred cumulative negative cash flows from operations since our
	inception, and have expended, and expect to continue to expend in
	the future, substantial funds to complete our planned product
	development efforts. As a result, there is substantial doubt about
	our ability to continue as a going concern.&#xA0;Continued
	operations are dependent upon our ability to complete equity or
	debt financing activities or collaboration arrangements. We believe
	that if we do not have sufficient funding, we may have to curtail
	or cease certain programs or operations within twelve months. As of
	June 30, 2016, our cash, cash equivalents and investments were
	$9,383,224 and our current liabilities were $13,994,439. On August
	4, 2016, we completed an underwritten offering of units, with each
	unit consisting of a share of common stock and a Series H warrant
	to purchase 0.75 of a share of common stock. Investors whose
	purchase of units in the offering would result in them beneficially
	owning more than 9.99% of our outstanding common stock following
	the completion of the offering had the opportunity to acquire units
	with Series I prefunded warrants substituted for any common stock
	they would have otherwise acquired. Gross proceeds were $9,225,000,
	with net proceeds to us, after deducting estimated offering
	expenses, of approximately $8,500,000. We issued 11,481,481 shares
	of common stock and ten year prefunded Series I warrants to
	purchase 2,218,045 shares of common stock at an exercise price of
	$0.01, together with Series H warrants to purchase 10,274,646
	shares of common stock at an exercise price of $0.70 per
	share.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	42
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage45"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Series I warrants are exercisable at an initial exercise price of
	$0.01 per share, exercisable immediately upon issuance and expire
	on the tenth anniversary of the date of issuance.&#xA0;The Series I
	warrants are subject to limitation on exercise if the holder and
	its affiliates would beneficially own more than 9.99% of the total
	number of Palatin&#x2019;s shares of common stock following such
	exercise. The Series H warrants are exercisable at an initial
	exercise price of $0.70 per share, are exercisable commencing six
	months following the date of issuance and expire on the fifth
	anniversary of the date of issuance. The Series H warrants are
	subject to the same beneficial ownership limitation as the Series I
	warrants.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	intend to utilize existing capital resources, including the
	proceeds from the financing, for general corporate purposes and
	working capital, including our bremelanotide clinical development
	program for HSDD, preclinical and clinical development of our MC1r
	and MC4r peptide programs and PL-3994 natriuretic peptide, and
	development of other portfolio products. Based on our current plan,
	we believe that the Phase 3 clinical trial program with
	bremelanotide, including submission of an NDA to the FDA, will cost
	at least $87,000,000. We intend to seek additional capital to
	support the Phase 3 program through collaborative arrangements on
	bremelanotide, public or private equity or debt financings, or
	other sources.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	believe that our existing capital resources, together with
	approximately $8,500,000 received from the August 2016 financing,
	will be adequate to fund our planned operations through the quarter
	ending December 31, 2016. Assuming the double blind efficacy
	portion of the Phase 3 clinical trial of bremelanotide for HSDD is
	successful, as to which there can be no assurance, we will need
	additional funding to complete required ancillary studies and
	clinical trials, prepare and submit regulatory filings for product
	approval, and establish commercial scale manufacturing capability.
	We will also need additional funding to complete required clinical
	trials for our other product candidates and, assuming those
	clinical trials are successful, as to which there can be no
	assurance, to complete submission of required regulatory
	applications to the FDA.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	anticipate incurring additional losses over at least the next few
	years. To achieve profitability, if ever, we, alone or with others,
	must successfully develop and commercialize our technologies and
	proposed products, conduct preclinical studies and clinical trials,
	obtain required regulatory approvals and successfully manufacture
	and market such technologies and proposed products. The time
	required to reach profitability is highly uncertain, and we do not
	know whether we will be able to achieve profitability on a
	sustained basis, if at all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Off-Balance
	Sheet Arrangements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	None.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Contractual
	Obligations
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	entered into various contractual obligations and commercial
	commitments. The following table summarizes our most significant
	contractual obligations as of June 30, 2016:
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_6"></A>
<DIV STYLE="TEXT-ALIGN: RIGHT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: RIGHT; MARGIN: 0PX 0PX 0PX AUTO; WIDTH: 100%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="5" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Payments due by Period
</FONT>
<BR>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Total
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Less than 1 Year
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	1 - 3 Years
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	3 - 5 Years
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	More than 5 Years
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Facility
	operating leases
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	923,166
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	255,985
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	445,837
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	221,344
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Capital
	lease obligations
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	43,707
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	29,138
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	14,569
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Notes
	payable
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	23,893,001
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	7,299,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	15,757,334
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	835,917
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	Agreements
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	2,524,033
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	2,524,033
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:50%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	contractual obligations
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	27,383,907
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	10,108,906
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	16,217,740
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,057,261
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
</EFX_MARKET>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<BR>
</FONT>
</DIV>
<EFX_MARKET_RISK>
<A NAME="FIS_MARKET_RISK"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	7A. Quantitative and Qualitative Disclosures About Market
	Risk.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Not
	applicable.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	43
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage46"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_MARKET_RISK>
<EFX_FINANCIAL_STATEMENTS>
<A NAME="FIS_FINANCIAL_STATEMENTS"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	8. Financial Statements and Supplementary Data.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Table
	of Contents
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consolidated
	Financial Statements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following consolidated financial statements are filed as part of
	this annual report:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Report
	of Independent Registered Public Accounting Firm
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	45
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consolidated
	Balance Sheets
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	46
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consolidated
	Statements of Operations
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	47
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consolidated
	Statements of Comprehensive Loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	48
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consolidated
	Statements of Stockholders&#x2019; (Deficiency) Equity
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	49
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consolidated
	Statements of Cash Flows
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	50
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Notes
	to Consolidated Financial Statements
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 15%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	51
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	44
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage47"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_AUDITORS_OPINION>
<A NAME="FIS_AUDITORS_OPINION"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; TEXT-DECORATION: UNDERLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
	FIRM
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Board of Directors and Stockholders
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin
	Technologies, Inc.:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	audited the accompanying consolidated balance sheets of Palatin
	Technologies, Inc. and subsidiary as of June 30, 2016 and 2015, and
	the related consolidated statements of operations,
	stockholders&#x2019; (deficiency) equity, comprehensive loss, and
	cash flows for each of the years in the three-year period ended
	June 30, 2016. These consolidated financial statements are the
	responsibility of the Company&#x2019;s management. Our
	responsibility is to express an opinion on these consolidated
	financial statements based on our audits.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	conducted our audits in accordance with the standards of the Public
	Company Accounting Oversight Board (United States). Those standards
	require that we plan and perform the audit to obtain reasonable
	assurance about whether the financial statements are free of
	material misstatement. An audit includes examining, on a test
	basis, evidence supporting the amounts and disclosures in the
	financial statements. An audit also includes assessing the
	accounting principles used and significant estimates made by
	management, as well as evaluating the overall financial statement
	presentation. We believe that our audits provide a reasonable basis
	for our opinion.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In our
	opinion, the consolidated financial statements referred to above
	present fairly, in all material respects, the financial position of
	Palatin Technologies, Inc. and subsidiary as of June 30, 2016 and
	2015, and the results of their operations and their cash flows for
	each of the years in the three-year period ended June 30, 2016, in
	conformity with U.S. generally accepted accounting
	principles.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	accompanying consolidated financial statements have been prepared
	assuming that the Company will continue as a going concern. As
	discussed in Note 1 to the consolidated financial statements, the
	Company has incurred recurring net losses and negative cash flows
	from operations and will require substantial additional financing
	to continue to fund its planned developmental activities. These
	conditions raise substantial doubt about its ability to continue as
	a going concern. Management&#x2019;s plans regarding those matters
	also are discussed in Note 1. The consolidated financial statements
	do not include any adjustments that might result from the outcome
	of this uncertainty.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/
	KPMG LLP
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Philadelphia,
	Pennsylvania
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September 19,
	2016
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	45
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage48"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_AUDITORS_OPINION>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
</DIV>
<EFX_BALANCE_SHEET>
<A NAME="FIS_BALANCE_SHEET"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Consolidated Balance Sheets
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
</DIV>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR>
<TD COLSPAN="1" ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	June 30, 2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	June 30, 2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ASSETS
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Current
	assets:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Cash
	and cash equivalents
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	8,002,668
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	27,299,268
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Available-for-sale
	investments
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,380,556
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Prepaid
	expenses and other current assets
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,424,282
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,896,747
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	current assets
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	10,807,506
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	29,196,015
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Property
	and equipment, net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	97,801
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	123,158
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	assets
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	146,428
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	155,279
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	assets
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	11,051,735
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	29,474,452
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Current
	liabilities:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accounts
	payable
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	713,890
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,106,484
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accrued
	expenses
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	7,767,733
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	6,223,483
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Notes
	payable, net of discount
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	5,485,392
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Capital
	lease obligations
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	27,424
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	25,871
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	current liabilities
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	13,994,439
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	7,355,838
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Notes
	payable, net of discount
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	14,189,809
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	9,781,086
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Capital
	lease obligations
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	14,324
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	41,749
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	non-current liabilities
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	439,130
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	91,304
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	liabilities
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	28,637,702
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	17,269,977
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Commitments
	and contengencies (Note 11)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stockholders&#x2019;
	(deficiency) equity:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Preferred
	stock of $0.01 par value &#x2013; authorized 10,000,000
	shares;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Series
	A Convertible; issued and outstanding 4,030 shares as of June 30,
	2016 and 4,697 shares as of June 30, 2015,
	respectively
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	40
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	47
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
	stock of $0.01 par value &#x2013; authorized 300,000,000
	shares;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;issued
	and outstanding 68,568,055 shares as of June 30, 2016 and
	57,128,433 as of June 30, 2015, respectively
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	685,680
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	571,284
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Additional
	paid-in capital
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	325,142,509
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	303,332,460
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accumulated
	other comprehensive loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,944
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accumulated
	deficit
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(343,412,252
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(291,699,316
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	stockholders&#x2019; (deficiency) equity
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(17,585,967
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	12,204,475
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	liabilities and stockholders&#x2019; equity
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	11,051,735
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	29,474,452
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_BALANCE_SHEET>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	accompanying notes are an integral part of these consolidated
	financial statements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	46
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage49"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_INCOME_STATEMENT>
<A NAME="FIS_INCOME_STATEMENT"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
</FONT>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	and Subsidiary
</FONT>
</DIV>
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consolidated
	Statements of Operations
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="3" ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:36%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 3%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 94%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Year Ended June 30,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 3%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2014
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	REVENUES:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	License
	and contract
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	12,951,730
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	OPERATING
	EXPENSES:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Research
	and development
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	43,071,051
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	24,560,233
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	10,826,921
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	General
	and administrative
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	6,179,084
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	5,677,654
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	4,960,731
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	operating expenses
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	49,250,135
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	30,237,887
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	15,787,652
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Loss
	from operations
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(49,250,135
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(17,286,157
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(15,787,652
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	OTHER
	INCOME (EXPENSE):
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Investment
	income
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	50,226
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	35,439
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	18,923
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Interest
	expense
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(2,513,027
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(661,697
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(6,211
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Foreign
	exchange transaction loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(284,656
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	other income (expense), net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(2,462,801
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(910,914
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	12,712
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Loss
	before income taxes
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(51,712,936
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(18,197,071
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(15,774,940
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Income
	tax benefit
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	531,508
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,846,646
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	NET
	LOSS
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(51,712,936
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(17,665,563
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(13,928,294
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Basic
	and diluted net loss per common share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.33
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.15
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.13
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Weighted
	average number of common shares outstanding used in computing basic
	and diluted net loss per common share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	156,553,534
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	121,014,506
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	106,679,476
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_INCOME_STATEMENT>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	accompanying notes are an integral part of these consolidated
	financial statements
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	47
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage50"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_7"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	and Subsidiary
</FONT>
<BR>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Consolidated Statements of Comprehensive Loss
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
</DIV>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="3" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 36%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 3%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 94%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Year Ended June 30,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 3%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2014
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(51,712,936
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(17,665,563
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(13,928,294
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	comprehensive loss:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Unrealized
	loss on available-for-sale investments
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(1,944
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	comprehensive loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(51,714,880
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(17,665,563
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(13,928,294
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	The
	accompanying notes are an integral part of these consolidated
	financial statements
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<BR>
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	48
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage51"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_STOCKHOLDERS_EQUITY>
<A NAME="FIS_STOCKHOLDERS_EQUITY"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Consolidated Statements of Stockholders&#x2019; (Deficiency)
	Equity
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT:0PX;FONT-SIZE:13PX;MARGIN-TOP:0PX;MARGIN-BOTTOM:0PX;WIDTH:100%;MARGIN-RIGHT:0PX;FONT-FAMILY:TIMES NEW ROMAN;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Additional
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="1" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Accumulated
	Other
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="1" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<BR>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="1" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
	&#xA0;
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 90%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Preferred Stock
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 90%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-SIZE: 11PX;">
<DIV>
<FONT>
	&#xA0;
</FONT>
<FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Common Stock
</FONT>
</FONT>
<FONT>
	&#xA0;
</FONT>
<FONT>
	&#xA0;
</FONT>
<FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</FONT>
<FONT>
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Paid-in
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Comprehensive
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Accumulated
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Shares
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Amount
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Shares
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Amount
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Capital
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Loss
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Deficit
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Total
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Balance,
	July 1, 2013
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	4,697
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	47
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	39,116,948
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	391,169
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	282,692,520
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(260,105,459
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	22,978,277
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stock-based
	compensation
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	378,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	3,788
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	817,552
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	821,340
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Withholding
	taxes related to restricted stock units
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(129,103
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,291
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(118,716
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(120,007
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Warrant
	exercises
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	50,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	37,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	37,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(13,928,294
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(13,928,294
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Balance,
	June 30, 2014
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	4,697
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	47
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	39,416,595
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	394,166
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	283,428,356
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(274,033,753
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	9,788,816
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stock-based
	compensation
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	705,833
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	7,058
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,160,221
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,167,279
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Sale
	of common stock units, net of costs
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	2,050,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	20,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	18,535,611
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	18,556,111
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Issuance
	of warrants on debt
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	267,820
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	267,820
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Withholding
	taxes related to restricted stock units
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(174,568
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,746
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(162,390
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(164,136
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Warrant
	exercises
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	15,130,573
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	151,306
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	102,842
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	254,148
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(17,665,563
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(17,665,563
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Balance,
	June 30, 2015
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	4,697
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	47
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	57,128,433
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	571,284
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	303,332,460
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(291,699,316
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	12,204,475
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stock-based
	compensation
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	662,186
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	6,622
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,836,743
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,843,365
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Sale
	of common stock units, net of costs
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	19,834,278
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	19,834,278
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Issuance
	of warrants on debt
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	305,196
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	305,196
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Withholding
	taxes related to restricted stock units
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(123,483
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,235
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(57,166
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(58,401
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Warrant
	exercises
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	10,890,889
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	108,909
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(108,909
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Series
	A Conversion
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(667
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(7
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	10,030
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	100
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(93
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Unrealized
	loss on investments
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,944
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,944
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(51,712,936
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(51,712,936
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Balance,
	June 30, 2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	4,030
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	40
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	68,568,055
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	685,680
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	325,142,509
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(1,944
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(343,412,252
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(17,585,967
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_STOCKHOLDERS_EQUITY>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	The
	accompanying notes are an integral part of these consolidated
	financial statements
</FONT>
</DIV>
</DIV>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	49
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage52"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_CASH_FLOW>
<A NAME="FIS_CASH_FLOW"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and Subsidiary
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consolidated Statements of Cash Flows
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="3" ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:36%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 3%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 94%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Year Ended June 30,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 3%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2014
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CASH
	FLOWS FROM OPERATING ACTIVITIES:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
	Net loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(51,712,936
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(17,665,563
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(13,928,294
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
	Adjustments to reconcile net loss to net cash
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
	used in operating activities:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Depreciation
	and amortization
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	43,052
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	117,590
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	111,906
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Non-cash
	interest expense
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	327,479
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	87,087
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stock-based
	compensation
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,843,365
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,167,279
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	821,340
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Changes
	in operating assets and liabilities:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:36PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Prepaid
	expenses and other assets
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	503,785
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,667,139
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	176,697
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:36PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accounts
	payable
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(392,594
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	845,204
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(77,446
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:36PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accrued
	expenses
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,676,209
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	4,666,196
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(311,859
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:36PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Unearned
	revenue
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:36PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	non-current liabilities
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	347,826
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	91,304
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	cash used in operating activities
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(47,363,814
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(13,358,042
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(12,207,656
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CASH
	FLOWS FROM INVESTING ACTIVITIES:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Proceeds
	from sale/maturity of investments
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	5,249,654
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Purchases
	of investments
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(1,387,022
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Purchases
	of property and equipment
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(17,695
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(6,239
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	cash (used in) provided by investing activities
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(1,404,717
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	5,243,415
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CASH
	FLOWS FROM FINANCING ACTIVITIES:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Payments
	on capital lease obligations
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(25,872
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(12,380
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(19,909
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Payment
	of withholding taxes related to restricted
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
	stock units
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(190,360
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(115,808
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(36,377
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Proceeds
	from exercise of common stock warrants
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	254,148
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	37,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Proceeds
	from the sale of common stock and warrants, net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
	of costs
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	19,834,278
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	18,556,111
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Proceeds
	from the issuance of notes payable and warrants
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	10,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	10,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Payment
	of debt issuance costs
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(146,115
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(209,366
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:48PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	cash provided by (used in) financing activities
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	29,471,931
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	28,472,705
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(18,786
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	NET
	(DECREASE) INCREASE IN CASH
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
	AND CASH EQUIVALENTS
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(19,296,600
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	15,114,663
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(6,983,027
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CASH
	AND CASH EQUIVALENTS, beginning of year
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	27,299,268
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	12,184,605
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	19,167,632
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CASH
	AND CASH EQUIVALENTS, end of year
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	8,002,668
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	27,299,268
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	12,184,605
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	SUPPLEMENTAL
	CASH FLOW INFORMATION:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Cash
	paid for interest
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,836,743
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	483,306
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	6,211
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Equipment
	acquired under capital lease
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	80,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:24PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Issuance
	of warrants in connection with debt financing
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	305,196
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	267,820
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CASH_FLOW>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	The
	accompanying notes are an integral part of these consolidated
	financial statements
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	50
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage53"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and Subsidiary
</FONT>
</DIV>
</DIV>
<EFX_NOTES_TO_FINANCIAL_STATEMENT>
<A NAME="FIS_NOTES_TO_FINANCIAL_STATEMENT"></A>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial
	Statements
</FONT>
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;ORGANIZATION
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Nature of Business
</FONT>
	&#x2013; Palatin
	Technologies, Inc. (Palatin or the Company) is a biopharmaceutical
	company developing targeted, receptor-specific peptide therapeutics
	for the treatment of diseases with significant unmet medical need
	and commercial potential. Palatin&#x2019;s programs are based on
	molecules that modulate the activity of the melanocortin and
	natriuretic peptide receptor systems. The melanocortin system is
	involved in a large and diverse number of physiologic functions,
	and therapeutic agents modulating this system may have the
	potential to treat a variety of conditions and diseases, including
	sexual dysfunction, obesity and related disorders, cachexia
	(wasting syndrome) and inflammation-related diseases. The
	natriuretic peptide receptor system has numerous cardiovascular
	functions, and therapeutic agents modulating this system may be
	useful in treatment of acute asthma, heart failure, hypertension
	and other cardiovascular diseases.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company&#x2019;s primary product in development is bremelanotide for
	the treatment of hypoactive sexual desire disorder (HSDD), which is
	a type of female sexual dysfunction (FSD). The Company also has
	drug candidates or development programs for obesity, erectile
	dysfunction, cardiovascular diseases, pulmonary diseases,
	inflammatory diseases and dermatologic diseases.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Key
	elements of the Company&#x2019;s business strategy include using its
	technology and expertise to develop and commercialize therapeutic
	products; entering into alliances and partnerships with
	pharmaceutical companies to facilitate the development,
	manufacture, marketing, sale and distribution of product candidates
	that the Company is developing; and partially funding its product
	candidate development programs with the cash flow generated from
	third parties.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Going Concern
</FONT>
	&#x2013; There is
	substantial doubt about the Company&#x2019;s ability to continue as
	a going concern. Since inception, the Company has incurred negative
	cash flows from operations, and has expended, and expects to
	continue to expend in the future, substantial funds to complete its
	planned product development efforts. As shown in the accompanying
	consolidated financial statements, the Company had an accumulated
	deficit as of June 30, 2016 of $343,412,252 and incurred a net loss
	for fiscal 2016 of $51,712,936. The Company anticipates incurring
	additional losses in the future as a result of spending on its
	development programs and will require substantial additional
	financing to continue to fund its planned developmental activities.
	To achieve profitability, if ever, the Company, alone or with
	others, must successfully develop and commercialize its
	technologies and proposed products, conduct successful preclinical
	studies and clinical trials, obtain required regulatory approvals
	and successfully manufacture and market such technologies and
	proposed products. The time required to reach profitability is
	highly uncertain, and there can be no assurance that the Company
	will be able to achieve profitability on a sustained basis, if at
	all. The accompanying consolidated financial statements have been
	prepared assuming that the Company continues as a going concern,
	which contemplates the realization of assets and the satisfaction
	of liabilities in the normal course of business. The consolidated
	financial statements do not include any adjustments relating to the
	recoverability and classification of recorded asset amounts or the
	amount or classification of liabilities that might result from the
	outcome of this uncertainty.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As
	discussed in Note 15, on August 4, 2016, the Company closed on an
	underwritten offering of units resulting in gross proceeds of
	$9,225,000, with net proceeds, after deducting estimated offering
	expenses, of approximately $8,500,000.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As of
	June 30, 2016, the Company&#x2019;s cash, cash equivalents and
	investments were $9,383,224 and current liabilities were
	$13,994,439. The Company intends to utilize existing capital
	resources, including the proceeds from the financing for general
	corporate purposes and working capital, including the Phase 3
	clinical trial program with bremelanotide for HSDD and preclinical
	and clinical development of our other product candidates and
	programs, including PL-3994 and melanocortin recetptor-1 and
	melanocortin receptor-4 programs. Management believes that the
	Phase 3 clinical trial program with bremelanotide, including
	regulatory filings for product approval, will cost at least
	$87,000,000.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Management believes
	that the Company&#x2019;s existing capital resources, together with
	approximately $8,500,000 received from the August 2016 financing,
	will be adequate to fund its planned operations through the quarter
	ending December 31, 2016. Assuming the double blind efficacy
	portion of the Phase 3 clinical trial of bremelanotide for HSDD is
	successful, as to which there can be no assurance, we will need
	additional funding to complete required ancillary studies and
	clinical trials, prepare and submit regulatory filings for product
	approval, and establish commercial scale manufacturing
	capability.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	51
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage54"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and Subsidiary
</FONT>
</DIV>
</DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company will need to raise additional capital to complete required
	ancillary studies and clinical trials, prepare and submit
	regulatory filings for product approval, and establish commercial
	scale manufacturing capability. The Company will also need
	additional funding to complete required clinical trials for its
	other product candidates and, assuming those clinical trials are
	successful, as to which there can be no assurance, to complete
	submission of required applications to the FDA. If the Company is
	unable to obtain approval or otherwise advance in the FDA approval
	process, the Company&#x2019;s ability to sustain its operations
	would be materially adversely affected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company may seek the additional capital necessary to fund its
	operations through public or private equity offerings,
	collaboration agreements, debt financings or licensing
	arrangements. Additional capital that is required by the Company
	may not be available on reasonable terms, or at all.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Concentrations &#x2013;
</FONT>
	Concentrations
	in the Company&#x2019;s assets and operations subject it to certain
	related risks. Financial instruments that subject the Company to
	concentrations of credit risk primarily consist of cash and cash
	equivalents and available-for-sale investments. The Company&#x2019;s
	cash and cash equivalents are primarily invested in one money
	market account sponsored by a large financial institution. For the
	years ended June 30, 2016 and 2014, the Company had no revenues
	reported. For the year ended June 30, 2015, 100% of revenues were
	from Gedeon Richter.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;SUMMARY
	OF SIGNIFICANT ACCOUNTING POLICIES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Principles of Consolidation
</FONT>
	&#x2013; The
	consolidated financial statements include the accounts of Palatin
	and its wholly-owned inactive subsidiary. All intercompany accounts
	and transactions have been eliminated in
	consolidation.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Use of Estimates
</FONT>
	&#x2013; The
	preparation of consolidated financial statements in conformity with
	accounting principles generally accepted in the United States of
	America (U.S. GAAP) requires management to make estimates and
	assumptions that affect the reported amounts of assets and
	liabilities and disclosure of contingent assets and liabilities at
	the date of the consolidated financial statements and the reported
	amounts of revenues and expenses during the reporting period.
	Actual results could differ from those estimates.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Cash and Cash Equivalents
</FONT>
	&#x2013; Cash
	and cash equivalents include cash on hand, cash in banks and all
	highly liquid investments with a purchased maturity of less than
	three months. Cash equivalents consist of $7,782,243 and
	$26,946,378 in a money market account at June 30, 2016 and 2015,
	respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC; COLOR: #000000">
	Investments
</FONT>
<FONT STYLE="COLOR: #000000">
	&#xA0;&#x2013; The Company determines the
	appropriate classification of its investments in debt and equity
	securities at the time of purchase and reevaluates such
	determinations at each balance sheet date. Debt securities are
	classified as held-to-maturity when the Company has the intent and
	ability to hold the securities to maturity. Debt securities for
	which the Company does not have the intent or ability to hold to
	maturity are classified as available-for-sale. Held-to-maturity
	securities are recorded as either short-term or long-term on the
	balance sheet, based on the contractual maturity date and are
	stated at amortized cost. Marketable securities that are bought and
	held principally for the purpose of selling them in the near term
	are classified as trading securities and are reported at fair
	value, with unrealized gains and losses recognized in earnings.
	Debt and marketable equity securities not classified as
	held-to-maturity or as trading are classified as available-for-sale
	and are carried at fair market value, with the unrealized gains and
	losses, net of tax, included in the determination of other
	comprehensive (loss) income.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	fair value of substantially all securities is determined by quoted
	market prices. The estimated fair value of securities for which
	there are no quoted market prices is based on similar types of
	securities that are traded in the market.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Fair Value of Financial Instruments
</FONT>
	&#x2013; The Company&#x2019;s financial instruments consist primarily
	of cash equivalents, accounts payable and notes payable. Management
	believes that the carrying values of cash equivalents,
	available-for-sale investments and accounts payable are
	representative of their respective fair values based on the
	short-term nature of these instruments. Management believes that
	the carrying amount of its notes payable approximates fair value
	based on terms of the notes.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Credit Risk
</FONT>
	&#x2013; Financial
	instruments which potentially subject the Company to concentrations
	of credit risk consist principally of cash and cash equivalents.
	Total cash and cash equivalent balances have exceeded insured
	balances by the Federal Depository Insurance Company
	(FDIC).
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	52
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage55"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and Subsidiary
</FONT>
</DIV>
</DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Property and Equipment
</FONT>
	&#x2013; Property
	and equipment consists of office and laboratory equipment, office
	furniture and leasehold improvements and includes assets acquired
	under capital leases. Property and equipment are recorded at cost.
	Depreciation is recognized using the straight-line method over the
	estimated useful lives of the related assets, generally five years
	for laboratory and computer equipment, seven years for office
	furniture and equipment and the lesser of the term of the lease or
	the useful life for leasehold improvements. Amortization of assets
	acquired under capital leases is included in depreciation expense.
	Maintenance and repairs are expensed as incurred while expenditures
	that extend the useful life of an asset are
	capitalized.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Impairment of Long-Lived Assets
</FONT>
	&#x2013;
	The Company reviews its long-lived assets for impairment whenever
	events or changes in circumstances indicate that the carrying
	amount of the assets may not be fully recoverable. To determine
	recoverability of a long-lived asset, management evaluates whether
	the estimated future undiscounted net cash flows from the asset are
	less than its carrying amount. If impairment is indicated, the
	long-lived asset would be written down to fair value. Fair value is
	determined by an evaluation of available price information at which
	assets could be bought or sold, including quoted market prices, if
	available, or the present value of the estimated future cash flows
	based on reasonable and supportable assumptions.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Revenue Recognition
</FONT>
	&#x2013; Under our
	license, co-development and commercialization agreement with Gedeon
	Richter (Note 4), we received consideration in the form of a
	license fee and development milestone payment.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Revenue
	resulting from license fees is recognized upon delivery of the
	license for the portion of the license fee payment that is
	non-contingent and non-refundable, if the license has standalone
	value. Revenue resulting from the achievement of development
	milestones is recorded in accordance with the accounting guidance
	for the milestone method of revenue recognition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Research and Development Costs
</FONT>
	&#x2013;
	The costs of research and development activities are charged to
	expense as incurred, including the cost of equipment for which
	there is no alternative future use.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Accrued Expenses &#x2013;
</FONT>
	Third parties
	perform a significant portion of our development activities. We
	review the activities performed under significant contracts each
	quarter and accrue expenses and the amount of any reimbursement to
	be received from our collaborators based upon the estimated amount
	of work completed. Estimating the value or stage of completion of
	certain services requires judgment based on available information.
	If we do not identify services performed for us but not billed by
	the service-provider, or if we underestimate or overestimate the
	value of services performed as of a given date, reported expenses
	will be understated or overstated.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Stock-Based Compensation &#x2013;
</FONT>
	The
	Company charges to expense the fair value of stock options and
	other equity awards granted. The Company determines the value of
	stock options utilizing the Black-Scholes option pricing model.
	Compensation costs for share-based awards with pro-rata vesting are
	determined using the quoted market price of the Company&#x2019;s
	common stock on the date of grant and allocated to periods on a
	straight-line basis, while awards containing a market condition are
	valued using multifactor Monte Carlo simulations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Income Taxes
</FONT>
	&#x2013; The Company and
	its subsidiary file consolidated federal and separate-company state
	income tax returns. Income taxes are accounted for under the asset
	and liability method. Deferred tax assets and liabilities are
	recognized for the future tax consequences attributable to
	differences between the financial statement carrying amounts of
	assets and liabilities and their respective tax basis and operating
	loss and tax credit carryforwards. Deferred tax assets and
	liabilities are measured using enacted tax rates expected to apply
	to taxable income in the years in which those temporary differences
	or operating loss and tax credit carryforwards are expected to be
	recovered or settled. The effect on deferred tax assets and
	liabilities of a change in tax rates is recognized in the period
	that includes the enactment date. The Company has recorded a
	valuation allowance against its deferred tax assets based on the
	history of losses incurred.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company did not have a sale of New Jersey state net operating loss
	(NJ NOL) carryforwards during the year ended June 30, 2016 and
	therefore did not record a tax benefit. During the years ended June
	30, 2015 and 2014, the Company sold New Jersey state net operating
	loss carryforwards, which resulted in the recognition of $531,508
	and $1,846,646, respectively, in tax benefits.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Net Loss per Common Share
</FONT>
	&#x2013; Basic
	and diluted earnings per common share (EPS) are calculated in
	accordance with the provisions of Financial Accounting Standards
	Board (FASB) Accounting Standards Codification (ASC) Topic 260,
	&#x201C;Earnings per Share,&#x201D;&#xA0;which includes guidance
	pertaining to the warrants, issued in connection with the July 3,
	2012, December 23, 2014, and July 2, 2015 private placement
	offerings, that are exercisable for nominal consideration and,
	therefore, are to be considered in the computation of basic and
	diluted net loss per common share. The Series A 2012 warrants
	issued on July 3, 2012 to purchase up to 31,988,151 shares of
	common stock are included in the weighted average number of common
	shares outstanding used in computing basic and diluted net loss per
	common share for all periods presented in the consolidated
	statements of operations.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	53
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage56"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and Subsidiary
</FONT>
</DIV>
</DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Series B 2012 warrants issued on July 3, 2012 to purchase up to
	35,488,380 shares of common stock are included in the weighted
	average number of common shares outstanding used in computing basic
	and diluted net loss per common share for all periods presented in
	the consolidated statements of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Series C 2014 warrants to purchase up to 24,949,325 shares of
	common stock were exercisable starting at December 23, 2014 and,
	therefore are included in the weighted average number of common
	shares outstanding used in computing basic and diluted net loss per
	common share starting on December 23, 2014.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Series E 2015 warrants to purchase up to 21,917,808 shares of
	common stock were exercisable starting at July 2, 2015 and,
	therefore are included in the weighted average number of common
	shares outstanding used in computing basic and diluted net loss per
	common share starting on July 2, 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As of
	June 30, 2016, 2015 and 2014, there were 32,167,737, 30,212,446,
	and 29,358,926 common shares issuable upon conversion of Series A
	Convertible Preferred Stock, the exercise of outstanding options
	and warrants (excluding the Series A 2012, Series B 2012, Series C
	2014, and Series E 2015 warrants issued in connection with the July
	3, 2012, December 23, 2014, and July 2, 2015 private placement
	offerings), and the vesting of restricted stock units,
	respectively. These share amounts have been excluded from the
	calculation of net loss per share as the impact would be
	anti-dilutive.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(3)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;NEW
	AND RECENTLY ADOPTED ACCOUNTING PRONOUNCEMENTS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In June
	2016, the FASB issued ASU No. 2016-13,
<FONT STYLE="FONT-STYLE: ITALIC">
	Financial Instruments - Credit Losses:
	Measurement of Credit Losses on Financial Instruments
</FONT>
	which
	requires measurement and recognition of expected credit losses for
	financial assets held at the reporting date based on historical
	experience, current conditions, and reasonable and supportable
	forecasts. This is different from the current guidance as this will
	require immediate recognition of estimated credit losses expected
	to occur over the remaining life of many financial assets. The new
	guidance will be effective for the Company on July 1, 2020. Early
	adoption will be available on July 1, 2019. The Company is
	currently evaluating the effect that the updated standard will have
	on its consolidated financial statements and related
	disclosures.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	March 2016, the FASB issued ASU No. 2016-09,
<FONT STYLE="FONT-STYLE: ITALIC">
	Compensation &#x2013; Improvement to Employee
	Share-Based Payment Accounting
</FONT>
	, which amends the current
	guidance related to stock compensation. The updated guidance
	changes how companies account for certain aspects of share-based
	payment awards to employees, including the accounting for income
	taxes, forfeitures, and statutory tax withholding requirements, as
	well as classification in the statement of cash flows. The update
	to the standard is effective for the Company on July 1, 2017, with
	early application permitted. We are evaluating the effect that the
	new guidance will have on its consolidated financial statements and
	related disclosures.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	February 2016, the FASB issued ASU No. 2016-02,
<FONT STYLE="FONT-STYLE: ITALIC">
	Leases,
</FONT>
	related to the recognition of
	lease assets and lease liabilities. The new guidance requires
	lessees to recognize almost all leases on their balance sheet as a
	right-of-use asset and a lease liability, other than leases that
	meet the definition of a short- term lease, and requires expanded
	disclosures about leasing arrangements. The recognition,
	measurement, and presentation of expenses and cash flows arising
	from a lease by a lessee have not significantly changed from the
	current guidance. Lessor accounting is similar to the current
	guidance, but updated to align with certain changes to the lessee
	model and the new revenue recognition standard. The new guidance is
	effective for the Company on July 1, 2019, with early adoption
	permitted. The Company is evaluating the impact that the new
	guidance will have on its consolidated financial statements and
	related disclosures.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	January 2016, the FASB issued ASU No. 2016-01,
<FONT STYLE="FONT-STYLE: ITALIC">
	Financial Instruments: Recognition and
	Measurement of Financial Assets and Financial Liabilities
</FONT>
	.
	The new guidance relates to the recognition and measurement of
	financial assets and liabilities. The new guidance makes targeted
	improvements to GAAP impacting equity investments (other than those
	accounted for under the equity method or consolidated), financial
	liabilities accounted for under the fair value election, and
	presentation and disclosure requirements for financial instruments,
	among other changes. The new guidance is effective for the Company
	on July 1, 2018, with early adoption prohibited other than for
	certain provisions. The Company is evaluating the impact that the
	new guidance will have on its consolidated financial statements and
	related disclosures.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	54
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage57"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and Subsidiary
</FONT>
</DIV>
</DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	November 2015, the FASB issued ASU No. 2015-17
<FONT STYLE="FONT-STYLE: ITALIC">
	, Income Taxes: Balance Sheet Classification
	of Deferred Taxes
</FONT>
	which simplifies the balance sheet
	classification of deferred taxes. The new guidance requires that
	deferred tax liabilities and assets be classified as noncurrent in
	a classified statement of financial position. The current
	requirement that deferred tax liabilities and assets of a
	tax-paying component of an entity be offset and presented as a
	single amount is not affected by the new guidance. The new guidance
	is effective for the Company on July 1, 2017, with early adoption
	permitted as of the beginning of an interim or annual reporting
	period. The new guidance may be applied either prospectively to all
	deferred tax liabilities and assets or retrospectively to all
	periods presented. The Company is evaluating the impact that the
	new guidance will have on its consolidated financial statements and
	related disclosures; however, at the present time the Company has
	recorded a valuation allowance against its deferred tax assets
	based on the history of losses incurred.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	April 2015, the FASB issued ASU No. 2015-03,
<FONT STYLE="FONT-STYLE: ITALIC">
	Simplifying the Presentation of Debt Issuance
	Costs
</FONT>
	, which requires debt issuance costs related to a
	recognized debt liability to be presented on the balance sheet as a
	direct deduction from the debt liability, similar to the
	presentation of debt discounts. In August 2015, the FASB issued a
	clarification that debt issuance costs related to line-of-credit
	arrangements were not within the scope of the new guidance and
	therefore should continue to be accounted for as deferred assets in
	the balance sheet, consistent with existing GAAP. The new standard
	is effective for the Company for its fiscal year ending June 30,
	2017. The Company is evaluating the effect of the standard on its
	consolidated financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	August 2014, the FASB issued ASU No. 2014-15,
<FONT STYLE="FONT-STYLE: ITALIC">
	Presentation of Financial Statements-Going
	Concern: Disclosures of Uncertainties about an Entity&#x2019;s
	Ability to Continue as a Going Concern
</FONT>
	. The amendments in
	this update provide guidance in U.S. GAAP about management's
	responsibility to evaluate whether there is substantial doubt about
	an entity's ability to continue as a going concern and to provide
	related footnote disclosures. In doing so, the amendments should
	reduce diversity in the timing and content of footnote disclosures.
	The new standard is effective for the Company for its fiscal year
	ending June 30, 2017. Early adoption is permitted. The Company is
	evaluating the effect of the standard, if any, on its consolidated
	financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="COLOR: #000000">
	In May 2014, the FASB issued ASU No.
	2014-09,
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; COLOR: #000000">
	Revenue from Contracts with
	Customers
</FONT>
<FONT STYLE="COLOR: #000000">
	, which requires an
	entity to recognize the amount of revenue to which it expects to be
	entitled for the transfer of promised goods or services to
	customers. The ASU will replace most existing revenue recognition
	guidance in U.S. GAAP when it becomes effective. In July 2015, the
	FASB voted to defer the effective date of the new standard until
	fiscal years beginning after December 15, 2017 with early
	application permitted for fiscal years beginning after December 15,
	2016. With the deferral, the new standard is effective for the
	Company on July 1, 2018, with early adoption permitted one year
	prior. The standard permits the use of either the retrospective or
	cumulative effect transition method. The Company is evaluating the
	effect that ASU 2014-09 will have on its consolidated financial
	statements and related disclosures. The Company has not yet
	selected a transition method nor has it determined the effect of
	the standard on its ongoing financial
	reporting.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(4)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;AGREEMENT
	WITH GEDEON RICHTER
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	August 2014, the Company entered into a license, co-development and
	commercialization agreement with Gedeon Richter on bremelanotide
	for FSD in Europe and selected countries. On September 16, 2015,
	the Company and Gedeon Richter mutually and amicably agreed to
	terminate the license, co-development and commercialization
	agreement. In connection with the termination of the license
	agreement, all rights and licenses to co-develop and commercialize
	bremelanotide for FSD indications granted by the Company under the
	license agreement to Gedeon Richter terminated and reverted to the
	Company, and neither party has any future material obligations
	under the license agreement. Neither the Company nor Gedeon Richter
	incurred any early termination penalties or other payment or
	reimbursement obligations as a result of the termination of the
	license agreement.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company viewed the delivery of the license for bremelanotide as a
	revenue generating activity that is part of its ongoing and central
	operations. The other elements of the agreement with Gedeon Richter
	were considered non-revenue activities associated with the
	collaborative arrangement. The Company believes the license had
	standalone value from the other elements of the collaborative
	arrangement because it conveyed all of the rights necessary to
	develop and commercialize bremelanotide in the licensed
	territory.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	55
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage58"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and Subsidiary
</FONT>
</DIV>
</DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	August 2013, the Company received an initial payment of $1,000,000
	from Gedeon Richter as a non-refundable option fee on the license,
	co-development and commercialization agreement, and in September
	2014, the Company received &#x20AC;6,700,000 ($8,763,347) on
	execution of the definitive agreement. During the year ended June
	30, 2015, the upfront payment of &#x20AC;7,500,000 ($9,763,347) was
	recorded as license revenue in the consolidated statements of
	operations. During the year ended June 30, 2015, the Company
	recorded revenue related to a milestone payment of &#x20AC;2,500,000
	($3,188,383) upon the initiation of the Company&#x2019;s Phase 3
	clinical trial program in the United States.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As a
	result of fluctuations in the conversion rates between the Euro and
	the U.S. Dollar between the transaction dates and the settlement
	dates, the Company recorded a foreign exchange loss of $284,656 for
	the year ended June 30, 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(5)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;PREPAID
	EXPENSES AND OTHER CURRENT ASSETS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Prepaid
	expenses
<FONT STYLE="FONT-WEIGHT: BOLD">
	&#xA0;
</FONT>
	and other
	current assets consist of the following:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; June 30,
<BR>
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_8"></A>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	2016
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; June 30,
<BR>
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	2015
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Clinical
	study costs
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,146,975
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,641,605
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Insurance
	premiums
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	23,010
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	30,039
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	254,297
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	225,103
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:4PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,424,282
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,896,747
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(6)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;INVESTMENTS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following summarizes the carrying value of our available-for-sale
	investments at June 30, 2016, which consist of corporate debt
	securities:
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	June 30,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_9"></A>
<DIV STYLE="MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Cost
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,387,022
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Amortization
	of premium
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(4,522
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Gross
	unrealized loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(1,944
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Fair
	value
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,380,556
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	were no available-for-sale investments at June 30,
	2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(7)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;FAIR
	VALUE MEASUREMENTS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	fair value of cash equivalents is classified using a hierarchy
	prioritized based on inputs. Level 1 inputs are quoted prices
	(unadjusted) in active markets for identical assets or liabilities.
	Level 2 inputs are quoted prices for similar assets and liabilities
	in active markets or inputs that are observable for the asset or
	liability, either directly or indirectly through market
	corroboration, for substantially the full term of the financial
	instrument. Level 3 inputs are unobservable inputs based on
	management&#x2019;s own assumptions used to measure assets and
	liabilities at fair value. A financial asset or liability&#x2019;s
	classification within the hierarchy is determined based on the
	lowest level input that is significant to the fair value
	measurement.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	56
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage59"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following table provides the assets carried at fair
	value:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX;">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-RIGHT:0PX;WIDTH:100%;MARGIN-LEFT:0PX;">
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	Carrying Value
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	Quoted prices in
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	active markets
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	(Level 1)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	Other quoted/observable inputs (Level 2)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	Significant unobservable inputs
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	(Level 3)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_10"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June
	30, 2016:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000000;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000000;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000000;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="PADDING-BOTTOM: 4PX;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; PADDING-BOTTOM: 2PX; MARGIN-LEFT: 0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Money
	Market Account
</FONT>
</DIV>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	7,782,243
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	7,782,243
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June
	30, 2015:
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Money
	Market Account
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	26,946,378
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	26,946,378
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(8)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;PROPERTY
	AND EQUIPMENT, NET
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Property and
	equipment, net, consists of the following:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; June 30,
<BR>
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_11"></A>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	2016
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; June 30,
<BR>
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	2015
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Office
	equipment
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,180,210
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,180,210
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Laboratory
	equipment
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	415,303
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	397,608
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Leasehold
	improvements
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	751,226
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	751,226
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	2,346,739
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	2,329,044
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Less:
	Accumulated depreciation and amortization
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(2,248,938
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(2,205,886
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:4PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	97,801
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	123,158
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	aggregate cost of assets acquired under capital leases was $146,115
	as of June 30, 2016 and June 30, 2015. Accumulated amortization
	associated with assets acquired under capital leases was $90,115 as
	of June 30, 2016 and $61,994 as of June 30, 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(9)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;ACCRUED
	EXPENSES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Accrued
	expenses
<FONT STYLE="FONT-WEIGHT: BOLD">
	&#xA0;
</FONT>
	consist of the
	following:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; June 30,
<BR>
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_12"></A>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	2016
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; June 30,
<BR>
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	2015
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Clinical
	study costs
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	6,983,581
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	5,594,839
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	research related expenses
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	69,609
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	176,105
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Professional
	services
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	231,482
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	201,831
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	483,061
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	250,708
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:4PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	7,767,733
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	6,223,483
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	57
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage60"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_13"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	(10)
</FONT>
	&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;
<FONT STYLE="FONT-WEIGHT: BOLD">
	NOTES
	PAYABLE:
</FONT>
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Notes
	payable consist of the following:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
<FONT STYLE="FONT-WEIGHT: BOLD;">
	June 30,
</FONT>
<BR>
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	June 30,
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Notes
	payable under venture loan
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	20,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	10,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Unamortized
	related debt discount
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(324,799
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(218,914
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Notes
	payable
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	19,675,201
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	9,781,086
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Less:
	current portion
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	5,485,392
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Long-term
	portion
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	14,189,809
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	9,781,086
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	On July
	2, 2015, the Company closed on a $10,000,000 venture loan led by
	Horizon Technology Finance Corporation (Horizon). The debt facility
	is a four-year senior secured term loan that bears interest at a
	floating coupon rate of one-month LIBOR (floor of 0.50%) plus 8.50%
	and provides for interest-only payments for the first eighteen
	months followed by monthly payments of principal payments of
	$333,333 plus accrued interest through August 1, 2019. The lenders
	also received five-year immediately exercisable Series G warrants
	to purchase 549,450 shares of Palatin common stock exercisable at
	an exercise price of $0.91 per share. The Company has recorded a
	debt discount of $305,196 equal to the fair value of these warrants
	at issuance, which is being amortized to interest expense over the
	term of the related debt. This debt discount is offset against the
	note payable balance and included in additional paid-in capital on
	the Company&#x2019;s balance sheet at June 30, 2016. In addition, a
	final incremental payment of $500,000 is due on August 1, 2019, or
	upon early repayment of the loan. This final incremental payment is
	being accreted to interest expense over the term of the related
	debt. The Company incurred approximately $146,000 of costs in
	connection with the loan agreement. These costs were capitalized as
	deferred financing costs and are being amortized to interest
	expense over the term of the related debt. In addition, if the
	Company repays all or a portion of the loan prior to the applicable
	maturity date, it will pay the lenders a prepayment penalty fee,
	based on a percentage of the then outstanding principal balance,
	equal to 3% if the prepayment occurs on or before 18 months after
	the funding date thereof or 1% if the prepayment occurs more than
	18 months after, but on or before 30 months after, the funding
	date.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	On
	December 23, 2014, the Company closed on a $10,000,000 venture loan
	which was led by Horizon. The debt facility is a four-year senior
	secured term loan that bears interest at a floating coupon rate of
	one-month LIBOR (floor of 0.50%) plus 8.50%, and provides for
	interest-only payments for the first eighteen months followed by
	monthly payments of principal payments of $333,333 plus accrued
	interest through January 1, 2019. The lenders also received
	five-year immediately exercisable Series D 2014 warrants to
	purchase 666,666 shares of common stock exercisable at an exercise
	price of $0.75 per share. The Company recorded a debt discount of
	$267,820 equal to the fair value of these warrants at issuance,
	which is being amortized to interest expense over the term of the
	related debt. This debt discount is offset against the note payable
	balance and included in additional paid-in capital on the
	Company&#x2019;s balance sheet at June 30, 2016 and June 30, 2015.
	In addition, a final incremental payment equal to $500,000 is due
	on January 1, 2019, or upon early repayment of the loan. This final
	incremental payment is being accreted to interest expense over the
	term of the related debt. The Company incurred approximately
	$209,000 of costs in connection with the loan agreement. These
	costs were capitalized as deferred financing costs and are being
	amortized to interest expense over the term of the related debt. In
	addition, if the Company repays all or a portion of the loan prior
	to the applicable maturity date, it will pay the lenders a
	prepayment penalty fee, based on a percentage of the then
	outstanding principal balance, equal to 3% if the prepayment occurs
	on or before 18 months after the funding date thereof or 1% if the
	prepayment occurs more than 18 months after, but on or before 30
	months after, the funding date.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company&#x2019;s obligations under these loan agreements are secured
	by a first priority security interest in substantially all of its
	assets other than its intellectual property. The Company also has
	agreed to specified limitations on pledging or otherwise
	encumbering its intellectual property assets.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	These
	loan agreements include customary affirmative and restrictive
	covenants, but do not include any covenants to attain or maintain
	specified financial metrics. These loan agreements include
	customary events of default, including payment defaults, breaches
	of covenants, change of control and a material adverse change
	default. Upon the occurrence of an event of default and following
	any applicable cure periods, a default interest rate of an
	additional 5% may be applied to the outstanding loan balances, and
	the lenders may declare all outstanding obligations immediately due
	and payable and take such other actions as set forth in the loan
	agreements. As of June 30, 2016, the Company was in compliance with
	all its loan covenants
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	58
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage61"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_14"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Scheduled future
	principal payments related to notes payable as of June 30, 2016 are
	as follows:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Year Ending June 30,
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2017
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	5,666,667
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2018
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	8,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2019
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	6,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 12PX; MARGIN-RIGHT: 0PX; PADDING-BOTTOM: 2PX; MARGIN-LEFT: 0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2020
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	333,333
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	20,000,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 12PX; MARGIN-RIGHT: 0PX; PADDING-BOTTOM: 2PX; MARGIN-LEFT: 0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Less:
	debt discount
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	(324,799
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	19,675,201
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(11)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;COMMITMENTS
	AND CONTINGENCIES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Operating Leases
</FONT>
	&#x2013; The Company
	currently leases facilities under two non-cancelable operating
	leases. The lease on our corporate offices was renewed effective
	July 1, 2015 and expires on June 30, 2020 and in June 2015 we
	entered into a lease for approximately 1,000 square feet of
	laboratory space which currently expires in July 2017. Future
	minimum lease payments under these leases are as
	follows:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV>
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Year Ending June 30,
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000000;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_15"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2017
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	255,985
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2018
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	224,493
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2019
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	221,344
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2020
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	221,344
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:4PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	923,166
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For the
	years ended June 30, 2016, 2015 and 2014, rent expense was
	$256,642, $222,215, and $219,686, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Capital Leases
</FONT>
	&#x2013; The Company has
	acquired certain of its equipment under leases classified as
	capital leases. Scheduled future payments related to capital leases
	as of June 30, 2016 are as follows:
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_16"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:88%;">
<DIV>
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Year Ending June 30,
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000000;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2017
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	29,138
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 12PX; MARGIN-RIGHT: 0PX; PADDING-BOTTOM: 2PX; MARGIN-LEFT: 0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2018
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	14,568
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:88%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	43,706
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 12PX; MARGIN-RIGHT: 0PX; PADDING-BOTTOM: 2PX; MARGIN-LEFT: 0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Amount
	representing interest
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	(1,958
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:88%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	41,748
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Other agreements
</FONT>
	&#x2013; In connection
	with its agreement with the Company&#x2019;s third-party contract
	manufacturer, Catalent Belgium S.A., the Company is obligated to
	pay a space reservation fee over the next four quarters of
	approximately &#x20AC; 2,300,000 ($2,524,033) in the
	aggregate.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Employment Agreements
</FONT>
	&#x2013; The
	Company has employment agreements with two executive officers which
	provide a stated annual compensation amount, subject to annual
	increases, and annual bonus compensation in an amount to be
	approved by the Company&#x2019;s Board of Directors. Each agreement
	allows the Company or the employee to terminate the agreement in
	certain circumstances. In some circumstances, early termination by
	the Company may result in severance pay to the employee for a
	period of 18 to 24 months at the salary then in effect,
	continuation of health insurance premiums over the severance period
	and immediate vesting of all stock options and restricted stock
	units. Termination following a change in control will result in a
	lump sum payment of one and one-half to two times the salary then
	in effect and immediate vesting of all stock options and restricted
	stock units.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	59
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage62"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Employee Retirement Savings Plan
</FONT>
	&#x2013; The Company maintains a defined contribution 401(k) plan
	for the benefit of its employees. The Company currently matches a
	portion of employee contributions to the plan. For the years ended
	June 30, 2016, 2015 and 2014, Company contributions were $138,184,
	$147,203, and $140,870, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Contingencies
</FONT>
	&#x2013; The Company
	accounts for litigation losses in accordance with ASC 450-20,
	&#x201C;Loss Contingencies.&#x201D; Under ASC 450-20, loss
	contingency provisions are recorded for probable losses when
	management is able to reasonably estimate the loss. Any outcome
	upon settlement that deviates from the Company&#x2019;s best
	estimate may result in additional expense or in a reduction in
	expense in a future accounting period. The Company records legal
	expenses associated with such contingencies as
	incurred.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company is involved, from time to time, in various claims and legal
	proceedings arising in the ordinary course of its business. The
	Company is not currently a party to any such claims or proceedings
	that, if decided adversely to it, would either individually or in
	the aggregate have a material adverse effect on its business,
	financial condition or results of operations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(12)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;STOCKHOLDERS&#x2019;
	(DEFICIENCY) EQUITY
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Series A Convertible Preferred Stock
</FONT>
	&#x2013;&#xA0;As of June 30, 2016, 4,030 shares of Series A
	Convertible Preferred Stock were outstanding. Each share of Series
	A Convertible Preferred Stock is convertible at any time, at the
	option of the holder, into the number of shares of common stock
	equal to $100 divided by the Series A Conversion Price. As of June
	30, 2016, the Series A Conversion Price was $6.65, so each share of
	Series A Convertible Preferred Stock is currently convertible into
	approximately 15.0 shares of common stock. The Series A Conversion
	Price is subject to adjustment, under certain circumstances, upon
	the sale or issuance of common stock for consideration per share
	less than either (i) the Series A Conversion Price in effect on the
	date of such sale or issuance, or (ii) the market price of the
	common stock as of the date of such sale or issuance. The Series A
	Conversion Price is also subject to adjustment upon the occurrence
	of a merger, reorganization, consolidation, reclassification, stock
	dividend or stock split which will result in an increase or
	decrease in the number of shares of common stock outstanding.
	Shares of Series A Convertible Preferred Stock have a preference in
	liquidation, including certain merger transactions, of $100 per
	share, or $403,000 in the aggregate as of June 30, 2016.
	Additionally, the Company may not pay a dividend or make any
	distribution to holders of any class of stock unless the Company
	first pays a special dividend or distribution of $100 per share to
	holders of the Series A Convertible Preferred Stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Financing Transactions &#x2013;
</FONT>
	On July
	2, 2015, the Company closed on a private placement of Series E
	warrants to purchase 21,917,808 shares of Palatin common stock and
	Series F warrants to purchase 2,191,781 shares of Palatin common
	stock. Certain funds managed by QVT Financial LP invested
	$5,000,000 and another accredited investment fund invested
	$15,000,000. The funds paid $0.90 for each Series E warrant and
	$0.125 for each Series F warrant, resulting in gross proceeds to
	the Company of $20,000,000, with net proceeds, after deducting
	estimated offering expenses, of approximately
	$19,834,278.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Series E warrants, which may be exercised on a cashless basis, are
	exercisable immediately upon issuance at an initial exercise price
	of $0.01 per share and expire on the tenth anniversary of the date
	of issuance.&#xA0;The Series E warrants are subject to limitation
	on exercise if QVT and its affiliates would beneficially own more
	than 9.99% (4.99% for the other accredited investment fund holder)
	of the total number of Palatin's shares of common stock following
	such exercise. The Series F warrants are exercisable at an initial
	exercise price of $0.91 per share, exercisable immediately upon
	issuance and expire on the fifth anniversary of the date of
	issuance. The Series F warrants are subject to the same beneficial
	ownership limitation as the Series E warrants.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	purchase agreement for the private placement provides that the
	purchasers have certain rights until the earlier of approval of
	bremelanotide for FSD by the U.S. Food and Drug Administration and
	July 3, 2018, including rights of first refusal and participation
	in any subsequent equity or debt financing. The purchase agreement
	also contains certain restrictive covenants so long as the funds
	continue to hold specified amounts of warrants or beneficially own
	specified amounts of the outstanding shares of common
	stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Common Stock Transactions
</FONT>
	&#x2013; On
	December 23, 2014, the Company closed on a private placement
	offering in which the Company sold 2,050,000 shares of its common
	stock and Series C 2014 warrants to purchase up to 24,949,325
	shares of common stock. Funds under the management of QVT Financial
	LP (QVT) invested $10,000,000 and an unrelated accredited
	investment fund invested $10,000,000. The funds paid $0.75 for each
	share of common stock and $0.74 for each Series C 2014 warrant,
	resulting in gross proceeds to Palatin of $20,000,000, with net
	proceeds, after deducting estimated offering expenses, of
	$18,556,111. The Series C 2014 warrants, which may be exercised on
	a cashless basis, are exercisable immediately upon issuance at an
	initial exercise price of $0.01 per share and expire on the tenth
	anniversary of the date of issuance. The Series C 2014 warrants are
	subject to limitation on exercise if QVT and its affiliates would
	beneficially own more than 9.99% (4.99% for the other accredited
	investment fund holder) of the total number of Palatin&#x2019;s
	shares of common stock following such exercise.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	60
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage63"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	purchase agreement for the private placement provides that the
	purchasers have certain rights until the earlier of approval of
	bremelanotide for FSD by the U.S. Food and Drug Administration and
	December 23, 2018, including rights of first refusal and
	participation in any subsequent equity or debt financing. The
	purchase agreement also contains certain restrictive covenants so
	long as the funds continue to hold specified amounts of warrants or
	beneficially own specified amounts of the outstanding shares of
	common stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Outstanding Stock Purchase Warrants
</FONT>
	&#x2013; As of June 30,
	2016, the Company had outstanding warrants exercisable for shares
	of common stock as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_17"></A>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PX AUTO; WIDTH: 50%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	Shares of Common Stock&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	Exercise Price per Share&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<FONT STYLE="COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Latest Termination Date&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	20,771,740
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1.00
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	March
	2, 2017
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	6,117,245
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.01
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July
	3, 2022
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	35,344,341
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.01
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	27, 2022
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	666,666
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.75
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December
	23, 2019
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	24,949,325
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.01
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December
	23, 2024
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	2,191,781
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.91
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July
	2, 2020
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	549,450
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.91
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July
	2, 2020
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	21,917,808
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	0.01
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July
	2, 2025
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); BORDER-BOTTOM: 4PX DOUBLE RGB(0, 0, 0); VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	112,508,356
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 4PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 4PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 4PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="MARGIN-LEFT: 0PX; PADDING-BOTTOM: 4PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	the year ended June 30, 2016, the Company issued 10,890,889 shares
	of common stock pursuant to the cashless exercise provisions of
	warrants at an exercise price of $0.01. During the year ended June
	30, 2015, the Company received $254,148 and issued 15,130,573
	shares of common stock pursuant to the exercise of warrants at
	exercise prices of $0.01 and $1.00, including warrants exercised
	pursuant to cashless exercise provisions. During the year ended
	June 30, 2014, the Company received $37,500 and issued 50,000
	shares of common stock pursuant to the exercise of warrants at an
	exercise price of $0.75 per share.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Stock Plan &#x2013;
</FONT>
	The Company&#x2019;s
	2011 Stock Incentive Plan was approved by the Company&#x2019;s
	stockholders at the annual meeting of stockholders held in May 2011
	and amended at the annual meeting of stockholders held on June 9,
	2016. The 2011 Stock Incentive Plan provides for incentive and
	nonqualified stock option grants and other stock-based awards to
	employees, non-employee directors and consultants for up to
	12,500,000 shares of common stock. The 2011 Stock Incentive Plan is
	administered under the direction of the Board of Directors, which
	may specify grant terms and recipients. Options granted by the
	Company generally expire ten years from the date of grant and
	generally vest over three to four years. The 2005 Stock Plan was
	terminated and replaced by the 2011 Stock Incentive Plan, and
	shares of common stock that were available for grant under the 2005
	Stock Plan became available for grant under the 2011 Stock
	Incentive Plan. No new awards can be granted under the 2005 Stock
	Plan, but awards granted under the 2005 Stock Plan remain
	outstanding in accordance with their terms. As of June 30, 2016,
	3,314,419 shares were available for grant under the 2011 Stock
	Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company also has outstanding options that were granted under the
	2005 Stock Plan. The Company expects to settle option exercises
	under any of its plans with authorized but currently unissued
	shares.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	61
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage64"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_18"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
</DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following table summarizes option activity and related information
	for the years ended June 30, 2016, 2015 and 2014:
</FONT>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="FONT-FAMILY:TIMES NEW ROMAN;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;WIDTH:100%;FONT-SIZE:13PX;">
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_19"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; BORDER-BOTTOM:SOLID 2PX #000;FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:80%;FONT-SIZE:11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000;">
	&#xA0;
	Number of Shares
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; BORDER-BOTTOM:SOLID 2PX #000;FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:80%;FONT-SIZE:11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000;">
	&#xA0;
	Weighted Average Exercise Price
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; BORDER-BOTTOM:SOLID 2PX #000;FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:80%;FONT-SIZE:11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000;">
	&#xA0;
	Weighted Average Remaining Term in Years
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; BORDER-BOTTOM:SOLID 2PX #000;FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:80%;FONT-SIZE:11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY:TIMES NEW ROMAN;FONT-WEIGHT:BOLD;">
	&#xA0;Agregate
	Instrinsic Value
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-WEIGHT:BOLD;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Outstanding
	- July 1, 2013
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	3,851,448
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1.99
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	8.2
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Granted
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	603,400
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1.02
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Forfeited
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(161,900
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.68
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Expired
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(50,975
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	24.95
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_20"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Outstanding
	- June 30, 2014
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	4,241,973
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	1.63
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	7.7
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Granted
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	975,800
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	1.06
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Forfeited
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(78,810
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	1.92
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Expired
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(8,733
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	36.47
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_21"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Outstanding
	- June 30, 2015
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	5,130,230
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	1.46
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	7.3
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Granted
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	355,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	0.54
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Forfeited
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(170,550
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	0.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Expired
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(52,940
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	22.53
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR: RGB(0, 0, 0); FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN: BOTTOM; WIDTH: 75%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Outstanding
	- June 30, 2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	5,261,740
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1.21
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	6.2
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Exercisable
	at June 30, 2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	3,769,402
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1.35
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	5.4
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Expected
	to vest at June 30, 2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,209,630
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	0.83
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	8.5
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For the
	years ended June 30, 2016, 2015 and 2014, the fair value of option
	grants is estimated at the grant date using the Black-Scholes
	model. The Company&#x2019;s weighted average assumptions for the
	years ended June 30, 2016, 2015 and 2014 were as
	follows:
</FONT>
</DIV>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_22"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	2014
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Risk-free
	interest rate
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1.4
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1.9
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1.9
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Volatility
	factor
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	73.5
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	83.4
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	97.1
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Dividend
	yield
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Expected
	option life (years)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	5.7
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	6.1
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	6.1
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Weighted
	average grant date fair value
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.35
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.76
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	0.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 16PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Expected
	volatilities are based on the Company&#x2019;s historical
	volatility. The expected term of options is based upon the
	simplified method, which represents the average of the vesting term
	and the contractual term. The risk-free interest rate is based on
	U.S. Treasury yields for securities with terms approximating the
	expected term of the option.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For the
	years ended June 30, 2016, 2015 and 2014 the Company recorded
	stock-based compensation related to stock options of $529,454,
	$572,609 and $520,855, respectively. As of June 30, 2016, there was
	$674,007 of unrecognized compensation cost related to unvested
	options, which is expected to be recognized over a weighted-average
	period of 2.31 years.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In June
	2016, the Company granted 262,500 options to its non-employee
	directors under the Company&#x2019;s 2011 Stock Incentive Plan. The
	Company will amortize the fair value of these options of $81,435,
	over the vesting period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	the year ended June 30, 2016, the Company granted an aggregate
	92,500 options to certain employees under the Company&#x2019;s 2011
	Stock Incentive Plan. The Company is amortizing the fair value of
	these options of $41,470, over the vesting period.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	62
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage65"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
	&#xA0;
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In June
	2015, the Company granted 570,000 options to its executive
	officers, 185,800 options to its employees and 160,000 options to
	its non-employee directors under the Company&#x2019;s 2011 Stock
	Incentive Plan. The Company is amortizing the fair value of these
	options of $446,748, $145,439 and $111,876, respectively, over the
	vesting period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In June
	2014, the Company granted 325,000 options to its executive
	officers, 143,400 options to its employees and 135,000 options to
	its non-employee directors under the Company&#x2019;s 2011 Stock
	Incentive Plan. The Company is amortizing the fair value of these
	options of $265,726, $117,247 and $97,530, respectively, over the
	vesting period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stock
	options granted to the Company&#x2019;s executive officers and
	employees vest over a 48 month period, while stock options granted
	to its non-employee directors vest over a 12 month
	period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	June 2016, the Company made the following modifications to certain
	stock options that were granted to a former non-employee director
	in recognition of their prior services; i) accelerated the vesting,
	and ii) extended the date to exercise vested stock options to 24
	months from the date of termination. An incremental $16,187 of
	stock-based compensation expense was recognized during the year
	ended June 30, 2016 and included in general and administrative
	expense in connection with these activities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	the year ended June 30, 2015, the Company made the following
	modifications to certain stock options that were granted to a
	terminated employee and former non-employee directors in
	recognition of their prior services; i) accelerated the vesting,
	and ii) extended the date to exercise vested stock options to 24
	months from the date of termination. An incremental $73,664 of
	stock-based compensation expense was recognized during the year
	ended June 30, 2015 and included in general and administrative
	expense in connection with these activities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	the year ended June 30, 2014, the Company made the following
	modifications to certain stock options that were granted to certain
	terminated employees in recognition of their prior services; i)
	accelerated the vesting, and ii) extended the date to exercise
	vested stock options to 24 months from the date of termination. An
	incremental $22,000 of stock-based compensation expense was
	recognized during the year ended June 30, 2014 and included in
	research and development expense in connection with these
	activities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Restricted Stock Units &#x2013;
</FONT>
	The following table
	summarizes restricted stock award activity for the years ended June
	30, 2016, 2015 and 2014:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 0PX; PADDING-BOTTOM: 0PX; MARGIN: 0PX;">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PX AUTO 0PX 0PX; WIDTH: 100%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 12PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; 2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; 2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; 2014
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_23"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Outstanding
	at beginning of year
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	1,028,017
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	957,150
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	757,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Granted
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	2,302,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	785,800
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	603,400
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Forfeited
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(2,563
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(9,100
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(25,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Vested
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(662,186
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(705,833
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(378,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Outstanding
	at end of year
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	2,665,768
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,028,017
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	957,150
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For the
	years ended June 30, 2016, 2015 and 2014 the Company recorded
	stock-based compensation related to restricted stock units of
	$1,297,724, $594,670 and $300,485, respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In June
	2016, the Company granted 262,500 restricted stock units to its
	non-employee directors under the Company&#x2019;s 2011 Stock
	Incentive Plan. The Company is amortizing the fair value of these
	options of $131,250, over the vesting period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	January 2016, the Company granted 50,000 restricted stock units to
	an employee and is amortizing the fair value of these restricted
	stock units of $30,000 over a 48 month vesting period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	December 2015, the Company granted 625,000 performance-based
	restricted stock units to its executive officers and 200,000
	performance-based restricted stock units to its employees under the
	Company&#x2019;s 2011 Stock Incentive Plan, which vest during the
	performance period, ending December 31, 2017, if and upon the
	earlier of: i) achievement of a closing price for the
	Company&#x2019;s common stock equal to or greater than $1.20 per
	share for 20 consecutive trading days, which is considered a market
	condition, or ii) entering into a collaboration agreement (U.S. or
	global) of bremelanotide for FSD, which is considered a performance
	condition. The Company determined that the performance condition
	was not probable of achievement on the date of grant since such
	condition is outside the control of the Company. The fair value of
	these awards, as calculated under a multifactor Monte Carlo
	simulation, was $338,250. The Company is amortizing the fair value
	over the derived service period of 0.96 years.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	63
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage66"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
</DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Also,
	in December 2015, the Company granted 625,000 restricted stock
	units to its executive officers, 340,000 restricted stock units to
	its non-employee directors and 200,000 restricted stock units to
	its employees under the Company&#x2019;s 2011 Stock Incentive Plan.
	For executive officers and employees, the restricted stock units
	vest 25% on the date of grant and 25% on the first, second and
	third anniversary dates from the date of grant. For non-employee
	directors, the restricted stock units vest 50% on the first and
	second anniversary dates from the date of grant. The Company is
	amortizing the fair value of these restricted stock units of
	$425,000, $231,200 and $136,000, respectively, over the vesting
	period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In June
	2015, the Company granted 400,000 restricted stock units to its
	executive officers, 185,800 restricted stock units to its employees
	and 160,000 restricted stock units to its non-employee directors
	under the Company&#x2019;s 2011 Stock Incentive Plan. The Company is
	amortizing the fair value of these restricted stock units of
	$432,000, $200,664, and $172,800, respectively, over the vesting
	period. In addition, in June 2015, the Company granted 20,000
	restricted stock units to former non-employee directors in
	recognition of their prior services. These restricted stock units
	vested upon issuance and the Company recognized the fair value of
	these restricted stock units of $21,600 as stock-based compensation
	expense which was included in general and administrative expense at
	June 30, 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	January 2015, the Company granted 20,000 restricted stock units to
	an employee and is amortizing the fair value of these restricted
	stock units of $16,000 over a 24 month vesting period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In June
	2014, the Company granted 325,000 restricted stock units to its
	executive officers, 143,400 restricted stock units to its employees
	and 135,000 restricted stock units to its non-employee directors
	under the Company&#x2019;s 2011 Stock Incentive Plan. The Company is
	amortizing the fair value of these restricted stock units of
	$331,500, $146,268 and $137,700, respectively, over the vesting
	period.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Generally,
	restricted stock units granted to the Company&#x2019;s executive
	officers, employees and non-employee directors in 2015 and 2014
	vest over 24 months, 48 months and 12 months,
	respectively.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In June
	2013, the Company granted 420,000 restricted stock units to its
	executive officers and 115,000 restricted stock units to employees
	under the Company&#x2019;s 2011 Stock Incentive Plan. The Company
	amortized the fair value of these restricted stock units of
	$260,000 and $71,000, respectively, over the 24 month vesting
	period ended June 30, 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In July
	2012, the Company granted 222,500 restricted stock units to its
	executive officers under the Company&#x2019;s 2011 Stock Incentive
	Plan. The Company amortized the fair value of these restricted
	stock units of $160,000 over the 24 months ending July
	2014.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	the year ended June 30, 2014, the Company accelerated the vesting
	of certain restricted stock units that were granted to a terminated
	employee in recognition of prior services. An incremental $12,000
	of stock-based compensation expense was recognized during the year
	ended June 30, 2014 and included in research and development
	expense in connection with these activities.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	connection with the vesting of restricted share units during the
	years ended June 30, 2016, 2015 and 2014, the Company withheld
	123,483, 174,568 and 129,103 shares with aggregate values of
	$58,401, $164,136 and $120,007, respectively, in satisfaction of
	minimum tax withholding obligations.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(13)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;INCOME
	TAXES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company has had no income tax expense or benefit since inception
	because of operating losses, except for amounts recognized for
	sales of New Jersey state net operating loss carryforwards and tax
	credits. Deferred tax assets and liabilities are determined based
	on the estimated future tax effect of differences between the
	financial statement and tax reporting basis of assets and
	liabilities, as well as for net operating loss carryforwards and
	research and development credit carryforwards, given the provisions
	of existing tax laws.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As of
	June 30, 2016, the Company had federal and state net operating loss
	carryforwards of approximately $302,600,000 and $139,400,000,
	respectively, which expire, if not utilized, between 2019 and 2036
	for federal tax purposes and between 2016 and 2036 for state tax
	purposes. As of June 30, 2016, the Company had federal research and
	development credits of approximately $10,000,000 that will begin to
	expire in 2019, if not utilized.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	64
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage67"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
</DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The Tax
	Reform Act of 1986 (the Act) provides for limitation on the use of
	net operating loss and research and development tax credit
	carryforwards following certain ownership changes (as defined by
	the Act) that could limit the Company&#x2019;s ability to utilize
	these carryforwards. The Company may have experienced various
	ownership changes, as defined by the Act, as a result of past
	financings. Accordingly, the Company&#x2019;s ability to utilize the
	aforementioned carryforwards may be limited. Additionally, U.S. tax
	laws limit the time during which these carryforwards may be applied
	against future taxes; therefore, the Company may not be able to
	take full advantage of these carryforwards for federal income tax
	purposes.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company&#x2019;s net deferred tax assets are as
	follows:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; June 30,
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_24"></A>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	2016
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-TOP: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	&#xA0; June 30,
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0); FONT-WEIGHT: BOLD;">
	2015
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	operating loss carryforwards
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	114,081,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	94,332,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Research
	and development tax credits
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	9,965,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	7,357,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Basis
	differences in fixed assets and other
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,491,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	1,208,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	125,537,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	102,897,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Valuation
	allowance
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(125,537,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(102,897,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	deferred tax assets
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In
	assessing the realizability of deferred tax assets, the Company
	considers whether it is more likely than not that some portion or
	all of the deferred tax assets will not be realized. The ultimate
	realization of deferred tax assets is dependent upon the generation
	of future taxable income and the application of loss limitation
	provisions related to ownership changes. Due to the Company&#x2019;s
	history of losses, the deferred tax assets are fully offset by a
	valuation allowance as of June 30, 2016 and 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Company did not have a sale of New Jersey state net operating loss
	(NJ NOL) carryforwards during the year ended June 30, 2016 and
	therefore did not record a tax benefit. During the years ended June
	30, 2015 and 2014, the Company sold New Jersey state net operating
	loss carryforwards, which resulted in the recognition of $531,508
	and $1,846,646, respectively, in tax benefits.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	65
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage68"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-WEIGHT: BOLD; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	and Subsidiary
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notes to Consolidated Financial Statements
</FONT>
</FONT>
</DIV>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(14)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;CONSOLIDATED
	QUARTERLY FINANCIAL DATA - UNAUDITED
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following tables provide quarterly data for the years ended June
	30, 2016 and 2015.
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="FONT-FAMILY:TIMES NEW ROMAN;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;WIDTH:100%;FONT-SIZE:13PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="4" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 48%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 96%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT>
	&#xA0;
</FONT>
<FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Three Months Ended
</FONT>
</FONT>
<FONT>
	&#xA0;
</FONT>
<FONT>
	&#xA0;
</FONT>
<FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</FONT>
<FONT>
	&#xA0;
</FONT>
<FONT>
	&#xA0;
</FONT>
<FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</FONT>
<FONT>
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_25"></A>
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	June 30,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	March 31,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	December 31,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	September 30,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="4" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 48%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:2%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:96%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT>
	&#xA0;
</FONT>
<FONT>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000;">
	(amounts
	in thousands, except per share
	data)
</FONT>
</FONT>
<FONT>
	&#xA0;
</FONT>
<FONT>
	&#xA0;
</FONT>
<FONT>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</FONT>
<FONT>
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:2%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Revenues
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Operating
	expenses
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	12,738
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	12,086
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	12,628
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	11,798
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	income (expense), net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(618
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(611
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(622
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(612
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Loss
	before income taxes
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(13,356
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(12,697
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(13,250
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(12,410
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; PADDING-BOTTOM: 2PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Income
	tax benefit
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	loss
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(13,356
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(12,697
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(13,250
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(12,410
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Basic
	and diluted net loss per
</FONT>
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	common
	share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.09
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.08
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.08
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.08
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Weighted
	average number of
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	common
	shares outstanding
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	used
	in computing basic and
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; PADDING-BOTTOM: 4PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	diluted
	net loss per common share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	156,841,053
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	156,744,867
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	156,456,801
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	156,176,618
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT>
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_26"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="4" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 48%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 96%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	Three Months Ended
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	June 30,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	March 31,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	December 31,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	September 30,
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2015
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2014
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; COLOR: RGB(0, 0, 0);">
	2014
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="4" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 48%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:2%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:96%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;COLOR:#000000;">
	(amounts
	in thousands, except per share data)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:2%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Revenues
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	8,020
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	4,932
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Operating
	expenses
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	11,782
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	8,722
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	5,697
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	4,038
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Other
	income (expense), net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(306
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(428
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(78
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(99
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(Loss)
	income before income taxes
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(12,088
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	(9,150
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	2,245
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-SIZE:13PX;">
	795
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Income
	tax benefit
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	532
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:SOLID 2PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Net
	(loss) income
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(12,088
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(9,150
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	2,777
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	795
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Basic
	net (loss) income per
</FONT>
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	common
	share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.09
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.07
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	0.03
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	0.01
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Diluted
	net (loss) income per
</FONT>
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	common
	share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.09
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	(0.07
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	0.03
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	0.01
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Weighted
	average number of
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	common
	shares outstanding
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	used
	in computing basic net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(loss)
	income per common share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	134,207,300
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	134,008,239
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	109,314,460
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	106,953,898
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Weighted
	average number of
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	common
	shares outstanding
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	used
	in computing diluted net
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:12PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:0PX;">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(loss)
	income per common share
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	134,207,300
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	134,008,239
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	109,815,718
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:5%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; COLOR:#000000;BORDER-BOTTOM:DOUBLE 4PX #000000;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:75%;FONT-FAMILY:TIMES NEW ROMAN;FONT-SIZE:13PX;">
	107,946,021
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; COLOR:#000000;FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(15)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;SUBSEQUENT
	EVENTS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Financing Transactions &#x2013;
</FONT>
	On
	August 4, 2016, the Company closed on an underwritten offering of
	units, with each unit consisting of a share of common stock and a
	Series H warrant to purchase 0.75 of a share of common stock.
	Investors whose purchase of units in the offering would result in
	them beneficially owning more than 9.99% of our outstanding common
	stock following the completion of the offering had the opportunity
	to acquire units with Series I prefunded warrants substituted for
	any common stock they would have otherwise acquired. Gross proceeds
	were $9,225,000, with net proceeds to us, after deducting estimated
	offering expenses, of approximately $8,500,000. We issued
	11,481,481 shares of common stock and ten year prefunded Series I
	warrants to purchase 2,218,045 shares of common stock at an
	exercise price of $0.01, together with Series H warrants to
	purchase 10,274,646 shares of common stock at an exercise price of
	$0.70 per share.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Series I warrants are exercisable at an initial exercise price of
	$0.01 per share, exercisable immediately upon issuance and expire
	on the tenth anniversary of the date of issuance.&#xA0;The Series I
	warrants are subject to limitation on exercise if the holder and
	its affiliates would beneficially own more than 9.99% of the total
	number of Palatin&#x2019;s shares of common stock following such
	exercise. The Series H warrants are exercisable at an initial
	exercise price of $0.70 per share, are exercisable commencing six
	months following the date of issuance and expire on the fifth
	anniversary of the date of issuance. The Series H warrants are
	subject to the same beneficial ownership limitation as the Series I
	warrants.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	66
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage69"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_NOTES_TO_FINANCIAL_STATEMENT>
</EFX_FINANCIAL_STATEMENTS>
<EFX_ACCOUNTING_CHANGES>
<A NAME="FIS_ACCOUNTING_CHANGES"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	9. Changes in and Disagreements with Accountants on Accounting and
	Financial Disclosure
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	None.
</FONT>
</DIV>
</EFX_ACCOUNTING_CHANGES>
<EFX_CONTROL_AND_PROCEDURES>
<A NAME="FIS_CONTROL_AND_PROCEDURES"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	9A. &#xA0;Controls and Procedures.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	management carried out an evaluation, with the participation of our
	Chief Executive Officer and our Chief Financial Officer, of the
	effectiveness of our disclosure controls and procedures (as defined
	in Rules 13a-15(e) or 15d-15(e) of the Exchange Act) as of the end
	of the period covered by this report. Based upon this evaluation,
	our Chief Executive Officer and our Chief Financial Officer
	concluded that, as of June 30, 2016, our disclosure controls and
	procedures were effective.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A
	control system, no matter how well designed and operated, cannot
	provide absolute assurance that the objectives of the control
	system are met, and no evaluation of controls can provide absolute
	assurance that all control issues and instances of fraud, if any,
	within a company have been detected.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Management&#x2019;s Report on Internal Control Over Financial
	Reporting
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Management is
	responsible for establishing and maintaining adequate internal
	control over financial reporting as defined in Rule 13a-15(f) or
	15d-15(f) of the Exchange Act. Our internal control system was
	designed to provide reasonable assurance to management and the
	board of directors regarding the preparation and fair presentation
	of published financial statements.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All
	internal control systems, no matter how well designed, have
	inherent limitations. Therefore, even those systems determined to
	be effective can provide only reasonable assurance with respect to
	financial statement preparation and presentation.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	There
	was no change in our internal control over financial reporting
	during the fourth quarter of the period covered by this Annual
	Report that has materially affected, or is reasonably likely to
	materially affect, our internal control over financial
	reporting.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Management assessed
	the effectiveness of our internal control over financial reporting
	as of June 30, 2016. In making this assessment, it used the
	criteria set forth by the Committee of Sponsoring Organizations of
	the Treadway Commission (COSO) in
<FONT STYLE="FONT-STYLE: ITALIC">
	Internal Control-Integrated Framework as
	adopted in 2013
</FONT>
	. Based on its assessment, management
	believes that, as of June 30, 2016, our internal control over
	financial reporting is effective based on those
	criteria.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	9B. &#xA0;Other Information.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	None.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	67
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage70"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_CONTROL_AND_PROCEDURES>
</EFX_PART_II>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_PART_III>
<A NAME="FIS_PART_III"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PART
	III
</FONT>
</DIV>
<EFX_DIRECTORS_AND_OFFICERS>
<A NAME="FIS_DIRECTORS_AND_OFFICERS"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	10. Directors, Executive Officers and Corporate
	Governance.
</FONT>
</DIV>
<EFX_NAME_AND_TITLE>
<A NAME="FIS_NAME_AND_TITLE"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Identification
	of Directors
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following table sets forth the names, ages, positions and committee
	memberships of our current directors. All directors hold office
	until the next annual meeting of stockholders or until their
	successors have been elected and qualified. All current directors
	were elected at our annual stockholders&#x2019; meeting on June 9,
	2016.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: CENTER; MARGIN: 0PX AUTO; WIDTH: 100%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-SIZE: 11PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Name
</FONT>
</DIV>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Age
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-SIZE: 11PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Position with
	Palatin
</FONT>
</DIV>
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl Spana,
	Ph.D.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	54
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Chief Executive
	Officer, President and a Director
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	John K. A.
	Prendergast, Ph.D. (3)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	62
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director, Chairman
	of the board of directors
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Robert K. deVeer,
	Jr. (1) (2)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	70
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	J. Stanley Hull (1)
	(2)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	64
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Alan W. Dunton,
	M.D. (1) (2)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	62
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Angela Rossetti (1)
	(3)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	63
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Arlene M. Morris
	(2) (3)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	64
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 44%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_NAME_AND_TITLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 10%; HEIGHT: 2PX; BACKGROUND-COLOR: #000000">
<!--LINE-->
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)
	Member of the audit committee.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2)
	Member of the compensation committee.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 12PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(3)
	Member of the nominating and corporate governance
	committee.
</FONT>
</DIV>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CARL
	SPANA, Ph.D., co-founder of Palatin, has been our Chief Executive
	Officer and President since June 14, 2000. He has been a director
	of Palatin since June 1996 and has been a director of our
	wholly-owned subsidiary, RhoMed Incorporated, since July 1995. From
	June 1996 through June 14, 2000, Dr. Spana served as an executive
	vice president and our chief technical officer. From June 1993 to
	June 1996, Dr. Spana was vice president of Paramount Capital
	Investments, LLC, a biotechnology and biopharmaceutical merchant
	banking firm, and of The Castle Group Ltd., a medical venture
	capital firm. Through his work at Paramount Capital Investments and
	The Castle Group, Dr. Spana co-founded and acquired several private
	biotechnology firms. From July 1991 to June 1993, Dr. Spana was a
	Research Associate at Bristol-Myers Squibb, a publicly-held
	pharmaceutical company, where he was involved in scientific
	research in the field of immunology. He was previously a member of
	the board of the life science company AVAX Technologies, Inc. Dr.
	Spana received his Ph.D. in molecular biology from the Johns
	Hopkins University and his B.S. in biochemistry from Rutgers
	University.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Dr.
	Spana&#x2019;s qualifications for our board include his leadership
	experience, business judgment and industry experience. As a senior
	executive of Palatin for over nineteen years, he provides in-depth
	knowledge of our company, our drug products under development and
	the competitive and corporate partnering landscape.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	JOHN K.
	A. PRENDERGAST, Ph.D., co-founder of Palatin, has served as the
	non-executive Chairman of the board since June 14, 2000, and as a
	director since August 1996. While Mr. Prendergast has served as a
	member of the board, he does not, and has not, served in a
	management or operational role with the company. Dr. Prendergast
	has been president and sole stockholder of Summercloud Bay, Inc.,
	an independent consulting firm providing services to the
	biotechnology industry, since 1993. Dr. Prendergast is a director
	and executive chairman of the board of directors of Antyra, Inc., a
	privately-held biopharmaceutical firm, and a director of Heat
	Biologics, Inc., a publicly traded clinical-stage immunotherapy
	company. He was previously a member of the board of the life
	science companies AVAX Technologies, Inc., Avigen, Inc. and
	MediciNova, Inc. From October 1991 through December 1997, Dr.
	Prendergast was a managing director of The Castle Group Ltd., a
	medical venture capital firm. Dr. Prendergast received his M.Sc.
	and Ph.D. from the University of New South Wales, Sydney, Australia
	and a C.S.S. in administration and management from Harvard
	University.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	68
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage71"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Dr.
	Prendergast brings a historical perspective to our board coupled
	with extensive industry experience in corporate development and
	finance in the life sciences field. His prior service on other
	publicly traded company boards provides experience relevant to good
	corporate governance practices.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ROBERT
	K. deVEER, Jr. has been a director of Palatin since November 1998.
	Since January 1997, Mr. deVeer has been the president of deVeer
	Capital LLC, a private investment company. He was a director of
	Solutia Inc., a publicly-held chemical-based materials company,
	until its merger with Eastman Chemical Company in July 2012. From
	1995 until his retirement in 1996, Mr. deVeer served as Managing
	Director, Head of Industrial Group, at New York-based Lehman
	Brothers. From 1973 to 1995, he held increasingly responsible
	positions at New York-based CS First Boston, including Head of
	Project Finance, Head of Industrials and Head of Natural Resources.
	He was a managing director, member of the investment banking
	committee and a trustee of the First Boston Foundation. He received
	a B.A. in economics from Yale University and an M.B.A. in finance
	from Stanford Graduate School of Business.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Mr.
	deVeer has extensive experience in investment banking and corporate
	finance, including the financing of life sciences companies, and
	serves as the audit committee&#x2019;s financial
	expert.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	J.
	STANLEY HULL has been a director of Palatin since September 2005.
	Mr. Hull has over three decades of experience in the field of sales
	and marketing. Mr. Hull joined GlaxoSmithKline, a research-based
	pharmaceutical company, in October 1987 and retired as Senior Vice
	President, Pharmaceuticals in May 2010, having previously served in
	the R&amp;D organization of Glaxo Wellcome as Vice President and
	Worldwide Director of Therapeutic Development and Product Strategy
	&#x2013; Neurology and Psychiatry. Prior to that, he was Vice
	President of Marketing &#x2013; Infectious Diseases and
	Gastroenterology for Glaxo Wellcome. Mr. Hull started his career in
	the pharmaceutical industry with SmithKline and French Laboratories
	in 1978. Mr. Hull received his B.S. in business administration from
	the University of North Carolina at Greensboro.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Mr.
	Hull has extensive experience in commercial operations, development
	and marketing of pharmaceutical drugs and corporate alliances
	between pharmaceutical companies and biotechnology
	companies.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ALAN W.
	DUNTON, M.D. has been a director of Palatin since June 2011. Since
	November 2015, he has been senior vice president of research and
	development for Purdue Pharma L.P., with responsibilities for
	overall research strategy and development programs. Previously he
	was president of Danerius, LLC, a biotechnology consulting company,
	which he founded in 2006. From January 2007 to March 2009, Dr.
	Dunton served as president and chief executive officer of Panacos
	Pharmaceuticals Inc. and he served as a managing director of
	Panacos from March 2009 to January 2011. Dr. Dunton is currently a
	member of the board of directors of the publicly traded company
	Oragenics, Inc. He previously served on the board of directors of
	the publicly traded companies Targacept, Inc., EpiCept Corporation
	(as Non-Executive Chairman), Adams Respiratory Therapeutics, Inc.
	(acquired by Reckitt Benckiser Group plc), MediciNova, Inc. and
	Panacos Pharmaceuticals, Inc. Dr. Dunton has served as a director
	or executive officer of various pharmaceutical companies, and from
	1994 to 2001, Dr. Dunton was a senior executive in various
	capacities in the Pharmaceuticals Group of Johnson &amp; Johnson.
	Dr. Dunton received his M.D. degree from New York University School
	of Medicine, where he completed his residency in internal medicine.
	He also was a Fellow in Clinical Pharmacology at the New York
	Hospital/Cornell University Medical Center.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Dr.
	Dunton has extensive drug development and clinical research
	experience, having played a key role in the development of more
	than 20 products to regulatory approval, and also has extensive
	experience as an executive and officer for both large
	pharmaceutical companies and smaller biotechnology and
	biopharmaceutical companies.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ANGELA
	ROSSETTI has been a director of Palatin since June 2013. In June
	2015 she became Executive Vice President of Cell Machines, Inc., an
	early stage biopharmaceutical company developing transformational
	biosimilars and novel protein therapies. Previously, Ms. Rossetti
	served in pharmaceutical marketing, communications and financial
	roles, including as Vice President at Pfizer Inc., where she led a
	global commercial medicine team for smoking cessation, and as an
	Assistant Vice President at Wyeth, managing a global hemophilia
	business. Previously, she was President of Ogilvy Healthworld, an
	advertising business in the pharmaceutical and biotechnology
	sectors, and served on the Biotech and Pharmaceutical Advisory
	Board of Danske Capital for six years. Ms. Rossetti is a director
	of Viramal Limited, a privately held specialty pharmaceutical
	company focused on women&#x2019;s health therapeutics located in the
	United Kingdom. Ms. Rossetti graduated from a joint program of the
	Albert Einstein College of Medicine and Benjamin N. Cardozo School
	of Law with an M.S.in Bioethics in 2014, has an M.B.A. in Finance
	from Columbia University Graduate School of Business and a B.A. in
	Biology from the University of Pennsylvania, and is an adjunct
	Assistant Professor at New York Medical College.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	69
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage72"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Ms.
	Rossetti has extensive experience in worldwide development and
	marketing of specialty pharmaceuticals, including prefilled syringe
	products, in communications and development of commercialization
	plans and in pharmaceutical and biotechnology finance.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ARLENE
	M. MORRIS has been a director of Palatin since June 2015. From
	March 2012 until May 2015 she was Chief Executive Officer of Syndax
	Pharmaceuticals, Inc., a privately held biopharmaceutical company
	focused on the development and commercialization of an epigenetic
	therapy for treatment-resistant cancers, and was President of
	Syndax Pharmaceuticals from September 2013 until May 2015 and a
	member of the board of directors from May 2011 until May 2015. From
	2003 to January 2011, Ms. Morris served as the President, Chief
	Executive Officer and a member of the board of directors of
	Affymax, Inc., a publicly traded biotechnology company. Ms. Morris
	has also held various management and executive positions at
	Clearview Projects, Inc., a corporate advisory firm, Coulter
	Pharmaceutical, Inc., a publicly traded pharmaceutical company,
	Scios Inc., a publicly traded biopharmaceutical company, and
	Johnson &amp; Johnson, a publicly traded healthcare company. She is
	currently a member of the board of directors of Viveve Medical,
	Inc., a publicly traded medical technology company focused on
	women&#x2019;s health, Biodel Inc., a publicly traded specialty
	pharmaceutical company, Dimension Therapeutics, Inc., a publicly
	traded gene therapy company, and Neovacs, SA, a French publicly
	traded biotechnology company. Ms. Morris received a B.A. in Biology
	and Chemistry from Carlow College.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Ms.
	Morris has extensive experience in the biotechnology industry,
	including prior leadership positions, current senior management and
	board service, and experience as chief executive officer of
	companies with product candidates in phase 3 clinical
	trials.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 16PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Board and Its Committees
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Committees and meetings
</FONT>
	. The board has
	an audit committee, a compensation committee and a nominating and
	corporate governance committee. During fiscal 2016, the board met
	five times, the audit committee met four times, the compensation
	committee met twice and the nominating and corporate governance
	committee met twice. Each director attended at least 75% of the
	total number of meetings of the board and committees of the board
	on which he served. The independent directors meet in executive
	sessions at least annually, following the annual board meeting. We
	do not have a policy requiring our directors to attend stockholder
	meetings. With the exception of Drs. Prendergast and Spana, the
	directors did not attend the annual meeting of stockholders held on
	June 9, 2016.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Audit committee
</FONT>
	. The audit committee
	reviews the engagement of the independent registered public
	accounting firm and reviews the independence of the independent
	registered public accounting firm. The audit committee also reviews
	the audit and non-audit fees of the independent registered public
	accounting firm and the adequacy of our internal control
	procedures. The audit committee is currently composed of four
	independent directors, Mr. deVeer (chair), and Dr. Dunton, Ms.
	Rossetti and Mr. Hull. The board has determined that the members of
	the audit committee are independent, as defined in the listing
	standards of the NYSE MKT, and satisfy the requirements of the NYSE
	MKT as to financial literacy and expertise. The board has
	determined that at least one member of the committee, Mr. deVeer,
	is the audit committee financial expert as defined by Item 407 of
	Regulation S-K. The responsibilities of the audit committee are set
	forth in a written charter adopted by the board and updated as of
	October 1, 2013, a copy of which is available on our web site at
	www.palatin.com.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Compensation committee.
</FONT>
	The
	compensation committee reviews and recommends to the board on an
	annual basis employment agreements and compensation for our
	officers, directors and some employees, and administers our 2011
	Plan and the options still outstanding which were granted under
	previous stock option plans. The compensation committee is composed
	of Dr. Dunton (chair), Ms. Morris and Messrs. deVeer and Hull. The
	board has determined that the members of the compensation committee
	are independent, as defined in the listing standards of the NYSE
	MKT. Our Chief Executive Officer aids the compensation committee by
	providing annual recommendations regarding the compensation of all
	executive officers, other than himself. Our Chief Financial Officer
	supports the committee in its work by gathering, analyzing and
	presenting data on our compensation arrangements and compensation
	in the marketplace.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	responsibilities of the compensation committee are set forth in a
	written charter adopted by the board effective October 1, 2013, a
	copy of which is available on our web site at www.palatin.com. The
	committee administers our 2011 Plan, under which it has delegated
	to an officer its authority to grant stock options to employees and
	to a single-member committee of the board its authority to grant
	restricted stock units to officers and to grant options and
	restricted stock units to our consultants, but in either instance
	not to grant options or restricted stock units to themselves, any
	member of the board or officer, or any person subject to Section 16
	of the Securities Exchange Act of 1934.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	70
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage73"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Nominating and corporate governance
	committee.
</FONT>
	The nominating and corporate governance committee
	assists the board in recommending nominees for directors, and in
	determining the composition of committees. It also reviews,
	assesses and makes recommendations to the board concerning policies
	and guidelines for corporate governance, including relationships of
	the board, the stockholders and management in determining our
	direction and performance. The responsibilities of the nominating
	and corporate governance committee are set forth in a written
	charter adopted by the board and updated as of October 1, 2013, a
	copy of which is available on our web site at www.palatin.com. The
	nominating and corporate governance committee is composed of Dr.
	Prendergast (chair) and Mss. Rossetti and Morris, each of whom
	meets the independence requirements established by the NYSE
	MKT.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Duration of Office.
</FONT>
	Unless a director
	resigns, all directors hold office until the next annual meeting of
	stockholders or until their successors have been elected and
	qualified. Directors serve as members of committees as the board
	determines from time to time.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Communicating
	With Directors
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Generally,
	stockholders or other interested parties who have questions or
	concerns should contact Stephen T. Wills, Secretary, Palatin
	Technologies, Inc., 4B Cedar Brook Drive, Cranbury, NJ 08512.
	However, any stockholder or other interest party who wishes to
	address questions regarding our business directly to the board of
	directors, or any individual director, can direct questions to the
	board members or a director by regular mail to the Secretary at the
	address above or by e-mail at boardofdirectors@palatin.com.
	Stockholders or other interested parties may also submit their
	concerns anonymously or confidentially by postal mail.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Communications are
	distributed to the board, or to any individual directors as
	appropriate, depending on the facts and circumstances outlined in
	the communication, unless the Secretary determines that the
	communication is unrelated to the duties and responsibilities of
	the board, such as product inquiries, resumes, advertisements or
	other promotional material. Communications that are unduly hostile,
	threatening, illegal or similarly unsuitable will also not be
	distributed to the board or any director. All communications
	excluded from distribution will be retained and made available to
	any non-management director upon request.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 16PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Board
	Role in Risk Oversight
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	board, as part of its overall responsibility to oversee the
	management of our business, considers risks generally when
	reviewing our strategic plan, financial results, business
	development activities, legal and regulatory matters. The board
	satisfies this responsibility through regular reports directly from
	our officers responsible for oversight of particular risks. The
	board&#x2019;s risk management oversight also includes full and open
	communications with management to review the adequacy and
	functionality of the risk management processes used by management.
	The board&#x2019;s role in risk oversight has no effect on the
	board&#x2019;s leadership structure. In addition, committees of the
	board assist in its risk oversight responsibility,
	including:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 36PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 36PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The audit committee
	assists the board in its oversight of the integrity of the
	financial reporting and our compliance with applicable legal and
	regulatory requirements. It also oversees our internal controls and
	compliance activities, and meets privately with representatives
	from our independent registered public accounting
	firm.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 36PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 36PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The compensation
	committee assists the board in its oversight of risk relating to
	compensation policies and practices. The compensation committee
	annually reviews our compensation policies, programs and
	procedures, including the incentives they create and mitigating
	factors that may reduce the likelihood of excessive risk taking, to
	determine whether they present a significant risk to our
	company.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 16PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Board
	Leadership Structure
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Since
	2000, the roles of chairman of the board and chief executive
	officer have been held by separate persons. John K.A. Prendergast,
	Ph.D., a non-employee director, has served as Chairman of the board
	since June 2000. Carl Spana, Ph.D., has been our Chief Executive
	Officer and President since June 2000. Generally, the chairman is
	responsible for advising the chief executive officer, assisting in
	long-term strategic planning, and presiding over meetings of the
	board, and the chief executive officer is responsible for leading
	our day-to-day performance. While we do not have a written policy
	with respect to separation of the roles of chairman of the board
	and chief executive officer, the board believes that the existing
	leadership structure, with the separation of these roles, provides
	several important advantages, including: enhancing the
	accountability of the chief executive officer to the board;
	strengthening the board&#x2019;s independence from management;
	assisting the board in reaching consensus on particular strategies
	and policies; and facilitating robust director, board, and
	executive officer evaluation processes.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	71
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage74"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 16PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Code
	of Corporate Conduct and Ethics
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We have
	adopted a code of corporate conduct and ethics, updated as of March
	11, 2016, that applies to all of our directors, officers and
	employees, including our Chief Executive Officer and Chief
	Financial Officer. You can view the code of corporate conduct and
	ethics at our website, www.palatin.com. We will disclose any
	amendments to, or waivers from, provisions of the code of corporate
	conduct and ethics that apply to our directors, principal executive
	and financial officers in a current report on Form 8-K, unless the
	rules of the NYSE MKT permit website posting of any such amendments
	or waivers.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Executive
	Officers
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Executive officers
	are appointed by the board and serve at the discretion of the
	board. Each officer holds his position until his successor is
	appointed and qualified. The current executive officers hold office
	under employment agreements.
</FONT>
</DIV>
<EFX_NAME_AND_TITLE>
<A NAME="FIS_NAME_AND_TITLE_2"></A>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PX AUTO 0PX 0PX; WIDTH: 100%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); BORDER-TOP: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; WIDTH: 25%;">
<DIV STYLE="BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-SIZE: 11PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Name
</FONT>
</DIV>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); BORDER-TOP: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Age
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="BORDER-TOP: 1PX SOLID RGB(255, 255, 255); BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 65%; VERTICAL-ALIGN: BOTTOM;">
<DIV STYLE="BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-SIZE: 11PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 12PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Position with
	Palatin
</FONT>
</DIV>
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 25%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl Spana,
	Ph.D.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	54
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 65%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Chief Executive
	Officer, President and Director
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 25%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen T. Wills,
	MST, CPA
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	59
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 65%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Chief Financial
	Officer, Chief Operating Officer, Executive Vice President,
	Secretary and Treasurer
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_NAME_AND_TITLE>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Additional
	information about Dr. Spana is included above under the heading
	&#x201C;Identification of Directors.&#x201D;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	STEPHEN
	T. WILLS, MST, CPA, has been Executive Vice President, Secretary,
	Treasurer and Chief Financial Officer since 1997 and was Executive
	Vice President of Operations from 2005 until June 2011, when he was
	appointed Chief Operating Officer and Executive Vice President.
	Since December 2015, Mr. Wills has also served as interim executive
	chairman and principal executive officer of Derma Sciences, Inc.,
	or Derma, a publicly-held company which provides wound and skin
	care products, and from July 1997 to July 2000, Mr. Wills was also
	a vice president and the chief financial officer of Derma. He is
	also currently a director of Derma, and was previously lead
	director and chair of the audit committee. Mr. Wills is a trustee
	of The Hun School of Princeton and is chair of its finance
	committee. From 1991 to August 2000, he was the president and chief
	operating officer of Golomb, Wills &amp; Company, P.C., a public
	accounting firm. Mr. Wills, a certified public accountant, received
	his B.S. in accounting from West Chester University, and an M.S. in
	taxation from Temple University.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Section
	16(A) Beneficial Ownership Reporting Compliance
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	rules of the SEC require us to disclose failures to file or late
	filings of reports of stock ownership and changes in stock
	ownership required to be filed by our directors, officers and
	holders of more than 10% of our common stock. To the best of our
	knowledge, all of the filings for our directors, officers and
	holders of more than 10% of our common stock were made on a timely
	basis in fiscal 2016, except that a report on Form 4 relating to an
	acquisition of our common stock by a director was inadvertently
	filed late on behalf of J. Stanley Hull on December 3,
	2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	11. Executive Compensation.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Fiscal
	2016 Summary Compensation Table
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following table summarizes the compensation earned by or paid to
	our principal executive officer and our principal financial
	officer, who constitute all of our executive officers, for our
	fiscal years ended June 30, 2016 and 2015. We have no defined
	benefit or actuarial pension plan, and no deferred compensation
	plan.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	72
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage75"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_COMPENSATION_TABLE>
<A NAME="FIS_COMPENSATION_TABLE"></A>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT:0PX;FONT-SIZE:13PX;MARGIN-TOP:0PX;MARGIN-BOTTOM:0PX;WIDTH:100%;MARGIN-RIGHT:0PX;FONT-FAMILY:TIMES NEW ROMAN;">
<TR STYLE="">
<TD COLSPAN="1" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Name and
	Principal Position
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-SIZE: 11PX">
<DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Fiscal
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Year
</FONT>
</DIV>
</DIV>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Salary
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Stock
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	awards (1)
	($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Option
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	awards (1)
	($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Nonequity
	incentive plan compensation (2)($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	All
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	other
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	compensation
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	(3)($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Total
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl
	Spana, Ph.D.,
</FONT>
	&#xA0;
</DIV>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	476,400
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	354,250
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	101,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	(4)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	13,598
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	945,248
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Chief Executive
	Officer and President
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2015
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	462,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	226,800
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	234,832
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	195,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	18,937
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1,138,069
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD COLSPAN="2" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 40%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen T. Wills,
	MST, CPA,
</FONT>
	&#xA0;
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	435,200
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	327,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	92,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	(4)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	13,568
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	867,768
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD COLSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Chief Financial
	Officer, Chief Operating Officer and Executive Vice
	President
</FONT>
	&#xA0;
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 20%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2015
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	422,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	205,200
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	211,916
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	203,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 5%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 75%; FONT-SIZE: 13PX;">
	18,438
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1,061,054
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_COMPENSATION_TABLE>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 10%; HEIGHT: 2PX; BACKGROUND-COLOR: #000000">
<!--LINE-->
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 4PX; PADDING-BOTTOM: 4PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)&#xA0;Amounts in
	these columns represent the aggregate grant date fair value for
	stock awards and option awards computed using either the
	Black-Scholes model or a multifactor Monte Carlo simulation. For a
	description of the assumptions we used to calculate these amounts,
	see Note 12 to the consolidated financial statements included in
	this Annual Report.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 4PX; PADDING-BOTTOM: 4PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2)&#xA0;Bonus
	amounts.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 4PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(3)&#xA0;Consists
	of matching contributions to 401(k) plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 4PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(4)&#xA0;Bonus
	amount for fiscal year 2016 paid after fiscal year end but accrued
	as of June 30, 2016.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 16PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Employment
	Agreements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Effective July 1,
	2016, we entered into employment agreements with Dr. Spana and Mr.
	Wills which continue through June 30, 2019 unless terminated
	earlier. Under these agreements, which replaced substantially
	similar agreements that expired on June 30, 2016, Dr. Spana is
	serving as Chief Executive Officer and President at a base salary
	of $476,400 per year and Mr. Wills is serving as Chief Financial
	Officer and Chief Operating Officer at a base salary of $435,200
	per year. Each agreement also provides for:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	annual
	discretionary bonus compensation, in an amount to be decided by the
	compensation committee and approved by the board, based on
	achievement of yearly performance objectives; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	participation in
	all benefit programs that we establish, to the extent the
	executive&#x2019;s position, tenure, salary, age, health and other
	qualifications make him eligible to participate.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Each
	agreement allows us or the executive to terminate the agreement
	upon written notice, and contains other provisions for termination
	by us for &#x201C;cause,&#x201D; or by the employee for &#x201C;good
	reason&#x201D; or due to a &#x201C;change in control&#x201D; (as these
	terms are defined in the employment agreements and set forth
	below). Early termination may, in some circumstances, result in
	severance pay at the salary then in effect, plus continuation of
	medical and dental benefits then in effect for a period of two
	years (Dr. Spana) or 18 months (Mr. Wills). In addition, the
	agreements provide that options and restricted stock units granted
	to these officers accelerate upon termination of employment except
	for voluntary resignation by the officer or termination for cause.
	In the event of retirement, termination by the officer for good
	reason, or termination by us other than for &#x201C;cause&#x201D;,
	options may be exercised until the earlier of twenty-four months
	following termination or expiration of the option term.
	Arrangements with our named executive officers in connection with a
	termination following a change in control are described below. Each
	agreement includes non-competition, non-solicitation and
	confidentiality covenants.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	73
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage76"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	compensation committee awarded performance-based bonuses to our
	named executive officers for fiscal 2016 and fiscal 2015, which
	were paid in September 2016 and June 2015, respectively, based on
	results of operations, including clinical trial operations and our
	financial condition.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stock
	Option and Restricted Stock Unit Grants
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	compensation committee determined that additional equity grants
	were necessary in order to reward, motivate and retain our
	executive officers. On December 8, 2015, we granted 325,000
	performance-based restricted stock units and 325,000
	non-performance-based restricted stock units to Dr. Spana and
	300,000 performance-based restricted stock units and 300,000
	restricted stock units to Mr. Wills. The performance-based
	restricted stock units vest during the performance period, ending
	December 31, 2017, if and upon the earlier of: (i) achievement of a
	closing price for the Company&#x2019;s common stock equal to or
	greater than $1.20 per share for 20 consecutive trading days, which
	is considered a market condition, or (ii) entering into a
	collaboration agreement (U.S. or global) of bremelanotide for FSD,
	which is considered a performance condition. The
	non-performance-based restricted stock units vest 25% on the date
	of grant and 25% on the first, second and third anniversary dates
	from the date of grant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	On June
	11, 2015, we granted 210,000 restricted stock units to Dr. Spana
	and 190,000 restricted stock units to Mr. Wills, which vest as to
	50% on each anniversary of the grant date. We also granted 300,000
	stock options to Dr. Spana and 270,000 stock options to Mr. Wills,
	which vest as to 25% on each anniversary of the grant date. These
	options have an exercise price of $1.08, the fair market value of
	the common stock on the date of grant, and they expire on June 11,
	2025.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Outstanding
	Equity Awards at 2016 Fiscal Year-End
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following table summarizes all of the outstanding equity-based
	awards granted to our named executive officers as of June 30, 2016,
	the end of our fiscal year.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PX AUTO 0PX 0PX; WIDTH: 100%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="4" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 40%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 96%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Option awards
	(1)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 2%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:20%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 5%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 90%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Stock awards
	(2)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 5%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_OPTIONS_AGGREGATE>
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<A NAME="FIS_OPTIONS_AGGREGATE"></A>
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Name
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Option
	or&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	stock&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	award&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	grant
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	date
</FONT>
</DIV>
</DIV>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Number
	of
</FONT>
</DIV>
<DIV>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	securities
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	underlying
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	unexercised
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	options
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	(#)
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	exercisable
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Number
	of
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	securities
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	underlying
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	unexercised
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	options
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	(#)
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	unexercisable
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Option
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	exercise
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	price
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Option
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	expiration
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	date
</FONT>
</DIV>
</DIV>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Number of shares
	or units of stock that have not vested
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	(#)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Market value of
	shares or units of stock that have not vested
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	($)
	(3)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl
	Spana
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10/06/06
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	12,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	24.90
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10/06/16
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/08
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	28,125
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	2.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/18
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/08
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	4,687
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	5.00
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/18
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/08
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	4,688
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	6.60
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/18
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/01/08
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	25,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/01/18
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/01/09
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	25,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	2.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/01/19
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/22/11
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	300,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.00
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/22/21
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/17/12
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	112,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	37,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.72
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/17/22
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/27/13
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	206,250
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	68,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.62
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/27/23
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/25/14
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	87,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	87,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.02
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/25/24
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/11/15
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	75,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	225,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.08
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/11/25
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/11/15
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	105,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	46,200
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12/08/15
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	243,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	107,250
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12/08/15
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	325,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	143,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="6" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 80%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	Stock Awards
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	673,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	296,450
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_OPTIONS_AGGREGATE>
</TABLE>
</DIV>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	74
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage77"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="NULL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="NULL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; MARGIN: 0PX AUTO 0PX 0PX; WIDTH: 100%; FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
<TR>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV STYLE="PADDING-BOTTOM: 2PX;">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
	&#xA0;
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="5" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 50%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 2%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 96%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Option awards
	(1)
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
<BR>
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 2%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD COLSPAN="2" ROWSPAN="1" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:20%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 90%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	&#xA0;
</FONT>
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Stock awards
	(2)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 5%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_27"></A>
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN;">
	Name
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Option
	or
</FONT>
</DIV>
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	stock
</FONT>
</DIV>
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	award
</FONT>
</DIV>
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	grant
</FONT>
</DIV>
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	date
</FONT>
</DIV>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Number
	of
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	securities
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	underlying
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	unexercised
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	options
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	(#)
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	exercisable
</FONT>
</DIV>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Number
	of
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	securities
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	underlying
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	unexercised
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	options
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	(#)
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	unexercisable
</FONT>
</DIV>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Option
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	exercise
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	price
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	($)
</FONT>
</DIV>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Option
</FONT>
</DIV>
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	expiration
</FONT>
</DIV>
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	date
</FONT>
</DIV>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Number of shares
	or units of stock that have not vested
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	(#)
</FONT>
</DIV>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Market value of
	shares or units of stock that have not vested
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	($)
	(3)
</FONT>
</DIV>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;Stephen T.
	Wills
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10/06/06
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	10,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	24.90
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10/06/16
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/08
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	22,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	2.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/18
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/08
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	3,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	5.00
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/18
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/08
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	3,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	6.60
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	03/26/18
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/01/08
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	20,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/01/18
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/01/09
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	20,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	2.80
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/01/19
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/22/11
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	250,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.00
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/22/21
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/17/12
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	101,250
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	33,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.72
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	07/17/22
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/27/13
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	187,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	62,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	0.62
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/27/23
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/25/14
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	75,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	75,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.02
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/25/24
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/11/15
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	67,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	202,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.08
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/11/25
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	06/11/15
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	95,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	41,800
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12/08/15
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	225,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	99,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#FFFFFF;">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 30%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12/08/15
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 5%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; FONT-SIZE: 13PX; DISPLAY: INLINE-BLOCK; WIDTH: 75%; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY: TIMES NEW ROMAN; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; WIDTH: 10%; PADDING-BOTTOM: 2PX; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%;">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	300,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	132,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR:#CCEEFF;">
<TD COLSPAN="6" STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:80%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
	Stock Awards
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	620,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN:BOTTOM;WIDTH:10%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	272,800
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 10%; HEIGHT: 2PX; BACKGROUND-COLOR: #000000">
<!--LINE-->
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)&#xA0;Stock
	option vesting schedules: all options granted on or before June 22,
	2011 have fully vested. Options granted after June 22, 2011 vest
	over four years with 1/4 of the shares vesting per year starting on
	the first anniversary of the grant date, provided that the named
	executive officer remains an employee. See &#x201C;Termination and
	Change-In-Control Arrangements&#x201D; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2)&#xA0;Stock
	award vesting schedule: stock awards consist of restricted stock
	units granted on June 11, 2015, which will vest on June 11, 2017,
	provided that the named executive officer remains an employee;
	restricted stock units granted on December 8, 2015, as to 243,750
	shares for Dr. Spana and 225,000 shares for Mr. Wills, which will
	vest in equal amounts over a three year period, provided that the
	named executive officer remains an employee; and performance-based
	restricted stock units granted on December 8, 2015 as to 325,000
	shares as to Dr. Spana and 300,000 shares as to Mr. Wills, which
	expire December 31, 2017 unless the specified performance criteria
	is met. See &#x201C;Stock Options and Restricted Stock Unit
	Awards&#x201D; above and &#x201C;Termination and Change-In-Control
	Arrangements&#x201D; below.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;(3)&#xA0;Calculated
	by multiplying the number of restricted stock units by $0.44, the
	closing market price of our common stock on June 30, 2016, the last
	trading day of our most recently completed fiscal
	year.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Termination
	and Change-In-Control Arrangements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	employment agreements, stock option agreements and restricted stock
	unit agreements with Dr. Spana and Mr. Wills contain the following
	provisions concerning severance compensation and the vesting of
	stock options and restricted stock units upon termination of
	employment or upon a change in control. The executive&#x2019;s
	entitlement to severance, payment of health benefits and
	accelerated vesting of options is contingent on the executive
	executing a general release of claims against us.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Termination Without Severance
	Compensation
</FONT>
	. Regardless of whether there has been a change
	in control, if we terminate employment for cause or the executive
	terminates employment without good reason (as those terms are
	defined in the employment agreement and set forth below), then the
	executive will receive only his accrued salary and vacation
	benefits through the date of termination. He may also elect to
	receive medical and dental benefits pursuant to COBRA for up to two
	years (Dr. Spana) or 18 months (Mr. Wills), but must remit the cost
	of coverage to us. Under the terms of our outstanding options and
	restricted stock units, all unvested options and restricted stock
	units would terminate immediately, and vested options would be
	exercisable for three months after termination.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	75
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage78"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Severance Compensation Without a Change in
	Control
</FONT>
	. If we terminate or fail to extend the employment
	agreement without cause, or the executive terminates employment
	with good reason, then the executive will receive as severance pay
	his salary then in effect, paid in a lump sum, plus medical and
	dental benefits at our expense, for a period of two years (Dr.
	Spana) or 18 months (Mr. Wills) after the termination date. In
	addition, upon such event all unvested options would immediately
	vest and be exercisable for two years after the termination date
	or, if earlier, the expiration of the option term, and all unvested
	restricted stock units would accelerate and become fully
	vested.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Severance Compensation After a Change in
	Control
</FONT>
	. If, within one year after a change in control, we
	terminate employment or the executive terminates employment with
	good reason, then the executive will receive as severance pay 200%
	(Dr. Spana) or 150% (Mr. Wills) of his salary then in effect, paid
	in a lump sum, plus medical and dental benefits at our expense, for
	a period of two years (Dr. Spana) or 18 months (Mr. Wills) after
	the termination date. We would also reimburse the executive for up
	to $25,000 in fees and expenses during the six months following
	termination, for locating employment. We would also reimburse the
	executive for any excise tax he might incur on &#x201C;excess
	parachute payments&#x201D; (as defined in Section 280G(b) of the
	Internal Revenue Code). All unvested options would immediately vest
	and be exercisable for two years after the termination date or, if
	earlier, the expiration of the option term. All unvested restricted
	stock units would vest upon a change in control, without regard to
	whether the executive&#x2019;s employment is
	terminated.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Option and Restricted Stock Unit Vesting Upon
	a Change in Control
</FONT>
	. Options and restricted stock units
	granted under the 2011 Stock Incentive Plan vest upon a change in
	control. If any options granted under the 2005 Stock Plan are to be
	terminated in connection with a change in control, those options
	will vest in full immediately before the change in
	control.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Definitions
</FONT>
	. Under the employment
	agreements, a &#x201C;change in control,&#x201D; &#x201C;cause&#x201D;
	and &#x201C;good reason&#x201D; are defined as follows:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A
	&#x201C;change in control&#x201D; occurs when:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)&#xA0;some
	person or entity acquires more than 50% of the voting power of our
	outstanding securities;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)&#xA0;the
	individuals who, during any twelve month period, constitute our
	board of directors cease to constitute at least a majority of the
	board of directors;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(c)&#xA0;we enter
	into a merger or consolidation; or
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(d)&#xA0;we sell
	substantially all our assets.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	term &#x201C;cause&#x201D; means:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)&#xA0;the
	occurrence of (i) the executive&#x2019;s material breach of, or
	habitual neglect or failure to perform the material duties which he
	is required to perform under, the terms of his employment
	agreement; (ii) the executive&#x2019;s material failure to follow
	the reasonable directives or policies established by or at the
	direction of our board of directors; or (iii) the executive&#x2019;s
	engaging in conduct that is materially detrimental to our interests
	such that we sustain a material loss or injury as a result thereof,
	provided that the breach or failure of performance is not cured, to
	the extent cure is possible, within ten days of the delivery to the
	executive of written notice thereof;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)&#xA0;the
	willful breach by the executive of his obligations to us with
	respect to confidentiality, invention and non-disclosure,
	non-competition or non-solicitation; or
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(c)&#xA0;the
	conviction of the executive of, or the entry of a pleading of
	guilty or nolo contendere by the executive to, any crime involving
	moral turpitude or any felony.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	term &#x201C;good reason&#x201D; means the occurrence of any of the
	following, with our failure to cure such circumstances within 30
	days of the delivery to us of written notice by the executive of
	such circumstances:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)&#xA0;any
	material adverse change in the executive&#x2019;s duties, authority
	or responsibilities, which causes the executive&#x2019;s position
	with us to become of significantly less responsibility, or
	assignment of duties and responsibilities inconsistent with the
	executive&#x2019;s position;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)&#xA0;a material
	reduction in the executive&#x2019;s salary;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(c)&#xA0;our
	failure to continue in effect any material compensation or benefit
	plan in which the executive participates, unless an equitable
	arrangement has been made with respect to such plan, or our failure
	to continue the executive&#x2019;s participation therein (or in a
	substitute or alternative plan) on a basis not materially less
	favorable, both in terms of the amount of benefits provided and the
	level of the executive&#x2019;s participation relative to other
	participants;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	76
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage79"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(d)&#xA0;our
	failure to continue to provide the executive with benefits
	substantially similar to those enjoyed by the executive under any
	of our health and welfare insurance, retirement and other
	fringe-benefit plans, the taking of any action by us which would
	directly or indirectly materially reduce any of such benefits, or
	our failure to provide the executive with the number of paid
	vacation days to which he is entitled; or
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(e)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;the
	relocation of the executive to a location which is a material
	distance from Cranbury, New Jersey.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_28"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 16PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
	Compensation
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following table sets forth the compensation we paid to all
	directors during fiscal 2016, except for Dr. Spana, whose
	compensation is set forth above in the Summary Compensation Table
	and related disclosure. Dr. Spana did not receive any separate
	compensation for his services as a director.
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Name
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Fees earned or
	paid in cash ($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Stock awards ($)
	(2)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Option awards
	($) (1) (2)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="FONT-SIZE: 11PX">
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Total
	($)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX;">
	&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	John K.A.
	Prendergast, Ph.D.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	95,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	105,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	23,267
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	223,767
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Robert K. deVeer,
	Jr.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	58,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	52,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	11,634
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	123,134
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Zola P. Horovitz,
	Ph.D. (3)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	43,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	25,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	68,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	J. Stanley
	Hull
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	52,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	52,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	11,634
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	116,884
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Alan W. Dunton,
	M.D.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	58,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	45,950
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	11,634
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	116,334
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Angela
	Rossetti
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	50,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	39,150
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	11,634
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	100,784
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 52%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Arlene
	Morris
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	50,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	32,350
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	11,634
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	93,984
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 10%; HEIGHT: 2PX; BACKGROUND-COLOR: #000000">
<!--LINE-->
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 8PX; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)&#xA0;The
	aggregate number of shares underlying option awards and stock
	awards outstanding at June 30, 2016 for each director
	was:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="MARGIN-LEFT: 0PX; PADDING-BOTTOM: 2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Option
	awards
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; DISPLAY: INLINE-BLOCK; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Stock
	awards
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; DISPLAY: INLINE-BLOCK; PADDING-BOTTOM: 2PX; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_29"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Dr.
	Prendergast&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	388,750
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	175,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Mr.
	deVeer&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	224,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	87,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Mr.
	Hull&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	221,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	87,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Dr.
	Dunton
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	150,000
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	77,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Ms.
	Rossetti
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	102,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	67,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 76%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Ms.
	Morris
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	57,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	57,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2)&#xA0;Amounts in
	these columns represent the aggregate grant date fair value for
	stock awards and option awards computed using the Black-Scholes
	model. For a description of the assumptions we used to calculate
	these amounts, see Note 12 to the consolidated financial statements
	included in this Annual Report. Amounts in this column include
	options granted on June 9, 2016 for our current fiscal year ending
	June 30, 2017.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(3)&#xA0;Dr.
	Horovitz ceased serving as a director effective June 9,
	2016.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Non-Employee Directors&#x2019; Equity
	Grants.
</FONT>
	Our non-employee directors receive an annual equity
	grant at the board meeting closest to the beginning of each fiscal
	year, or such other date as may be determined by the
	board.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	On June
	9, 2016, as the annual equity grant for our current fiscal year
	ending June 30, 2017, the Chairman of the board received 75,000
	restricted stock units which vest on June 9, 2017, and an option to
	purchase 75,000 shares of common stock, and each other serving
	non-employee director received 37,500 restricted stock units which
	vest on June 9, 2017, and an option to purchase 37,500 shares of
	common stock. All of the options have an exercise price of $0.50
	per share, the closing price of our common stock on the date of
	grant, vest in twelve monthly installments beginning on July 31,
	2016, expire ten years from the date of grant and provide for
	accelerated vesting in the event of involuntarily termination as a
	director following a change in control, with exercise permitted
	following accelerated vesting for up to the earlier of one year
	after termination or the expiration date of the
	option.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	77
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage80"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	On
	December 8, 2015, the compensation committee determined that
	additional equity grants were necessary in order to reward,
	motivate and retain the non-employee directors, and we granted the
	Chairman of the board 100,000 restricted stock units and the other
	serving non-employee directors a total of 240,000 restricted stock
	units, consisting of 50,000 to each of Mr. deVeer, Mr. Hull and Dr.
	Horovitz, 40,000 to Dr. Dunton, 30,000 to Ms. Rossetti and 20,000
	to Ms. Morris. The restricted stock units vest as to 50% on the
	first and second anniversary of the grant date, conditioned on
	continued service as a director through the applicable vesting
	dates.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	On June
	11, 2015, as the annual equity grant for our fiscal year ending
	June 30, 2016, the Chairman of the board received 40,000 restricted
	stock units which vest on June 11, 2016, and an option to purchase
	40,000 shares of common stock, and each other serving non-employee
	director received 20,000 restricted stock units which vest on June
	11, 2016, and an option to purchase 20,000 shares of common stock.
	All of the options have an exercise price of $1.08 per share, the
	closing price of our common stock on the date of grant, vest in
	twelve monthly installments beginning on July 31, 2015, expire ten
	years from the date of grant and provide for accelerated vesting in
	the event of involuntarily termination as a director following a
	change in control, with exercise permitted following accelerated
	vesting for up to the earlier of one year after termination or the
	expiration date of the option.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Non-Employee Directors&#x2019; Cash
	Compensation
</FONT>
	. Dr. Prendergast serves as Chairman of the
	board and for our fiscal year ended June 30, 2016 received an
	annual retainer of $87,500, payable quarterly. Other non-employee
	directors received an annual base retainer of $40,000, payable on a
	quarterly basis. The chairperson of the audit committee received an
	additional annual retainer of $12,500, the chairperson of the
	compensation committee received an additional annual retainer of
	$12,500 and the chairperson of the corporate governance committee
	received an additional annual retainer of $7,500. Members of the
	foregoing committees, other than the non-employee Chairman,
	received an additional retainer of one-half the retainer payable to
	the committee chairperson. For the fiscal year ending June 30,
	2017, cash compensation is unchanged.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Non-Employee Directors&#x2019; Expenses.
</FONT>
	Non-employee directors are reimbursed for expenses incurred in
	performing their duties as directors, including attending all
	meetings of the board and any committees on which they
	serve.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Employee Directors.
</FONT>
	Employee directors
	are not separately compensated for services as directors, but are
	reimbursed for expenses incurred in performing their duties as
	directors, including attending all meetings of the board and any
	committees on which they serve.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	12. Security Ownership of Certain Beneficial Owners and Management
	and Related Stockholder Matters.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Securities Authorized for Issuance Under
	Equity Compensation Plans.
</FONT>
	The table below provides
	information on our equity compensation plans as of June 30,
	2016:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD COLSPAN="4" ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 100%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:2%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:96%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	Equity
	Compensation Plan Information
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	as
	of June 30, 2016
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:2%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<A NAME="FIS_UNIDENTIFIED_TABLE_30"></A>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Plan
	category
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Number of
	securities to be issued upon exercise of outstanding options,
	warrants and rights
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Weighted-average
	exercise price of outstanding options, warrants and
	rights
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN: BOTTOM; WIDTH: 80%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0); DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-WEIGHT: BOLD;">
	Number of
	securities remaining available for future issuance under equity
	compensation plans (excluding securities reflected in column
	(a))
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 2PX; WIDTH: 10%; VERTICAL-ALIGN: BOTTOM; DISPLAY: INLINE-BLOCK; FONT-WEIGHT: BOLD; FONT-SIZE: 11PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	(a)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	(b)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	(c)
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Equity compensation
	plans approved by security holders
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	7,927,508
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	(1)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	$
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	1.21
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	(2)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:5%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; VERTICAL-ALIGN:BOTTOM;WIDTH:75%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	3,314,419
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; VERTICAL-ALIGN:BOTTOM;WIDTH:10%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Equity compensation
	plans not approved by security holders
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #000000;">
	-
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:4PX;MARGIN-LEFT:12PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Total
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:DOUBLE 4PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:DOUBLE 4PX #000000;">
	7,927,508
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:DOUBLE 4PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:DOUBLE 4PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:DOUBLE 4PX #000000;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:DOUBLE 4PX #000000;">
	3,314,419
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:4PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)&#xA0;Consists
	of 4,825,550 options and 2,665,768 restricted stock units granted
	under our 2011 Stock Incentive Plan and 436,190 options granted
	under our 2005 Stock Plan. Our 2005 Stock Plan has terminated, but
	termination does not affect awards that are currently outstanding
	under this plan. The shares subject to outstanding awards under the
	2005 Stock Plan, if forfeited prior to exercise, will become
	available for issuance under the 2011 Stock Incentive
	Plan.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	78
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage81"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2)&#xA0;The amount
	in column (a) for equity compensation plans approved by security
	holders includes 2,665,768 shares reserved for issuance on vesting
	of outstanding restricted stock units, granted under our 2011 Stock
	Incentive Plan, which vest on various dates through January 11,
	2020, subject to the fulfillment of service conditions. Because no
	exercise price is required for issuance of shares on vesting of the
	restricted stock units, the weighted-average exercise price in
	column (b) does not take the restricted stock units into
	account.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Beneficial Ownership Tables.
</FONT>
	The tables
	below show the beneficial stock ownership and voting power, as of
	September 16, 2016, of:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	each director, each
	of the named executive officers, and all current directors and
	officers as a group; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-SIZE: 13PX">
	&#x25CF;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	all persons who, to
	our knowledge, beneficially own more than five percent of the
	common stock or Series A preferred stock.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;Beneficial
	ownership&#x201D; here means direct or indirect voting or investment
	power over outstanding stock and stock which a person has the right
	to acquire now or within 60 days after September 16, 2016. See the
	footnotes for more detailed explanations of the holdings. Except as
	noted, to our knowledge, the persons named in the tables
	beneficially own and have sole voting and investment power over all
	shares listed.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	common stock has one vote per share and the Series A preferred
	stock has approximately 15 votes per share of Series A preferred
	stock. Voting power is calculated on the basis of the aggregate of
	common stock and Series A preferred stock outstanding as of
	September 16, 2016, on which date
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
	85,934,037 shares of
	common stock and 4,030 shares of Series A preferred stock,
	convertible into 60,592 shares of common stock, were
	outstanding.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	address for all members of our management and directors is c/o
	Palatin Technologies, Inc., 4B Cedar Brook Drive, Cranbury, NJ
	08512. Addresses of other beneficial owners are in the
	table.
</FONT>
</DIV>
<EFX_BENEFICIAL_OWNERS>
<A NAME="FIS_BENEFICIAL_OWNERS"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MANAGEMENT:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;Class
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%;">
<DIV STYLE="TEXT-ALIGN: CENTER; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-LEFT: 0PX; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;Name
	of beneficial owner
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM:2PX;WIDTH:10%;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;BORDER-BOTTOM:SOLID 2PX #000000;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	Amount
	and nature of beneficial ownership
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM:2PX;WIDTH:10%;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM:2PX;WIDTH:10%;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;BORDER-BOTTOM:SOLID 2PX #000000;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	Percent
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;of
	class
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM:2PX;WIDTH:10%;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM:2PX;WIDTH:10%;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: CENTER; VERTICAL-ALIGN:BOTTOM;WIDTH:80%;BORDER-BOTTOM:SOLID 2PX #000000;DISPLAY:INLINE-BLOCK;">
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	Percent
	of total voting
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-WEIGHT:BOLD;FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;power
</FONT>
</DIV>
<DIV>
<FONT STYLE="FONT-SIZE:13PX;FONT-FAMILY:TIMES NEW ROMAN;">
	&#xA0;&#xA0;
</FONT>
</DIV>
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM:2PX;WIDTH:10%;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl Spana,
	Ph.D.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	1,721,079
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(1)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	2.0
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen T.
	Wills
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	1,574,041
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(2)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	1.8
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	John K.A.
	Prendergast, Ph.D.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	410,517
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(3)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Robert K. deVeer,
	Jr.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	264,560
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(4)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	J. Stanley
	Hull
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	235,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(5)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Alan W. Dunton,
	M.D.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	167,520
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(6)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Angela
	Rossetti
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	112,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(7)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 32%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Arlene M.
	Morris
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	52,500
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(8)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	*
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_BENEFICIAL_OWNERS>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD COLSPAN="2" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="MARGIN-LEFT:0PX;PADDING-BOTTOM:2PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD COLSPAN="2" STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 64%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV STYLE="TEXT-ALIGN: LEFT; TEXT-INDENT:0PX;MARGIN-RIGHT:0PX;PADDING-BOTTOM:2PX;MARGIN-LEFT:132PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All current
	directors and executive officers as a group (eight
	persons)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	4,538,217
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	(9)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 12%; BORDER-LEFT: 1PX SOLID RGB(255, 255, 255);">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	5.1
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
<TD STYLE="BORDER-LEFT: 1PX SOLID RGB(255, 255, 255); VERTICAL-ALIGN: BOTTOM; BORDER-RIGHT: 1PX SOLID RGB(255, 255, 255); WIDTH: 12%;">
<DIV>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:5%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	&#xA0;
</FONT>
<FONT STYLE="TEXT-ALIGN: RIGHT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;FONT-SIZE:13PX;DISPLAY:INLINE-BLOCK;WIDTH:75%;BORDER-BOTTOM:SOLID 2PX #FFFFFF;">
	1.9
</FONT>
<FONT STYLE="TEXT-ALIGN: LEFT; FONT-FAMILY:TIMES NEW ROMAN;VERTICAL-ALIGN:BOTTOM;DISPLAY:INLINE-BLOCK;WIDTH:10%;PADDING-BOTTOM:2PX;FONT-SIZE:13PX;">
	%
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	*Less
	than one percent.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)&#xA0;Includes
	918,750 shares of common stock underlying outstanding options,
	45,653 shares of common stock underlying outstanding warrants and
	81,250 shares of common stock underlying restricted stock units but
	does not include shares of common stock underlying outstanding
	options or restricted stock unit awards that have not vested and
	will not vest within 60 days.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2)&#xA0;Includes
	795,000 shares of common stock underlying outstanding options,
	45,653 shares of common stock underlying outstanding warrants and
	75,000 shares of common stock underlying restricted stock units but
	does not include shares of common stock underlying outstanding
	options or restricted stock unit awards that have not vested and
	will not vest within 60 days.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(3)&#xA0;Includes
	338,750 shares of common stock underlying outstanding options but
	does not include shares of common stock underlying outstanding
	options or restricted stock unit awards that have not vested and
	will not vest within 60 days.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(4)&#xA0;Includes
	197,500 shares of common stock underlying outstanding options but
	does not include shares of common stock underlying outstanding
	options or restricted stock unit awards that have not vested and
	will not vest within 60 days.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(5)&#xA0;Includes
	194,000 shares of common stock underlying outstanding options but
	does not include shares of common stock underlying outstanding
	options or restricted stock unit awards that have not vested and
	will not vest within 60 days.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(6)&#xA0;Includes
	125,000 shares of common stock underlying outstanding options but
	does not include shares of common stock underlying outstanding
	options or restricted stock unit awards that have not vested and
	will not vest within 60 days.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(7)&#xA0;Includes
	77,500 shares of common stock underlying outstanding options but
	does not include shares of common stock underlying outstanding
	options or restricted stock unit awards that have not vested and
	will not vest within 60 days.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(8)&#xA0;Consists
	of 32,500 shares of common stock underlying outstanding options but
	does not include shares of common stock underlying outstanding
	options or restricted stock unit awards that have not vested and
	will not vest within 60 days.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(9)&#xA0;Includes
	2,926,556 shares of common stock underlying outstanding options,
	warrants and restricted stock units.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	79
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage82"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_BENEFICIAL_OWNERS>
<A NAME="FIS_BENEFICIAL_OWNERS_2"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MORE
	THAN 5% BENEFICIAL OWNERS:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Class
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 46%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Name and address
	of beneficial owner
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 18%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Amount and
	nature of beneficial ownership (1)
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 13%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Percent
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	of
	class
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 13%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	Percent of total
	voting
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-SIZE: 11PX;">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN;">
	power
</FONT>
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Common
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	QVT
	Financial LP
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	1177
	Avenue of the Americas, 9th Floor
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	New
	York, New York 10036
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	9,089,296
	(2)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	9.9%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	4.7%
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
</EFX_BENEFICIAL_OWNERS>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Steven
	N. Ostrovsky
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	43
	Nikki Ct.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Morganville, NJ
	07751
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	500
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	12.4%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Thomas
	L. Cassidy IRA Rollover
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	38
	Canaan Close
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	New
	Canaan, CT 06840
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	500
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	12.4%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Jonathan E.
	Rothschild
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	300
	Mercer St., #28F
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	New
	York, NY 10003
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	500
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	12.4%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Arthur
	J. Nagle
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	19
	Garden Avenue
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Bronxville, NY
	10708
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	250
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	6.2%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Thomas
	P. and Mary E. Heiser, JTWROS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	10
	Ridge Road
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Hopkinton, MA
	01748
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	250
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	6.2%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Carl
	F. Schwartz
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	31
	West 87th St.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	New
	York, NY 10016
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	250
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	6.2%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Michael J.
	Wrubel
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	3650
	N. 36 Avenue, #39
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Hollywood, FL
	33021
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	250
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	6.2%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Myron
	M. Teitelbaum, M.D.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	175
	Burton Lane
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Lawrence, NY
	11559
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	250
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	6.2%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Laura
	Gold Galleries Ltd. Profit Sharing Trust Park South Gallery at
	Carnegie Hall
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	154
	West 57th Street, Suite 114
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	New
	York, NY 10019
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	250
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	6.2%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Laura
	Gold
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	180 W.
	58th Street
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	New
	York, NY 10019
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	250
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	6.2%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Series
	A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Preferred
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX; WIDTH: 100%;">
<!--RULE BELOW PARAGRAPH-->
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 46%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	Nadji
	T. Richmond
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	20 E.
	Wedgewood Glen
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	The
	Woodlands, TX 77381
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 18%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	230
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	5.7%
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	*
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 7.3PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 7%; HEIGHT: 2PX; BACKGROUND-COLOR: #000000">
<!--LINE-->
<BR>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 7.3PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	*Less
	than one percent.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	80
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage83"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 7.3PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)
	Unless otherwise indicated by footnote, all share amounts represent
	outstanding shares of the class indicated, and all beneficial
	owners listed have, to our knowledge, sole voting and dispositive
	power over the shares listed.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2) QVT
	Financial LP (QVT Financial) is the investment manager for QVT Fund
	V LP (Fund V) and other private investment funds (collectively, the
	Funds). The information contained herein with respect to the Funds
	is based on information included in filings by QVT Financial and
	the Funds with the SEC. Based on a Form 13F filed by QVT Financial
	on August 15, 2016 for the period ending June 30, 2016, the Funds
	beneficially own in the aggregate 9,089,296 shares of common stock,
	including 5,049,922 shares of common stock underlying outstanding
	warrants. QVT Financial has the power to direct the vote and
	disposition of the common stock held by the Funds, and accordingly
	QVT Financial may be deemed to be the beneficial owner of an
	aggregate amount of 9,089,296 shares of common stock, consisting of
	the shares beneficially owned by the Funds.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	QVT
	Financial GP LLC, as General Partner of QVT Financial, may be
	deemed to beneficially own the same number of shares of common
	stock reported by QVT Financial. QVT Associates GP LLC, as General
	Partner of the Funds may be deemed to beneficially own the
	aggregate number of shares of common stock beneficially owned by
	the Funds, and accordingly, QVT Associates GP LLC may be deemed to
	be the beneficial owner of an aggregate amount of 9,089,296 shares
	of common stock.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 7.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Exercise of
	warrants held by the Funds is restricted if, as a result of an
	exercise, the beneficial ownership of the holder and its affiliates
	and any other party or person that could be deemed to be a group
	would exceed 9.99% of the outstanding common stock. Beneficial
	ownership as listed in the table above excludes warrants which are
	not exercisable because of that restriction, but includes warrants
	which are exercisable based on the common shares
	outstanding.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	13. Certain Relationships and Related Transactions, and Director
	Independence.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	board of directors has determined that all of the directors except
	for Dr. Spana (our Chief Executive Officer and President) are
	independent directors, as defined in the listing standards of the
	NYSE MKT.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As a
	condition of employment, we require all employees to disclose in
	writing actual or potential conflicts of interest, including
	related party transactions. Our code of corporate conduct and
	ethics, which applies to employees, officers and directors,
	requires that the audit committee review and approve related party
	transactions. Since July&#xA0;1, 2015, there have been no
	transactions or proposed transactions in which we were or are to be
	a participant, in which any related person had or will have a
	direct or indirect material interest.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	14. Principal Accountant Fees and Services.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	KPMG
	LLP, or KPMG, served as our independent registered public
	accounting firm for fiscal 2016 and fiscal 2015.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Audit Fees
</FONT>
	. For fiscal 2016, KPMG
	billed us a total of $235,500 for professional services rendered
	for the audit of our annual consolidated financial statements,
	review of our consolidated financial statements in our Forms 10-Q
	and services provided in connection with regulatory filings. For
	fiscal 2015, the total billed for the same services was
	$419,200.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Audit-Related Fees
</FONT>
	. For fiscal 2016 and
	2015, KPMG did not perform or bill us for any audit-related
	services.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Tax Fees
</FONT>
	. For fiscal 2016, KPMG billed
	us a total of $16,000 for professional services rendered for tax
	compliance. For fiscal 2015, KPMG billed us $15,500 for
	professional services rendered for tax compliance.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	All Other Fees
</FONT>
	. KPMG did not perform or
	bill us for any services other than those described above for
	fiscal 2015 and 2016.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-STYLE: ITALIC">
	Policy on Audit Committee Pre-Approval of
	Audit and Permissible Non-Audit Services of Independent
	Auditors
</FONT>
	. Consistent with SEC policies regarding auditor
	independence, the audit committee has responsibility for
	appointing, setting compensation for and overseeing the work of the
	independent registered public accounting firm. In recognition of
	this responsibility, the audit committee has established a policy
	to pre-approve all audit and permissible non-audit services
	provided by the independent registered public accounting
	firm.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	audit committee pre-approves fees for each category of service. The
	fees are budgeted and the audit committee requires the independent
	registered public accounting firm and management to report actual
	fees versus the budget periodically throughout the year by category
	of service. During the year, circumstances may arise when it may
	become necessary to engage the independent registered public
	accounting firm for additional services not contemplated in the
	original pre-approval. In those instances, the audit committee
	requires specific pre-approval before engaging the independent
	registered public accounting firm.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	audit committee may delegate pre-approval authority to one or more
	of its members. The member to whom such authority is delegated must
	report, for informational purposes only, any pre-approval decisions
	to the audit committee at its next scheduled meeting.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	81
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage84"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_DIRECTORS_AND_OFFICERS>
</EFX_PART_III>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_PART_IV>
<A NAME="FIS_PART_IV"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PART
	IV
</FONT>
</DIV>
<EFX_EXHIBITS>
<A NAME="FIS_EXHIBITS"></A>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Item
	15. Exhibits, Financial Statement Schedules.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)&#xA0;&#xA0;&#xA0;&#xA0;
	Documents filed as part of the report:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;&#xA0;&#xA0;&#xA0;1.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;
	Financial statements: The following consolidated financial
	statements are filed as a part of this report under Item 8 &#x2013;
	Financial Statements and Supplementary Data:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2014;
	Report of Independent Registered Public Accounting
	Firm
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2014;
	Consolidated Balance Sheets
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2014;
	Consolidated Statements of Operations
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2014;
	Consolidated Statements of Comprehensive Loss
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2014;
	Consolidated Statements of Stockholders&#x2019; (Deficiency)
	Equity
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2014;
	Consolidated Statements of Cash Flows
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2014;
	Notes to Consolidated Financial Statements
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;&#xA0;&#xA0;&#xA0;2.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;
	Financial statement schedules: None.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;&#xA0;&#xA0;&#xA0;3.&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;
	Exhibits: The exhibits, listed on the accompanying exhibit index
	that is set forth after the signature page, are filed or
	incorporated by reference (as stated thereon) as part of this
	Annual Report on Form 10-K.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	82
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage85"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
</EFX_EXHIBITS>
</EFX_PART_IV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_SIGNATURES>
<A NAME="FIS_SIGNATURES"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	SIGNATURES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Pursuant to the
	requirements of Section 13 or 15(d) of the Securities Exchange Act
	of 1934, the registrant has duly caused this report to be signed on
	its behalf by the undersigned, thereunto duly
	authorized.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN
	TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	By:
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	/s/ Carl Spana
	&#xA0;
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl
	Spana, Ph.D.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	President and Chief
	Executive Officer
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(principal
	executive officer)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Date:
	September 19, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-TOP: 6.7PX; PADDING-BOTTOM: 6.7PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Pursuant to the
	requirements of the Securities Exchange Act of 1934, this report
	has been signed below by the following persons on behalf of the
	registrant and in the capacities and on the dates
	indicated.
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Signature
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Title
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Date
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; TEXT-DECORATION: UNDERLINE;">
	/s/ Carl Spana &#xA0;&#xA0;&#xA0;&#xA0;
</FONT>
</DIV>
</FONT>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	President,
	Chief Executive Officer and Director
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl
	Spana
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(principal
	executive officer)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/ Stephen T.
	Wills &#xA0;&#xA0;&#xA0;&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Executive
	Vice President, Chief Financial Officer
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen
	T. Wills
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and
	Chief Operating Officer (principal financial and accounting
	officer)
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/ John K. A.
	Prendergast &#xA0;&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Chairman
	and Director
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	John K.
	A. Prendergast
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/ Robert K.
	deVeer, Jr, &#xA0;&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Robert
	K. deVeer, Jr.
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/ J. Stanley Hull
	&#xA0;&#xA0;
</FONT>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	J.
	Stanley Hull
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; TEXT-DECORATION: UNDERLINE;">
	/s/
<FONT STYLE="FONT-SIZE: 13PX; TEXT-DECORATION: UNDERLINE;">
	&#xA0;
</FONT>
	Alan W.
	Dunton &#xA0;&#xA0;
</FONT>
</DIV>
</FONT>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Alan W.
	Dunton
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; TEXT-DECORATION: UNDERLINE;">
	/s/ Angela Rossetti&#xA0; &#xA0;&#xA0;
</FONT>
</DIV>
</FONT>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Angela
	Rossetti
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; TEXT-DECORATION: UNDERLINE;">
	/s/ Arlene M. Morris&#xA0; &#xA0;&#xA0;
</FONT>
</DIV>
</FONT>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Director
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 34%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Arlene
	M. Morris
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 47%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	83
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage86"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_31"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Exhibit Index
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; BORDER-BOTTOM: 2PX SOLID RGB(35, 31, 32);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Exhibit Number
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 39%; BORDER-BOTTOM: 2PX SOLID RGB(35, 31, 32);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Description
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 10%; BORDER-BOTTOM: 2PX SOLID RGB(35, 31, 32);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Filed Herewith
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 9%; BORDER-BOTTOM: 2PX SOLID RGB(35, 31, 32);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 19%; BORDER-BOTTOM: 2PX SOLID RGB(35, 31, 32);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Filing Date
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 13%; BORDER-BOTTOM: 2PX SOLID RGB(35, 31, 32);">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	SEC File No.
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Restated Certificate of Incorporation of Palatin Technologies,
	Inc., as amended.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September 27, 2013
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Bylaws of Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	February 8, 2008
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Warrant Agreement, dated March 1, 2011, between American Stock
	Transfer&amp; Trust Company and Palatin Technologies,
	Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 13, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Series B Warrant Certificate.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 13, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Series A 2012 Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 6, 2012
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Series B 2012 Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 6, 2012
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of
	Series C 2014 Common Stock Purchase Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December
	30,
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2014
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of
	Series D 2014 Common Stock Purchase Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December
	30,
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2014
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.7
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of
	Series E 2015 Common Stock Purchase Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 7,
	2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.8
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of
	Series F 2015 Common Stock Purchase Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 7,
	2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.9
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of
	Series G 2015 Common Stock Purchase Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 7,
	2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.10
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of
	Series H 2016 Common Stock Purchase Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	August
	2, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.11
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of
	Series I 2016 Common Stock Purchase Warrant.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	August
	2, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.1&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1996 Stock Option Plan, as amended.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September 28, 2009
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.2&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Option Certificate (Incentive Option) Under the 2005 Stock
	Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September 21, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.3&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Incentive Stock Option Under the 2005 Stock
	Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September 21, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.4&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Opinion Certificate (Non-Qualified Opinion) Under the 2005
	Stock Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September 21, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.5&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Non-Qualified Stock Option Agreement Under the 2005 Stock
	Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September 21, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.6&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2007 Change in Control Severance Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	February 8, 2008
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.7&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2005 Stock Plan, as amended.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 15, 2009
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.8&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Executive Officer Option Certificate.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 14, 2008
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.9&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Amended Restricted Stock Unit Agreement.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 14, 2008
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.10&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Amended Option Certificate (Incentive Option) Under the
	2005 Stock Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 14, 2008
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.11&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Employment Agreement, effective as of July 1, 2016, between Carl
	Spana and Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June 13, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	84
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage87"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="NULL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_32"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.12&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Employment Agreement, effective as of July 1, 2016, between Stephen
	T. Wills and Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June 13, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.13
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Underwriting Agreement, datedFebruary 24, 2011, by and between Roth
	Capital Partners, LLC and Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	February 24, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.14&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2011 Stock Incentive Plan, as amended.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June 13, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.15&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Restricted Share Unit Agreement Under the 2011 Stock
	Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 13, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.16&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Nonqualified Stock Option Agreement under the 2011 Stock
	Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 13, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.17&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Incentive Stock Option Agreement under the 2011 Stock
	Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	May 13, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.18&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Restricted Share Unit Agreement under the 2011 Stock
	Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December 11, 2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.19&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Performance-Based Restricted Share Unit Agreement under the
	2011 Stock Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December 11, 2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.20&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Restricted Share Unit Agreement for Non-Employee Directors
	under the 2011 Stock Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December 11, 2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.21&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Amended form of Restricted Share Unit Agreement under the 2011
	Stock Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	February 12, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.22&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Amended form of Performance-Based Restricted Share Unit Agreement
	under the 2011 Stock Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	February 12, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.23&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Amended form of Restricted Share Unit Agreement for Non-Employee
	Directors under the 2011 Stock Incentive Plan.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-Q
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	February 12, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.24
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Form of Indenture.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	S-3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	August 3, 2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	333-206047
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.25
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Letter Agreement, dated October 7, 2011, between Biotechnology
	Value Fund, L.P. and Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	October 7, 2011
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.26
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Purchase Agreement, dated July 2, 2012, by and between QVT Fund IV
	LP, QVT Fund V LP and Quintessence Fund L.P. and Palatin
	Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 6, 2012
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.27
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Registration Rights Agreement, dated July 2, 2012, by and between
	QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P. and
	Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 6, 2012
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.28
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Securities
	Purchase Agreement, dated December 23, 2014, by and between Palatin
	Technologies, Inc. and the investors named therein.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December
	30,
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2014
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	85
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage88"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="NULL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_33"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.29
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Registration
	Rights Agreement, dated December 23, 2014, by and between Palatin
	Technologies, Inc. and the investors named therein.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December
	30,
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2014
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.30
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Placement
	Engagement Letter, dated December 22, 2014, by and between Palatin
	Technologies, Inc. and Piper Jaffray &amp; Co.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	December
	30,
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2014
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.31
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Amended and Restated Venture Loan and Security Agreement, dated
	July 2, 2015, by and between Palatin Technologies, Inc. and Horizon
	Technology Finance Corporation, Fortress Credit Co LLC, Horizon
	Credit II LLC and Fortress Credit Opportunities V CLO
	Limited.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 7,
	2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.32
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Securities
	Purchase Agreement, dated July 2, 2015, by and between Palatin
	Technologies, Inc. and the investors named therein.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 7,
	2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.33
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Registration
	Rights Agreement, dated July 2, 2015, by and between Palatin
	Technologies, Inc. and the investors named therein.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	July 7,
	2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.34
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Underwriting
	Agreement, dated August 1, 2016, by and between Palatin
	Technologies, Inc. and Canaccord Genuity Inc., on behalf of itself
	and as representative of the underwriters named
	therein.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	August
	2, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.35&#x2020;&#x2020;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	License, Co-Development and Commercialization Agreement, dated
	August 29, 2014, by and between Chemical Works of Gedeon Richter
	Plc. and Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-K/A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	October 9, 2014
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.36
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="COLOR: #231F20">
	Termination Agreement, dated September 16, 2015, by and
	between
</FONT>
<FONT STYLE="COLOR: #231F20">
	Chemical Works of
	Gedeon Richter Plc. and Palatin Technologies,
	Inc.
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10-K
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September 18, 2015
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	001-15543
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<A HREF="#PTN_EX1037_HTM">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.37&#x2020;&#x2020;
</FONT>
</A>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Commercial Supply Agreement dated June 20, 2016, by and between
	Catalent Belgium S.A. and Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<A HREF="#PTN_EX1038_HTM">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.38&#x2020;&#x2020;
</FONT>
</A>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Manufacturing Preparation and Services Agreement dated June 20,
	2016, by and between Catalent Belgium S.A. and Palatin
	Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<A HREF="#PTN_EX21_HTM">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	21
</FONT>
</A>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Subsidiaries of Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<A HREF="#PTN_EX23_HTM">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	23
</FONT>
</A>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consent of KPMG LLP.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<A HREF="#PTN_EX311_HTM">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	31.1
</FONT>
</A>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certification of Chief Executive Officer.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="NULL">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	86
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage89"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="NULL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_UNIDENTIFIED_TABLE>
<A NAME="FIS_UNIDENTIFIED_TABLE_34"></A>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<A HREF="#PTN_EX312_HTM">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	31.2
</FONT>
</A>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certification of Chief Financial Officer.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<A HREF="#PTN_EX321_HTM">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	32.1
</FONT>
</A>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certification of principal executive officer pursuant to U.S.C.
	Section 1350, as adopted pursuant to Section 906 of the
	Sarbanes-Oxley Act of 2002.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<A HREF="#PTN_EX322_HTM">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	32.2
</FONT>
</A>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certification of principal financial officer pursuant to U.S.C.
	Section 1350, as adopted pursuant to Section 906 of the
	Sarbanes-Oxley Act of 2002.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	101.INS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	XBRL Instance Document.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	101.SCH
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	XBRL Taxonomy Extension Schema Document.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	101.CAL
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	XBRL Taxonomy Extension Calculation Linkbase Document.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	101.LAB
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	XBRL Taxonomy Extension Label Linkbase Document.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	101.PRE
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	XBRL Taxonomy Extension Presentation Linkbase
	Document.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="BACKGROUND-COLOR: RGB(204, 238, 255);">
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	101.DEF
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 39%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	XBRL Taxonomy Extension Definition Linkbase Document.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 10%;">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	X
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 9%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 19%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 13%;">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_UNIDENTIFIED_TABLE>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #231F20; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2020; Management contract or compensatory plan or
	arrangement.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x2020;&#x2020;
	Confidential treatment granted or requested as to certain portions,
	which portions are omitted and filed separately with the
	SEC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	87
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_SIGNATURES>
</EFX_FORM>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage90"></A>
<A NAME="PTN_EX1037_HTM"></A>
<EFX_EXHIBIT_10>
<A NAME="FIS_EXHIBIT_10"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Exhibit 10.37
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	*** OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
	COMMISSION
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTION
	240.24b-2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	COMMERCIAL
	SUPPLY AGREEMENT
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(Bremelanotide&#x2014;Pre-filled
	syringe in auto-injector)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	THIS COMMERCIAL SUPPLY AGREEMENT
</FONT>
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Agreement
</FONT>
	&#x201D;) is
	made as of this 10
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	TH
</FONT>
	day of June, 2016
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Effective
	Date
</FONT>
	&#x201D;)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	BETWEEN
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(1)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin
	Technologies, Inc., a New Jersey corporation, with a place of
	business at 4-B Cedar Brook Drive, Cranbury, New Jersey, USA 08512
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Palatin
</FONT>
	&#x201D;);
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(2)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent Belgium
	S.A., a Belgian company, with a place of business at Rue Font St.
	Landry, 10 Parc Mercator B-1120, Neder over Heembeek, Belgium
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent
</FONT>
	&#x201D;).
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	RECITALS
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<A NAME="PTN_EX1037_HTM__REF117562540">
<!--ANCHOR-->
</A>
	Palatin is a
	biopharmaceutical company that develops, tests and commercializes,
	directly or through third parties, pharmaceutical
	products.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent is a
	leading provider of advanced technologies, and development,
	manufacturing and packaging services for pharmaceutical,
	biotechnology and consumer healthcare companies.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin desires to
	engage Catalent to provide certain services to Palatin in
	connection with the processing of Palatin&#x2019;s Product, and
	Catalent desires to provide such services, all pursuant to the
	terms and conditions set out in this Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	D.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent and
	Palatin have entered into that certain Binding Terms for
	Incorporation into a Capital and a Commercial Supply Agreement,
	dated April 1, 2016 (the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Binding Terms
</FONT>
	&#x201D;), which Binding
	Terms shall be superseded in its entirety by this Agreement and the
	Manufacturing Preparation and Services Agreement (as defined
	hereafter).
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	THEREFORE
</FONT>
	, the parties agree as
	follows:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	DEFINITIONS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	following terms have the following meanings in this
	Agreement:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Acknowledgement
</FONT>
	&#x201D; has the meaning
	set out in Clause 4.3.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage91"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="COLOR: #000000">
	&#x201C;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #000000">
	Affiliate
</FONT>
<FONT STYLE="COLOR: #000000">
	&#x201D; means (a) with respect to Palatin, any
	corporation or other business entity that, directly or indirectly,
	is controlled by, controls, or is under common control with
	Palatin; and (b) with respect to Catalent, Catalent, Inc., Catalent
	Pharma Solutions, Inc. and any corporation or other business entity
	controlled, directly or indirectly, by Catalent Pharma Solutions,
	Inc. For such purposes, &#x201C;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #000000">
	control
</FONT>
<FONT STYLE="COLOR: #000000">
	&#x201D; means the direct or indirect ownership of
	at least fifty percent (50%) of the voting interest in such
	corporation or other entity or the power in fact to control the
	management directions of such entity.
</FONT>
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Agreement
</FONT>
	&#x201D; has the meaning set out
	in the introductory paragraph, and includes all its Attachments and
	other appendices (all of which are incorporated herein by
	reference).
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	ANDA
</FONT>
	&#x201D; has the meaning set out in
	Clause 9.2.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.5
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Annual Product Maintenance Fee
</FONT>
	&#x201D;
	has the meaning set forth in Clause 7.1C.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.6
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	API
</FONT>
	&#x201D;
	means the compound bremelanotide, as further described in the
	Specifications.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.7
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	API Inventions
</FONT>
	&#x201D; has the meaning
	set out in Section 11.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.8
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Applicable Laws
</FONT>
	&#x201D; means,
<FONT STYLE="COLOR: #000000">
	with respect to Palatin,
</FONT>
	all
	laws, statutes, statutory provisions or subordinate legislation,
	currently in effect or enacted or promulgated during the Term, and
	as amended from time to time, of each jurisdiction in which API or
	Product is produced, marketed, distributed, used or sold; and with
	respect to Catalent, cGMP and all other laws, statutes, statutory
	provisions and subordinate legislation, currently in effect or
	enacted or promulgated during the Term, and as amended from time to
	time, of the jurisdiction in which Catalent Processes
	Product.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.9
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Auto Injector Assembly Line
</FONT>
	&#x201D; has
	the meaning set forth in Clause 3.5.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.10
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Batch
</FONT>
	&#x201D;
	means a defined quantity of Product that has been or is being
	Processed in accordance with the Specifications.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.11
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Binding
	Terms
</FONT>
	&#x201D; has the meaning set forth in the
	Recitals.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.12
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent
	Defective Processing
</FONT>
	&#x201D; has the meaning set out in
	Clause 5.2.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.13
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent
</FONT>
	&#x201D;
	has the meaning set out in the introductory paragraph. Catalent
	shall have the right to cause any of its Affiliates to perform any
	of its obligations hereunder, and Palatin shall accept such
	performance as if it were performance by Catalent.;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	,
<FONT STYLE="FONT-STYLE: ITALIC">
	however
</FONT>
	, that Catalent shall remain
	fully liable for the performance by its Affiliate of
	Catalent&#x2019;s obligations under this Agreement to the same
	extent as if Catalent had performed or failed to perform its
	obligations under this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.14
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent
	CAPEX Expenditures
</FONT>
	&#x201D; has the meaning set forth in the
	Manufacturing Preparation and Services Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.15
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent
	Indemnitees
</FONT>
	&#x201D; has the meaning set out in Clause
	13.2.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.16
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent
	IP
</FONT>
	&#x201D; has the meaning set out in Section
	11.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.17
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	cGMP
</FONT>
	&#x201D;
	means current Good Manufacturing Practices promulgated by the
	Regulatory Authorities in the jurisdictions included in Applicable
	Laws. This includes 2003/94/EEC Directive (as supplemented by
	Volume 4 of EudraLex published by the European Commission), as
	amended, if and as implemented in the relevant constituent country;
	and in the United States, this includes 21 C.F.R. Parts 210 and
	211, as amended.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage92"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.18
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Change
	of Control
</FONT>
	&#x201D; means, with respect to a party: (a) any
	merger, reorganization, consolidation, or other business
	combination of such party with a third party that results in the
	voting securities of such party outstanding immediately prior
	thereto ceasing to represent at least fifty percent (50%) of the
	combined voting power of the surviving entity immediately after
	such merger, reorganization, consolidation, or other business
	combination; (b) a third party becoming the beneficial owner of
	fifty percent (50%) or more of the combined voting power of such
	party in a single transaction or series of related transactions; or
	(c) the sale, transfer, exchange or other disposition to a third
	party of all or substantially all of a party&#x2019;s assets or
	business relating to this Agreement (whether alone or in connection
	with a sale, transfer, exchange or other disposition of other
	assets or businesses of such party).
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.19
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Commencement
	Date
</FONT>
	&#x201D; means 60 days from the first date on which the
	FDA gives market Regulatory Approval with respect to the
	Product.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.20
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Confidential
	Information
</FONT>
	&#x201D; has the meaning set out in Clause
	10.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.21
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Contract
	Year
</FONT>
	&#x201D; means each consecutive 12 month period beginning
	on the Commencement Date or anniversary thereof, as
	applicable.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.22
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	CPR
</FONT>
	&#x201D;
	has the meaning set out in Clause 18.10.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.23
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Defective
	Product
</FONT>
	&#x201D; has the meaning set out in Clause
	5.2.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.24
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Discloser
</FONT>
	&#x201D;
	has the meaning set out in Clause 10.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.25
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Effective
	Date
</FONT>
	&#x201D; has the meaning set out in the introductory
	paragraph.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.26
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	&#x201C;Equipment
</FONT>
	&#x201D;
	means any equipment to be supplied by Catalent to use in the
	Processing.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.27
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Exception
	Notice
</FONT>
	&#x201D; has the meaning set out in Clause
	5.2.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.28
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Facility
</FONT>
	&#x201D;
	means Catalent&#x2019;s facility in Brussels, Belgium or such other
	Catalent facility as mutually agreed by the parties.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.29
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	FDA
</FONT>
	&#x201D;
	means the United States Food and Drug Administration or any
	successor thereto.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.30
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Firm
	Commitment
</FONT>
	&#x201D; has the meaning set out in Clause
	4.2.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.31
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	GDUFA
	Fees
</FONT>
	&#x201D; has the meaning set out in Clause
	9.2.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.32
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Invention
</FONT>
	&#x201D;
	has the meaning set out in Section 11.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.33
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Losses
</FONT>
	&#x201D;
	has the meaning set out in Clause 13.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.34
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Manufacturing
	Preparation and Services Agreement
</FONT>
	&#x201D; means that certain
	agreement of even date herewith between Catalent and Palatin
	pursuant to which Catalent (itself or through its Affiliates) has
	agreed to upgrade its manufacturing capacity and infrastructure to
	provide certain services in relation to the manufacture of the
	Product and to reserve certain manufacturing capacity on its
	upgraded facilities.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage93"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.35
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Minimum
	Requirement
</FONT>
	&#x201D; has the meaning set out in Clause
	4.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.36
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Palatin
</FONT>
	&#x201D;
	has the meaning set out in the introductory paragraph, or any
	successor or permitted assign.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.37
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Palatin
	Indemnitees
</FONT>
	&#x201D; has the meaning set out in Clause
	13.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.38
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Palatin
	IP
</FONT>
	&#x201D; has the meaning set out in Section
	11.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.39
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Palatin-supplied
	Materials
</FONT>
	&#x201D; means any materials to be supplied by or on
	behalf of Palatin to Catalent for Processing, as provided in
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment C
</FONT>
	,
	including API, Ypsomed auto injector components and parts, and
	reference standards.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.40
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Price
</FONT>
	&#x201D;
	shall have the meaning set forth in
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment D
</FONT>
	hereto.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.41
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Process
</FONT>
	&#x201D;
	or &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Processing
</FONT>
	&#x201D;
	means the compounding, filling, producing, manufacturing,
	assembling and packaging (clinical, secondary or retail packaging)
	of Palatin-supplied Materials and Raw Materials into Product by
	Catalent, in accordance with the Specifications and under the terms
	of this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.42
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Processing
	Date
</FONT>
	&#x201D; means the day on which the first step of
	physical Processing is scheduled to occur, as identified in an
	Acknowledgement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.43
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Process
	Inventions
</FONT>
	&#x201D; has the meaning set out in Section
	11.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.44
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Product
</FONT>
	&#x201D;
	means the pharmaceutical product containing the API, as more
	specifically described in the Specifications.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.45
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Product
	Maintenance Services
</FONT>
	&#x201D; has the meaning set out in
	Clause 2.3.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.46
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Purchase
	Order
</FONT>
	&#x201D; has the meaning set out in Clause
	4.3.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.47
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Quality
	Agreement
</FONT>
	&#x201D; has the meaning set out in Clause
	9.6.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.48
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Raw
	Materials
</FONT>
	&#x201D; means all raw materials, supplies,
	components, syringes, and packaging necessary to manufacture and
	ship Product in accordance with the Specifications, as provided in
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment C
</FONT>
	, but
	excluding Palatin-supplied Materials.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.49
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Recall
</FONT>
	&#x201D;
	has the meaning set out in Clause 9.5.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.50
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Recipient
</FONT>
	&#x201D;
	has the meaning set out in Clause 10.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.51
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Regulatory
	Approval
</FONT>
	&#x201D; means any approvals, permits, product and/or
	establishment licenses, registrations or authorizations, including
	European marketing authorizations and applications and US
	Investigational New Drug applications, New Drug Applications and
	Abbreviated New Drug Applications, as applicable, of any Regulatory
	Authorities that are necessary or advisable in connection with the
	development, manufacture, testing, use, storage, exportation,
	importation, transport, promotion, marketing, distribution or sale
	of API or Product in the Territory.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.52
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Regulatory
	Authority
</FONT>
	&#x201D; means the regulatory bodies or agencies in
	the Territory that are responsible for (A) the regulation
	(including pricing) of any aspect of pharmaceutical or medicinal
	products intended for human use or (B) health, safety or
	environmental matters generally. This includes the European
	Medicines Agency; and in the United States, this includes the
	United States Food and Drug Administration.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage94"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.53
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Representatives
</FONT>
	&#x201D;
	of an entity means such entity&#x2019;s duly-authorized officers,
	directors, employees, agents, accountants, attorneys or other
	professional advisors.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.54
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201D;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Required
	Disclosure
</FONT>
	&#x201D; has the meaning set out in Clause
	10.5.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.55
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Review
	Period
</FONT>
	&#x201D; has the meaning set out in Clause
	5.2.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.56
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Rolling
	Forecast
</FONT>
	&#x201D; has the meaning set out in Clause
	4.2.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.57
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Specifications
</FONT>
	&#x201D;
	means the procedures, requirements, standards, quality control
	testing and other data and the scope of services as set out in
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment C
</FONT>
	, as
	modified from time to time in accordance with Section
	8.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.58
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Supply
	Failure
</FONT>
	&#x201D; has the meaning set forth in Clause
	4.7.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.59
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Term
</FONT>
	&#x201D;
	has the meaning set out in Clause 16.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.60
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Territory
</FONT>
	&#x201D;
	means the European Union and the United States and its territories
	and possessions, those countries that are listed in Attachment E,
	and any other country that the parties agree in writing to add to
	this definition of Territory in an amendment to this Agreement;
	provided, however, that Territory shall not be amended to include
	countries that are targeted by the comprehensive sanctions,
	restrictions or embargoes administered by the United Nations,
	European Union, United Kingdom, or the United States. Catalent
	shall not be obliged to Process Products for sale in any of such
	countries if it is prevented from doing so, or would be required to
	obtain or apply for special permission to do so, due to any
	restrictions (such as embargoes) imposed on it by any governmental
	authorities, including without limitation, those imposed by the US
	Office of Foreign Asset Control.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.61
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Uncured
	Supply Failure
</FONT>
	&#x201D; has the meaning set out in Clause
	4.7.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.62
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Unit
	Pricing
</FONT>
	&#x201D; has the meaning set out in Clause
	7.1B.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.63
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Validation
	Services
</FONT>
	&#x201D; has the meaning set out in Clause
	2.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.64
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Vendor
</FONT>
	&#x201D;
	has the meaning set out in Clause 3.2B.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	VALIDATION,
	PROCESSING &amp; RELATED SERVICES
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Validation Services
</FONT>
	. Catalent
	shall perform the Product qualification, validation and stability
	services set out in
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment A
</FONT>
	(the
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Validation
	Services
</FONT>
	&#x201D;).
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Supply and Purchase of Product
</FONT>
	.
	Catalent shall Process Product in accordance with the
	Specifications, Applicable Laws and this Agreement. Except as set
	forth in Clause 4.7, Palatin and its Affiliates shall purchase ***
	from Catalent no less than *** of Palatin&#x2019;s and its
	Affiliates&#x2019; requirements of Product in the Territory in
	accordance with this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Product Maintenance Services
</FONT>
	.
	Palatin will receive the product maintenance services set out in
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment B
</FONT>
	(the
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Product Maintenance
	Services
</FONT>
	&#x201D;).
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage95"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Other Related Services
</FONT>
	.
	Catalent shall provide any other Product-related services as the
	parties may agree in writing. Such writing shall include the scope
	and fees for any such services and shall be appended to this
	Agreement. The terms and conditions of this Agreement shall govern
	such services unless otherwise agreed by the parties.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MATERIALS,
	EQUIPMENT AND AUTO INJECTOR ASSEMBLY LINES
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Palatin-supplied
	Materials
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin shall
	supply to Catalent for Processing, at *** cost, all
	Palatin-supplied Materials, in quantities sufficient to meet
	Palatin&#x2019;s requirements for Product. Palatin shall deliver DDP
	(Incoterms 2010) such items and associated certificates of analysis
	to the Facility no later than *** (but not earlier than *** unless
	otherwise agreed by Catalent) before the Processing Date. Palatin
	shall be responsible at its cost for securing necessary export or
	import, or similar clearances, permits or certifications required
	in respect of such supply. Catalent shall use Palatin-supplied
	Materials solely for Processing. To the extent not previously
	provided, Palatin shall provide to Catalent, prior to delivery of
	any Palatin-supplied Materials, a copy of all associated material
	safety data sheets, safe handling instructions, health and
	environmental information, and any regulatory certifications or
	authorizations that may be required under Applicable Laws relating
	to the API and Product, and shall promptly provide any updates
	thereto.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Within ***
	following receipt of Palatin-supplied Materials, Catalent shall
	inspect such items to verify their identity. Unless otherwise
	expressly required by the Specifications, Catalent shall have no
	obligation to test such items to confirm that they meet the
	associated specifications or certificate of analysis or otherwise;
	but in the event that Catalent detects a nonconformity with
	Specifications, Catalent shall give Palatin prompt notice of such
	nonconformity. Catalent shall not be liable for any defects in
	Palatin-supplied Materials, or in Product as a result of defective
	Palatin-supplied Materials unless Catalent failed to properly
	perform the foregoing obligations. Catalent shall follow
	Palatin&#x2019;s reasonable written instructions in respect of
	return or disposal of defective Palatin-supplied
	Materials.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin shall
	retain title to Palatin-supplied Materials at all times, and
	Palatin shall bear the risk of loss thereof, except in the event of
	losses related to Catalent&#x2019;s gross negligence or willful
	misconduct, in which case Catalent&#x2019;s liability shall be
	limited pursuant to Section 14 below.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Raw Materials
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall
	procure Raw Materials only from vendors that are approved in
	writing by Palatin or otherwise qualified in accordance with the
	provisions of the Quality Agreement. Catalent shall be responsible
	for procuring Raw Materials as necessary to meet the Firm
	Commitment. Catalent shall not be liable for any delay in delivery
	of Product if (i) Catalent is unable to obtain, in a timely manner,
	a particular Raw Material necessary for Processing and (ii)
	Catalent placed orders for such Raw Materials promptly following
	receipt of Palatin&#x2019;s Firm Commitment. In the event that any
	Raw Material becomes subject to purchase lead time beyond the Firm
	Commitment time frame, the parties will negotiate in good faith an
	appropriate amendment to this Agreement, including Clause
	4.2.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In certain
	instances, Palatin may require a specific supplier, manufacturer or
	vendor (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Vendor
</FONT>
	&#x201D;) to be used for Raw
	Material. In such an event, (i) such Vendor will be identified in
	the Specifications and (ii) the Raw Materials from such Vendor
	shall be deemed Palatin-supplied Materials for purposes of this
	Agreement. If the cost of the Raw Material from any such Vendor
	(other than a Vendor specified in the Specifications as of the
	Effective Date) is greater than Catalent&#x2019;s costs for the same
	raw material of equal quality from other vendors, Catalent shall
	add the difference between Catalent&#x2019;s cost of the Raw
	Material and the Vendor&#x2019;s cost of the Raw Material to the
	Unit Pricing. Palatin will be responsible for all reasonable,
	out-of-pocket costs incurred by Catalent associated with
	qualification of any such Vendor who has not been previously
	qualified by Catalent.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage96"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the event of (i)
	a Specification change for any reason, (ii) obsolescence of any Raw
	Material or (iii) termination or expiry of this Agreement, Palatin
	shall bear the cost of any unused Raw Materials (including
	packaging), so long as Catalent (a) purchased such Raw Materials in
	quantities consistent with Palatin&#x2019;s then current Firm
	Commitment and any minimum purchase obligations required by the
	vendor and (b) used commercially reasonable efforts to mitigate
	such costs by using any such unused Raw Materials in the
	manufacture of other products.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Artwork and Labeling
</FONT>
	. Palatin
	shall provide, or approve prior to Catalent&#x2019;s procurement of
	applicable Raw Material, all artwork, advertising and labeling
	information necessary for Processing, if any. Such artwork,
	advertising and labeling information is and shall remain the
	exclusive property of Palatin, and Palatin shall be solely
	responsible for the content thereof. Such artwork, advertising and
	labeling information or any reproduction thereof may not be used by
	Catalent, during or after the Term, in any manner other than
	performing its obligations hereunder.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.5
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Auto Injector Assembly Line
</FONT>
	.
	Catalent and Palatin agree that in order to scale up Processing of
	the Product, pursuant to the terms of the Manufacturing Preparation
	and Services Agreement Catalent shall undertake a Processing line
	expansion for auto injector assembly (such expanded Processing
	line, the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Auto Injector
	Assembly Line
</FONT>
	&#x201D;). With respect to all equipment and
	components of the Auto Injector Assembly Line, notwithstanding any
	amounts that Palatin contributes to the purchase of equipment and
	components in connection with the establishment of such Auto
	Injector Assembly Line, Catalent shall solely own all right, title
	and interest in and to such line, and all equipment and components
	relating thereto, and shall bear the risk of loss thereof. *** The
	parties shall work together in good faith to plan and schedule such
	Palatin priority access based on a combination of Palatin&#x2019;s
	(i) Rolling Forecasts and Firm Commitment and (ii) Minimum
	Requirements for the applicable Contract Year(s). In the event that
	during a Contract Year(s), Catalent uses the Auto Injector Assembly
	Line for another Catalent customer in keeping with the priority
	access requirements set forth in this Clause 3.5, then
	***.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MINIMUM
	REQUIREMENT, FORECASTS &amp; PURCHASE ORDERS
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Minimum Requirement
</FONT>
	. During
	each Contract Year, Palatin (or its Affiliates or licensees) shall
	purchase the minimum number of units of Product set out on
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment D
</FONT>
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Minimum
	Requirement
</FONT>
	&#x201D;). If during any Contract Year Palatin
	purchases a number of units of Product that is less than the
	Minimum Requirement (the difference, a &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Purchase Shortfall
</FONT>
	&#x201D;), then within
	*** after the end of such Contract Year, Palatin shall pay Catalent
	an amount equal to ***.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Forecast
</FONT>
	. On or before the ***,
	and thereafter on a *** basis on or before the *** of each
	succeeding ***, Palatin shall furnish to Catalent a written ***
	rolling forecast of the quantities of Product that Palatin intends
	to order from Catalent during such period (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Rolling Forecast
</FONT>
	&#x201D;); provided that
	to the extent feasible at least *** of the total number of units
	purchased in the relevant Contract Year shall be purchased in each
	of the first and second six months of such relevant Contact Year.
	The *** of such Rolling Forecast shall constitute a binding
	commitment to purchase the quantities of Product specified therein
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Firm
	Commitment
</FONT>
	&#x201D;) and *** of the Rolling Forecast shall be
	non-binding, good faith estimates.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage97"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Purchase Orders
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Concurrently with
	the submission of each Rolling Forecast, Palatin shall submit to
	Catalent a binding, non-cancelable purchase order for Product,
	specifying the Batch size (to the extent the Specifications permit
	Batches of different sizes) and the requested delivery date for
	each Batch (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Purchase
	Order
</FONT>
	&#x201D;);
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that each Purchase Order
	shall be for not less than the Firm Commitment (but only to the
	extent the Firm Commitment was not covered in a previous Purchase
	Order). Purchase Orders for quantities of Product in excess of the
	Firm Commitment shall be submitted by Palatin at least *** in
	advance of the delivery date requested in the Purchase
	Order.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Within *** after
	receipt of a Purchase Order, Catalent shall issue a written
	acknowledgement (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Acknowledgement
</FONT>
	&#x201D;) that it accepts
	or rejects such Purchase Order. Each acceptance Acknowledgement
	shall either confirm the delivery date set out in the Purchase
	Order or provide a reasonable alternative delivery date (which, in
	any event, shall be ***), and shall include the Processing Date.
	Catalent may reject any Purchase Order in excess of the Firm
	Commitment or otherwise not given in accordance with this
	Agreement;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	,
<FONT STYLE="FONT-STYLE: ITALIC">
	however
</FONT>
	, that Catalent
	shall use its commercially reasonable efforts to supply Palatin
	with quantities of Product which are up to *** in excess of the
	quantities specified in the Firm Commitment, subject to
	Catalent&#x2019;s other supply commitments and manufacturing,
	packaging and equipment capacity. A properly submitted Purchase
	Order shall be *** within *** after receipt of such Purchase
	Order.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the event of a
	conflict between the terms of any Purchase Order or Acknowledgement
	and this Agreement, the terms of this Agreement shall control
	unless the terms of the Purchase Order expressly override the terms
	set forth herein.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Catalent&#x2019;s Cancellation of
	Purchase Orders
</FONT>
	. Notwithstanding Clause 4.5, Catalent
	reserves the right to cancel all, or any part of, a Purchase Order
	upon written notice to Palatin, and Catalent shall have no further
	obligations or liability with respect to such Purchase Order, if
	Palatin refuses or fails to timely supply conforming
	Palatin-supplied Materials in accordance with Clause 3.1 and such
	failure is not cured within *** after the giving of written notice
	of such failure. Any such cancellation of Purchase Orders shall not
	constitute a breach of this Agreement by Catalent nor shall it
	absolve Palatin of its obligation in respect of the Minimum
	Requirement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.5
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Palatin&#x2019;s Modification or
	Cancellation of Purchase Orders
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin may modify
	the delivery date or quantity of Product in a Purchase Order only
	by submitting a written change order to Catalent at least *** in
	advance of the earliest Processing Date covered by such change
	order. To the extent the change order modifies the delivery date or
	modifies the quantity of Product in a Purchase Order, such change
	order shall be effective and binding against Catalent only upon the
	written approval of Catalent, and notwithstanding the foregoing,
	Palatin shall remain responsible for the Firm
	Commitment.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage98"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Changes to or
	postponement of any Batch of Product by Palatin will not reduce or
	in any way affect Palatin&#x2019;s Minimum Requirement obligations
	set out in Clause 4.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.6
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Unplanned Delay or Elimination of
	Processing
</FONT>
	. Catalent shall use commercially reasonable
	efforts to meet the Purchase Orders, subject to the terms and
	conditions of this Agreement. Catalent shall provide Palatin with
	as much advance notice as practicable, and shall provide at least
	*** advance notice where possible, if Catalent determines that any
	Processing will be delayed or eliminated for any
	reason.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.7
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Supply Failure
</FONT>
	. For purposes of
	this Agreement, a &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Supply
	Failure
</FONT>
	&#x201D; shall mean a failure by Catalent to supply
	Product meeting the Specifications, subject to Clauses 5.2, 5.3 and
	5.4, in the quantities ordered by Palatin (subject to the
	limitations and terms set forth in Clauses&#xA0;4.3 and 4.4) for
	***, where such failure is ***. In the event of *** (such event, an
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Uncured Supply
	Failure
</FONT>
	&#x201D;), Palatin shall have the right to ***. In the
	event of such Uncured Supply Failure,*** the parties shall meet to
	discuss in good faith how to equitably manage any Minimum
	Requirement for the then current Contract Year, ***.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.8
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Observation of Processing
</FONT>
	. In
	addition to Palatin&#x2019;s audit right pursuant to Clause 9.4,
	Palatin may send *** Representatives to the Facility to observe
	Processing for a maximum of *** (unless otherwise agreed by
	Catalent in writing), upon at least *** prior notice, at reasonable
	times during regular business hours. Such Palatin Representatives
	shall abide by all Catalent safety rules and other applicable
	policies and procedures, and Palatin shall be responsible for such
	compliance. Palatin shall defend, indemnify and hold harmless
	Catalent for any action, omission or other activity of such Palatin
	Representatives while on Catalent&#x2019;s premises. Palatin&#x2019;s
	Representatives shall be required to sign Catalent&#x2019;s standard
	visitor confidentiality agreement prior to being allowed access to
	the Facility.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	TESTING;
	SAMPLES; RELEASE
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Batch Records and Data;
	Release
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Subject to Clause
	5.1B, unless otherwise agreed to by the parties in writing, within
	*** after Catalent completes Processing of a Batch, Catalent shall
	provide Palatin with copies of executed Batch records prepared in
	accordance with the Specifications;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that if testing reveals an
	out-of-Specification result, Catalent shall provide such Batch
	records within *** after resolution of the out-of-Specification
	result. After Catalent completes Processing of a Batch, Catalent
	shall also provide Palatin or its designee with a certificate of
	analysis for such Batch. Issuance of a certificate of
	conformance/analysis constitutes release of the Batch by Catalent
	to Palatin. Palatin shall be responsible for final release of
	Product (including testing), at its cost, to the
	market.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If testing reveals
	an out-of-Specification result with respect to a Batch, Catalent
	shall report such result to Palatin as soon as practicable, and in
	any event within *** after obtaining such result. Within *** after
	resolution of the out-of-Specification result, Catalent shall
	provide Palatin a written report detailing the cause of such
	out-of-Specification result and the manner in which it was
	resolved. Catalent shall provide Palatin with such further
	information as Palatin reasonably requests with respect to such
	out-of-Specification result.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Testing; Rejection
</FONT>
	. Following
	Palatin&#x2019;s receipt of a shipment of a Batch, Palatin or
	Palatin&#x2019;s designee may test samples of such Batch to confirm
	that the Specifications have been met. Unless within *** after
	Palatin&#x2019;s receipt of a Batch (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Review Period
</FONT>
	&#x201D;), Palatin or its
	designee notifies Catalent in writing (an &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Exception Notice
</FONT>
	&#x201D;) that such Batch
	is not in compliance with Clause 12.1A (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Defective Product
</FONT>
	&#x201D;), and provides
	a sample of the alleged Defective Product, the Batch shall be
	deemed accepted by Palatin and Palatin shall have no right to
	reject such Batch. Upon timely receipt of an Exception Notice from
	Palatin, Catalent shall in its sole discretion conduct an
	appropriate investigation to determine whether or not it agrees
	with Palatin that Product is Defective Product and to determine the
	cause of any nonconformity. If Catalent agrees that Product is
	Defective Product and determines that the cause of nonconformity is
	attributable to Catalent&#x2019;s negligence or willful misconduct
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent Defective
	Processing
</FONT>
	&#x201D;), then Clause 5.4 shall
	apply.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage99"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Discrepant Results
</FONT>
	. If the
	parties disagree as to whether Product is Defective Product and/or
	whether the cause of the nonconformity is Catalent Defective
	Processing, without regard to whether Catalent conducts an
	appropriate investigation as provided in Clause 5.2, and this is
	not resolved within *** of the Exception Notice date, the parties
	shall cause a mutually acceptable independent third party to review
	records, test data and to perform comparative tests and/or analyses
	on samples of the alleged Defective Product and its components,
	including Palatin-supplied Materials. The independent party&#x2019;s
	results as to whether or not Product is Defective Product and the
	cause of any nonconformity shall be final and binding. Unless
	otherwise agreed to by the parties in writing, the costs associated
	with such testing and review shall be borne by Catalent if Product
	is Defective Product attributable to Catalent Defective Processing,
	and by Palatin in all other circumstances. For avoidance of doubt,
	where the cause of nonconformity cannot be determined or assigned,
	it shall be deemed not Catalent Defective Processing.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Defective Processing
</FONT>
	. Catalent
	shall, ***, either (A) *** or (B) ***. This shall be
	Palatin&#x2019;s sole and exclusive remedy under this Agreement for
	Defective Product attributable to Catalent Defective Processing,
	other than as provided in Clause 4.7, 9.5 and 13.1 of this
	Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	DELIVERY
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Delivery
</FONT>
	. Catalent shall
	deliver Product Ex Works (Incoterms 2010) the Facility promptly
	following Catalent&#x2019;s release of Product. Catalent shall
	segregate and store all Product until tender of delivery. Title to
	Product shall transfer to Palatin upon Catalent&#x2019;s tender of
	delivery. Palatin shall qualify or validate at least three carriers
	to ship Product and then designate the priority of such qualified
	carriers to Catalent, and Catalent shall not, without
	Palatin&#x2019;s prior written consent, utilize any other carrier
	for purposes of delivering Product to Palatin or its designees.
	Catalent shall include with each shipment of Product the applicable
	Purchase Order number, the Batch number and the quantity of
	Product.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Storage Fees
</FONT>
	. If Catalent
	performs in accordance with the Purchase Order, and Palatin fails
	to take delivery of any Product on any agreed delivery date,
	Catalent shall store such Product and Palatin shall be invoiced on
	the first day of each month following such scheduled delivery for
	reasonable storage costs. All such storage shall be under
	conditions set forth in the Specifications. For each such Batch of
	stored Product, risk of loss shall transfer to Palatin upon
	placement into storage and Catalent shall have the right to ship
	such Product to Palatin within two months after
	billing.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Bill and Hold
</FONT>
	. From time to
	time, at Palatin&#x2019;s request, the agreed delivery date of the
	Purchase Order may be extended under a bill and hold arrangement as
	more fully set forth below. For each such Batch of stored Product,
	Palatin agrees that: (A) Palatin has made a fixed commitment to
	purchase the Product, (B) risk of loss for such Product passes to
	Palatin upon placement into storage, (C) such Product shall be on a
	bill and hold basis for legitimate business purposes, (D) Palatin
	shall identify a fixed delivery date for the Product and (E)
	Palatin shall agree to be invoiced and to pay such invoice in
	accordance with the payment terms set forth in Clause 7.3 of this
	Agreement. Upon making a request for a bill and hold arrangement,
	Palatin shall provide Catalent with a letter confirming items (A)
	through (E) of this Clause 6.3 for each Batch of stored
	Product.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage100"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PAYMENTS;
	LICENSING; CHANGE OF CONTROL
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Fees
</FONT>
	. In consideration for
	Catalent performing services hereunder:
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin shall pay
	to Catalent the fees for Validation Services set out on
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment A
</FONT>
	.
	Catalent shall submit an invoice to Palatin for such fees upon the
	completion of the relevant phase of the Validation
	Services.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin shall pay
	Catalent the unit pricing for Product set out on
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment D
</FONT>
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Unit
	Pricing
</FONT>
	&#x201D;). Catalent shall submit an invoice to Palatin
	for such fees upon tender of delivery of Product as provided in
	Clause 6.1.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Except as provided
	in Clause 3.5, Palatin shall pay Catalent the annual fees for
	Product Maintenance Services set out on
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Attachment D
</FONT>
	(the
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Annual Product Maintenance
	Fee
</FONT>
	&#x201D;). Catalent shall submit an invoice to Palatin for
	such Annual Product Maintenance Fee payable upon *** and upon each
	anniversary of such date thereafter during the Term.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	D.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Other Fees
</FONT>
	. Palatin shall pay
	Catalent for all other fees and expenses of Catalent owing in
	accordance with the terms of this Agreement, including pursuant to
	Clauses 2.4, 4.1, 6.2, 9.2.1 and 16.4. Catalent shall submit an
	invoice to Palatin for such fees as and when
	appropriate.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Unit Pricing Adjustment
</FONT>
	. From
	and after ***, the Unit Pricing shall be adjusted ***, effective as
	of ***. Catalent shall give Palatin written notice of such
	adjustment by ***. The written notice shall specify the basis for
	each adjustment in the Price, including increases or decreases in
	the cost of Raw Materials, continuous improvement benefits and any
	increase or decrease of any other component of Unit Pricing. The
	amount of any increase in the cost of components of Unit Pricing
	other than Raw Materials shall not exceed ***. The cost of Raw
	Materials shall be passed through to Palatin ***. To manage the
	cost of Raw Materials, Palatin, at its option, may negotiate the
	terms of a supply agreement with any supplier of Raw Materials,
	including but not limited to *** with respect to the supply of
	***.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Payment Terms
</FONT>
	. Payment of all
	Catalent invoices shall be due *** after the later of (A) the date
	of the invoice and (B) the date of delivery. Palatin shall make
	payment in euros. Unless an invoice is disputed by Palatin in good
	faith, if any payment is not received by Catalent by its due date,
	then Catalent may charge interest on the outstanding sum from the
	due date (both before and after any judgment) at *** per month
	until paid in full (or, if less, the maximum amount permitted by
	Applicable Laws). Further, if Palatin shall fail to make any
	payment when due other than for an invoice disputed by Palatin in
	good faith, and shall not have cured such non-payment within ***
	after receiving from Catalent written notice of non-payment, then
	Catalent shall have the right, at its option, to suspend any
	further performance hereunder until such default is corrected,
	without thereby releasing Palatin from its obligations under this
	Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Taxes
</FONT>
	. All taxes, duties and
	other levies assessed (excluding tax based on net income) on or in
	connection with Palatin-supplied Materials, services or Product in
	connection with provision or sale to Catalent or Palatin, shall be
	reimbursed by Palatin to Catalent (and shall be included in
	invoices) and all charges are exclusive of any applicable taxes,
	duties and levies which shall be added to invoices directed at
	Palatin.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage101"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="COLOR: #000000; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.5
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Palatin
	and Third Party Expenses
</FONT>
	. Except as may be expressly covered
	by Product Maintenance Service fees,
<FONT STYLE="COLOR: #000000">
	Palatin shall be responsible for 100% of its own
	and all third-party expenses associated with the development,
	Regulatory Approvals and commercialization of Product, including
	regulatory filings and post-approval marketing
	studies.
</FONT>
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.6
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Development Batches
</FONT>
	. Each Batch
	produced under this Agreement pursuant to a Purchase Order or
	Palatin&#x2019;s written request, including those necessary to
	support the validation portion of Palatin&#x2019;s submissions for
	Regulatory Approvals, will be considered to be a &#x201C;development
	batch&#x201D; unless and until Processing has been validated.
	Palatin shall be responsible for the cost of each such development
	Batch, even if such development Batch fails to meet the
	Specifications, unless the cause of nonconformity is attributable
	to Catalent&#x2019;s gross negligence or willful misconduct.
	Catalent and Palatin shall cooperate in good faith to resolve any
	problems causing the out-of-Specification Batch.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.7
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Licensing Transaction by
	Palatin
</FONT>
	. In the event that Palatin enters into a marketing
	and/or licensing agreement with a third party pursuant to which
	agreement such third party acquires the right to market, sell and
	have sold the Product (i) within North America (comprising at least
	the United States of America) or (ii) worldwide, then the terms of
	Clause 3.3 of the Manufacturing Preparation and Services Agreement
	shall apply. For the avoidance of doubt, neither this Agreement nor
	the Manufacturing Preparation and Services Agreement shall
	terminate upon such event.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.8
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Palatin Change of Control.
</FONT>
	In
	the event of a Change of Control of Palatin, then the terms of
	Clause 3.4 of the Manufacturing Preparation and Services Agreement
	shall apply. For the avoidance of doubt, neither this Agreement nor
	the Manufacturing Preparation and Services Agreement shall
	terminate upon such event.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	8.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CHANGES
	TO SPECIFICATIONS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All
	Specifications and any changes thereto agreed to by the parties
	from time to time shall be in writing, dated and signed by the
	parties. Any change to the Process shall be deemed a Specification
	change. No change in the Specifications shall be implemented by
	Catalent, whether requested by Palatin or requested or required by
	any Regulatory Authority, until the parties have agreed in writing
	to such change, the implementation date of such change, and any
	increase or decrease in costs, expenses or fees directly resulting
	from such change (including any change to Unit Pricing). Catalent
	shall respond promptly to any request made by Palatin for a change
	in the Specifications, and both parties shall use commercially
	reasonable, good faith efforts to agree to the terms of such change
	in a timely manner. As soon as reasonably practicable after a
	request is made for any change in Specifications, Catalent shall
	notify Palatin of the costs associated with such change and shall
	provide such supporting documentation as Palatin may reasonably
	require. Palatin shall pay all direct costs associated with such
	agreed upon changes. If there is a conflict between the terms of
	this Agreement and the terms of the Specifications, this Agreement
	shall control unless the parties mutually agree that the terms of
	the Specifications expressly override the terms set forth herein.
	Catalent reserves the right to postpone effecting changes to the
	Specifications until such time as the parties agree to and execute
	the required written amendment.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage102"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	RECORDS;
	REGULATORY MATTERS
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Record Keeping
</FONT>
	. Catalent shall
	maintain materially complete and accurate Batch, laboratory data,
	reports and other technical records relating to Processing in
	accordance with Catalent standard operating procedures and all
	Applicable Laws. Such information shall be maintained for a period
	of at least *** from the relevant finished Product expiry date or
	longer if required under Applicable Laws or the Quality
	Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Regulatory Compliance
</FONT>
	. Catalent
	shall obtain and maintain all permits and licenses with respect to
	general Facility operations required by any Regulatory Authority in
	the jurisdiction in which Catalent Processes Product. Palatin shall
	obtain and maintain all other Regulatory Approvals and other
	authorizations and certificates, including those necessary for
	Catalent to commence Processing. During the Term, Catalent will
	assist Palatin with all regulatory matters relating to Processing,
	at Palatin&#x2019;s request and sole expense. Catalent reserves the
	right to assess Palatin for any regulatory fees that may be
	established by any Regulatory Authority subsequent to the Effective
	Date of this Agreement, which fees result directly from
	Catalent&#x2019;s formulation, development, manufacturing,
	processing, filling, packaging, storing or testing of the Product
	or Palatin-supplied Materials. Except as required under Applicable
	Laws or by any governmental agency, Palatin shall not identify
	Catalent in any regulatory filing or submission with a Regulatory
	Authority without Catalent&#x2019;s prior written consent. Such
	consent shall not be unreasonably withheld and shall be
	memorialized in a writing signed by authorized representatives of
	both parties. Upon Catalent&#x2019;s written request, Palatin shall
	provide Catalent with a copy of any Regulatory Approvals required
	to distribute, market and sell Product in one or more countries
	within the Territory. If Palatin is unable to provide such
	information, Catalent shall have no obligation to deliver Product
	to Palatin, notwithstanding anything to the contrary in this
	Agreement. The parties intend and commit to cooperate to allow each
	party to satisfy its obligations under Applicable Laws relating to
	Processing under this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 48PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.2.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	GDUFA
	Fees
</FONT>
	. Palatin shall reimburse Catalent for any fees Catalent
	may be required to pay pursuant to the US Generic Drug User Fee
	Amendments of 2012 (&#x201C;GDUFA Fees&#x201D;), *** GDUFA Fees are
	assessed on Catalent when an Abbreviated New Drug Application
	(&#x201C;ANDA&#x201D;) applicant identifies Catalent in an ANDA
	application filed with FDA. GDUFA Fees are assessed by the FDA
	annually and shall be paid by Palatin annually, where applicable.
	Prior to October 1st of each year, and where applicable, Catalent
	will invoice Palatin for *** for each Catalent manufacturing or
	packaging facility identified in any Palatin ANDA(s) pursuant to
	FDA regulations (this includes but is not limited to any Catalent
	facility which manufactured or packaged Palatin&#x2019;s
	registration batches).
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Governmental Inspections and
	Requests
</FONT>
	. Catalent shall promptly advise Palatin if an
	authorized agent of any Regulatory Authority (A) notifies Catalent
	that it intends to or does visit the Facility for the purpose of
	reviewing the Processing or (B) takes any regulatory action with
	respect to the Product or the Processing. Catalent shall promptly
	provide to Palatin a report of the result of any such inspection by
	any Regulatory Authority to the extent directly related to the
	Processing of the Product and furnish to Palatin a copy of all
	written information provided by such Regulatory Authority to the
	extent specifically and directly related to the Processing of the
	Product, if any, within 10 days of Catalent&#x2019;s receipt of such
	information, in each case redacted as appropriate to protect any
	Confidential Information of Catalent and/or confidential
	information Catalent&#x2019;s other customers. Palatin acknowledges
	that it may not direct the manner in which Catalent fulfills its
	obligations to permit inspection by and to communicate with
	Regulatory Authorities. Notwithstanding the foregoing, Catalent
	shall not initiate or participate in any communications with any
	Regulatory Authority concerning the Product or the Processing
	thereof without prior consultation with Palatin, unless Catalent
	(i)&#xA0;reasonably believes it is required by Applicable Law to
	make the communication under conditions that make such prior
	consultation impossible or impractical, in which case Catalent
	shall promptly thereafter notify Palatin in writing of the nature
	and content of the communication, or (ii) is requested to do so by
	Palatin. If any inspection by Regulatory Authorities is related to
	the Processing of the Product, Palatin shall reimburse Catalent for
	all reasonable and documented costs associated with such inspection
	attributable to the Processing of the Product. If deficiencies are
	identified in connection with any inspection by Regulatory
	Authorities related to or otherwise affecting the Processing of the
	Product, Catalent shall use commercially reasonable efforts to
	correct all such deficiencies in a timely manner. Catalent shall
	advise Palatin periodically of progress being made with respect to
	such deficiencies and notify Palatin, in writing, upon completion
	of any corrective action taken.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	13
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage103"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Palatin Facility Audits
</FONT>
	. During
	the Term, Palatin&#x2019;s Representatives shall be granted access
	upon *** prior notice, at reasonable times during regular business
	hours, to (A) the portion of the Facilities where Catalent performs
	Processing, (B) relevant personnel involved in Processing and (C)
	Processing records described in Clause 9.1, in each case solely for
	the purpose of verifying that Catalent is Processing in accordance
	with cGMPs, the Specifications and the Product master Batch
	records. Palatin may not conduct an audit under this Clause 9.4
	more than ***; provided, that additional inspections may be
	conducted in the event there is a material quality or compliance
	issue concerning Product or its Processing. Palatin&#x2019;s Quality
	Assurance Manager will arrange Palatin audits with Catalent Quality
	Management. Audits shall be designed to minimize, to the extent
	reasonably possible, disruption of operations at the applicable
	Facility. Palatin&#x2019;s Representatives shall be required to sign
	Catalent&#x2019;s standard visitor confidentiality agreement prior
	to being allowed access to the Facility. Such Representatives shall
	comply with the Facility&#x2019;s rules and regulations. Palatin
	shall defend, indemnify and hold harmless Catalent for any action
	or activity of such Representatives while on Catalent&#x2019;s
	premises.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.5
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Recall
</FONT>
	. If Catalent believes a
	recall, field alert, Product withdrawal or field correction
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Recall
</FONT>
	&#x201D;) may
	be necessary with respect to any Product supplied under this
	Agreement, Catalent shall promptly notify Palatin. Catalent will
	not act to initiate a Recall without the express prior written
	approval of Palatin, unless otherwise required by Applicable Laws.
	If Palatin believes a Recall may be necessary with respect to any
	Product supplied under this Agreement, Palatin shall promptly
	notify Catalent and Catalent shall provide all necessary
	cooperation and assistance to Palatin. Palatin shall provide
	Catalent with an advance copy of any proposed submission to a
	Regulatory Authority in respect of any Recall, and shall consider
	in good faith any comments from Catalent. The cost of any Recall
	shall be borne by Palatin, and Palatin shall reimburse Catalent for
	expenses incurred in connection with any Recall, in each case
	unless such Recall is caused solely by Catalent&#x2019;s breach of
	its obligations under this Agreement
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
	with
	respect to Processing, violation of Applicable Laws or its
	negligence or willful misconduct, then such cost shall be borne by
	Catalent;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	,
<FONT STYLE="FONT-STYLE: ITALIC">
	however
</FONT>
	, that for purposes
	hereof, such Catalent cost shall be limited to reasonable, actual
	and documented administrative costs incurred by Palatin (or its
	Affiliates, licensees or distributors) for such Recall and, subject
	to Section 14, replacement of the Product subject to Recall in
	accordance with Section 5.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.6
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Quality Agreement
</FONT>
	. Within six
	months after the Effective Date, and in any event prior to the
	first Processing of Product hereunder, the parties shall negotiate
	in good faith and enter into a quality or technical agreement (the
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Quality
	Agreement
</FONT>
	&#x201D;). The Quality Agreement shall in no way
	determine liability or financial responsibility of the parties for
	the responsibilities set out therein. In the event of a conflict
	between any of the provisions of this Agreement and the Quality
	Agreement with respect to quality-related activities, including
	compliance with cGMP, the provisions of the Quality Agreement shall
	govern. In the event of a conflict between any of the provisions of
	this Agreement and the Quality Agreement with respect to any
	commercial matters, including allocation of risk, liability and
	financial responsibility, the provisions of this Agreement shall
	govern.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	14
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage104"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	9.7
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Quality Assurance/Quality Control
	Standards
</FONT>
	. Upon Palatin&#x2019;s written request, Catalent
	shall deliver to Palatin copies of Catalent&#x2019;s quality
	assurance/quality control investigations, deviations,
	out-of-Specification notifications and change controls relevant to
	the Processing of Product. Catalent shall notify Palatin of any
	material changes made to any of the foregoing or any Specification
	during the Term.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CONFIDENTIALITY
	AND NON-USE
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Definition
</FONT>
	.
	As used in this Agreement, the term &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Confidential Information
</FONT>
	&#x201D; includes
	all information furnished by or on behalf of Catalent or Palatin
	(the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Discloser
</FONT>
	&#x201D;), its Affiliates or any
	of its or their respective Representatives, to the other party (the
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Recipient
</FONT>
	&#x201D;),
	its Affiliates or any of its or their respective Representatives,
	whether furnished before, on or after the Effective Date and
	furnished in any form, including written, verbal, visual,
	electronic or in any other media or manner and information acquired
	by observation or otherwise during any site visit at the other
	party&#x2019;s facility. Confidential Information includes all
	proprietary technologies, know-how, trade secrets, discoveries,
	inventions and any other intellectual property (whether or not
	patented), analyses, compilations, business or technical
	information and other materials prepared by either party, their
	respective Affiliates, or any of its or their respective
	Representatives, containing or based in whole or in part on any
	information furnished by the Discloser, its Affiliates or any of
	its or their respective Representatives. Confidential Information
	also includes the existence of this Agreement and its
	terms.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Exclusions
</FONT>
	.
	Notwithstanding Clause 10.1, Confidential Information does not
	include information that (A) is or becomes generally available to
	the public or within the industry to which such information relates
	other than as a result of a breach of this Agreement, (B) is
	already known by the Recipient at the time of disclosure as
	evidenced by the Recipient&#x2019;s written records, (C) becomes
	available to the Recipient on a non-confidential basis from a
	source that is entitled to disclose it on a non-confidential basis
	or (D) was or is independently developed by or for the Recipient
	without reference to the Confidential Information of the Discloser
	as evidenced by the Recipient&#x2019;s written records.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Mutual
	Obligation
</FONT>
	. The Recipient agrees that it will not use the
	Discloser&#x2019;s Confidential Information except in connection
	with the performance of its obligations hereunder and will not
	disclose, without the prior written consent of the Discloser,
	Confidential Information of the Discloser to any third party,
	except that the Recipient may disclose the Discloser&#x2019;s
	Confidential Information to any of its Affiliates and its or their
	respective Representatives that (A) need to know such Confidential
	Information for the purpose of performing under this Agreement, (B)
	are advised of the contents of this Clause and (C) are bound to the
	Recipient by obligations of confidentiality at least as restrictive
	as the terms of this Clause. Each party shall be responsible for
	any breach of this Clause by its Affiliates or any of its or their
	respective Representatives.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Permitted
	Disclosure
</FONT>
	. The Recipient may disclose the Discloser&#x2019;s
	Confidential Information to the extent required under Applicable
	Laws or by the rules of any stock exchange on which the securities
	of the Discloser are listed in each case upon the reasonable advice
	of Recipient&#x2019;s legal counsel;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that prior to making any such
	legally required disclosure, the Recipient shall give the Discloser
	as much prior notice of the requirement for and contents of such
	disclosure as is practicable under the circumstances and use
	reasonable efforts to limit the scope of any such disclosure and to
	obtain confidential treatment of all Confidential Information of
	Discloser disclosed pursuant to such requirement. Any such
	disclosure, however, shall not relieve the Recipient of its
	confidentiality obligations as set forth in this Section
	10.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	15
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage105"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.5
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Disclosure
	of this Agreement
</FONT>
	. A public disclosure of this Agreement or
	the Manufacturing Preparation and Services Agreement is permitted
	if,
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
	upon
	the reasonable advice of legal counsel of the party making the
	public disclosure, it is required by law (a &#x201C;Required
	Disclosure&#x201D;), including without limitation in a filing with
	the US Securities and Exchange Commission or the NYSE MKT, provided
	that the party making the public disclosure shall provide copies of
	the Required Disclosure to the non-disclosing party reasonably in
	advance of such filing or other disclosure for the non-disclosing
	party&#x2019;s review and comment (but not approval). Each party
	shall consider in good faith any comments provided by the other
	party with respect to the content of the Required Disclosure,
	including with respect to the redaction of this Agreement and any
	other agreement that is to be filed or otherwise publicly disclosed
	in connection with the Required Disclosure, and shall incorporate
	such comments or redactions in the Required Disclosure if doing so
	does not interfere with the disclosing party&#x2019;s ability to
	comply with any requirements under applicable law or any request or
	requirement of the US Securities and Exchange Commission or the
	NYSE MKT.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.6
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	No
	Implied License
</FONT>
	. Except as expressly set out in Clause 10.1,
	the Recipient will obtain no right of any kind or license under any
	Confidential Information of the Discloser, including any patent
	application or patent, by reason of this Agreement. All
	Confidential Information will remain the sole property of the
	Discloser, subject to Section 11.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.7
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Return
	of Confidential Information
</FONT>
	. Upon expiry or termination of
	this Agreement, the Recipient will (and will cause its Affiliates
	and its and their respective Representatives to) cease its use and,
	upon written request, within *** either return or destroy (and
	certify as to such destruction) all Confidential Information of the
	Discloser, including any copies thereof, except for a single copy
	which may be retained for the sole purpose of ascertaining
	compliance with its obligations under this Agreement and any copies
	remaining on the Recipient&#x2019;s standard computer back-up
	devices.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10.8
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Survival
</FONT>
	.
	The obligations of confidentiality and non-use contained in this
	Section 10 will terminate *** after the expiry or termination of
	this Agreement, except with respect to trade secrets, for which the
	obligations of confidentiality and non-use contained in this
	Section 10 will continue for so long as such information remains a
	trade secret under applicable law.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	11.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	INTELLECTUAL
	PROPERTY
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	For
	purposes hereof, &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Palatin
	IP
</FONT>
	&#x201D; means all intellectual property and embodiments
	thereof owned by or licensed to Palatin as of the Effective Date or
	developed by Palatin other than in connection with this Agreement;
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent IP
</FONT>
	&#x201D;
	means all intellectual property and embodiments thereof owned by or
	licensed to Catalent as of the Effective Date or developed by
	Catalent other than in connection with this Agreement;
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Invention
</FONT>
	&#x201D;
	means any intellectual property developed by either party or
	jointly by the parties in connection with this Agreement; *** The
	parties shall cooperate to achieve the allocation of rights to
	Inventions anticipated herein and each party shall be solely
	responsible for costs associated with the protection of its
	intellectual property.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	REPRESENTATIONS
	AND WARRANTIES
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Catalent.
</FONT>
	Catalent represents, warrants and undertakes to Palatin
	that:
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	16
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage106"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	at the time of
	delivery by Catalent as provided in Clause 6.1, all Product shall
	have been Processed in accordance with Applicable Laws and in
	conformance with the Specifications and the Quality Agreement and
	will not be adulterated, misbranded or mislabeled within the
	meaning of Applicable Laws;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that Catalent shall not be
	liable for defects attributable to Palatin-supplied Materials
	(including artwork, advertising and labeling);
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent will
	comply with all Applicable Laws applicable to Catalent&#x2019;s
	performance under this Agreement and its use of any
	Palatin-supplied Materials;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	To Catalent&#x2019;s
	knowledge, there are no patents owned by others, or trade secrets
	or other proprietary rights of others, that would be infringed by
	the Catalent IP in Catalent&#x2019;s performance of the
	Agreement;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	D.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent and its
	employees, affiliates, contractors, and agents have never been (i)
	debarred or (ii) convicted of a crime for which a person can be
	debarred, under Section 335(a) or 335(b) of the Federal Food, Drug,
	and Cosmetic Act; and
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	E.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent will not
	release any Batch of Product if the required certificates of
	conformance indicate that Product does not comply with the
	Specifications.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Palatin
</FONT>
	.
	Palatin represents, warrants and undertakes to Catalent
	that:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	all
	Palatin-supplied Materials shall have been produced in accordance
	with Applicable Laws, shall comply with all applicable
	specifications, including the Specifications, shall not be
	adulterated, misbranded or mislabeled within the meaning of
	Applicable Laws, and shall have been provided in accordance with
	the terms and conditions of this Agreement;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	the content of all
	artwork provided to Catalent shall comply with all Applicable
	Laws;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	all Product
	delivered to Palatin by Catalent will be held, used and disposed of
	by or on behalf of Palatin in accordance with all Applicable Laws,
	and Palatin will otherwise comply with all laws, rules, regulations
	and guidelines applicable to Palatin&#x2019;s performance under this
	Agreement;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	D.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin will not
	release any Batch of Product if the required certificates of
	conformance indicate that Product does not comply with the
	Specifications and if Palatin does not hold all necessary
	Regulatory Approvals to market and sell the Product;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	E.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin has all
	necessary authority to use and to permit Catalent to use pursuant
	to this Agreement all intellectual property related to Product or
	Palatin-supplied Materials (including artwork), and the Processing
	of the foregoing, including any copyrights, trademarks, trade
	secrets, patents, inventions and developments; to Palatin&#x2019;s
	knowledge, there are no patents owned by others related to the
	Palatin IP utilized with the Product that would be infringed or
	misused by Palatin&#x2019;s performance of the Agreement; and, to
	Palatin&#x2019;s knowledge, no trade secrets or other proprietary
	rights of others related to the Palatin IP utilized with the
	Product would be infringed or misused by Palatin&#x2019;s
	performance of this Agreement; and
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	F.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	to Palatin&#x2019;s
	knowledge, the work to be performed by Catalent under this
	Agreement will not violate or infringe upon any trademark,
	tradename, copyright, patent, trade secret, or other intellectual
	property or other right held by any person or entity.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	17
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage107"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Mutual
</FONT>
	:
	No transactions or dealings under this Agreement shall be conducted
	with or for an individual or entity that is designated as the
	target of any sanctions, restrictions or embargoes administered by
	the United Nations, European Union, United Kingdom, or the United
	States.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	12.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Limitations
</FONT>
	.
	Save as expressly set out in this Agreement, neither party gives
	any representation or warranty in respect of the subject matter of
	this Agreement, and all representations and warranties that may be
	implied (by statute or otherwise) are hereby excluded to the
	maximum extent permitted by law.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	13.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	INDEMNIFICATION
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	13.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Indemnification
	by Catalent
</FONT>
	. Catalent shall defend, indemnify and hold
	harmless Palatin, its Affiliates, and their respective directors,
	officers and employees (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Palatin Indemnitees
</FONT>
	&#x201D;) from and
	against any and all claims, losses, demands, liabilities, damages,
	costs and expenses (including reasonable attorneys&#x2019; fees and
	reasonable investigative costs) in connection with any claim or
	action by any third party (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Losses
</FONT>
	&#x201D;) arising out of or
	resulting from (A) any breach of its representations, warranties or
	obligations set out in this Agreement, (B) any negligence or
	willful misconduct by Catalent or (C) any actual or alleged
	infringement or violation of any patent, trade secret, copyright,
	trademark or other proprietary rights of a third party by the
	Catalent IP used in Catalent&#x2019;s performance of its obligations
	under this Agreement, but for the avoidance of doubt not with
	respect to any such infringement or violation due to Palatin IP,
	API Inventions or Palatin-supplied Materials; in each case except
	to the extent that any of the foregoing arises out of or results
	from any Palatin Indemnitee&#x2019;s negligence, willful misconduct
	or breach of this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	13.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Indemnification
	by Palatin
</FONT>
	. Palatin shall defend, indemnify and hold
	harmless Catalent, its Affiliates, and their respective directors,
	officers and employees (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent Indemnitees
</FONT>
	&#x201D;) from and
	against any and all Losses arising out of or resulting from (A) any
	breach of its representations, warranties or obligations set out in
	this Agreement, (B) any manufacture, packaging, sale, promotion,
	distribution or use of or exposure to Product or Palatin-supplied
	Materials, including product liability or strict liability, (C)
	Palatin&#x2019;s exercise of control over the Processing, to the
	extent that Palatin&#x2019;s instructions or directions violate
	Applicable Laws, (D) the conduct of any clinical trials utilizing
	Product or API, (E) any actual or alleged infringement or violation
	of any third party patent, trade secret, copyright, trademark or
	other proprietary rights by intellectual property or other
	information provided by Palatin, including Palatin-supplied
	Materials, or (F) any negligence or willful misconduct by Palatin;
	in each case except to the extent that any of the foregoing arises
	out of or results from any Catalent Indemnitee&#x2019;s negligence,
	willful misconduct or breach of this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	13.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Indemnification
	Procedures
</FONT>
	. All indemnification obligations in this
	Agreement are conditioned upon the indemnified party (A) promptly
	notifying the indemnifying party of any claim or liability of which
	the indemnified party becomes aware (including a copy of any
	related complaint, summons, notice or other instrument);
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that failure to
	provide such notice within a reasonable period of time shall not
	relieve the indemnifying party of any of its obligations hereunder
	except to the extent the indemnifying party is prejudiced by such
	failure, (B) cooperating with the indemnifying party in the defense
	of any such claim or liability and any related settlement
	negotiations (at the indemnifying party&#x2019;s expense) and (C)
	not compromising or settling any claim or liability without prior
	written consent of the indemnifying party.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage108"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	14.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	LIMITATIONS
	OF LIABILITY
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	14.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	TOTAL
	LIABILITY
</FONT>
	. CATALENT&#x2019;S TOTAL LIABILITY UNDER THIS
	AGREEMENT SHALL IN NO EVENT EXCEED ***
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	14.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	INDIRECT
	DAMAGES
</FONT>
	. NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY
	FOR INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE OR CONSEQUENTIAL LOSS
	OR DAMAGES, OR FOR LOSS OF REVENUES, PROFITS OR DATA, ARISING OUT
	OF PERFORMANCE UNDER THIS AGREEMENT, WHETHER IN CONTRACT OR IN TORT
	OR OTHERWISE, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE
	POSSIBILITY OF SUCH DAMAGES.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	15.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	INSURANCE
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Each
	party shall, at its own cost and expense, obtain and maintain in
	full force and effect during the Term the following in US dollars
	or foreign currency equivalent: (A) Commercial General Liability
	Insurance with a per-occurrence limit of not less than ***; (B)
	Products and Completed Operations Liability Insurance with a
	per-occurrence limit of not less than ***; and (C) All Risk
	Property Insurance, including transit coverage, in an amount equal
	to the full replacement value of its property while in, or in
	transit to, a Catalent facility as required under this Agreement.
	Each party may self-insure all or any portion of the required
	insurance as long as, together with its Affiliates, its US GAAP or
	foreign currency equivalent net worth is greater than *** or its
	annual EBITDA (earnings before interest, taxes, depreciation and
	amortization) is greater than ***. Each required insurance policy,
	other than self-insurance, shall be obtained from an insurance
	carrier with an A.M. Best rating of at least A- VII. If any of the
	required policies of insurance are written on a claims made basis,
	such policies shall be maintained throughout the Term and for a
	period of at least *** thereafter. Each party shall obtain a waiver
	of subrogation clause from its property insurance carriers in favor
	of the other party, and such waivers will operate the same whether
	insurance is carried through third parties or self-insured. Upon
	the other party&#x2019;s written request from time to time, each
	party shall promptly furnish to the other party a certificate of
	insurance or other evidence of the required insurance.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	16.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	TERM
	AND TERMINATION
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	16.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Term
</FONT>
	.
	This Agreement shall commence on the Effective Date and shall
	continue until the end of the fifth Contract Year (the
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Initial Term
</FONT>
	&#x201D;),
	unless earlier terminated in accordance with Clause 16.3 or Clause
	16.4 (the Initial Term as may be extended in accordance with Clause
	16.2, the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Term
</FONT>
	&#x201D;).
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	16.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Renewal
</FONT>
	.
	The Initial Term shall automatically be extended for one 24-month
	period unless at least *** prior to the end of the Initial Term one
	party gives the other party written notice of its desire to
	terminate as of the end of the Initial Term.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	16.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Regulatory
	Approval
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the event that
	Palatin fails to obtain Regulatory Approval from the FDA prior to
	***, then the parties shall meet to discuss in good faith such
	situation and shall agree upon an appropriate rental fee that
	Palatin shall pay to Catalent for the Auto Injector Assembly Line
	on a monthly basis until such time as Regulatory Approval is
	obtained or the Agreement is terminated hereunder, which payment
	shall in no event be less than***. The parties shall negotiate in
	good faith the minimum monthly rental payment to be made in the
	event that Catalent is using the Auto Injector Assembly Line on its
	own behalf or on behalf of a third party customer during such
	period..
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	19
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage109"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the event that
	Palatin fails to obtain Regulatory Approval from the FDA prior to
	***, then the parties shall meet to discuss in good faith such
	situation;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	,
<FONT STYLE="FONT-STYLE: ITALIC">
	however
</FONT>
	, that
	notwithstanding such discussions, on or after such date, (i)
	Palatin shall pay to Catalent an amount equal to *** and (ii)
	Catalent shall have the right to terminate the Agreement after such
	date pursuant to the terms of this Section 16.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	16.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Termination
</FONT>
	.
	This Agreement may be terminated:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	by either party if
	steps are taken by or against the other party for the appointment
	of a liquidator, an administrator, a receiver, administrative
	receiver, manager, interim receiver, trustee, trustee in
	bankruptcy, nominee or supervisor or the other party proposes or
	enters into an agreement or arrangement with its creditors
	generally or makes an assignment for the benefit of its creditors
	generally, or otherwise suffers or permits the taking of any steps
	for adjudicating it to be bankrupt or insolvent and any such
	process, if reasonably shown to be warranted, frivolous or
	vexatious, is not withdrawn, dismissed or discharges within ***, or
	any equivalent or similar action to the above in consequence of the
	insolvency of that party is taken in any jurisdiction and is not
	withdrawn, dismissed or discharged in the circumstances described
	above;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	by either party if
	the other party materially breaches any of the provisions of this
	Agreement and such breach is not cured within *** after the giving
	of written notice requiring the breach to be remedied;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that in the case of a failure
	of Palatin to make payments in accordance with the terms of this
	Agreement, Catalent may terminate this Agreement if such payment
	breach is not cured within *** of receipt of notice of non-payment
	from Catalent;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	by Palatin pursuant
	to Clause 4.7;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	D.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	by Palatin upon
	notice and payment of the termination penalty provided in Clause
	16.5D; and
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	E.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	by Catalent
	pursuant to Clause 16.3B.
</FONT>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	16.5
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Effect
	of Termination
</FONT>
	. Expiry or termination of this Agreement
	shall be without prejudice to any rights or obligations that
	accrued to the benefit of either party prior to such expiry or
	termination. In the event of a termination of this
	Agreement:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	A.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall
	promptly return to Palatin, at Palatin&#x2019;s expense and
	direction, all remaining inventory of Product and Palatin-supplied
	Materials;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that
	all outstanding undisputed invoices have been paid in
	full;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	B.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin shall pay
	Catalent all undisputed invoiced amounts outstanding, plus, upon
	receipt of an undisputed invoice(s), amounts for any (i) Product
	that has been shipped pursuant to Purchase Orders but not yet
	invoiced, (ii) Product Processed pursuant to Purchase Orders that
	has been completed but not yet shipped, and (iii) in the event that
	this Agreement is terminated for any reason other than by Palatin
	pursuant to Clause 16.3A, 16.3B or 16.3C, all Product in process of
	being Processed pursuant to Purchase Orders (or, alternatively,
	Palatin may instruct Catalent to complete such work in process, and
	the resulting completed Product shall be governed by clause (ii));
	and
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	20
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage110"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	C.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the event that
	this Agreement is terminated for any reason other than by Palatin
	pursuant to Clause 16.3A, 16.3B or 16.3C, Palatin shall pay
	Catalent for all out-of-pocket costs and expenses incurred, and all
	noncancellable commitments made, in connection with
	Catalent&#x2019;s performance of this Agreement, so long as such
	costs, expenses or commitments were made by Catalent consistent
	with Palatin&#x2019;s then current Firm Commitment and any minimum
	purchase obligations required by the vendor;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided, however
</FONT>
	, that notwithstanding
	the foregoing, Palatin shall have no obligation to pay Catalent for
	costs, expenses or commitments made with respect to Product in
	process of being Processed pursuant to Purchase Orders (it being
	understood that the amounts payable pursuant to Clause 16.4B(ii)
	shall fully compensate Catalent with respect to such Product in
	process).
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	D.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If this Agreement
	is terminated by Palatin pursuant to Clause 16.4D or for any reason
	other than pursuant to Clause 16.4B or 16. 4C, then Palatin shall
	pay Catalent a termination penalty in accordance with the following
	schedule:
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 8%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 52%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Date of Termination
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 40%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Amount of Termination Penalty
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 8%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 52%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	On or
	before the last day of Contract Year 1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 40%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<EFX_UNIDENTIFIED_TABLE>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 8%">
<A NAME="FIS_UNIDENTIFIED_TABLE_35"></A>
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 52%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	Contract Year 2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 40%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 8%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 52%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	Contract Year 3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 40%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 8%">
<DIV>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 52%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	During
	Contract Year 4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 40%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</EFX_UNIDENTIFIED_TABLE>
</TABLE>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	E.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Survival
</FONT>
	. The rights and
	obligations of the parties shall continue under Sections 11
	(Intellectual Property), 13 (Indemnification), 14 (Limitations of
	Liability), 17 (Notice), 18 (Miscellaneous); under Clauses 10
	(Confidentiality and Non-Use) and 15 (Insurance), in each case to
	the extent expressly stated therein; and under Clauses 7.3 (Payment
	Terms), 7.4 (Taxes), 7.5 (Palatin and Third Party Expenses), 9.1
	(Record Keeping), 9.5 (Recall), 12.4 (Limitations on Warranties),
	16.4 (Effect of Termination) and 16.5 (Survival), in each case in
	accordance with their respective terms if applicable,
	notwithstanding expiry or termination of this
	Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	17.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	NOTICE
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All
<FONT STYLE="COLOR: #000000">
	notices and other communications
	hereunder shall be in writing and shall be deemed given: (A) when
	delivered personally or by hand; (B) when delivered by facsimile
	transmission (receipt verified); (C) when received or refused, if
	sent by registered or certified or recorded post (return receipt
	requested), postage prepaid; or (D) when delivered by courier
	service; in each case, to the parties at the following addresses
	(or at such other address for a party as shall be specified by like
	notice;
</FONT>
<FONT STYLE="FONT-STYLE: ITALIC; COLOR: #000000">
	provided
</FONT>
<FONT STYLE="COLOR: #000000">
	, that notices of a change of address shall be
	effective only upon receipt thereof):
</FONT>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -240PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	To
	Palatin:&#xA0;Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4-B
	Cedar Brook Drive
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Cranbury, New
	Jersey 08512 USA
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attn:
	Chief Financial Officer
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Facsimile: (609)
	495-2202
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	21
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage111"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -240PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	With a
	copy to:&#xA0;Thompson Hine LLP
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	335
	Madison Avenue, 12
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	th
</FONT>
	Floor
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	New
	York, New York 10017 USA
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attn:
	Faith Charles, Esq.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Facsimile: (212)
	344-6101
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -240PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	To
	Catalent:&#xA0;Catalent Belgium S.A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Rue
	Font St. Landry
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10 Parc
	Mercator B-1120
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Neder
	over Heembeek, Belgium
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attn:
	General Manager
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Facsimile:
	32-2-788-39-59
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -240PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	With a
	copy to:&#xA0;Catalent Pharma Solutions
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	14
	Schoolhouse Road
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Somerset, NJ 08873
	USA
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attn:
	General Counsel (Legal Department)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Facsimile: +1 (732)
	537-6491
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MISCELLANEOUS
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.1
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Entire
	Agreement; Amendments
</FONT>
	. This Agreement, together with the
	Manufacturing Preparation and Services Agreement, the Quality
	Agreement and each Purchase Order, constitutes the entire
	understanding between the parties, and supersedes any contracts,
	agreements or understandings (oral or written) of the parties, with
	respect to the subject matter hereof, including, for avoidance of
	doubt, that certain quotation letter (QTE- BRU 2012 059J) signed
	12
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	th
</FONT>
	October 2012 and the Binding Terms. For the avoidance of doubt,
	this Agreement does not supersede any existing generally applicable
	confidentiality agreement between the parties as it relates to time
	periods prior to the date hereof or to business dealings not
	covered by this Agreement. No term of this Agreement may be amended
	except upon written agreement of both parties, unless otherwise
	expressly provided in this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.2
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Captions;
	Certain Conventions
</FONT>
	. The headings used in this Agreement are
	for convenience only and are not to be interpreted or construed as
	a substantive part of this Agreement. Unless otherwise expressly
	provided herein or the context of this Agreement otherwise
	requires, (A) words of any gender include each other gender, (B)
	words such as &#x201C;herein&#x201D;, &#x201C;hereof&#x201D;, and
	&#x201C;hereunder&#x201D; refer to this Agreement as a whole and not
	merely to the particular provision in which such words appear, (C)
	words using the singular shall include the plural, and vice versa,
	(D) the words &#x201C;include(s)&#x201D; and &#x201C;including&#x201D;
	shall be deemed to be followed by the phrase &#x201C;but not limited
	to&#x201D;, &#x201C;without limitation&#x201D; or words of similar
	import, (E) the word &#x201C;or&#x201D; shall be deemed to include
	the word &#x201C;and&#x201D; (e.g., &#x201C;and/or&#x201D;) and (F)
	references to &#x201C;Clause&#x201D; or other subdivision, or to an
	Attachment or other appendix, without reference to a document are
	to the specified provision or Attachment of this Agreement. This
	Agreement shall be construed as if it were drafted jointly by the
	parties.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.3
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Further
	Assurances
</FONT>
	. The parties agree to execute such further
	instruments and to undertake such other acts as may be reasonably
	necessary or appropriate to give full effect to the terms of this
	Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.4
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	No
	Waiver
</FONT>
	. In no event shall any delay, failure or omission (in
	whole or in part) in enforcing, exercising or pursuing any right,
	power, privilege, claim or remedy conferred by or arising under
	this Agreement or by law, be deemed to be or construed as a waiver
	of that or any other right, power, privilege, claim or remedy in
	respect of the circumstances in question, or operate so as to bar
	the enforcement of that, or any other right, power, privilege,
	claim or remedy, in any other instance at any time or times
	subsequently.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	22
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage112"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.5
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Severability
</FONT>
	.
	If any term of this Agreement is declared invalid or unenforceable
	by a court or other body of competent jurisdiction, the remaining
	terms of this Agreement will continue in full force and
	effect.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.6
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Independent
	Contractors
</FONT>
	. The relationship of the parties is that of
	independent contractors, and nothing in this Agreement is intended
	to create or will be construed as creating between the parties the
	relationship of joint venture, co-partners, employer/employee or
	principal/agent.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.7
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Successors
	and Assigns
</FONT>
	. Neither party may assign this Agreement, in
	whole or in part, without the prior written consent of the other
	party;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	,
<FONT STYLE="FONT-STYLE: ITALIC">
	however
</FONT>
	, that either party
	may, without the other party&#x2019;s consent, assign this Agreement
	in its entirety to an Affiliate or to a successor to substantially
	all of the business or assets of the assigning party or the
	assigning party&#x2019;s business unit responsible for performance
	under this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.8
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Third
	Party Rights
</FONT>
	. This Agreement shall not confer any rights or
	remedies upon any person or entity other than the parties to this
	Agreement and their respective successors and permitted assigns,
	and a person or entity who is not a party to this Agreement has no
	rights to enforce any term of this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.9
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Governing
	Law
</FONT>
	. This Agreement and the legal relations between the
	parties in connection herewith shall be governed by, and construed
	in accordance with, the laws of the State of New Jersey, USA,
	without regard to the conflict of law principles thereof. The
	United Nations Convention on Contracts for the International Sale
	of Goods shall not apply to this Agreement.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.10
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Alternative
	Dispute Resolution
</FONT>
	. Any dispute that arises between the
	parties in connection with this Agreement shall first be presented
	to the senior executives of the parties for consideration and
	resolution. If such executives cannot reach a resolution of the
	dispute within a reasonable time, not to exceed 30 days unless
	otherwise agreed by the parties in writing, then such dispute shall
	be submitted to arbitration by the International Institute for
	Conflict Prevention and Resolution, 575 Lexington Avenue, 21st
	Floor, New York, NY&#xA0; 10022 (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	CPR
</FONT>
	&#x201D;) by one arbitrator mutually
	agreed upon by the Parties. If no agreement can be reached within
	30 days after names of potential arbitrators have been proposed by
	the CPR, then the CPR will choose one arbitrator having reasonable
	experience in commercial transactions of the type provided for in
	this Agreement. The arbitration shall take place in the English
	language in New York City, New York, in accordance with the CPR
	administered arbitration rules then in effect, and judgment upon
	any award rendered in such arbitration will be binding and may be
	entered in any court having jurisdiction thereof. Unless otherwise
	agreed to by the parties in writing, the arbitration shall commence
	within 60 days of the date on which a written demand for
	arbitration is filed. The arbitrator&#x2019;s decision shall set
	forth a reasoned basis for any award of damages or finding of
	liability. The arbitrator shall not have power to award damages in
	excess of actual compensatory damages and shall not multiply actual
	damages or award punitive damages..
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.11
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Prevailing
	Party
</FONT>
	. In any dispute resolution proceeding between the
	parties in connection with this Agreement, the prevailing party
	will be entitled to recover its reasonable attorney&#x2019;s fees
	and costs in such proceeding from the other party.
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	23
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage113"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.12
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Publicity
</FONT>
	.
	Neither party will make any press release or other public
	disclosure regarding this Agreement or the transactions
	contemplated hereby without the other party&#x2019;s express prior
	written consent, except as required under Applicable Laws, by any
	governmental agency or by the rules of any stock exchange on which
	the securities of the disclosing party are listed, in which case
	the party required to make the press release or public disclosure
	shall use commercially reasonable efforts to obtain the approval of
	the other party as to the form, nature and extent of the press
	release or public disclosure prior to issuing the press release or
	making the public disclosure. Notwithstanding the foregoing, the
	parties hereto intend to make a jointly agreed press release with
	respect to the Agreement within 60 days after the Effective Date or
	at such other time as mutually agreed by the parties.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.13
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Right
	to Dispose
</FONT>
	. If Catalent requests in writing from Palatin
	direction with respect to disposal of any inventories of Product,
	Palatin-supplied Materials, Palatin Equipment, other equipment,
	samples or other items belonging to Palatin and is unable to obtain
	a response from Palatin within 90 days after making such request,
	Catalent shall be entitled in its sole discretion to dispose of all
	such items.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.14
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Force
	Majeure
</FONT>
	. Except as to payments required under this
	Agreement, neither party shall be liable in damages for, nor shall
	this Agreement be capable of termination by reason of, any delay in
	such party&#x2019;s performance, or breach of its obligations,
	hereunder if such delay or breach is caused by events beyond such
	party&#x2019;s reasonable control, including acts of God, law or
	regulation or other action or failure to act of any government or
	agency thereof, war or insurrection, civil commotion, destruction
	of production facilities or materials by earthquake, fire, flood or
	weather, labor disturbances, epidemic or failure of suppliers,
	public utilities or common carriers. If the events shall continue
	unabated for 90 days, then both parties shall meet to discuss and
	negotiate in good faith what modifications to this Agreement should
	result from such events.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	18.15
</FONT>
<FONT ID="TAB2" STYLE="LETTER-SPACING: 12PX; COLOR: BLACK">
	&#xA0;
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE">
	Counterparts
</FONT>
	.
	This Agreement may be executed in two or more counterparts, each of
	which will be deemed an original but all of which together will
	constitute one and the same instrument. Delivery of an executed
	counterpart of this Agreement by fax or e-mail in an image format
	(e.g., .pdf file) shall be as effective as delivery of a manually
	executed counterpart of this Agreement.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(signature
	page follows)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	24
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage114"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	IN WITNESS WHEREOF
</FONT>
	, the parties have
	caused their respective duly authorized representatives to execute
	this Agreement effective as of the Effective Date.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 35%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="COLOR: #000000">
	CATALENT
	BELGIUM S.A.
</FONT>
	&#xA0;&#xA0;
<BR>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 6%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 35%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="COLOR: #000000">
	PALATIN
	TECHNOLOGIES, INC.
</FONT>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 35%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 6%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 35%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 35%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	/s/
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Eric
	Kummer
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 6%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 35%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	/s/
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen
	T. Wills
<BR>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Name:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Eric
	Kummer
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 6%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Name:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen
	T. Wills
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Title:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	General
	Manager
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 6%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Title:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CFO/CO
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June
	14, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: CENTER">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	25
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage115"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ATTACHMENT A
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	VALIDATION SERVICES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	[To be agreed by the parties within ninety (90) days following the
	Effective Date
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and, when agreed to, to form a part of this Agreement.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attachment to reflect standard Catalent quotation format, including
	pricing.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-STYLE: ITALIC; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If no validation services are desired, state &#x201C;N/A&#x201D; on
	this page.]
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage116"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ATTACHMENT B
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PRODUCT MAINTENANCE SERVICES
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage117"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ATTACHMENT C
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	SPECIFICATIONS
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage118"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ATTACHMENT D
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	UNIT PRICING, FEES AND MINIMUM REQUIREMENT
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; PAGE-BREAK-AFTER: ALWAYS; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
<A NAME="eolPage119"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ATTACHMENT E
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	COUNTRIES INCLUDED IN TERRITORY
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Canada
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Kosovo
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Former
	Yugoslav Republic of Macedonia
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Turkey
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Albania
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Andorra
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Bosnia
	and Herzegovina
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Iceland
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Liechtenstein
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Monaco
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Montenegro
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Norway
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	San
	Marino
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Serbia
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Switzerland
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Vatican
	City State
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Armenia
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Azerbaijan
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Belarus
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Georgia
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Kazakhstan
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Kyrgyzstan
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Moldova
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Russia
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Tajikistan
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Ukraine
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Uzbekistan
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Turkmenistan
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Mongolia
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Vietnam
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_EXHIBIT_10>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage120"></A>
<A NAME="PTN_EX1038_HTM"></A>
<EFX_EXHIBIT_10>
<A NAME="FIS_EXHIBIT_10_2"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Exhibit
	10.38
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
	OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE
	COMMISSION
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CONFIDENTIAL
	TREATMENT REQUESTED UNDER 17 C.F.R. SECTION 240.24b-2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MANUFACTURING PREPARATION AND SERVICES AGREEMENT
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Agreement
</FONT>
	&#x201D;)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	effective
	as of this 10
<FONT STYLE="FONT-SIZE: 70%; VERTICAL-ALIGN: TOP">
	th
</FONT>
	day of June 2016
	(the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Effective
	Date
</FONT>
	&#x201D;), by and between
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PALATIN TECHNOLOGIES, INC.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4-B
	Cedar Brook Drive
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Cranbury,
	New Jersey 08512
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	U.S.A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Palatin
</FONT>
	&#x201D;)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	and
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CATALENT BELGIUM S.A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Rue
	Font. St. Landry
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10 Parc
	Mercator B-1120
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Neder
	over Heembeek
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Belgium
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent
</FONT>
	&#x201D;)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	WHEREAS
</FONT>
	, Palatin is engaged in the
	development, marketing and sales of pharmaceutical
	products;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	WHEREAS
</FONT>
	, Catalent is a company engaged
	in the processing and supply of pharmaceutical products holding the
	necessary manufacturing licenses and permits in this
	respect;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	WHEREAS
</FONT>
	, it is necessary for Catalent
	(itself or through its Affiliates) to upgrade its manufacturing
	capacity and infrastructure to provide certain services in relation
	to the manufacture of the Product (as further defined herein)
	subject to this Agreement and to reserve certain manufacturing
	capacity on its upgraded facilities;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	WHEREAS
</FONT>
	, Palatin also wishes to entrust
	Catalent (itself or through its Affiliates) to perform certain
	Services (as further defined herein) in relation to the Product and
	Catalent agrees to perform such Services in accordance with the
	terms of this Agreement;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	WHEREAS
</FONT>
	, Catalent and Palatin have
	entered into that certain Binding Terms for Incorporation into a
	Capital and a Commercial Supply Agreement, dated April 1, 2016 (the
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Binding
	Terms
</FONT>
	&#x201D;), which Binding Terms shall be superseded in
	its entirety by this Agreement and the Supply Agreement (as defined
	hereafter).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	NOW THEREFORE
</FONT>
	, in consideration of the
	foregoing premises and the following mutual covenants and for other
	good and valuable consideration, the receipt and sufficiency of
	which is hereby acknowledged, the parties hereto agree as
	follows:
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 1 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage121"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-TOP: 12PX; ; PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	DEFINITIONS
	AND GENERAL
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The following terms
	shall, unless the context otherwise requires, have the respective
	meanings set out below and grammatical variations of such terms
	shall have corresponding meanings:
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Affiliate
</FONT>
	&#x201D; means (a) with respect
	to Palatin, any corporation or other business entity that, directly
	or indirectly, is controlled by, controls, or is under common
	control with Palatin; and (b) with respect to Catalent, Catalent,
	Inc. and any corporation or other business entity controlled,
	directly or indirectly, by Catalent Pharma Solutions, Inc. For such
	purposes, &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	control
</FONT>
	&#x201D; means the direct or
	indirect ownership of at least fifty percent (50%) of the voting
	interest in such corporation or other entity or the power in fact
	to control the management directions of such entity.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent CAPEX Expenditures
</FONT>
	&#x201D; has
	the meaning set forth in
<FONT STYLE="FONT-WEIGHT: BOLD">
	Section
	3.1
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Change of Control
</FONT>
	&#x201D; means, with
	respect to a party: (a) any merger, reorganization, consolidation,
	or other business combination of such party with a third party that
	results in the voting securities of such party outstanding
	immediately prior thereto ceasing to represent at least fifty
	percent (50%) of the combined voting power of the surviving entity
	immediately after such merger, reorganization, consolidation, or
	other business combination; (b) a third party becoming the
	beneficial owner of fifty percent (50%) or more of the combined
	voting power of such party in a single transaction or series of
	related transactions; or (c) the sale, transfer, exchange or other
	disposition to a third party of all or substantially all of a
	party&#x2019;s assets or business relating to this Agreement
	(whether alone or in connection with a sale, transfer, exchange or
	other disposition of other assets or businesses of such
	party).
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Facility
</FONT>
	&#x201D; means Catalent&#x2019;s
	facility in Brussels, Belgium or such other Catalent facility as
	mutually agreed by the parties.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	GMP Space Reservation Fee
</FONT>
	&#x201D; means
	the amount owed by Palatin to Catalent for access to
	Catalent&#x2019;s *** resources *** and for reservation of the
	applicable part of the Facility space pursuant to the terms of this
	Agreement, which amount shall total ***.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Manufacturing Preparation
</FONT>
	&#x201D; has the
	meaning given in
<FONT STYLE="FONT-WEIGHT: BOLD">
	Section
	2.1
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Manufacturing Preparation Plan
</FONT>
	&#x201D;
	means the plan as detailed in
<FONT STYLE="FONT-WEIGHT: BOLD">
	ANNEX
	1
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	&#x201C;Product&#x201D;
</FONT>
	means the
	proprietary Palatin product containing the active pharmaceutical
	ingredient, bremelanotide.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	&#x201C;Supply Agreement&#x201D;
</FONT>
	means
	that certain agreement covering the commercial manufacturing and
	supply of the Product between Catalent and Palatin of even date
	herewith.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Services
</FONT>
	&#x201D; has the meaning given in
<FONT STYLE="FONT-WEIGHT: BOLD">
	Section 2.2
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Term
</FONT>
	&#x201D; has the meaning given in
<FONT STYLE="FONT-WEIGHT: BOLD">
	Section 4.1
</FONT>
	.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All monetary
	amounts are expressed in this Agreement in Euros (EUR), the
	official currency of the euro area with the exception of the amount
	set forth in
<FONT STYLE="FONT-WEIGHT: BOLD">
	Section
	3.4(iii)
</FONT>
	, which amount is expressed in United States
	Dollars.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The division of
	this Agreement into sections, subsections and Annexes and the
	insertion of headings are for convenience of reference only and
	shall not affect the interpretation of this Agreement. Unless
	otherwise indicated, any reference in this Agreement to a section
	or an annex refers to the specified Section or ANNEX to this
	Agreement. In this Agreement, the terms &#x201C;this
	Agreement&#x201D;, &#x201C;hereof&#x201D;, &#x201C;herein&#x201D;,
	&#x201C;hereunder&#x201D; and similar expressions refer to this
	Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 2 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage122"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Except as otherwise
	expressly provided herein or unless the context otherwise requires,
	all references to the singular shall include the plural and vice
	versa.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Any reference
	herein to a &#x201C;day&#x201D; (including &#x201C;week&#x201D;) shall
	be references to a business day, excluding any Saturday, Sunday or
	public holiday (in the country or countries in which Palatin or
	Catalent or the Facility are physically located).
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent may
	delegate certain activities hereunder to its Affiliates and Palatin
	hereby agrees to such delegation subject to the following sentence:
	Catalent hereby agrees that regardless of such delegation, Catalent
	shall remain fully liable for the performance of its obligations
	under this Agreement by its Affiliate(s) to the same extent as if
	Catalent had performed or failed to perform its obligations under
	this Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-TOP: 12PX; ; PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MANUFACTURING
	PREPARATION AND SERVICES
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall have
	available all necessary manufacturing equipment and infrastructure
	at the Facility (collectively, &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Manufacturing Preparation
</FONT>
	&#x201D;) in
	accordance with the Manufacturing Preparation Plan as set out in
<FONT STYLE="FONT-WEIGHT: BOLD">
	ANNEX 1
</FONT>
	to manufacture and
	supply the Product to Palatin pursuant to the terms of the Supply
	Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall take
	all actions necessary to make available the Manufacturing
	Preparation for the Products at the Facility in accordance with the
	Manufacturing Preparation Plan (the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Services
</FONT>
	&#x201D;). Catalent shall provide
	the Services in a timely manner in accordance with the estimated
	timelines set forth in
<FONT STYLE="FONT-WEIGHT: BOLD">
	ANNEX
	1
</FONT>
	or such other timelines as the parties agree upon in
	writing. If either party anticipates that certain timelines of the
	Manufacturing Preparation Plan may not be met, then it shall notify
	the other party as soon as reasonably practicable. Within *** of
	receipt of such notice, the parties shall meet to discuss in good
	faith and find an appropriate course of action to remedy the
	situation.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 48PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall
	provide the Services in conformance with that level of care and
	skill ordinarily exercised by other professionals in similar
	circumstances and in compliance with all applicable laws and
	regulations.
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall have
	sole legal title to the Facility and any improvements thereto and
	the Manufacturing Preparation and the right to use it for any other
	purposes and customers at its own discretion, subject to the right
	of Palatin and its Affiliates to have priority for the use of the
	Manufacturing Preparation pursuant to the terms of the Supply
	Agreement, and provided that Catalent supplies Palatin with Product
	as set out in the Supply Agreement. Catalent shall be solely
	responsible for maintenance and repair of the Manufacturing
	Preparation, if and as needed.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall send
	to Palatin a written *** report describing the progress of each
	event of the Manufacturing Preparation Plan set forth in
<FONT STYLE="FONT-WEIGHT: BOLD">
	ANNEX 1.
</FONT>
	Catalent shall
	inform Palatin about significant accomplished phases and completed
	equipment and infrastructure build-outs of the Manufacturing
	Preparation Plan.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall at
	all times use its commercially reasonable efforts to minimize the
	costs associated with the implementation of the Manufacturing
	Preparation. Catalent will provide an initial cost overview as set
	forth in
<FONT STYLE="FONT-WEIGHT: BOLD">
	ANNEX 1
</FONT>
	. In case
	such cost overview shows significant variations (more than ***)
	from the cost anticipated by both parties for the implementation of
	the Manufacturing Preparation as set forth in the initial cost
	overview in
<FONT STYLE="FONT-WEIGHT: BOLD">
	ANNEX 1
</FONT>
	, the
	parties shall agree in good faith on the allocation of such cost
	variation.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 3 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage123"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall
	perform the Services in a transparent manner and provide Palatin
	such information regarding the Services and the Manufacturing
	Preparation as Palatin may reasonably request from time to time,
	including providing copies of relevant documentation with respect
	to the Manufacturing Preparation set up and the fees and costs
	associated therewith. Palatin shall have the right to inspect the
	Facility, subject to any confidentiality obligations that Catalent
	has in relation to other customers, and the activities being
	performed in connection with the Services and/or the Manufacturing
	Preparation Plan upon giving reasonable prior written notice and
	during normal business hours.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.7
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	If this Agreement
	expires or is terminated for any reason in accordance with
<FONT STYLE="FONT-WEIGHT: BOLD">
	Article 4
</FONT>
	, Catalent shall,
	to the extent possible and as soon as reasonably feasible, cancel
	any purchase orders placed in relation to any equipment or costs
	incurred in connection with the infrastructure upgrade that
	Catalent agreed to implement as part of the Manufacturing
	Preparation under this Agreement. Catalent shall also use its
	reasonable efforts to minimize the costs incurred associated with
	any such equipment or infrastructure upgrade including mitigating
	any commitments towards its suppliers, and shall not enter into any
	applicable further purchasing commitments.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-TOP: 12PX; ; PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	PAYMENTS;
	LIMITATION OF LIABILITY
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall make
	all payments to any vendors and suppliers with respect to the
	Manufacturing Preparation (the total amount of such payments by
	Catalent, the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Catalent
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD">
	CAPEX Expenditures
</FONT>
	&#x201D;). Catalent
	shall provide written reports to Palatin on a *** basis, by ***,
	reflecting up-to-date Catalent CAPEX Expenditures (each, a
	&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	CAPEX Report
</FONT>
	&#x201D;),
	and Palatin shall have the right, upon giving reasonable prior
	written notice and during normal business hours, to review the
	actual costs and supporting documents with respect
	thereto.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent shall
	reserve GMP space within the Facility for the period beginning ***
	and continuing throughout the Term of this Agreement. Palatin shall
	pay to Catalent the GMP Space Reservation Fee in *** installments.
	***. The *** last installment ***. Catalent shall issue to Palatin
	an invoice for the first installment of the GMP Space Reservation
	Fee ***. Catalent shall issue to Palatin an invoice for each
	succeeding installment *** thereafter until the GMP Space
	Reservation Fee has been paid in full. Each payment shall be due
	*** after the date of the applicable invoice.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin shall
	promptly notify Catalent if Palatin enters into a marketing and/or
	licensing agreement with a third party pursuant to which agreement
	such third party acquires the right to market, sell and have sold
	the Product (i) within North America (comprising at least the
	United States of America) or (ii) worldwide. Upon receiving such
	notice, ***. For the avoidance of doubt, neither this Agreement nor
	the Supply Agreement shall terminate upon such event.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	In the event of a
	Change of Control of Palatin, then within *** after the actual
	effective date of such Change of Control, ***. For the avoidance of
	doubt, neither this Agreement nor the Supply Agreement shall
	terminate upon such event.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The limitation of
	liability of Catalent and Palatin under this Agreement shall be as
	set forth in
<FONT STYLE="FONT-WEIGHT: BOLD">
	Article 14
</FONT>
	of
	the Supply Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-TOP: 12PX; ; PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	TERM
	AND TERMINATION
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	This Agreement
	shall come into force on the Effective Date and continue in full
	force and effect until completion of each party&#x2019;s obligations
	hereunder or until such other date as the parties may mutually
	agree upon in writing (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Term
</FONT>
	&#x201D;). In the case of Catalent,
	such obligations shall be completed upon such date as the
	Manufacturing Preparation has been built, installed and
	qualified.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Either party may
	terminate this Agreement immediately at any time by written notice
	to the other party if:
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	an event where the
	other party materially breaches a provision of this Agreement and
	fails or is unable to remedy such breach within *** of receipt of
	notice in writing specifying the breach and requiring it to be
	remedied; or
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	steps are taken by
	or against the other party for the appointment of a liquidator, an
	administrator, a receiver, administrative receiver, manager,
	interim receiver, trustee, trustee in bankruptcy, nominee or
	supervisor or the other party proposes or enters into an agreement
	or arrangement with its creditors generally or makes an assignment
	for the benefit of its creditors generally, or otherwise suffers or
	permits the taking of any steps for adjudicating it to be bankrupt
	or insolvent and any such process, if reasonably shown to be
	warranted, frivolous or vexatious, is not withdrawn, dismissed or
	discharges within ***, or any equivalent or similar action to the
	above in consequence of the insolvency of that party is taken in
	any jurisdiction and is not withdrawn, dismissed or discharged in
	the circumstances described above.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 4 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage124"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin shall have
	the right to terminate this Agreement in whole or in part at its
	own convenience at any time upon *** prior written notice. In the
	event of such termination, within *** after the effective date of
	such termination Palatin shall pay to Catalent ***.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Termination of this
	Agreement shall be without prejudice to any claim or right of
	action of either party against the other party for any prior breach
	of this Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Upon termination of
	this Agreement by either party or expiration of this Agreement,
	each party shall return to the other party or such party&#x2019;s
	designee (as such party shall in its sole discretion direct) any
	materials or documents that have been supplied by such party to the
	other party under this Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Any termination or
	expiry of the Supply Agreement shall be without prejudice to the
	validity of this Agreement or any claim or right of action of
	either party against the other party arising out of this
	Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-TOP: 12PX; ; PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<A NAME="PTN_EX1038_HTM__REF317242706">
<!--ANCHOR-->
</A>
	CONFIDENTIALITY
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Neither party shall
	disclose to any third party nor use for any purpose outside of the
	scope of this Agreement any information which is not in the public
	domain (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Confidential
	Information
</FONT>
	&#x201D;) and which was disclosed in connection
	with this Agreement by: (a) a party or any of its Affiliates; or
	(b)&#xA0;any unaffiliated third party at the request of a party
	((a) and/or (b) the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Disclosing Party
</FONT>
	&#x201D;). The party
	receiving the Confidential Information (the &#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Receiving Party
</FONT>
	&#x201D;) may only provide
	the Disclosing Party&#x2019;s Confidential Information to its and
	its Affiliates&#x2019; directors, officers, employees, advisors, and
	consultants (&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	Representatives
</FONT>
	&#x201D;) who are informed
	of the confidential nature of the Confidential Information and who
	are bound by obligations of confidentiality and non-use no less
	restrictive than those contained herein and provided that the
	Receiving Party shall be responsible for any breach of this
	Agreement by its Representatives, which shall be considered a
	breach by the Receiving Party. The obligations of confidentiality
	and non-use shall expire for Confidential Information
	which:
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	is or becomes part
	of the public domain without a violation of this
	Agreement;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	was already in the
	possession of the Receiving Party at the time of receipt from the
	Disclosing Party, as shown by documentary evidence; or
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 48PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(c)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	after the date of
	this Agreement is received by the Receiving Party, without a
	confidentiality obligation, from a third party whose direct or
	indirect source is not the Disclosing Party.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The Receiving Party
	may disclose the Disclosing Party&#x2019;s Confidential Information
	to the extent required under applicable laws or by the rules of any
	stock exchange on which the securities of the Disclosing Party are
	listed in each case upon the reasonable advice of the Receiving
	Party&#x2019;s legal counsel;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that prior to making any such
	legally required disclosure, the Receiving Party shall give the
	Disclosing Party as much prior notice of the requirement for and
	contents of such disclosure as is practicable under the
	circumstances and shall use reasonable efforts to limit the scope
	of any such disclosure and to obtain confidential treatment of all
	Confidential Information disclosed pursuant to such requirement.
	Any such disclosure, however, shall not relieve the Receiving Party
	of its confidentiality obligations as set forth in
<FONT STYLE="FONT-WEIGHT: BOLD">
	Section 5.1
</FONT>
	.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 5 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage125"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="COLOR: #000000">
	The obligations of confidentiality and non-use
	contained in this
</FONT>
<FONT STYLE="FONT-WEIGHT: BOLD; COLOR: #000000">
	Section 5
</FONT>
<FONT STYLE="COLOR: #000000">
	will terminate *** after the expiry or termination
	of this Agreement, except with respect to trade secrets, for which
	the obligations of confidentiality and non-use contained in this
	Clause will continue for so long as such information remains a
	trade secret under applicable law.
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Upon expiration or
	termination of this Agreement, the Receiving Party
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
	will (and will cause
	its Affiliates and its and their respective Representatives to)
	cease its use and, upon written request, within *** either return
	or destroy (and certify as to such destruction) all Confidential
	Information of the Disclosing Party, including any copies thereof,
	except for a single copy which may be retained for the sole purpose
	of ascertaining compliance with its obligations under this
	Agreement and any copies remaining on the Receiving Party&#x2019;s
	standard computer back-up devices.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-TOP: 12PX; ; PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	DISPUTE
	RESOLUTION
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Governing Law
</FONT>
	. This Agreement and the
	legal relations between the parties in connection herewith shall be
	governed by, and construed in accordance with, the laws of the
	State of New Jersey, USA, without regard to the conflict of law
	principles thereof. The United Nations Convention on Contracts for
	the International Sale of Goods shall not apply to this
	Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Alternative Dispute Resolution
</FONT>
	. Any
	dispute that arises between the parties in connection with this
	Agreement shall first be presented to the senior executives of the
	parties for consideration and resolution. If such executives cannot
	reach a resolution of the dispute within a reasonable time, not to
	exceed thirty (30) days unless otherwise agreed by the parties in
	writing, then such dispute shall be submitted to arbitration by the
	International Institute for Conflict Prevention and Resolution, 575
	Lexington Avenue, 21st Floor, New York, NY&#xA0; 10022
	(&#x201C;
<FONT STYLE="FONT-WEIGHT: BOLD">
	CPR
</FONT>
	&#x201D;) by one
	arbitrator mutually agreed upon by the Parties. If no agreement can
	be reached within thirty (30) days after names of potential
	arbitrators have been proposed by the CPR, then the CPR will choose
	one arbitrator having reasonable experience in commercial
	transactions of the type provided for in this Agreement. The
	arbitration shall take place in the English language in New York
	City, New York, in accordance with the CPR administered arbitration
	rules then in effect, and judgment upon any award rendered in such
	arbitration will be binding and may be entered in any court having
	jurisdiction thereof. Unless otherwise agreed to by the parties in
	writing, the arbitration shall commence within sixty (60) days of
	the date on which a written demand for arbitration is filed. The
	arbitrator&#x2019;s decision shall set forth a reasoned basis for
	any award of damages or finding of liability. The arbitrator shall
	not have power to award damages in excess of actual compensatory
	damages and shall not multiply actual damages or award punitive
	damages.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	6.3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Remedy for Breach
</FONT>
	. The parties
	understand and agree that monetary damages may not be sufficient
	remedy for breach of this Agreement and that the injured party will
	be entitled to seek equitable relief, including injunction and
	specific performance, for any such breach.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-TOP: 12PX; ; PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MISCELLANEOUS
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Relationship of the Parties
</FONT>
	.
<FONT STYLE="COLOR: #000000">
	For the purposes of this Agreement,
	each party shall be an independent contractor and not an agent or
	employee of the other party. Neither party shall have authority or
	power to make any statements, representations or commitments of any
	kind, or to take any action which is binding on the other
	party,
</FONT>
	unless expressly so authorized
<FONT STYLE="COLOR: #000000">
	to do so by an instrument in writing signed by
	authorized representatives of such other party.
</FONT>
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Notices
</FONT>
	. All notices and other
	communications hereunder shall be in writing and shall be deemed
	given: (a) when delivered personally or by hand; (b) when delivered
	by facsimile transmission (receipt verified); (c) when received or
	refused, if sent by registered or certified or recorded post
	(return receipt requested), postage prepaid; or (d) when delivered
	by courier service; in each case, to the parties at the following
	addresses (or at such other address for a party as shall be
	specified by like notice;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	, that notices of a change of
	address shall be effective only upon receipt thereof):
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 6 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage126"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent Belgium
	S.A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Rue
	Font. St. Landry
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	10 Parc
	Mercator B-1120
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Neder
	over Heembeek
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Belgium
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attn:
	General Manager
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Fax:
	32-2-788-39-59
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	With a copy to:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent Pharma
	Solutions
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	14
	Schoolhouse Road
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Somerset, NJ
	08873
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	USA
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attn:
	General Counsel (Legal Department)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Email&#xA0;:
	GenCouns@catalent.com
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin
	Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4-B
	Cedar Brook Drive
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Cranbury, New
	Jersey 08512
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	U.S.A.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attn:
	Chief Financial Officer
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Fax:
	(609) 495-2202
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	With a copy to:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Thompson Hine
	LLP
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	335
	Madison Avenue, 12th Floor
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	New
	York, New York 10017 USA
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Attn:
	Faith Charles, Esq.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 96PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Facsimile: (212)
	344-6101
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.3
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Annexes
</FONT>
	.
<FONT STYLE="COLOR: #000000">
	All Annexes (and any amendments to such Annexes)
	and their enclosures form an integral part of this Agreement and
	are incorporated herein by reference.
</FONT>
	This Agreement shall
	govern
<FONT STYLE="COLOR: #000000">
	if there
</FONT>
	is any conflict
	between the terms of such Annexes and the terms of this
	Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.4
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Entire Agreement
</FONT>
	. This Agreement
	(including the Annexes hereto) and the Supply Agreement constitute
	the entire agreement between the parties related to the subject
	matter covered by this Agreement, shall supersede and prevail over
	any other prior or contemporaneous arrangements regarding this
	subject matter, whether written or oral, including without
	limitation the Binding Terms (as defined in the Recitals hereto),
	and is binding upon the parties hereto and their successors and
	permitted assigns. For the avoidance of doubt, this Agreement does
	not supersede any existing generally applicable confidentiality
	agreement between the parties as it relates to time periods prior
	to the date hereof or to business dealings not covered by this
	Agreement. No term of this Agreement may be amended except upon
	written agreement of both parties, unless otherwise expressly
	provided in this Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.5
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Assignment
</FONT>
	. Neither party may assign
	this Agreement, in whole or in part, without the prior written
	consent of the other party;
<FONT STYLE="FONT-STYLE: ITALIC">
	provided
</FONT>
	,
<FONT STYLE="FONT-STYLE: ITALIC">
	however
</FONT>
	, that either party may, without
	the other party&#x2019;s consent, assign this Agreement in its
	entirety to an Affiliate or to a successor to substantially all of
	the business or assets of the assigning party or the assigning
	party&#x2019;s business unit responsible for performance under this
	Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.6
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Severability
</FONT>
	. If any term of this
	Agreement is declared invalid or unenforceable by a court or other
	body of competent jurisdiction, the remaining terms of this
	Agreement will continue in full force and effect.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 7 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage127"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.7
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	No Waiver
</FONT>
	. In no event shall any delay,
	failure or omission (in whole or in part) in enforcing, exercising
	or pursuing any right, power, privilege, claim or remedy conferred
	by or arising under this Agreement or by law, be deemed to be or
	construed as a waiver of that or any other right, power, privilege,
	claim or remedy in respect of the circumstances in question, or
	operate so as to bar the enforcement of that, or any other right,
	power, privilege, claim or remedy, in any other instance at any
	time or times subsequently.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 16PX; ; MARGIN-LEFT: 0PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 48PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	7.8
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<FONT STYLE="FONT-WEIGHT: BOLD">
	Counterparts
</FONT>
	. This Agreement (and any
	Annexes and amendments hereto) may be executed in two or more
	counterparts, each of which will be deemed an original but all of
	which together will constitute one and the same instrument.
	Delivery of an executed counterpart of this Agreement by fax or
	e-mail in an image format (e.g., .pdf file) shall be as effective
	as delivery of a manually executed counterpart of this
	Agreement.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(signature
	page follows)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 8 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage128"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	parties have caused their respective duly authorized
	representatives to execute this Agreement effective as of the
	Effective Date.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="MARGIN-RIGHT:0PX;WIDTH:100%;MARGIN-LEFT:0PX;">
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 35%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin
	Technologies, Inc.
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 6%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 35%;">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Catalent
	Belgium S.A.
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 35%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	/s/
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen
	T. Wills&#xA0;
<BR>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 6%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; WIDTH: 35%; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	/s/
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Eric
	Kummer
<BR>
</FONT>
</DIV>
</TD>
<TD ROWSPAN="1" STYLE="VERTICAL-ALIGN: TOP; PADDING-BOTTOM: 2PX; WIDTH: 12%;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Name:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen
	T. Wills&#xA0;
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 6%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Name:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Eric
	Kummer
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Title:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	CFO/COO&#xA0;
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 6%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Title:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	General
	Manager&#xA0;
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Date:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June
	20, 2016&#xA0;
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 6%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP; BORDER-BOTTOM: 2PX SOLID RGB(0, 0, 0);">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	Date:
</FONT>
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	June
	14, 2016&#xA0;&#xA0;&#xA0;
<BR>
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
<TR STYLE="">
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 6%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 35%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
<TD STYLE="WIDTH: 12%; VERTICAL-ALIGN: TOP;">
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-SIZE: 13PX; FONT-FAMILY: TIMES NEW ROMAN">
	&#xA0;
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 9 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage129"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX;">
	&#xA0;
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<BR>
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	ANNEX 1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	MANUFACTURING PREPARATION PLAN
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 10 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; PAGE-BREAK-AFTER: ALWAYS; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK LINE-->
</DIV>
<A NAME="eolPage130"></A>
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: RIGHT; WIDTH: 100%">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 11PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT>
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="TEXT-DECORATION: UNDERLINE; FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	INITIAL COST OVERVIEW FOR THE MANUFACTURING
	PREPARATION
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	***
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 16PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV ID="PN" STYLE="TEXT-ALIGN: RIGHT">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Page 11 of
	11
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_EXHIBIT_10>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage131"></A>
<A NAME="PTN_EX21_HTM"></A>
<EFX_EXHIBIT_21>
<A NAME="FIS_EXHIBIT_21"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	EXHIBIT
	21
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	SUBSIDIARIES OF THE
	REGISTRANT
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="WIDTH: 100%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 33%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Name of
	Subsidiary
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 34%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	State
	of Incorporation
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 34%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Name
	Under Which
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Subsidiary
	Does Business
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: MIDDLE; WIDTH: 33%">
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	RhoMed
	Incorporated
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 34%">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	New
	Mexico
</FONT>
</DIV>
</TD>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 34%">
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	RhoMed
	Incorporated
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_EXHIBIT_21>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage132"></A>
<A NAME="PTN_EX23_HTM"></A>
<EFX_EXHIBIT_23>
<A NAME="FIS_EXHIBIT_23"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Exhibit
	23
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<EFX_EXPERTS_CONSENT>
<A NAME="FIS_EXPERTS_CONSENT"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-WEIGHT: BOLD; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Consent
	of Independent Registered Public Accounting Firm
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The
	Board of Directors
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Palatin
	Technologies, Inc.:
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 13.3PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	We
	consent to the incorporation by reference in the registration
	statements (Nos. 333-33569, 333-56605, 333-64951, 333-72873,
	333-84421, 333-52024, 333-54918, 333-74990, 333-100469, 333-101764,
	333-104370, 333-112908, 333-128585, 333-132369, 333-140648,
	333-146392, 333-170227, 333-174251, 333-183837, 333-185113,
	333-201821, 333-206003, and 333-206047) on Form S-3 and in the
	registration statements (Nos. 333-57079, 333-83876, 333-128854,
	333-149093, 333-163158, 333-174257, 333-191467, and 333-206009) on
	Form S-8 of Palatin Technologies, Inc. of our report dated
	September 19, 2016, with respect to the consolidated balance sheets
	of Palatin Technologies, Inc. and subsidiary as of June 30, 2016
	and 2015, and the related consolidated statements of operations,
	stockholders&#x2019; (deficiency) equity, comprehensive loss and
	cash flows for each of the years in the three-year period ended
	June 30, 2016, which report appears in the June 30, 2016 annual
	report on Form 10-K of Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Our
	report dated September 19, 2016 contains an explanatory paragraph
	that states that the Company has incurred recurring net losses and
	negative cash flows from operations and will require substantial
	additional financing to continue to fund its planned developmental
	activities. These conditions raise substantial doubt about its
	ability to continue as a going concern. The consolidated financial
	statements do not include any adjustments that might result from
	the outcome of that uncertainty.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/
	KPMG LLP
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Philadelphia,
	Pennsylvania
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	September
	19, 2016
</FONT>
</DIV>
</EFX_EXPERTS_CONSENT>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX;">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_EXHIBIT_23>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage133"></A>
<A NAME="PTN_EX311_HTM"></A>
<EFX_EXHIBIT_31>
<A NAME="FIS_EXHIBIT_31"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	EXHIBIT
	31.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certification of
	Chief Executive Officer
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	I, Carl
	Spana, certify that:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	I have reviewed
	this Annual Report on Form 10-K of Palatin Technologies,
	Inc.;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Based on my
	knowledge, this report does not contain any untrue statement of a
	material fact or omit to state a material fact necessary to make
	the statements made, in light of the circumstances under which such
	statements were made, not misleading with respect to the period
	covered by this report;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Based on my
	knowledge, the financial statements, and other financial
	information included in this report, fairly present in all material
	respects the financial condition, results of operations and cash
	flows of the registrant as of, and for, the periods presented in
	this report;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The registrant's
	other certifying officer and I are responsible for establishing and
	maintaining disclosure controls and procedures (as defined in
	Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
	over financial reporting (as defined in Exchange Act Rules
	13a-15(f) and 15d-15(f)) for the registrant and have:
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Designed such
	disclosure controls and procedures, or caused such disclosure
	controls and procedures to be designed under our supervision, to
	ensure that material information relating to the registrant,
	including its consolidated subsidiary, is made known to us by
	others within those entities, particularly during the period in
	which this report is being prepared;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Designed such
	internal control over financial reporting, or caused such internal
	control over financial reporting to be designed under our
	supervision, to provide reasonable assurance regarding the
	reliability of financial reporting and the preparation of financial
	statements for external purposes in accordance with generally
	accepted accounting principles;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(c)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Evaluated the
	effectiveness of the registrant's disclosure controls and
	procedures and presented in this report our conclusions about the
	effectiveness of the disclosure controls and procedures, as of the
	end of the period covered by this report based on such evaluation;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(d)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Disclosed in this
	report any change in the registrant's internal control over
	financial reporting that occurred during the registrant's most
	recent fiscal quarter that has materially affected, or is
	reasonably likely to materially affect, the registrant's internal
	control over financial reporting; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The registrant's
	other certifying officer and I have disclosed, based on our most
	recent evaluation of internal control over financial reporting, to
	the registrant's auditors and the audit committee of the
	registrant's board of directors:
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All significant
	deficiencies and material weaknesses in the design or operation of
	internal control over financial reporting which are reasonably
	likely to adversely affect the registrant's ability to record,
	process, summarize and report financial information;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Any fraud, whether
	or not material, that involves management or other employees who
	have a significant role in the registrant's internal control over
	financial reporting.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Date:
	September 19, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; WIDTH: 35%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; MARGIN: 0PX AUTO 0PX 0PX;">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/
	Carl Spana
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl
	Spana, President and Chief Executive Officer
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_EXHIBIT_31>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage134"></A>
<A NAME="PTN_EX312_HTM"></A>
<EFX_EXHIBIT_31>
<A NAME="FIS_EXHIBIT_31_2"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	EXHIBIT
	31.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certification of
	Chief Financial Officer
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	I,
	Stephen T. Wills, certify that:
</FONT>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	1.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	I have reviewed
	this Annual Report on Form 10-K of Palatin Technologies,
	Inc.;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	2.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Based on my
	knowledge, this report does not contain any untrue statement of a
	material fact or omit to state a material fact necessary to make
	the statements made, in light of the circumstances under which such
	statements were made, not misleading with respect to the period
	covered by this report;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	3.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Based on my
	knowledge, the financial statements, and other financial
	information included in this report, fairly present in all material
	respects the financial condition, results of operations and cash
	flows of the registrant as of, and for, the periods presented in
	this report;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	4.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The registrant's
	other certifying officer and I are responsible for establishing and
	maintaining disclosure controls and procedures (as defined in
	Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control
	over financial reporting (as defined in Exchange Act Rules
	13a-15(f) and 15d-15(f)) for the registrant and have:
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Designed such
	disclosure controls and procedures, or caused such disclosure
	controls and procedures to be designed under our supervision, to
	ensure that material information relating to the registrant,
	including its consolidated subsidiary, is made known to us by
	others within those entities, particularly during the period in
	which this report is being prepared;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Designed such
	internal control over financial reporting, or caused such internal
	control over financial reporting to be designed under our
	supervision, to provide reasonable assurance regarding the
	reliability of financial reporting and the preparation of financial
	statements for external purposes in accordance with generally
	accepted accounting principles;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(c)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Evaluated the
	effectiveness of the registrant's disclosure controls and
	procedures and presented in this report our conclusions about the
	effectiveness of the disclosure controls and procedures, as of the
	end of the period covered by this report based on such evaluation;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(d)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Disclosed in this
	report any change in the registrant's internal control over
	financial reporting that occurred during the registrant's most
	recent fiscal quarter that has materially affected, or is
	reasonably likely to materially affect, the registrant's internal
	control over financial reporting; and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 24PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	5.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	The registrant's
	other certifying officer and I have disclosed, based on our most
	recent evaluation of internal control over financial reporting, to
	the registrant's auditors and the audit committee of the
	registrant's board of directors:
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(a)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	All significant
	deficiencies and material weaknesses in the design or operation of
	internal control over financial reporting which are reasonably
	likely to adversely affect the registrant's ability to record,
	process, summarize and report financial information;
	and
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="PADDING-BOTTOM: 8PX; ; MARGIN-LEFT: 72PX; DISPLAY: TABLE">
<DIV STYLE="DISPLAY: TABLE-ROW">
<DIV STYLE="TEXT-ALIGN: LEFT; DISPLAY: TABLE-CELL; WIDTH: 24PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	(b)
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; DISPLAY: TABLE-CELL">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Any fraud, whether
	or not material, that involves management or other employees who
	have a significant role in the registrant's internal control over
	financial reporting.
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; PADDING-BOTTOM: 8PX; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Date:
	September 19, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; WIDTH: 35%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; MARGIN: 0PX AUTO 0PX 0PX;">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/
	Stephen T. Wills
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen
	T. Wills, Executive Vice President, Chief Financial Officer and
	Chief Operating Officer
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_EXHIBIT_31>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage135"></A>
<A NAME="PTN_EX321_HTM"></A>
<EFX_EXHIBIT_32>
<A NAME="FIS_EXHIBIT_32"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 264PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	EXHIBIT
	32.1
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certification
	of Principal Executive Officer
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Pursuant
	to 18 U.S.C. Section 1350
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As
	Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
	2002
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	I, Carl
	Spana, President and Chief Executive Officer of Palatin
	Technologies, Inc., hereby certify, to my knowledge, that the
	Annual Report on Form 10-K for the year ended June 30, 2016 of
	Palatin Technologies, Inc. (the &#x201C;Form 10-K&#x201D;) fully
	complies with the requirements of Section 13(a) or 15(d) of the
	Securities Exchange Act of 1934 and the information contained in
	the Form 10-K fairly presents, in all material respects, the
	financial condition and results of operations of Palatin
	Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 240PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: -240PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Dated:
	September 19, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; WIDTH: 35%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; MARGIN: 0PX AUTO 0PX 0PX;">
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 100%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/
	Carl Spana
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: BOTTOM; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Carl
	Spana, President and Chief Executive Officer (Principal Executive
	Officer)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CERTIFICATION>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_EXHIBIT_32>

<DIV CLASS="eolNewPage"></DIV>
<A NAME="eolPage136"></A>
<A NAME="PTN_EX322_HTM"></A>
<EFX_EXHIBIT_32>
<A NAME="FIS_EXHIBIT_32_2"></A>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="HDR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: RIGHT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 264PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	EXHIBIT
	32.2
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<EFX_CERTIFICATION>
<A NAME="FIS_CERTIFICATION_2"></A>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Certification
	of Principal Financial Officer
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Pursuant
	to 18 U.S.C. Section 1350
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	As
	Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
	2002
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	I,
	Stephen T. Wills, Executive Vice President, Chief Financial Officer
	and Chief Operating Officer of Palatin Technologies, Inc., hereby
	certify, to my knowledge, that the Annual Report on Form 10-K for
	the year ended June 30, 2016 of Palatin Technologies, Inc. (the
	&#x201C;Form 10-K&#x201D;) fully complies with the requirements of
	Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and
	the information contained in the Form 10-K fairly presents, in all
	material respects, the financial condition and results of
	operations of Palatin Technologies, Inc.
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Dated:
	September 19, 2016
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV STYLE="TEXT-ALIGN: LEFT">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="TEXT-ALIGN: LEFT; WIDTH: 35%; FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX; MARGIN: 0PX AUTO 0PX 0PX;">
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%; BORDER-BOTTOM: 2PX SOLID #000000">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	/s/
	Stephen T. Wills
</FONT>
</DIV>
</TD>
</TR>
<TR>
<TD STYLE="VERTICAL-ALIGN: TOP; WIDTH: 100%">
<DIV STYLE="TEXT-ALIGN: LEFT; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	Stephen
	T. Wills, Executive Vice President, Chief Financial Officer and
	Chief Operating Officer (Principal Financial Officer)
</FONT>
</DIV>
</TD>
</TR>
</TABLE>
</DIV>
</EFX_CERTIFICATION>
<DIV STYLE="TEXT-ALIGN: JUSTIFY; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
<DIV ID="PGBRK" STYLE="WIDTH: 100%; MARGIN-LEFT: 0PX; TEXT-INDENT: 0PX; MARGIN-RIGHT: 0PX">
<DIV ID="FTR">
<DIV STYLE="TEXT-ALIGN: LEFT; WIDTH: 100%; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; TEXT-INDENT: 0PX">
<FONT STYLE="FONT-FAMILY: TIMES NEW ROMAN; FONT-SIZE: 13PX">
	&#xA0;
</FONT>
</DIV>
</DIV>
<DIV ID="PB" STYLE="TEXT-ALIGN: CENTER; MARGIN-LEFT: 0PX; MARGIN-RIGHT: 0PX; MARGIN-BOTTOM: 6PX; WIDTH: 100%; HEIGHT: 1PX; BACKGROUND-COLOR: #000000">
<!--PAGE BREAK-->
</DIV>
</DIV>
</EFX_EXHIBIT_32>

<!-- FOOTER LOGO -->
</BODY>
</HTML>
